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In recent years, several beneficial activities of plants have been attributed to their 
polyphenolic composition [1,2]. On the other hand, Mediterranean region is rich in 
medicinal plants, both in wild or cultivated forms, that because of their medicinal value 
are potential candidates for exploitation by various industries, including the food and 
farmaceutic.  
This first section of the Doctoral Thesis aimed to introduce the subject of the present 
work. For that, a general description of Thymus and Salvia genus together with the target 
plant species is made, followed by an overview of their characteristic phenolic 
constituents. Moreover, the potential health effects of these genera reported in the 
literature up to this moment, are summarized.  
Part of the information presented in this section was published in the chapters “Advances 
in analysis of phenolic compounds of Salvia, Thymus and Lavandula plants” and 
"Beneficial effects of Salvia plants: correlation with bioactive components" which was 
published in "Govil, JN & Manohar Pathak, Recent Progress in Medicinal Plants Series", 
2016, Vol 44: Phytotherapeutics III, Studium Press LLC, USA, Chapter 5. pp 75-108 and 
Chapter 8, pp 161-198, respectively. 
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1.1. General description of the plants 
1.1.2 Salvia genus 
Salvia is the largest genus in the Lamiaceae family plants, with over 900 species [3]. The 
name Salvia has its origin in the Latin word Salvare, that means “healer”, in reference to 
the curative properties of these plant, which has been used since ancient times as a 
medicinal herb [4,5]. The plants of this genus are distributed worldwide, although they 
are particular prevalent in tropical and temperate regions of Europa around the 
Mediterranean area, in South-East Asia and in Central and South America [3,6]. Salvia 
plants are mostly aromatic and perennial shrubs, with flowers of distinct colors (e.g. 
violet, blue, lilac or pale-blue), size and structure, such as their staminal lever, the length 
and form of the corolla tube, and floral nectary morphology. In general, stems are long, 
reaching between 50 to 100 cm, with 3 to 5 branches. These contain opposite, simple, 
ovate and petiolate leaves [7–9].  
Sage have been used for centuries in culinary, in cosmetic, in fragrance industry and in 
traditional medicine [4,5]. The latter application includes their use on a wide range of 
ailments, including digestive, respiratory, renal, hepatic, neurological, cardiac, blood 
circulation and metabolic, among others [10–13]. In these sense, many species of genus 
Salvia have been recognized to have potential uses in medical procedures and 
applications in pharmaceutical and cosmetic industries because their biological 
properties [1,14], mainly focused in its essential oils [15–18]. However, several 
researchers found that polar extracts, rich in phenolic compounds particularly phenolic 
acids and flavonoids, are also related with their biological properties, such as 
antimicrobial, antioxidant, anti-inflammatory, hypoglycaemic and others [2,19,20].  
This research aims to evaluate the phenolic compounds of aqueous extracts of eight 
sage species: Salvia officinalis, the cultivar Salvia officinalis 'Icterina', Salvia elegans, 
Salvia greggii, Salvia farinacea var. victoria blue, Salvia apiana, Salvia africana and 
Salvia mexicana (Figure 1). Additionaly, the antioxidant, anti-inflammatory, antitumoral 
and antibacterial properties of the extracts will be screened, in order to evaluate their 
potency for the development of novel functional foods and/or therapeutic ingredients for 
the synthesis of new generation and alternative chemical drugs with low toxicity [2,21,22] 
S. officinalis, also known as Dalmatian sage, is one of the most studied species. It is 
cultivated in Europe as a culinary herb or as an ornamental plant, where it was possibly 
introduced by Romans in ancient times or monks during the middle-ages by having a 
historical reputation of promoting health and treating ailments [4,23]. This specie has 
several cultivars, including S. officinalis ‘Icterina’ which is a cultivar characterized by 
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its yellow green variegated leaves [24]. In turn, the remaining Salvia species focused in 
the present study remain less-distributed and poorly studied regardless being used in 
culinary and/or traditional medicine. In particular, S. greggii, commonly known as 
‘‘autumn sage’’, is a biennial plant originating in both Mexico and Texas (USA) [25], 
although it is currently spread in southwestern United States and Arizona and cultivated 
in some parts of the world. It grows as a soft, evergreen shrub taller with about 1.2 m, 
and similarly to S. officinalis, its leaves are green and smoothie [26]. Its flowers, which 
appear between spring to autumn, can be of different colors, usually are red but may 
also appear as pink, purple, white or orange, and are characterized by an intense aroma 
and abundant néctar [27].  
Figure 1 – Salvia species. A, B and C: Jardim Botânico da UTAD Retrieved from 
https://jb.utad.pt/jardim;  D and E: HooksgreenHerbs Retrieved from https://www.hooksgreenherbs.com; 
F, G and H: Consulta Plantas Retrieved from http://www.consultaplantas.com. 
Additionally, S. elegans is known as pineapple sage because its leaves smell like 
pineapple and can be used as a flavoring in food. In Mexico, this species is popularly 
known as “mirto” and has been widely used in mexican traditional medicine for treating 
central nervous system disorders, affording to treat headache and high blood pressure 
A) S. officinalis B) S. greggii C) S. mexicana D) S. elegans 
F) S. apiana E) S. officinalis 'Icterina' H) S. africana G) S. farinacea  
var. victoria blue 
23 
Andrea F. Afonso, 2019 | PHENOLIC COMPOSITION AND HEALTH-BENEFITHS OF SALVIA AND THYMUS 
[28,29]. In turn, S. apiana, also recognized as white sage, is a branched shrub growing 
up to 1.5 m, with silvery white leaves highly aromatic, stems hollow, and white to pale 
lavender flowers, attractive to pollinators as honeybees (bee sage) [30,31]. This species 
is native to California, where some tribes consider it to be sacred and medicinal, and in 
addition is used in cosmetic applications and natural food additive [30,32]. Moreover, S. 
farinacea var. victoria blue, known as mealy cup sage, is a perennial shrub typically 
growing 45-90 cm, native to Mexico and Texas [9], whose gray-green leaves are 
drooping, irregularly-serrate, ovate-lanceolate and it contains a compact multi-branched 
rich violet-blue flowers spikes, resembling lavender [9,33,34]. On another hand, S. 
mexicana, also known as "Limelight", is an herbaceous perennial native to a wide area 
of central Mexico, that has large calyces bright lime green, dark leaves and purple-blue 
flowers not more than 4 cm long, visited by pollinators [35,36]. In addition, S. africana 
L., is an aromatic, hardy shrub up to 2 m in height, originating from Africa, whose 
essential oils composition was been studied [18,37,38].  
1.1.1. Thymus genus 
Thymus is a Latin name of plant genus, which is considered to derive from the Greek 
word thyo (perfume) by some authors, while others consider the Greek word thymos 
(courage, strength) [39]. Thymus genus belongs to Lamiaceae family and includes about 
350 aromatic species that are distributed around the world, being particularly abundant 
in the west Mediterranean region [40,41]. These species are perennial and are 
characterized as being herbaceous subshrubs or shrubs with 10 to 30 cm tall, containing 
small and simple leaves, ramified and prostrated branches and big clusters of pink, white, 
cream or violet flowers [40]. 
Thymus species are recognized as being strongly aromatic and thus are widely used as 
spices to enhance sensory attributes, flavouring and improving the preservation of foods 
[42]. Because of these properties, compounds of thyme species have been investigated 
for the development of nutraceuticals and functional foods as health promoting 
ingredients [40,43,44]. The beneficial properties of thyme species include antimicrobial, 
antioxidant, anti-inflammatory, cardioprotective, neuroprotective, anticarcinogenic and 
hypoglycaemic activities, among others [1,45–47]. Although these applications have 
been mostly associated with essential oils [42,48,49], nowadays, Thymus polar extracts 
are an attractive target for the screening of health-benefits compounds for possible 
industrial applications in food, cosmetics or pharmaceutical industries [1,2].  
Amongst Thymus plants, Thymus vulgaris is the most widespread worldwide and also 
the most studied. Other common species include Thymus serpyllum and Thymus 
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capitatus, among others [43,50]. In this context, it is the main aim of this this work to 
evaluate the phenolic composition and the possible biological properties of decoctions 
from six less-spread thyme species, namely Thymus pulegioides, Thymus zygis, Thymus 
caespititius, Thymus herba-barona, Thymus fragrantissimus and Thymus 
pseudolanuginosus (Figure 2).  
Wild populations of T. pulegioides are known to exist in regions as distanct as Canadá 
and New Zealand [39], and in Europe, as well [50]. In Portugal, T. pulegioides takes the 
vulgar name Pojinha, large thyme or broad-leaved thyme, and is mainly found in the 
meadows of north of Portugal, particularly in Trás-os-Montes, where it is highly prized in 













Figure 2 – Thymus species. A, B, C and D: Jardim Botânico da UTAD Retrieved from 
https://jb.utad.pt/jardim; E and F: HooksgreenHerbs Retrieved from https://www.hooksgreenherbs.com. 
On another hand, T. caespititius, is an Ibero-Macaronesian specie, whose geographical 
distribution seems to be very old, occurring in the northwest of the Iberian Peninsula and 
also in Madeira and Azores. T. caespititius differs from other species of Thymus because 
the plants have very long stems and also flat, non-revolute and glabrous leaves [39]. In 
addition, T. herba-barona, also know as caraway thyme, is endemic in Mediterranean 
islands, particullarly in Majorca, Corsica and Sardinia, occurring in mountain areas at 
high altitudes [51]. It is used in folk medicine as a diaphoretic, sedative, antiseptic and 
A)  T. pulegioides C) T. herba-barona B) T. caespititius 
F) T. fragrantissimus E) T. pseudolanuginosus D) T. zygis 
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antimycotic and for the treatment of insomnia and is also utilized in perfumery and 
cosmetics. The bioactivity of this thyme has been extensively reported and associated 
mostly with its composition in essential oils [52,53]. Addictionaly, T. zygis, also known 
as red thyme, is a small aromatic widespread endemic plant in the Mediterranean and is 
commonly used as a spice in several foods, as well as a remedy for whooping cough, 
bronchitis and rheumatism, mainly due to its claimed anti-inflammatory properties 
[42,54]. In turn, T. pseudolanuginosus, commonly called as woolly thyme because of 
its characteristic hairs stems, is a perennial ground plant that is used to cover the soil. 
The leaves have little, if any fragrance, and are unsuitable for culinary use [55]. 
Moreover, T. fragrantissimus is also called oragne thyme because it has grey-green 
and orange scented leaves. Because of its orange aroma, it is widely used as culinary 
ingredient in soups, fish, meat, salads and vegetables cook dishes, albeit it is also 
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1.2. Phenolic compounds in Thymus and Salvia species 
Previous studies on the chemical composition of Thymus and Salvia species have mainly 
dealt with their essential oils [42,48,57]. However in recent years, researchers have 
focused on other secondary metabolites, particularly the phenolic compounds [40,58]. 
These compounds, ubiquitous in plants are an essential part of the human diet, and are 
of considerable interest due to their health properties [2,20,47].  
A detailed overview on the phenolic compounds of Thymus and Salvia genera is 
described in this section. Data is summarized in Tables 1, 2, 3 and 4 and the structure 
of polyphenols is depicted in Figures 4, 5, 6, 7, 8 and 9. 
“Phenolic compounds” is a generic term that refers to a large number of compounds: 
approximately 8000 different phenolics dispersed throughout the plant kingdom. 
Chemically, they are organic compounds formed by at least one phenol ring, in which 
the hydrogen is usually replaced by a more active residue, such as hydroxyl, methyl or 
acetyl. They occur in different  chemical structures, from simple phenolic molecules to 
complex high-molecular weight polymers, synthesized in plants through the pentose 
phosphate, shikimate and phenylpropanoid pathways [59–61]. The variable biological 
properties of the phenolics result from these structural diversity, and usually they contain 
more than one phenolic ring, and thus are often referred to as polyphenols [59,62].  
Polyphenols can be divided into different groups according to their number of phenol 
rings tand on the basis of structural elements that bind these rings, and they are 
commonly found conjugated to sugars and organic acids. The most common 
classification of phenolic metabolites distinguishes the flavonoid and non-flavonoid 
compounds [59,60,62–64]. The chemical structure of non-flavonoid metabolites consists 
of the following subgroups: phenolic acids (hydroxycinnamic acids and hydroxybenzoic 
acids), lignans, stilbenes, tannins and lignins. On the other hand, flavonoid compounds 
group are divided into six main subclasses: flavonols, flavones, flavanones, flavan-3-ols, 
isoflavones and anthocyanidins [59,62–64]. The classification of phenolic compounds is 
presented in Figure 3. 
1.2.1. Non-flavonoid compounds 
Phenolic acids comprise important compounds that belong to non-flavonoid group, and 
are frequently divided in two subgroups, the hydroxycinnamic and hydroxybenzoic acids 
(Figure 3). Hydroxycinnamic acids are aromatic compounds with a three-carbon side 
chain (C6–C3) (Figure 4A), and include caffeic acid, chlorogenic acid, o-, m- and p-
coumaric acid, ferulic acid and sinapic acid. 
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Figure 3 - The general classification of phenolic compounds 
As products of the phenylpropanoid pathway, hydroxycinnamic acids have a basic 
structure of trans-phenyl-3-propenoic acid, with one or more hydroxyl groups attached 
to the phenyl moiety (Figure 4A). Instead, hydroxybenzoic acids are phenolic acids 
composed of simple phenols, also known as hydroxybenzoates, and include gallic, p-
hydroxybenzoic, protocatechuic, vanillic and syringic acids, which in common have the 
general C6–C1 structure (Figure 4B). The plant hydroxybenzoic acids occur mostly in 
the glycoside form [59,62,63]. Lamiaceae plants and, in particular, Salvia and Thymus 
genera, are mostly enriched in hydroxycinnamic acids, although others also occur 
[40,65]. The occurrence of non-flavonoid phenolics in the two plants genus is 
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1.2.1.1. Hydroxycinnamic acid 
Amongst hydroxycinnamic acids, rosmarinic acid (1), an ester of caffeic acid and 3,4-
dihydroxyphenylacetic acid, is a major phenolic component in Salvia and Thymus plants 
(Table 1). The content of this caffeic acid ester in S. officinalis is quite variable (1.2 to 22 
mg/g dry plant) [66–69]. Additionaly, this acid was described as a major phenolic 
constituent in methanolic extracts of Salvia tomentosa (10.2 mg/g dry plant) [70], Salvia 
cadmica (6.5 mg/g dry plant) [71], Salvia fruticosa (4.5 mg/g dry plant) [72], Salvia 
verbenaca, Salvia argentea and Salvia aegyptiaca (12.8, 4.8 and 6.0 mg/g dry plant, 
respectively) [66]. Likewise, it represents the most frequent detected compound in other 
Salvia plants, including Salvia nemorosa [73], Salvia sclarea L. [74], Salvia fruticosa, 
Salvia pomifera [75], Salvia halophila [76] and others [77]. 
Rosmarinic acid was also found in methanolic and aqueous extracts of T. vulgaris, 
presenting values in the range of 0.7 - 21.9 mg/g dry plant [68,78,79]. In addition, T. 
serpyllum (wild thyme) presented high amounts of this caffeic acid, ranging from 21.7 
[80] to 57.7 mg/g dry plant [79]. In the recent years, others thyme species have been 
studied for phenolic characterization, presenting variable rosmarinic acid content: 1.7 to 
43 mg/g dry plant in different populations of Thymus mastichina [81], 15.2 mg/g dry plant 
in methanolic extracts of Thymus praecox subsp. grossheimii var. grossheimii [82], 20.6 
mg/g dry plant of methanolic extract of Thymus nummularius [83], 3.3 and 0.7 mg/g dry 
plant in methanolic and aqueous extracts of T. capitatus, respectively [84]. Additionaly, 
rosmarinic acid was found in high amounts in the methanolic extracts of Thymus 
glabrescens, T. pulegioides and Thymus pannonicus with concentratiosn between 0.8 
and 1.4 mg/g dry plant [85].  
Salvia and Thymus plants also contain distinct rosmarinic acid derivatives. In 
particular, extracts of Salvia miltiorrhiza and T. serpyllum were reported to contain 
rosmarinic acid glucoside (2) [80,86],  while (caffeoyl)rosmarinic acid (3) was 
described to occur in T. vulgaris [87] and in Thymus x citriodorus [88]. In turn, rosmarinic 
acid methylester (4) was detected in distinct Salvia species [89,90] and in T. vulgaris 
[78]. 
More complex derivatives of rosmarinic acid like lithospermic acid (5), methyl and 
ethyl derivatives of lithospermic acid (6-8) [86,91,92], prolithospermic (9), sagerinic 
acid (10), salvinal (11), magnesium lithospermate B (12) and ammonium-potassium 
lithospermate B (13) are frequently found in Salvia genus [89], while they are rare in 
Thymus. Amongst those compounds, lithospermic acid is the most widely distributed 
one, as it was described to occur in Salvia species, mainly in S. miltiorrhiza [86,93] and 
in T. serpyllum [78] as well. In turn, the remaining compounds were mainly detected in 
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S. miltiorrhiza, which is the most studied Salvia species because of its vast usage in 
Chinese traditional medicine [86]. 
Notably, Salvia plants also typically contain other caffeic acid oligomers, which are 
overall named as salvianolic acids. Their name arises from the fact that they were 
isolated for the first time in Salvia genus. Chemically, these compounds are depsides 
(esters formed from two or more phenolic acids), in this particular case of 3, 4-
dihydroxyphenyl-lactic acid and a caffeic acid derivative or a caffeic acid dimer, forming 
several types of carbon skeletons [94]. Among others, salvianolic acids K, D, B and I 
(14-29) have been largely described in S. miltiorrhiza [86,91–93,95–97]. Salvianolic 
acids were also found in other Salvia plants, including salvianolic acid K (14), that is 
known to occur in S. officinalis, S. fruticosa and S. pomifera, with concentrations of 21.3, 
15.3 and 6.7 mg/g dry plant, respectively [75], and salvianolic acid E (23), was reported 
to occur in Salvia veneris [98] and in Salvia reuterana [99] . 
Caffeic acid (30) i.e., the monomeric unit of rosmarinic acid and of its derivatives, was 
detected as a minor phenolic component in a high number of Salvia plants and in some 
Thymus species (Table 1). Reported levels of this hydroxycinnamic acid in Salvia and 
Thymus species are in the range of 0.1-2.96 and 0.1-5.17 mg/g of dry plant, respectively 
[66,67,73,80,85,100]. Simple caffeic acid derivatives also appear as minor phenolic 
constituents in the two plant genera herein in focus. Caffeic acid hexoside (31) was 
described to occur in S. officinalis [58] and in T. vulgaris [58,101], while caffeic acid 
ethyl ester (32) was identified in T. serpyllum [102]. Moreover, chlorogenic acid (3-O-
caffeoylquinic acid) (33) was reported to occur in the methanolic extracts of different 
Salvia species: 0.06 and 0.09 mg/g dry plant in S. argentea [66] and in S. cadmica [71], 
respectively. Additionaly, chlorogenic acid was described to occur in several Thymus 
species, presenting contents in the range 0.02 and 7.88 mg/g of dry plant [80,81,83–85]. 
Other caffeic acid metabolites, known as yunnaneic acids (34-41) A, B, C, D, E, F, G 
and H, were identified in roots of Salvia yunannesis [103,104].   
Besides caffeic acid and/or caffeic acid derivatives, several other hydroxycinnamic acids 
can often be found in the two plant genera. E.g. ferulic acid (42) was detected in the 
methanolic extracts of different Salvia species, with contents of 0.04-0.7 mg/g dry plant 
[66,71]. These coumpounds were described to occur in several Thymus species, whose 
amounts ranged from 0.03 to 4.6 mg/g of dry plant [80,84,105].  Moreover, isoferulic 
acid (43) is know to occur in  S. miltiorrhiza [86] and S. reuterana [99].
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Table 1 – Non-flavonoid phenolic compounds of Salvia and Thymus genera 
Compound Salvia species Thymus species 
Hydroxycinnamic acids   
Rosmarinic acid (1) S. amplexicaulis [77,106], 
S. euphratica var. euphratica, S. euphratica var. leiocalycina [107], 
S. cadmica [71,77], S. fruticosa [1,72,108,109], S. halophila [76], 
S. kronenburgii [110], S. miltiorrhiza [86,92,93,97], S. nemorosa [73], 
S. officinalis [58,66–68,95,109,111–113], S. pomifera [109], S. ringens 
[114] 
S. sclarea [74], S. splendens [115], S. syriaca [116], S. tomentosa [70] 
S. trichoclada, S. verticillata [1,110], S. veneris [98] 
S. aegyptiaca, S. argentea, S. verbenaca [66],  
S. aytachii, S. cassia, S. cerino-pruinosa, S. ekimiana, S. eriophora, S. 
freyniana, S. marashica, S. nutans, S. pilifera, S. potentillifolia, S. sericeo-
tomentosa var. sericeo-tomentosa, S. sericeo-tomentosa var. hatayica, S. 
suffruticosa x bracteata, S. tchiatcheffii [77], 
S. azurea, S. forskaohlei, S. jurisicii, S. nemorosa, S. triloba [117],  
S. bowleyana, S. cavaleriei, S. chinensis, S. flava, S. lavandulifolia, S. 
prionitis, S. sonchifolia, S. yunnanensis [118] 
T. capitatus [84], T. x citriodorus [88], T. lotocephalus [119], 
T. mastichina [81,120],T. nummularius [83],  
T. serpyllum [78–80,85,102], T. praecox  ssp. grossheimii [82], 
T. pulegioides [85,121], T. quinquecostatus var. japonica [122],  
T. sipthorpii [1], T. sipyleus [123] 
T. glabrescens, T. pannonicus, T. praecox, T. pulegioides [85] 
T. vulgaris [58,68,78,79,87,111–113,124,125] 
 
Rosmarinic acid glucoside (2) S. miltiorrhiza [86] T. serpyllum [80], T. vulgaris [101] 
(caffeoyl)rosmarinic acid (3)  T. x citriodorus [88], T. vulgaris [87] 
Rosmarinic acid methylester (4) S. bowleyana, S. prionitis, S. sonchifolia [118], S. miltiorrhiza [86] 
S. plebeia  [90], S. splendens [126] 
T. vulgaris [78]  
Lithospermic acid (5) S. miltiorrhiza [86,91–93], S. reuterana [99], S. sonchifolia [118] T. serpyllum [78] 
Lithospermic acid monomethyl ester (6) S. miltiorrhiza [86]  
Lithospermic acid dimethyl ester (7) S. miltiorrhiza [86]  
Ethyl lithospermate (8) S. miltiorrhiza [86,91]  
Prolithospermic acid (9) S. miltiorrhiza [89,91]  
Sagerinic acid (10) S. officinalis [95]  
Salvinal (11) S. miltiorrhiza [86]  
Magnesium lithospermate B (12) S. miltiorrhiza [86]  
Ammonium-potassium lithospermate B (13) S. miltiorrhiza [86]  
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Salvianolic acid K (14) S. fruticosa, S. officinalis [95,101,109], S. pomifera [109] T. vulgaris [101] 
Salvianolic acid D (15) S. miltiorrhiza [92], S. reuterana [99]   
Salvianolic acid B (16) S. miltiorrhiza [86,92,93,96], S. reuterana [99]   
Ethyl lithospermate B (17) S. miltiorrhiza [86,91]  
Dimethyl lithospermate B (18)  S. miltiorrhiza [91]  
Salvianolic acid I (19) S. fruticosa, S. officinalis [95,118], S. pomífera [109] T. vulgaris [101] 
Salvianolic acid A (20) S. miltiorrhiza [86,92,93], S. reuterana [99]   
Salvianolic acid C (21) S. miltiorrhiza [86,91,92]  
Isosalvianolic acid C (22) S. miltiorrhiza  [86]   
Salvianolic acid E (23) S. miltiorrhiza [86,91,92], S. reuterana [99], S. veneris [98]  
Salvianolic acid H (24) S. officinalis, S. fruticosa, S. pomífera [109]  
 
Salvianolic acid J (25) S. miltiorrhiza [86,92]   
Salvianolic acid L (26) S. miltiorrhiza [92]  
Norsalvianolic acid L (27) S. miltiorrhiza [127]   
Salvianolic acid F (28) S. miltiorrhiza [92,97,118], S. officinalis, S. fruticosa, S. pomífera [109]  
Salvianolic acid G (29) S. miltiorrhiza [86,92,118]  
Caffeic acid (30) S. amplexicaulis [106], S. cadmica [71,77], S. bicolor [128],  
S. euphratica var. euphratica, S. euphratica var. leiocalycina [107], 
S. fruticosa [1,72,108,109], S. halophila [76], S. hispanica [129],  
S. miltiorrhiza [86,92,93,97], S. nemorosa [73],  
S. officinalis  [58,66–68,95,109,111–113,130,131], S. pomifera [109] 
S. plebeia [132], S. reuterana [99], S. ringens [114], S. sclarea [74],  
S. splendens [115], S. syriaca [116],S. tomentosa [70], S. veneris [98], 
S. virgata [133], S. aegyptiaca, S. argentea, S. verbenaca [66], 
S. amplexicaulis, S. cadmica, S. cerino-pruinosa, S. nutans, S. pilifera, S. 
tchiatcheffii [77],  
S. azurea, S. forskaohlei, S. jurisicii, S. nemorosa, S. triloba [117], 
S. kronenburgii, S. trichoclada, S. vertisillata subsp. vertisillata [110], 
S. albimaculata, S. bowleyana, S. calycina, S. chinensis, S. horminum, S. 
limbata, S. plebeia, S. sonchifolia [118] 
T. lotocephalus [119], T. quinquecostatus [122] 
T. serpyllum [78,80,85], T. sipthorpii [1],  





Caffeic acid hexoside (31) S. officinalis [58], S. veneris  [98]  T. vulgaris  [58,101] 
Caffeic acid ethyl ester  (32)  T. serpyllum [102]  
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Chlorogenic acid (33) S. argentea [66],S. bicolor [128], S. cadmica [71], S. euphratica var. 
euphratica [107], S. fruticosa [72,108], S. nemorosa [73], 
S. officinalis [58,131,135], S. pilifera [77], S. tomentosa [70],  
S. sclareoides [136], S. syriaca [116], 
S. amplexicaulis, S. aytachii, S. ekimiana, S. freyniana, S. marashica, S. 
nutans, S. potentillifolia, S. sericeo-tomentosa var. sericeo-tomentosa, S. 
sericeo-tomentosa var. hatayica, S. suffruticosa x bracteata, S. 
tchiatcheffii [77], S. azurea, S. forskaohlei, S. jurisicii, S. nemorosa, S. 
triloba [117] , S. horminum, S. triloba [118],  
S. kronenburgii, S. trichoclada, S. vertisillata subsp. vertisillata [110]  
T. capitatus [84], T. mastichina [81], T. nummularius [83], 
T. serpyllum [80,102], T. vulgaris [58] 
 
Yunnaneic acids A (34), B (35), C (36), D 
(37), E (38), F (39), G (40), H (41) 
S. yunannesis [103,104,137,138]  
Ferulic acid (42) S. bicolor [139], S. cadmica [71], S. euphratica var. euphratica, S. 
euphratica var. leiocalycina [107], S. fruticosa [72,108] 
S. miltiorrhiza [92,97], S. nemorosa [73], S. officinalis [66,100,135,140] 
S. reuterana [99], S. tomentosa [70], 
S. sclareoides [136], S. syriaca [116], 
S. aegyptiaca, S. argentea, S. verbenaca [66], 
S. amplexicaulis, S. aytachii, S. cadmica, S. cassia, S. cerino-pruinosa, 
S. ekimiana, S. eriophora, S. freyniana, S. marashica, S. nutans, S. 
pilifera, S. potentillifolia, S. sericeo-tomentosa var. hatayica, S. 
suffruticosa x bracteata, S. tchiatcheffii [77] 
 
T. capitatus [84], T. hirtus [105],  
T. serpyllum [80,85], T. sipthorpii [1], T. vulgaris [58,130] 




 Isoferulic acid (43) S. miltiorrhiza [86], S. reuterana [99]  
p-coumaric acid (44) S. bicolor [139], S. cadmica [71], S. euphratica var. euphratica, S. 
euphratica var. leiocalycina [107], S. fruticosa [72], S. nemorosa [73] 
S. officinalis [100,134,135], S. reuterana [99], S. sclareoides [136],  
S. sericeo-tomentosa var. sericeo-tomentosa [70], S. syriaca [116], 
S. verbenaca [66], 
S. amplexicaulis,  S. aytachii, S. cassia, S. cerino-pruinosa, S. ekimiana, 
S. eriophora, S. marashica, S. nutans, S. potentillifolia, S. suffruticosa x 
bracteata, S. tchiatcheffii [77] 
T. capitatus [84], T. hirtus [105], T. serpyllum [80,85], T. sipthorpii [1], 
T. vulgaris [58,130],  
T. glabrescens, T. pannonicus, T. pulegioides, T. praecox [85] 
 
 
 o-coumaric acid (45) S. bicolor [128], S. cadmica [71,77], S. euphratica var. euphratica, S. 
euphratica var. leiocalycina [107], S. halophila [76],  
S. nemorosa [73,117], S. syriaca [116],S. virgata [133], 
S. aytachii, S. cerino-pruinosa, S. ekimiana, S. freyniana, S. marashica, 
S. sericeo-tomentosa var. sericeo-tomentosa, S. sericeo-tomentosa var. 
hatayica [77], S. officinalis, S. triloba [117] 
 
 
Sinapic acid (46) S. bicolor [128], S. cadmica [71], S. nemorosa [73], S. syriaca [116]  
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Hydroxybenzoic acids   
Gallic acid (47) S. argentea [66], S. bicolor [128], S. cadmica [71],  
S. euphratica var. euphratica, S. euphratica var. leiocalycina [107],  
S. fruticosa [72], S. halophila [76], S. officinalis [58,66,117,135]  
S. ringens [114], S. sclareoides [136] 
S. sericeo-tomentosa var. sericeo-tomentosa [70] 
T. capitatus [84], T. hirtus [105], T. nummularius [83] 
T. serpyllum [80], T.sipthorpii [1], T. vulgaris [58,68,141] 
 
 
Gentisic acid (48) S. bicolor [128], S. officinalis [134], S. sclareoides [136] T. vulgaris [134] 
Syringic acid (49) S. bicolor [139], S. cadmica [71], S. nemorosa [73],  
S. officinalis [23,58,134], S. sclareoides [136], S. syriaca, [116] 
S. amplexicaulis, S. cadmica, S. cassia, S. cerino-pruinosa, S. eriophora, 
S. freyniana, S. marashica, S. nutans, S. potentillifolia, S. sericeo-
tomentosa var. sericeo-tomentosa, S. sericeo-tomentosa var. hatayica , 
S. tchiatcheffii [77] 
T. capitatus [84], T. hirtus [105], T. serpyllum [102], T. sipthorpii [1] 




Protocatechuic acid (50) S. cadmica [71], S. euphratica var. euphratica [107], 
S. miltiorrhiza  [86,91,92,127], S. nemorosa [73],  
S. officinalis [58,117,131], S. syriaca, [116] 
S. amplexicaulis, S. aytachii , S. bicolor, S. ekimiana, S. freyniana, S. 
potentillifolia [77], S. azurea, S. forskaohlei [117] 
T. capitatus [84], T. nummularius [83], T. quinquecostatus [122] 





Protocatechuic ethyl ester (51) S. hispanica [142]  
Protocatechuic aldehyde (52) S. miltiorrhiza [86,91–93,127]  
p- hydroxybenzoic acid (53) S. bicolor [139], S. fruticosa [108], S. halophila [76], S. nemorosa [73] 
S. miltiorrhiza [127], S. officinalis  [58], S. syriaca, [116], S. virgata [133]  
S. argéntea, S. verbenaca [66], S. amplexicaulis, S. ekimiana, S. aytachii, 
S. cadmica, S. cassia, S. nutans, S. pilifera, S. potentillifolia [77] 
 
T. capitatus [84], T. serpyllum [102], T. vulgaris  [58] 
 
Vanillic acid (54) S. fruticosa [72,108], S. officinalis [58,112,135], S. sclareoides [136], 
S. sericeo-tomentosa var. sericeo-tomentosa [70], S. verbenaca [66],  
S. aytachii, S. cadmica, S. cassia, S. ekimiana, S. eriophora, S. 
freyniana, S. marashica, S. pilifera, S. potentillifolia, S. sericeo-tomentosa 
var. sericeo-tomentosa, S. sericeo-tomentosa var. hatayica, S. 
suffruticosa x bracteata, S. tchiatcheffii [77] 
T. capitatus [84], T. serpyllum [102], T. vulgaris [58] 
 
Hydroxyphenylpropanoic acids  
Danshensu (55) S. miltiorrhiza [86,91,92,97,118,127], S. officinalis [131],  
S. chinensis, S. prionitis, S. sonchifolia [118]  
 
Danshensu methyl ester (56) S. miltiorrhiza [127]  
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Another hydroxycinnamic acid, p-coumaric acid (44), was described to be present in 
different Salvia plants, with contents varying between 0.02-0.14 mg/g dry plant [66,71]. 
This compound was also found in different Thymus plants, namely T. capitatus 
(concentration of 0.1 mg/g dry plant) [84]. In addition, its structural isomer (o-coumaric 
acid (45)) was largely described in Salvia plants [71,73,116,128]. Moreover, sinapic 
acid (46) was reported in different Salvia species [71,73,116] and curiously, its amounts 
in Salvia bicolor (1.53 mg/g dry plant) reached 8% of the total quantified phenolics [128]. 
1.2.1.2. Hydroxybenzoic acids 
Hydroxybenzoic acids commonly appear as minor phenolic components in Salvia and 
Thymus plants (Table 1). In more detail, gallic acid (47) was found in many species, 
with contents in S. officinalis and S. argentea reported to amount for 0.03 and 0.02 mg/g 
of dry plant, respectively [66], while S. bicolor presented 4.1 mg/g of dry plant [128]. 
Furthermore, its content in Thymus hirtus sp. algeriensis and wild thyme (T. serpyllum) 
accounted for 2.8 and 0.6 mg/g of dry plant, respectively [80,105]. In addition, gentisic 
acid (48) was detected in S. bicolor [128] and in T. vulgaris [143], while syringic acid 
(49) was found in several Salvia [71,73,116] and Thymus [84,102,105] species. Other 
hydroxybenzoic acids in sage and thyme plants include protocatechuic acid (50) 
[71,73,80,83,84,116,131]. Additionaly, derivatives of this compound, particularly 
protocatechuic ethyl ester (51) was reported in Salvia hispanica [142], and 
protocatechuic aldehyde (52), was described to be a phenolic constituent of Thymus 
quinquecostatus var. japonica [122], S. miltiorrhiza [86,92,93] and S. officinalis [67]. 
Likewise, p-hydroxybenzoic acid (53) and vanillic acid (54) were exhaustively 
reported in different species of Salvia plants [73,108,116] (see Table 1). Moreover, 
vanillic acid was described to occur in several Thymus species, with amounts estimated 
between 0.06 and 1.2 mg/g dry plant [84,102,105]. 
1.2.1.3. Others 
Notably, other non-flavonoid phenolic constituents were previously detected in Salvia 
plants. E.g. danshensu (55), a hydroxyphenylpropanoic acid, is known to occur in high 
amounts in S. officinalis and in S. miltiorrhiza [67,86,92,93,97,131,137], although it was 
also identified in other species, like S. veneris [98]. In addition, a methyl derivative of this 
compound (56) was detected in S. miltiorrhiza [127].  
35 
































































1 R1= R2= H 
2 R1= Glc R2= H 
















5 R1 = R2= H 
6 R1= H R2= CH3 
7 R1= R2= CH3 


































12 R= Mg2+  
13 R= NH4






















































































16 R1= H R2= H 
17 R1= H R2= C2H5 
































20 R= X 







































































Fig. 5: (Contd...) 
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30 R1= R2= H 
31 R1= Hex R2= H 









































34 R= H 






















































Caff- Caffeoyl unit; Glc- Glucosyl unit; Hex- Hexosyl unit 
 
Figure 5 – Chemical structures non-flavonoid phenolics reported in Thymus and Salvia plants. 
47 R1= R2= R3= OH R4= R5= H 
48 R1= R4= OH R2= R3= R5= H 
49 R1= R3= OCH3 R2= OH R4= R5= H 
50 R1= R4= R5= H R2= R3= OH  
51 R1= R4= H R2= R3= OH R5= CH2CH3 
53 R1= R3= R4= R5= H R2= OH 







42 R1= OH R2= OCH3 R3= R4= H 
43 R1= OCH3 R2= OH R3= R4= H 
44 R1= OH R2= R3= R4= H 
45 R1= R2= R4= H R3= OH 














R 55 R= H 
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1.2.2. Flavonoids 
Flavonoids are characterized by a C15 structure (C6-C3-C6) with a heterocyclic 
benzopyran ring (C ring), an aromatic ring (A ring) and a phenyl constituent as the B ring 
(Figure 6A), all of them with several structural variations. They are divided into six main 
subclasses: flavonols, flavones, flavanones, flavan-3-ols, isoflavones and 
anthocyanidins, according to their oxidation state, the connection of an aromatic ring and 
the functional groups of the C ring. In the physiological state, flavonoids occur usually in 
association with sugar as glycosides [59,60,62–64,144].  
In the particular case of Salvia and Thymus plants, special emphasis must be devoted 
to flavones, flavonols and flavanones. Their occurrence in the two plant genera are 
resumed in Tables 2, 3 and 4 and the corresponding structures are depicted in Figures 
7, 8 and 9, respectively.  
The sub-classe of flavones are characterized by the presence of a double bond between 
2 and 3 position, containing several A- and B-rings substitutions and lacking oxygenation 
at the 3-position of the C-ring (Figures 6B), while flavonols and flavanones are 
respectively characterized by a 3-hydroxyflavone backbone and absence of the double 
bond between the 2- and 3-positions and the presence of a chiral center at the 2-position 










Figure 6 –General structure of flavonoids (A); flavones (B); flavonols (C); flavanones (D) 
1.2.2.1. Flavones 
Amongst flavones, sage and thyme plants mainly contain mono-glycosidic derivatives of 
luteolin and apigenin (Table 2 and Figure 7). Luteolin-O-glucosides (with prevalence of 
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and Thymus species. In fact, these were previously detected in S. officinalis 
[66,131,145,146] as well as in other Salvia species, including S. sclarea, S. argentea, S. 
aegyptica and S. fruticosa, with amounts of 0.08 – 0.9 mg/g of dry plant [66,74,108]. 
Luteolin-7-O-glucoside was also reported in Thymus, namely in a hydromethanolic 
extract of T. serpyllum (accounting for 51.8 mg/g dry plant)  [80], as well in other distinct 
Thymus species [88,124,141,147]. Luteolin-O-glucosides derivatives detected in 
Thymus plants also include luteolin-7-O-(6”-feruloyl)-ß-glucopyranoside (58),  which 
was found in Thymus sipyleus [123] and Thymus schimperi [147].  
Other sugars such as glucuronic acid and rutinose are also frequently linked to the 
flavone skeleton on Salvia and Thymus plants. The 7-O-glucuronide derivative of 
luteolin (59) was previously detected in S. officinalis [101,131,148,149] and in T. 
serpyllum (9 and 14 mg/g of dry plant) [78,80], among other Thymus species 
[78,88,123,147]. In turn, luteolin-3’-O-glucuronide (60) together with luteolin-O-
diglucuronide (61) were found in S. officinalis [131,145,149], with the latter also 
occurring in S. fruticosa, S. pomifera [75] and in T. serpyllum [80]. O-rutinoside 
derivatives of luteolin (or in particular 7-O-rutinoside (62)) were detected in sage plants 
such as S. officinalis, S. fruticosa and S. pomifera [67,75], as well as in Thymus plants 
[58,78], namely in T. vulgaris and T. serpyllum, where it was reported to account for 1.4 
mg/g of dry plant [78].  Less frequent luteolin derivatives on the two plant genera 
comprise 6-hydroxyluteolin-7-O-glucoside (63) and 6-hydroxyluteolin-7-O-
glucuronide (64), which occur in S. officinalis [75,149] and the luteolin-3’-methylether 
(65), which was previously reported in Salvia palaestina [150].  
In turn, luteolin (66) (i.e. the aglycone form of the above compounds) is widely reported 
in Salvia and Thymus (Table 2). This was found as a major phenolic compound in T. 
serpyllum (48.04 mg/g dry plant) [80,102], although in the majority of cases, it represents 
a minor phenolic component. Concentrations in different populations of T. mastichina 
were reported in the range of 0-0.7 mg/g dry plant [81], while levels in other Thymus 
species varied between 0.36 and 0.55  mg/g of dry plant [69,78,84,134]. Moreover, levels 
of 0.26 to 0.50 mg/g dry plant were previously described for S. officinalis and S. cadmica, 
respectively [71,100].  
In addition to luteolin and/or luteolin derivatives, considerable amounts of apigenin and/or 
apigenin glycosides are frequently reported in sage and thyme plants. As shown in Table 
2, apigenin (67) contents in Salvia and Thymus species were found to vary in the ranges 
0.006 - 0.22 mg/g and 0.04 – 0.12 mg/g dry plant, respectively [66,71,100].  
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Apigenin-7-O-glucoside (68) is the most typical O-glycosidic form of apigenin found in 
the two plant genera. This has been reported in several Salvia species, namely S. 
officinalis, S. sclarea and S. fruticosa [74,75,108,131], with a content of 1.1 mg/g plant 
reported for S. aegyptaca [66]. This flavone was also described to be a phenolic 
constituent of several Thymus species [58,79,85,113,124], with a content of 0.028 mg/g 
dry plant from T. glabrescens [85]. 
Others glycosidic derivatives of apigenin previously described to be present in Salvia 
and/or Thymus species comprise apigenin-7-O-glucuronide (69), which was detected 
in T. vulgaris, T. serpyllum, T. x citriodorus and S. officinalis [67,80,88,101], and 
apigenin-7-O-rutinoside (70), known to occur in Salvia plants [58,75]. Albeit less 
frequent, the 6,8-di-C-glucoside derivative of apigenin (71) was already reported in S. 
officinalis [95,149]. 
Other flavones besides the luteolin and apigenin derivatives can exist in Salvia and 
Thymus plants, though with much less frequency. E.g. genkwanin aglycone (72) was 
detected in S. officinalis [66] and in different thyme species [151], while hispidulin-O-
glucuronide (73) was found in sage species [75,101]. In turn, scutellarein (74) was 
described in S. officinalis [112], and hispidulin (75) was identified in Salvia plebeia, S. 
officinalis and in T. vulgaris [112,132]. Other rare aglycones derived from methylated 
flavones might also occur in thyme and sage plants, namely thymusin (76) and 
thymonin (77), which was described in several Thymus species [151], together with 
salvigenin (78), known to occur in S. apiana [152] and in Salvia chloroleuca [153], while 
cirsimaritin (79), was also detected in S. apiana [152], in T. serpyllum [102] and in other 









Fer- Feruloyl unit;Glc- Glucosyl unit; GlcU- Glucuronyl unit; Rut- Rutinosyl unit 












57 R1= R3= R5 = R6= H R2 = Glc R4 = OH  
58 R1= R3= R5 = R6= H R2= GlcFer R4= OH 
59 R1= R3= R5 = R6= H R2 = GlcU R4= OH  
60 R1= R2 = R3= R5 = R6= H R4= OGlcU 
61 R1= R3= R5 = R6= H R2= GlcU R4= OGlcU 
62 R1= R3= R5 = R6= H R2 = Rut R4= OH  
63 R1= OH R3= R5 = R6= H R2 = Glc R4 = OH  
64 R1= OH R3= R5 = R6= H R2 = GlcU R4 = OH  
65 R1= R2= R3= R5= R6= H R4= OCH3 
66 R1= R2= R3= R5= R6= H R4= OH 
Apigenin derivatives 
 
67 R1= R2= R3= R4= R5= R6= H  
68 R2= Glc R1= R3= R4= R5= R6= H 
69 R2= GlcU R1= R3= R4= R5= R6 = H 
70 R2= Rut R1= R3= R4= R5= R6= H  
71 R1= R3= Glc R2= R4= R5= R6= H 
Other flavones  
72 R2= CH3 R1= R3= R4= R5= R6= H  
73 R1= OCH3 R2= GlcU R3= R4= R5= R6= H 
74 R1=OH R2=R3=R4=R5=R6=H 
75 R1= OCH3 R2= H R3= R4= R5= R6= H 
76 R1= OH R2= CH3 R3= OCH3 R4= R5 = R6= H 
77 R1= OH R2= CH3 R3= R4= OCH3 R5 = R6= H 
78 R1= OCH3 R2= R5 = CH3 R3= R4= R6= H 
79 R1= OCH3 R2= CH3 R3 = R4= R5= R6= H 
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Table 2 – Flavones of Salvia and Thymus genera 
Compound Salvia species Thymus species 
Luteolin-O-glucoside (57) S. aegyptiaca, S. argentea [66] 
S. fruticosa [108,109], 
S. officinalis [66,67,109,113,131,141] 
S. plebeia [132], S. sclarea [74],  
S. veneris [98] 
T. x citriodorus [88], T. serpyllum [79,80], 
T. schimperi [147], T. sipyleus [123],  




 T. schimperi [147], T. sipyleus [123] 
Luteolin-7-O-glucuronide (59) S. fruticosa [109], S. officinalis [67,109,131] 
S. pomifera  [109], S. palaestina [150] 
S. veneris [98] 
T. x citriodorus [154], T. schimperi [147]  
T. serpyllum [78,80], T. sipyleus [123], 
T. vulgaris [78,112] 
 
Luteolin-3’-O-glucuronide (60) S. officinalis [95,149]  
Luteolin-O-diglucuronide (61) S. officinalis [109,131], 
S. fruticosa, S. pomifera [109] 
 
T. serpyllum [80] 
 
Luteolin-O-rutinoside (62) S. officinalis [67,109,112], 
S. fruticosa, S. pomifera [109]  




S. officinalis [109,149], 





S. officinalis [109,149], 
S. fruticosa, S. pomifera [109] 
 
Luteolin-3’-methylether (65) S. palaestina [150]  
Luteolin (66) S. aegyptiaca [66],S. amplexicaulis[106], 
S. argentea [66], S. cadmica [71],  
S. chloroleuca [153], S. fruticosa [72,108,109], 
S. nemorosa [73] 
S. officinalis [66,67,100,109,112], 
S. plebeia [90,132], S. ringens [114], 
S. sclarea [74], S. syriaca [116], 
S. tomentosa [70], S. verbenaca [66] 
T. capitatus [84], T. lotocephalus [119] 
T. mastichina [81,120],  
T. nummularius [83] 
T. schimperi [147],  
T. serpyllum [78,80,102] 
T. vulgaris [78,112,134] 
 
Apigenin (67) S. argentea, S. aegyptiaca [66], 
S. amplexicaulis [106], S. cadmica [71], 
S. fruticosa [72,108,109], S. nemorosa[73],  
S. officinalis [66,67,100,109,112,113], 
S. pomifera [109], S. ringens [114], 
S. sclarea [74], S. syriaca [116], 
S. tomentosa [70], S. verbenaca [66] 
T. lotocephalus [119], T. mastichina [120], 
T. nummularius [83], T. serpyllum, T. 
glabrescens, T. pannonicus,T. praecox, T. 
pulegioides [85], T. vulgaris [78,100,113] 
 
Apigenin-7-O-glucoside (68) S. argentea, S. aegyptiaca [66], 
S. fruticosa [108,109], 
S. officinalis [66,109,113,131], 
S. pomifera [109], S. sclarea [74] 
 
T. x citriodorus [154] 
T. glabrescens,T. pannonicus, T. praecox, 
T. pulegioides [85], T. serpyllum [79,85] 
T. vulgaris [58,79,113,124,141] 
Apigenin-7-O-glucuronide (69) S. officinalis [67,109,131], 
S. fruticosa, S. pomifera [109] 
 
T. x citriodorus [154], T. serpyllum [80], T. 
vulgaris [101] 
 
Apigenin-7-O-rutinoside (70) S. officinalis [58,109], 
S. fruticosa, S. pomifera [109] 
T. vulgaris [58] 
Apigenin-6,8-di-C-glucoside (71) S. officinalis [95,149]  
Genkwanin (72) S. aegyptiaca, S. officinalis, S. verbenaca [66] T. comptus, T. glabrescens, T. longidens, 
T. pulegioides, T. tosevii, T. thracicus [151] 
Hispidulin-glucuronide (73) S. officinalis [101,109], 
S. fruticosa, S. pomifera [109] 
 
Scuttelarein (74) S. officinalis [112]  
Hispidulin (75) S. officinalis [112], S. plebeian [132] T. vulgaris [112] 
Thymusin (76)  T. alsarensis, T. glabrescens, T. 
longidens, T. macedonicus, T. oehmianus, 
T. thracicus, T. tosevii [151] 
Thymonin (77)  T. alsarensis, T. glabrescens, T. 
macedonicus, T. oehmianus, T. tosevii, T. 
thracicus, [151] 
Salvigenin (78) S. apiana [152], S. chloroleuca [153] T. albanus, T. grisebachii, T. longidens, T. 
pseudoatticus [151] 
Cirsimaritin (79) S. apiana [152] T. grisebachii, T. pseudoatticus [151],  
T. serpyllum [102] 
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1.2.2.2. Flavonols 
The most common flanonols in Salvia and Thymus plants include quercetin and 
kaempferol, as well as their derivatives (Table 3 and Figure 10). Quercetin (80) was 
detected in several Salvia species [1,71,114], namely in the methanolic extract of S. 
nemorosa (0.02 mg/g dry plant) [73] and in S. officinalis and S. fruticosa, with contents 
of 1.8 and 0.8 mg/g of dry plant, respectively [72,100,108]. In Thymus, this flavonol was 
previously detected in diverse species [83,85,120] and levels of 0.023 mg/g dry plant 
were reported in T. capitatus [84].  
Quercetin-3-O-rutinoside i.e., rutin (81) is the most common quercetin  derivative of 
the two plant genera. This was already found  in several Salvia species,  including Salvia 
ringens, Salvia amplexicaulis, Salvia syriaca, S. miltiorrhiza and S. nemorosa 
[73,93,106,114,116]. Likewise, its occurrence was described in Thymus plants, such as 
T. capitatus, T. hirtus and T. serpyllum (0.008, 0.6 and 1.35 mg/g dry plant, respectively) 
[80,84,105]. Other quercetin derivatives, namely quercetin-3-O-glucoside (82) and 
dihydroquercetin (83) were detected in S. fruticosa with contents of 0.28 and 0.016 
mg/g dry plant, respectively [108], having the latter compound also been reported in 
different Thymus species, including T. glabrescens, T. pannonicus, T. serpyllum and T. 
pulegioides [85]. Moreover, quercetin-3-O-galactoside (84) was detected in S. officinalis 
and in T. vulgaris [113]. On the other hand, kaempferol (85) was described as a phenolic 
constituent of S. fruticosa and S. cadmica (0.054 and 0.056 mg/g dry plant, respectively) 
[71,108] among others [73,155]. Its occurrence was also previously described in Thymus 
plants, namely T. capitatus (0.049 mg/g dry plant) [84] and T. nummularis (0.12 mg/g dry 
plant) [83]. Additionally, kaempferol-3-glucoside (86) and dihydrokaempferol (87) 
was detected in S. fruticosa  [108].  In turn, kaempferol-O-rhamnoside (88) together 
with kaempferol-O-3-glucoside have only been found in Salvia plants [106,108,114], 
while kaempferol-O-glucoronide (89) and methyl-kaempferol-O-rutinoside (90) was 
reported for T. serpyllum (15.2 and 17.4 mg/g dry plant, respectively) [80]. Moreover, 
isorhamnetin (91) and isorhamnetin-O-hexoside (92) are known to be present in 
Thymus plants (T. vulgaris [58]), while morin (93) and/or myricetin (94) was identified 























Gal- Galactosyl unit; Glc- Glucosyl unit; GlcU- Glucuronyl unit; Hex - Hexosyl; Rha- Rhamnosyl unit; Rut- Rutinosyl unit 
Figure 8 - Chemical structures of flavonols reported in Salvia and Thymus plants 
Table 3 – Flavonols of Salvia and Thymus genera. 
Compound Salvia species Thymus species 
Quercetin (80) S. cadmica [71], S. fruticosa [72,108], 
S. hispanica [129], S. nemorosa [73], 
S. officinalis [100,135], S. ringens [114], 
S. syriaca [116], S. tomentosa [70] 
 
T. capitatus [84], T. mastichina [120], 
T. nummularius [83], 
T. glabrescens, T. pannonicus, T. 
praecox, T. pulegioides [85],  
T. serpyllum [79,85],  
T. vulgaris [58,79,130] 
Rutin (81) S. amplexicaulis [106], S. fruticosa [72], 
S. miltiorrhiza [93], S. nemorosa [73], 
S. officinalis [113], S. syriaca [116], 
S. ringens [114], S. tomentosa [70] 
 
T. capitatus [84], T. hirtus [105],  
T. nummularius [83], 
T. glabrescens, T. pannonicus, T. 
praecox, T. pulegioides [85], 
T. serpyllum [80,85], T. vulgaris [58,113] 
 
   
Quercetin-3-O-glucoside (82) S. fruticosa [108], S. officinalis [58]  
Dihydroquercetin (83) S. fruticosa [108] T. glabrescens, T. pannonicus, T. 
praecox, T. pulegioides, T. serpyllum 
[85]  
Quercetin-3-O-galactoside (84) S. officinalis [113,135] T. vulgaris [113] 
Kaempferol (85) S. cadmica [71], S. fruticosa [72,108] 
S. hispanica [129], S. nemorosa [73] 
S. officinalis [135,155], S. syriaca [116], 
S. tomentosa [70] 
 
T. capitatus [84], T. mastichina [120] 
T. nummularius [83] 
 
Kaempferol-3-glucoside (86) S. fruticosa [108] 
 
 
Dihydrokaempferol (87) S. fruticosa [108] 
 
 
Kaempferol-rahmnoside (88) S. amplexicaulis [106], S. ringens [114] 
 
 
Kaempferol-O-glucuronide (89)  T.serpyllum [80] 
   
Kaempferol-O-rutinoside (90)  T.serpyllum [80] 
Isorhamnetin (91) S. officinalis  [58] T. vulgaris [58] 
Isorhamnetin-hexoside (92) S. officinalis  [58], S. veneris [98] T. vulgaris [58] 
Morin (93) S. fruticosa [72], S. tomentosa [70]  
Myricetin (94) S. fruticosa [72], S. hispanica [129], 














80 R1= R2= R4= R5= R6= H R3= OH 
81 R1= R2= R4= R5= H R3= OH R6= Rut 
82 R3= OH R1= R2= R4= R5= H R6= Glc 
84 R3= OH R1= R2= R4= R4= H R6= Gal 
Kaempferol derivatives 
85 R1= R2= R3= R4= R5= R6= H 
86 R1= R2= R3= R4= R5= H R6= Glc 
88 R1= R2= R3= R4= R5= H R6= Rha 
89 R1= R2= R3= R4= R5= H R6= GlcU 
90 R1= R2= R3= R4= R5= H R6= Rut 
 
Other flavonols 
91 R3= OCH3 R1= R2= R4= R5= R6= H 
92 R1= R2= R4= R5= H R3= OCH3 R6= Hex 
93 R1= R3= R4= R5= R6= H R2= OH 
94 R1= R2= R4= R6= H R3= R5= OH 
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1.2.2.3. Flavanones 
Amongst flavanones, naringenin, eriodictyol and hesperitin, along with some of their 
glycosidic forms are known to exist in Thymus and Salvia plants (Table 4 and Fig. 5). 
Naringenin (95)  was detected in S. mexicana, S. fruticosa, S. argentea and S. 
verbenaca [66,108,156] and in distint Thymus species such as T. capitatus (8.3 mg/g of 
dry plant) [84] and T. nummularis (0.064 mg/g dry plant) [83]. In addition, the content of 
this polyphenolic compounds on dry-weight basis in T. pulegioides and in T. pannonicus 
was about 0.025 mg/g dry plant [85]. Instead, the 7-O-rutinoside derivative of naringenin 
(96) was identified in T. vulgaris and in S. officinalis, accounting for 0.3 and 0.04 mg/g of 
dry plant, respectively [78,135]. Other naringenin-O-derivative, the naringenin-O-
glucoside (97), was also reported in T. vulgaris and T. x citriodorus species (0.3 and 0.6 
mg/g of dry plants, respectively) [78,88].  
Eriodictyol and/or eriodictyol derivatives are typiccaly found in Salvia and Thymus plants 
(Table 4 and Figure 5). Among them, eriodictyol (98) was previoulsy detected in S. 
syriaca, S. cadmica and S. nemorosa [71,73,116] and in several Thymus species 
[41,85,101,147,151], namely T. vulgaris (1.5 mg/g of dry plant) [78]. Moreover, hexosides 
of this flavanone, namely eriodictyol-O-glucoside (99) and eriodictyol-O-glucuronide 
(100), are known to occur in T. vulgaris [78,101] and eriocitrin (eriodictyol-7-O-
rutinoside) (101) was reported in S. officinalis [131]. Some of these derivatives are also 
known to occur in T. x citriodorus [88] and/or in T. serpyllum [102]. 
Beyond the most prevalent flavanones, hesperidin (hesperetin-7-O-rutinoside) (102) 
was described to account for 1 mg/g of dry plant in T. vulgaris [78] and in Salvia species 
[73,108,116], such as S. cadmica and S. verbenaca (0.2 and 0.46 mg/g of dry plant, 
respectively) [66,71]. Furthermore, hesperetin (103) was identified in S. fruticosa [72], 







Glc- Glucosyl unit; GlcU- Glucuronyl unit; Rut- Rutinosyl unit 
Figure 9 – Chemical structures of flavanones reported in Salvia and Thymus plants. 
Flavanones 
 
95 R1= R2= H R3= OH 
96 R1= Rut R2= H R3= OH 
97 R1= Glc R2= H R3= OH 
98 R1= H R2= R3= OH 
99 R1= Glc R2= R3= OH 
100 R1= GlcU R2= R3= OH 
101 R1= Rut R2= R3= OH 
102 R1= Rut R2= OH R3= OCH3 
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Table 4 – Flavanones of Salvia and Thymus genera 
Flavanones Salvia species Thymus species 
Naringenin (95) S. argentea, S. verbenaca [66] 
S. fruticosa [108],  
S. mexicana [156] 
 
 
T. capitatus [84], T. glabrescens [85,151], 
T. nummularius [83], T. pannonicus,  
T. praecox [85], T. pulegioides [85,151] 
T. serpyllum [41,85], T. vulgaris [78] 
T. longicaulis, T. rohlenae, T. moesiacus, T. 
jankae, T. albanus, T. balcanus, T. oehmianus, 
T. tosevii, T. grisebachii, T. longidens, T. 
thracicus, T. pseudoatticu [151],  
 
Naringenin-7-O-rutinoside (96) S. officinalis [135] T. vulgaris [78] 
Naringenin-O-glucoside (97)  T. vulgaris [78] 
Eriodictyol (98) S. cadmica [71], S. nemorosa [73],  
S. syriaca [116] 
 
T. glabrescens [85,151], 
T. longicaulis, T. rohlenae, T. moesiacus, T. 
jankae, T. albanus, T. balcanus, T. oehmianus, 
T. tosevii, T. grisebachii, T. longidens, T. 
thracicus, T. pseudoatticu [151], 
T. pannonicus, T. praecox [85],  
T. pulegioides [85,151], T. serpyllum [41,85] 
T. schimperi [147], T. vulgaris [78,87,101] 
 
Eridioctyol-O-glucoside (99)  T. x citriodorus [88], T. vulgaris [78,101] 
 








S. cadmica [71], S. fruticosa [108], 
S. nemorosa [73], S. syriaca [116],  
S. verbenaca [66] 
T. nummularius [83], T. vulgaris [78] 
 
Hesperetin (103) S. fruticosa [72], S. tomentosa [70] 
 
T. pannonicus [85], T. praecox [85] 
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1.3. Beneficial effects 
Several plants belonging to Salvia and Thymus genera have been recognized to have 
potential uses in medical procedures and applications in pharmaceutical and cosmetic 
industries because their biological properties [1,14,157]. Several researchers found that 
polar extracts are rich in phenolic compounds, particularly phenolic acids and flavonoids, 
which are related with their biological properties, namely antimicrobial, antioxidant, anti-
inflammatory, among others [19,20,47]. These health beneficial activities can combat 
oxidative stress conditions, protecting against chronic diseases such as cardiovascular 
diseases, diabetes, cancers, ageing and other degenerative diseases in humans 
[1,158,159]. A summary of the main beneficial properties associated to the plant genera 
target in this work is given below, highlighted the most relevant studies (Tables 5, 6, 7 
and 8). Particular emphasis will be devoted to antioxidant, anti-inflammatory, anticancer 
and antibacterial properties, since these are the most exploited ones up to the moment 
for Salvia and Thymus genus, as well as those investigated in the practical part of the 
present work. 
1.3.1. Antioxidant activity 
Oxidative stress is a condition characterized by an imbalance between pro-oxidants and 
antioxidant defenses. Reactive oxygen species (ROS) such as superoxide (O2-), 
hydroxyl radical (●OH) and hydrogen peroxide (H2O2), together with reactive nitrogen 
species (RNS) such as nitric oxide (NO) and peroxynitrite (ONOO¯), are generated in a 
variety of intracellular processes. To minimize the oxidative damage, enzymatic and non-
enzymatic antioxidants have been evolved. Enzymatic antioxidants include superoxide 
dismutase (SOD), which catalyze ONOO¯ to produce H2O2, that in its turn, can be 
neutralized by catalase or glutathione peroxidase. In turn, non-enzymatic antioxidants 
also counteract oxidative damage, among them, vitamins A, C and E, glutathione 
(reduced form, GSH), and β-carotene provide major protection against oxidative stress 
[160–163].  
In normal physiological conditions, cells are able to maintain a redox homeostasis, i.e., 
the balance between reactive species formation and their elimination. Still, when 
equilibrium is disrupted, oxidative stress is settled, and in this biological condition, the 
overproduction of reactive species leads to several mitochondrial and cellular damages, 
namely in lipids, proteins, DNA and other macromolecules, that is closely associated to 
aging processes [164,165] and to the physiopathology of several inflammatory-related 
diseases [160,163,166], including initiation and/or development of cancer [163,167,168].  
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Diet supplementation with antioxidant compounds by a daily consumption of plant-based 
products, that contains large amount of polyphenols and phytochemicals, could provide 
an important tool to counteract the adverse effects of oxidative stress [2,20,160]. Its 
antioxidant properties are involved in the prevention of several diseases [1,2,169], 
indicating an inverse relationship between the dietary intake of antioxidant-rich foods and 
the incidence of human disease [160,170]. 
Many plants, including Lamiaceae species, have been used in traditional medicine for 
their claimed antioxidant capacities and/or ability to ameliorate oxidative-stress related 
disorders. As for plants in general, the antioxidant potential of sage and thyme species 
have mostly been assessed for phenolic-enriched extracts [1,65,171]. These compounds 
can combat oxidative stress conditions and thus possess others health beneficial 
activities (e.g. anti-inflammatory) protecting against related diseases [1,47,158,159]. In 
these context, in recent years there has been an effort to gather scientific data to 
corroborate the traditional usage of these plants and its application in food industry, 
namely in the development of natural additives and safe food products [1,2,14,65]. 
Important literature gathered on this topic is resumed in Table 5.  
The most common methods to screen the antioxidant properties of plants are based on 
the (i) scavenging of stable free radicals such as DPPH● (2.2-diphenyl-1-picrylhydrazyl), 
ABTS● (2.2´-azino-bis-3-ethylbenzthiazoline-6-sulphonic acid), ●OH, O2●- and NO●; ii) the 
reduction of metal ions from the higher to the lower oxidation state by reducing power 
method (RP) and ferric reducing antioxidant power assay (FRAP); iii) the oxygen radical 
absorbance capacity (ORAC) that measures the radical chain breaking ability of 
antioxidants by the inhibition of peroxyl radical (RO2•)–induced oxidation  and trolox 
equivalence antioxidant capacity (TEAC); iv) the inhibition of lipid peroxidation by ß-
carotene bleaching test; and v) the inhibition of lipid peroxidation by decreasing the 
thiobarbituric acid reactive substances (TBARS). The extensive use of such assays is 
mainly attributed to their simplicity and quickness of execution [172,173]. As shown in 
Table 5, several Salvia and Thymus species have been screened for their antioxidant 
capacities through chemical methods. Most studies present the antioxidant activity 
expressed as EC50 values (half maximal effective concentration), which is equivalent to 
sample concentration that provides 50% of antioxidant activity. Note that, in some cases, 
the antioxidant activity is also displayed as Trolox Equivalents (TE) per dry weight (DW). 
 Antioxidant activity of Salvia plants 
Among sage plants, S. officinalis is the most widespread worldwide and also the most 
studied regarding antioxidant capacity [174]. Due to its high antioxidant capacity, S. 
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officinalis phenolic extracts are also frequently used as a reference to assess antioxidant 
properties of other less investigated plants [66,175]. DPPH EC50 values of distinct 
extracts from this species were established in the range of 1.98 and 10.1 μg/mL 
[66,176,177], being close to that of the flavonol quercetin (2.79 μg/mL) [178]. The 
antioxidant activity of S. officinalis phenolic-rich extracts has also been extensively 
assessed by the ABTS● scavenging assay (EC50= 4.79-50.8 μg/mL) [176,178], through 
evaluation of the ability to scavenge superoxide (EC50= 5.3-10.1 μg/mL) [177] and 
hydroxyl radicals (EC50= 1.36 μg/mL) [176], and also by the ORAC assay (0.4-1.8 mmol 
TE/100 mL) [179]. Moreover, metanolic extracts and decoctions of S. officinalis were 
shown to exhibit very low EC50 values, as estimated by ß-carotene bleaching (EC50=6.6 
and 50.9 μg/mL, respectively) and TBARS assays (EC50= 2.1 and 10.4 μg/mL, 
respectively) [180].  
Overall, recent data concerning phenolic-rich extracts of other Salvia species also 
highlight their promising potential, among which S. nemorosa and S. sclarea represent 
the most studied species [10,73,74,175,181]. In this context, Kostic et al [74], reported 
good antioxidant ability of ethanolic extracts of S. sclarea by DPPH● (EC50=27.0 μg/mL) 
and inhibition of ß-carotene (EC50= 19.1 μg/mL) methods, the latter being promising than 
that of rosmarinic acid (EC50= 32.6 μg/mL). In addition, methanolic extracts of S. 
nemorosa and S. sclarea collected in Iran, showed DPPH● EC50 values in the range of 
82 to 191 μg/mL [10,73]. In addition, Jeshvaghani et al. [175] exhibited the potency of 
these two extracts, presenting EC50 values about 1.4–2.2 lower than BHT (3.5-di-tert-
butyl-4-hydroxytoluene), used as standard reference solution. These two species 
exhibited antioxidant potential based in other chemical in vitro tests, namely ORAC and 
ABTS assays [181].  
Several other polar extracts from different populations of Salvia plants possess 
antioxidant potential. In this regard, methanolic extracts of Salvia from Tunisia origin (S. 
aegyptiaca, S. argentea and S. verbenaca), were shown to scavenge DPPH● (EC50=21-
77 μg/mL) and ABTS● (141-318 μM TE/mg DW), as well as to reduce the ferric form (81-
205 mM Fe(II)/mg DW) [66]. Other several Salvia plants have shown to be good 
antiradicalar sources. E.g. DPPH EC50 values of methanolic: chloroform (1:1) extracts of 
14 Salvia plants from South Africa, which in general contained rosmarinic acid as major 
phenolic constituent, were shown to vary between 1.6 µg/mL (Salvia schlechteri) and 
74.2 µg/mL (Salvia garipensis) [38]. In the same line, polar extracts of S. amplexicaulis 
[106] and S. ringens [114], both rich in kaempferol glycosides, were suggested as good 
antioxidant agents, as estimated by DPPH●, ABTS● and FRAP methods. In addition, 
phenolic-rich extracts from different populations of S. fruticosa [108] and aqueous and 
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methanolic extracts of S. cadmica from Turkey [71], were demonstrated to scavenge 
DPPH● and ABTS● and reduce the ferric ion as well (Table 5). 
In good agreement with these results, other Salvia polar extracts, such as S. 
amplexicaulis [106], S. halophila [76], Salvia virgata, Salvia persica, Salvia cereal and S. 
reuterana [175], showed inhibition of the -carotene bleaching capacity, in some cases 
equals those of the standard compounds. Similary, the potential of Salvia species to 
inhibit lipid peroxidation by TBARS was reported for S. halophila, with inhibition 
percentage equal to reference commercial compound BHT [76]. 
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Table 5 – Antioxidant properties of phenolic-enriched extracts of distinct Salvia species 
Salvia species Origin Solvent extraction 
(major components) 
Results of screen assay 
Ref 
S. aegyptiaca  Tunisia 
MeOH (RA, caffA deriv, 
Api-7-Glc, Lut-7-Glc, Nar, 
DT) 
DPPH (EC50, µg/mL): 21.1-22.6 / FRAP (mM Fe(II)/mg): 149-164 / ABTS (μM TE/mg dry plant): 312-
318, collection site 
[66] 
S. amplexicaulis Lithuania EtOH, H2O, CO2 (ND) 
ORAC (µM TE/g DW): 4735 (EtOH), 676 (H2O), 1914 (CO2) /  ABTS (µM TE/g DW): 1177 (EtOH), 
79.5 (H2O) 
[181] 
S. amplexicaulis Macedonia 
DCM, EA (Hyper, 
Coumarin) 
H2O, EtOH, MeOH (RA, 
Lut- 5-O-Glc, Kam-3-O-
acetil Glc-7-O-Rhm) 
DPPH (EC50, μg/mL): 27.8 (EtOH), 15.8 (H2O), 15.1 (MeOH), 196.5 EA, 593.2 (DCM), 5.1 (AA) / 
ABTS (mg AAE/g): 2.8 (EtOH), 2.8 (H2O), 2.4 (MeOH), 0.7 EA, 0.4 (DCM), 2.8 (BHT)  / FRAP (μmol 
Fe(II)/g)= 979 (EtOH), 1372 (H2O), 1178 (MeOH), 112 EA, 117 (DCM), 445 (BHT)  / β-carot bleach 
(%): 40.4 (EtOH), 41.8 (H2O), 13.3 (MeOH), 58 (BHT) 
[106] 
S. argentea Tunisia 
MeOH (RA, caffA deriv, 
Api-7-Glc, Lut-7-Glc, Nar, 
DT) 
DPPH (EC50, µg/mL)= 33.9-77.1 / FRAP (mM Fe(II)/mg)= 81.6-105 / ABTS (μM TE/mg )= 141-173, 
collection site 
[66] 
S. bicolor Egypt 
MeOH (PrcA, CouA, GA, 
Lut-7-O-Glc) 
DPPH (EC50, µg/mL) = 321 (MeOH), 250 (GA) [128] 
S. cadmica Turkey 
EA, MeOH, H2O (RA, 
caffA, Lut, Api) 
DPPH (µmol TE/g dry plant)= 5.9 (EA), 54.7 (MeOH), 40.5 (H2O) / CUPRAC (µmol TE/g dry plant)= 
20.9 (EA), 50.9 (MeOH), 54.5 (H2O) / ABTS (µmol TE/g dry plant)= 7.1 (EA), 84.9 (MeOH), 102.2 





1 and 2) 
MeOH (RA, ChlgA, caffA) 
FRAP (µM Trolox/g DW): 31.83-202.93; 135.81-326.22 / ABTS (µM Trolox/g DW): 60.94-242.3; 
199.64-312.49 / DPPH (µM Trolox/g DW): 182.99-192.62; 185.30-192.19, populations 1 and 2, 
respetively 
[108] 
S. halophila Turkey 
Hexane (ND), EA (RA, 
CaffA, Lut), MeOH (RA, 
GA, Lut-Glc), MeOH 50% 
(CaffA, o-coumaric, p-
OH-BA, Lut-Glc), H2O 
(RA) 
DPPH (EC50, mg/mL)= 0.4 (EA), 0.6 (50% MeOH), 1.0 (H2O, MeOH) / FRAP (AAE mmol/g extract)= 
1.0 (EA, 50% MeOH), < 1.0 (H2O, MeOH, Hexane), 0.025 (GA) / β-carot bleach (AA%)= 80 
(Hexan), 65 (EA), < 40 (MeOH, 50% MeOH, H2O), 90 (BHT) / Iron (II) Thiocyanate (%)=  91 
(hexan), 89 (EA), 70 (50% MeOH), 68 (H2O), 18 (MeOH), 90 (BHT), at 1% conc / TBARS (%)= 94 
(hexan), 91 (H2O), 82 (50% MeOH), 80 (EA), 52 (MeOH), 90 (BHT), at 1% conc. 
[76] 
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S. miltiorrhiza Commercial 
H2O (ND), 95% EtOH 
(ND) 
DPPH (EC50, µg/mL): 202 (H2O), 105 (EtOH) [171] 
S. miltiorrhiza China H2O (Danshensu, SA A, 
SA B) 
DPPH (EC50, µg/mL)= 131/ ORAC (µmol/g) = 757  [183] 
S. nemorosa Lithuania EtOH, H2O, CO2 (ND) 
ORAC (µM TE/g DW): 2392 (EtOH), 718 (H2O), 1193 (CO2) /  ABTS (µM TE/g DW): 1005 (EtOH), 
150 (H2O) 
[181] 
S. nemorosa Iran 80% MeOH (ND) DPPH (EC50, μg/mL)= 138.4 (80% MeOH), 1.79 (quercetin) [10] 
S. nemorosa Iran MeOH (RA, caffA, Que)  DPPH (EC50, μg/mL)= 82 (MeOH), 64 (BHT)  [73] 
S. nemorosa Iran MeOH (ND) 
DPPH (EC50 μg/ml): 473 (MeOH), 211 (BHT) / β-carot bleach (%): 20 (MeOH), < 20% (BHT), at 500 
μg/ml 
[175] 
S. officinalis Iran MeOH (ND) 
DPPH (EC50 μg/ml): 233 (MeOH), 211 (BHT) / β-carot bleach (%): 79 (MeOH), < 20% (BHT), at 500 
μg/ml 
[175] 
S. officinalis Algerian MeOH-H2O (RA, Flav) DPPH (EC50 μg/ml): 1.98 / ABTS (EC50 μg/ml): 4.79 / OH scav (IC50 μg/ml): 1.36 [176] 
S. officinalis Portugal DE, EA, n-but, H2O (ND) 
DPPH (EC50 μg/ml): 3.9 (EA), 4.1 (n-but), 2.8 (H2O) / O2- scav (EC50 μg/ml): 5.5 (DE), 5.3 (EA), 8.9 
(n-but) 10.1 (H2O) 
[177] 
S. officinalis Spain 
H2O inf,  H2O dec, 80% 
MeOH (RA, Lut-O-Glc, 
Lut-O-Glr) 
DPPH (EC50 μg/ml): 96 (H2O inf), 75.5 (H2O dec), 33 (80% MeOH) / RP (IC50 μg/ml): 84 (H2O inf), 
66.5 (H2O dec), 25 (80% MeOH) / β-carot bleach (EC50 μg/ml): 139 (H2O inf), 50.9 (H2O dec), 6.6 
(80% MeOH) / TBARS (EC50 μg/ml): 18.0 (H2O inf), 10.4 (H2O dec), 2.1 (80% MeOH) 
[180] 
S. officinalis  Lithuania CO2, EtOH, H2O 
ORAC (µM TE/g DW): 2535 (EtOH), 1143 (H2O), 6015 (CO2) /  ABTS (µM TE/g DW): 1080 (EtOH), 
225 (H2O) 
[181] 
S. officinalis Commercial 
H2O, MeOH (RA, SA K 
isomer, Lut-Hex, Api-Glr) 
DPPH (EC50, μg/ml)= 69 (MeOH), 2.79 (Que) / ABTS (EC50 μg/ml): 19.9 (MeOH), 50.8 (H2O), 1.17 
(Que)  
[178] 
S. officinalis  Commercial H2O  (RA and deriv) ORAC (mmol TE/100mL): 0.4 to 1.8 [179] 
S. officinalis Tunisia 
MeOH (RA, caffA deriv, 
Api-7-Glc, Lut-7-Glc, Nar, 
DT) 
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DPPH (EC50, µg/mL): 3.01 (salpalaestinin); 1.0 (methyl-3-O-methylRsm), 1.1 (BHA) [150] 
S. ringens Macedonia 
EtOH (Kam-3-O-Glu-7-O-
Rhm, rutin); MeOH (RA, 
Kam-3-O-Glu-7-O-Rhm, 
rutin); DCM (Hyperoside); 
EA (Lut, Kam-3-O-Glu-7-
O-Rhm)  
DPPH (EC50, μg/mL): 17.3 (EtOH), 20.3 (MeOH), 266.2 (DCM), 22.2 (EA), 5.1 (AA) / ABTS (mg 
AAE/g): 2.44 (EtOH), 1.19 (MeOH), 0.58 (DCM), 2.36 (EA), 2.8 (BHT) / FRAP (μmol Fe(II)/g): 
1088.3 (EtOH), 274.8 (MeOH), 191.1 (DCM), 969.8 (EA), 180 (AA) 
[114] 
S. sclarea Lithuania EtOH, H2O, CO2 (ND) 
ORAC (µM TE/g DW): 3820 (EtOH), 867 (H2O), 570 (CO2) /  ABTS (µM TE/g DW): 1634 (EtOH), 
153 (H2O) 
[181] 
S. sclarea Iran 80% MeOH (ND) DPPH (EC50, μg/mL)= 190.7 (80% MeOH), 1.79 (quercetin) [10] 
S. sclarea Iran MeOH (ND) 
DPPH (EC50 μg/ml): 290 (MeOH), 211 (BHT) / β-carot bleach (%): 35 (MeOH), < 20% (BHT), at 500 
μg/ml 
[175] 
S. sclarea Serbia 
EtOH (RA, Lut-7-glc, Api-
7-Glc) 
DPPH (EC50 μg/ml): 27.0 (EtOH), 6.1 (RA), 2.4 (BHA) / β-carot bleach (EC50 μg/ml): 19.1 (EtOH), 
32.6 (RA), 0.03 (BHA) 
[74] 
S. verbenaca  Tunisia 
MeOH (RA, caffA deriv, 
Lut, Nar, DT) 
DPPH (EC50 µg/mL): 23-36.3 / FRAP (mM Fe(II)/mg): 106-159 / ABTS (μM TE/mg ): 165-205, 
collection site 
[66] 
S. virgata Iran MeOH (ND) 
DPPH (EC50 μg/ml): 198 (MeOH), 211 (BHT) / ↓β-carot bleach (%): 95 (MeOH), < 20% (BHT), at 
500 μg/ml 
[175] 
Other Salvia species   
S. cereal S. reuterana,  
S. persica 
Iran MeOH (ND) 
DPPH (EC50 μg/ml): 598 (S. reuterana), 883 (S. cereal), 1810 (S. persica), 211 (BHT) / β-carot 
bleach (%): 30 (S. reuterana), 55 (S. cereal), 95 (S. persica), < 20% (BHT), at 500 μg/ml 
[175] 
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S. aethiopis, S. 
atropatana, S. 
eremophila, S. 
hypoleuca, S. limbata, 
S. santolinifolia, S. 
syriaca, S. 
xanthocheila 
Iran 80% MeOH (ND) DPPH (EC50, μg/mL)= 89.5 (S. atropatana) - 557 (S. limbata), 1.79 (quercetin) [10] 
S. africana-caerulea, S. 
africana-lutea, S. 
albicaulis, S. aurita, S. 
chamelaeagnea, S. 
disermas,S. dolomítica, 
S. garipensis, S. 
lanceolata, S. muirii, S. 
namaensis, S. radula, 
S. repens, S. runcinata, 
S. schlechteri, S. 
stenophylla 
South Africa MeOH:CHCl3 (RA)  
DPPH (EC50, µg/mL): 1.61 ( S. schlechteri), 74.2 (S. garipensis), >100 (S. dolomitica, S. radula),  




AA– ascorbic acid; AAE - ascorbic acid equivalent; ABTS– 2.2′-azino-bis-(3-ethylbenzothiazoline-6-sulphonic acid) radical scavenging assay; Api – apigenin; BA – benzoic acid; BHA - 2(3)-t-butyl-4-
hydroxyanisole; BHT - 3.5-di-tert-butyl-4 hydroxytoluene; CaffA/CaffA deriv– caffeic acid/caffeic acid derivative; ChlgA - chlorogenic acid¸β-carot bleach– β-carotene/linoleic acid bleaching inhibition assay; 
CouA - Coumaric acid; CUPRAC– cupric ion reducing antioxidant capacity; Deriv– derivatives; DCM-dichloromethane; DE - diethyl ether; dec – decoction; DPPH– 2.2-diphenyl-1-picrylhydrazyl radical 
scavenging assay; DT – diterpenes; DW– dry weight; EA- ethyl acetate; EtOH- ethanol; Hex – hexoside; FA - ferulic acid; Flav – flavonoids; FRAP– ferric reducing antioxidant power; GA – gallic acid; GAE– 
gallic acid equivalents; Glc–glucoside; Glr - glucuronide; Hyper – Hyperoside; inf – infusion; Kam – kaempferol; LA perox– linoleic acid peroxidation; Lut – luteolin; Lut – luteolin; MeOH- methanol; Nar – 
naringin; n-but - n-butanol; ND– not determined; OH scav– hydroxyl radical scavenging assay; O2- scav– O2- radical scavenging assay; ORAC– oxygen radical absorbance capacity; p-OH-BA – p-
hydroxybenzoic acid; PrcA - Protocatchuic acid; QA - quinic acid; Que – quercetin; RA– rosmarinic acid; Rhm - rhamnoside; RP – reducing power; Rsm - rosmarinat; SA - salvianolic acid; TBARS– 
thiobarbituric acid reactive substances assay; TE– trolox equivalent. 
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 Antioxidant activity of Thymus plants 
The antioxidant activity of Thymus species has also been extensively assessed and its 
phenolic content and/or composition have closely associated to their antioxidant 
properties [81], as well as to their health benefits [1]. In more detail, water, methanolic 
and hydroalcoholic extracts of T. vulgaris, i.e., the most investigated Thymus species, 
DPPH● radical EC50 values have been reported in the range of 1.8 and 44.7 μg/mL 
[45,176,178]. Moreover, phenolic-rich extracts of T. vulgaris were shown to be good 
ABTS● (EC50= 0.7-13.8 μg/mL) [176,178] and OH● (EC50= 0.24 μg/mL) [176] scavenging 
agents.  
In the last years, the antioxidant activity of distinct thyme extracts has been investigated 
with promising results. In particular, a methanolic extract of T. nummularius, also called 
Thymus pseudopulegioides, was claimed to have higher DPPH● scavenging ability 
(EC50= 5.7 μg/mL) than BHT (EC50= 47.1 μg/mL), and 1.5 times better than in both ABTS 
and ß-carotene bleaching inhibition methods [83]. Besides that, high radical scavenging 
ability was demonstrated for water extracts of three Thymus species (Thymus carnosus, 
Thymus camphoratus and T. mastichina) originated from Portugal, presenting  low EC50 
values for DPPH● (EC50= 3.2-3.9 μg/mL) and for superoxide radical (EC50= 9.5-13.6 
μg/mL) [177]. Moreover, hydromethanolic extracts of T. capitatus [84] and T. mastichina 
[81], which presented rosmarinic acid as major phenolic constituent, were shown to have 
high antioxidant potential based in DPPH (18- 149 mg TE/g DW) and FRAP assays (30–
154 mg TE/g DW). In the same line, aqueous extracts of Thymus atlanticus, Thymus 
satureioides and T. zygis, were also evaluated for the DPPH● scavenging ability and for 
the capacity in reducing iron, whose results were equal or better than the reference 
commercial compound [54,184]. In the same line,  Kindl et al [45] reported the antioxidant 
potencial of ethanolic extracts of six Thymus species from Croatia, namely Thymus 
longicaulis, T. praecox subsp. polytrichus, T. pulegioides, T. serpyllum subsp. serpyllum, 
Thymus striatus and T. vulgaris, which were shown to possess low EC50 values (μg/mL) 
for DPPH (3.01-6.01), RP (11.4-15.1) and TBARS methods (34.3 -80.0). 
Commonly, the antiradicalar/antioxidant activity of Salvia and Thymus extracts has been 
positively correlated to their phenolic content and to the presence of specific phenolic 
compounds [66,81,106,108], which frequently appear as major components of its polar 
extracts (e.g. rosmarinic acid, caffeic acid, apigenin7-O-glucoside, luteolin-7-O-
glucoside) [66,71,74,76,81,83,84,106,108,180,184]. Amongst them, rosmarinic acid is 
frequently the principal phenolic acid in the said extracts and it is believed to play a 
central role in their antioxidant abilities [66,74,81,83,106,108]. In fact, this caffeic acid 
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dimer was shown to be sixtheen folder better than α-tocopherol [83], twice as high than 
trolox [45], and 0.4 times higher than the BHA (2(3)-t-butyl-4-hydroxyanisole) [74], in 
DPPH radical-scavenging assay. Rosmarinic acid has also higher reducing power 
capacity (EC50= 2.7 μg/mL) than trolox (EC50= 6.6 μg/mL) [45] and higher ABTS●  
scavenging ability than BHT [83]. Besides that, this caffeic acid is also known to prevent 
lipid peroxidation, as reported by Ertas et al. [83], whose  EC50 value was 1.2-fold higher 
than BHT in the ß-carotene bleaching inhibition assay. 
Moreover rosmarinic acid, some of its derivatives together with other non-flavonoids (e.g. 
danshensu) and flavonoid compounds (e.g. luteolin, apigenin, quercetin and their 
glycosides) might also positively contribute to the antioxidant capacity of these plant 
extracts (Table 6) [1,2,65,174]. In fact, salvianolic acid B, salvianolic acid A and 
litospermic acid, were demonstrated to be the main phenolic compounds contributing to 
the high antioxidant capacity of a traditional Chinese medicine formula enriched in 
danshen, as assessed by the DPPH method (EC50 values of 8.80, 12.1 and 15.6 μM 
respectively) [183]. In addition to caffeic and/or rosmarinic acid derivatives, flavonoids 
(in particular luteolin, apigenin and its derivatives) might also contribute to the antioxidant 
capacity of Salvia and Thymus species (Table 6), since they are good 
antiradicalar/antioxidants as evaluated in chemical and cellular models. Namely, luteolin 
and apigenin (50 μg/mL) were demonstrated to drastically decrease the levels of 
intracellular ROS under oxidative-stress conditions on a hepatic cellular model [185]. 
Moreover, luteolin, was shown to exhibit high antioxidant activity, being 2.3 and 1.5 folder 
better than trolox in DPPH assay-scavenging and in RP method, respectively [45]. 
Furthermore, it was demonstrated to effectively prevent lipid peroxidation events, 
exhibiting an EC50 value of 2.03 μg/ml in the TBARS assay, which is ten-times lower than 
that of rosmarinic acid [45].  
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Table 6 – Antioxidant properties of phenolic-enriched extracts of distinct Thymus species 
Thymus plants Origin Solvent extraction 
(Major components) 
Results of screen assay Ref 
T. atlanticus Morocco H2O (RA, caffA, Que) DPPH (EC50, μg/ml)= 120 (H2O), 510 (trolox) / FRAP (mmol trolox/g extract)= 40.0 (H2O), 44.3 (trolox) [184] 
T.camphoratus   Portugal 
DE, EA, n-but, H2O 
(ND) 
DPPH (EC50 μg/ml): 3.1 (DE), 2.7 (EA), 6.4 (n-but), 3.2 (H2O)/ O2- scav (EC50 μg/ml): 7.8 (DE), 11.0 
(n-but), 9.5 (H2O) 
[177] 
T. capitatus Greece 
70% MeOH (RA, FA, 
Nar, Lut); H2O (RA, 
Caff, Epi, Epig) 
DPPH (mg TE/g DW): 56.2 / ABTS (mg TE/g DW): 75.2 / FRAP (mg TE/g DW): 76.1 [84] 
T. carnosus  Portugal 
DE, EA, n-but, H2O 
(ND) 
DPPH (EC50 μg/ml): 4.0 (DE), 3.0 (EA), 5.2 (n-but), 3.6 (H2O) / O2- scav (EC50 μg/ml): 12.3 (DE), 8.9 
(EA), 8.9 (n-but), 13.6 (H2O) 
[177] 
T. longicaulis Croatia EtOH (ND) 
DPPH (EC50 μg/ml): 3.01 (EtOH), 0.66 (RA),0.73 (Lut), 1.67 (Trolox) / RP (EC50 μg/ml): 11.8 (EtOH), 
2.67 (RA), 4.51 (Lut), 6.64 (Trolox)  / TBARS (EC50 μg/ml): 34.3 (EtOH), 21.1 (RA), 2.03 (Lut) 
[45] 
T. longicaulis Italy 
EtOH-H2O (RA, SA K, 
Lut-O-hex, Quer-O-
Hex) 
DPPH (EC50, μg/mL): 9.5 (H2O-MeOH), 5.1 (trolox) / ABTS (EC50, μg/mL): 9.5 (H2O-MeOH), 5.1 
(trolox)  / RP (μM TE/g extract): 475 (H2O-MeOH) / ORAC (μM TE/g extract): 776.5 (H2O-MeOH) 
[186] 
T. mastichina   Portugal 
DE, EA, n-but, H2O 
(ND) 
DPPH (EC50 μg/ml): 2.7 (DE), 3.7 (EA), 4.0 (n-but), 3.9 (H2O) / O2- scav (EC50 μg/ml): 10.0 (DE), 4.9 
(EA), 6.9 (n-but), 12.2 (H2O) 
[177] 
T. mastichina   Portugal MeOH, H2O (ND) 
DPPH (EC50 mg/ml): 0.69 (MeOH), 2.57 (H2O), 0.04 (trolox) / RP (EC50 mg/ml): 0.23 (MeOH), 0.7 
(H2O), 0.03 (trolox) / β-carot bleach (EC50 mg/ml): 0.9 (MeOH), 0.003 (trolox) / TBARS (EC50 mg/ml): 
0.43 (MeOH), 0.004 (trolox)  
[44] 
T. mastichina   Spain 
50% MeOH (RA, 
CaffA, Lut, Lut-Glc) 
DPPH (mg TE/g DW): 18-149 / FRAP (mg TE/g dw): 30 – 154, different populations [81] 
T. nummularius Turkey 
MeOH (QA, RA, Lut, 
Kam) 
DPPH (EC50 μg/ml): 5.73 (MeOH), 1.21 (RA), 47.1 (BHT), 19.6 (α-Toc) / ABTS (EC50 μg/ml): 7.1 
(MeOH), 1.7 (RA), 10.9 (BHT)  / β-carot bleach (EC50 μg/ml): 6.54 (MeOH), 12.1 (RA), 9.95 (BHT) 
[83] 
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T. pulegioides Portugal MeOH (ND) 
DPPH (EC50 μg/ml): 680 / RP (EC50 μg/ml): 490 / β-carot bleach (EC50 μg/ml): 30 / TBARS (EC50 
μg/ml): 220  
[43] 
T. pulegioides Croatia EtOH (ND) 
DPPH (EC50 μg/ml): 4.18 (EtOH), 0.66 (RA), 0.73 (Lut), 1.67 (Trolox) / RP (EC50 μg/ml): 11.4 (EtOH), 
2.67 (RA), 4.51 (Lut), 6.64 (Trolox)  / TBARS (EC50 μg/ml): 34.8 (EtOH), 21.1 (RA), 2.03 (Lut) 
[45] 
T. satureioides Morocco H2O (RA, caffA, Quer) DPPH (EC50, μg/ml)= 440 (H2O), 510 (trolox) / FRAP (mmol trolox/g extract)= 40.1 (H2O), 44.3 (trolox) [184] 
T. vulgaris Croatia EtOH (ND) 
DPPH (EC50 μg/ml): 5.6 (EtOH), 0.66 (RA),0.73 (Lut), 1.67 (Trolox) / RP (EC50 μg/ml): 14.1 (EtOH), 
2.67 (RA), 4.51 (Lut), 6.64 (Trolox)  / TBARS (EC50 μg/ml): 69.6 (EtOH), 21.1 (RA), 2.03 (Lut) 
[45] 
T. vulgaris Algerian MeOH-H2O (RA, Flav) DPPH (EC50 μg/ml): 1.78 / ABTS (EC50 μg/ml): 0.69 / OH scav (EC50 μg/ml): 0.24 [176] 
T. vulgaris Commercial 
H2O, MeOH (RA, SA K 
isomer, Lut-Hex, Eri-
Glc) 
DPPH (EC50, μg/ml): 44.7 (MeOH), 2.79 (Que) / ABTS (EC50 μg/ml): 13.8 (MeOH), 49.6 (H2O), 1.17 
(Que)  
[178] 
T. zygis Morocco H2O (RA, caffA, Quer) DPPH (EC50, μg/ml): 440 (H2O), 510 (trolox) / FRAP (mmol trolox/g extract): 65.0 (H2O), 44.3 (trolox) [184] 
Other Thymus species    





Croatia EtOH (ND) 
DPPH (EC50 μg/ml): 3.4 (T. praecox), 4.06 (T. striatus), 6.01 (T. serpyllum) 0.73 (Lut), 1.67 (Trolox) / 
RP (EC50 μg/ml): 15.1 (T. praecox), 14.7 (T. striatus), 14.5 (T. serpyllum), 2.67 (RA), 4.51 (Lut), 6.64 
(Trolox)  / TBARS (EC50 μg/ml): 78.7 (T. praecox), 63.0 (T. striatus), 80.0 (T. serpyllum), 21.1 (RA), 
2.03 (Lut) 
[45] 
AA– ascorbic acid; AAE - ascorbic acid equivalent; ABTS– 2,2′-azino-bis-(3-ethylbenzothiazoline-6-sulphonic acid) radical scavenging assay; Api – apigenin; BHA - 2(3)-t-butyl-4-hydroxyanisole; BHT 
- 3.5-di-tert-butyl-4 hydroxytoluene; CaffA/CaffA deriv– caffeic acid/caffeic acid derivative; β-carot bleach– β-carotene/linoleic acid bleaching inhibition assay; Deriv– derivatives; DCM-dichloromethane; 
DE - diethyl ether; dec – decoction; DPPH– 1,1-diphenyl-2-picrylhydrazyl radical scavenging assay; DW– dry weight; EA- ethyl acetate; Epi - epicatechin; Epig - epigallocatechine; Eri – eriodictyol; 
EtOH- ethanol; Hex – hexoside; FA - ferulic acid; Flav – flavonoids; FRAP– ferric reducing antioxidant power; Glc–glucoside; Glr - glucuronide; Kam – kaempferol; Lut – luteolin; MeOH- methanol; Nar 
– naringin; n-but - n-butanol; ND– not determined; OH scav– hydroxyl radical scavenging assay; O2- scav– O2- radical scavenging assay; ORAC– oxygen radical absorbance capacity; Que – quercetin; 
RA– rosmarinic acid; Rhm - rhamnoside; RP – reducing power; SA - salvianolic acid; TBARS– thiobarbituric acid reactive substances assay; TE– trolox equivalente.  
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1.3.2. Anti-inflammatory activity 
Inflammation is the first biological response of the immune system against tissue injury or 
infection, that involves both localized and systemic effects. Tissue damage induces the first 
mechanism of immune recognition (innate immunity), which involves physical, chemical, and 
biological barriers, specialized cells and soluble molecules, such as plasma enzyme mediators 
by the kinin, clotting and fibrinolytic systems [187,188]. This unspecific response allows the 
recognition of pathogens via a series of conserved microbial motifs, known as pathogen 
associated molecular patterns (PAMPs), through pathogen-recognition receptors (PRRs) 
present in immune cells. Toll-like receptors (TLRs) are a class of important PRRs, that could 
recognize PAMPs such as bacterial endotoxin LPS (lipopolysaccharide), being the TLR4 one 
of the well-known. When activated, PRRs triggers a series of signaling cascades that culminate 
in the activation of nuclear transcription factors such as nuclear factor kappa B (NF-κB) and 
activating protein-1 (AP-1). Such factors regulate the expression of a series of target genes 
involved in inflammation, namely chemokines and pro-inflammatory cytokines. The latter 
include interleukins (e.g. IL-1β, IL-6, IL-8, IL-12), interferon (INF-γ) and tumor necrosis factor 
(TNF-α), that in turn stimulate and amplify the inflammation, inducing many of the localized 
and systemic changes peculiarly of inflammatory response [161,187,189]. The activation of 
adherent molecules by chemokines and complement split products is also triggered, enabling 
leukocytes migration into tissue spaces and  the release of inflammatory mediators, which will 
culminate in changes on the vasculature of the damaged tissue, vasodilatation, vascular 
permeability and release of soluble mediators and extravasation of fluids. This process results 
in cellular influx and migration of antigen presenting cells from the periphery to the lymphoid 
organs activating the adaptive immunity development [161,187,189]. In turn, the breakdown of 
phospholipids in the membrane of immune cells are degraded into lyso-platelet activation 
factor to yield platelet activation factor (PAF) and arachidonic acid, whose metabolism 
generate prostaglandins and tromboxanes by the cyclooxygenases pathway and leukotrienes 
by lipoxygenase pathway, stimulated by the enzymes cyclooxygenases (constitutive COX-1 
and inducible COX-2) and by 5-lipoxygenase (5-LOX), respectively [188,190,191]. 
Oxidative stress is also an important factor in the triggering and progression of inflammation, 
occuring overproduction of ROS and RNS, in which the enzyme NO synthase (iNOS) plays an 
important role, contributing to tissue damage [161,187]. Overall, these oxidative agents result 
from activation of phagocytic cells, whilst nonphagocytic cells can also produce reactive 
species in response to proinflammatory cytokines. Moreover, recent findings have shown that 
the costimulation of TLR produces oxidative stress with unbalance of proinflammatory cytokine 
production [161]. 
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Despite the protective role of inflammation, when acute inflammation is not resolved and lasts 
longer or gets deregulated, a chronic inflammation emerges, which is characterized by 
progressive degeneration of the tissue and activation of the adaptive immune system 
[187,188]. In attempting to repair the damaged tissue, T cells produce cytokines such as INF-
γ and TNF-α, thus activating specifically macrophages, developing in chronic inflammation. 
This condition has a detrimental effect in several diseases including atherosclerosis, 
rheumatoid arthritis, infection, asthma, obesity, diabetes, neurodegenerative diseases, cancer 
and inflammatory bowel disease [192,193]. Thus, the proinflammatory stimulus (cytokines or 
microbial antigens) bind to the cell receptors triggering the NF-kB or mitogen-activated protein 
kinase (MAPK) signaling cascades, culminating in transcription of several proinflammatory 
genes encoding biochemical mediators, such as cytokines and enzymes [187,188]. Several 
molecules involved in these cascades events are the target of anti-inflammatory and 
immunomodulatory drugs. 
Drug-based therapies employing corticosteroids and a variety of nonsteroidal anti-
inflammatory drugs (with greater specificity for the COX-2 enzyme or inhibition of 5-LOX) also 
have side effects [188,191,194]. In addition, since inflammation can be counteracted by anti-
inflammatory cytokines (IL-4, IL-10, IL-13), transforming growth factor (TGF)-β and specific 
receptors for IL-1 and TNF-α [187], several drugs have been developed to inhibit cytokine 
activity (e.g. inhibitors of TNF-α and IL-1) commoly used to control chronic inflammatory 
diseases [195]. Thus, it seems to be important to replace the use of immunomodulators with 
natural compounds that mimic their effects, focusing on the development of alternative and 
innovative therapeutics for the treatment of these diseases. 
A growing body of experimental evidence suggests that plant extracts or their bioactive 
compounds (e.g. phenolic compounds) have potencial therapeutic application in the treatment 
of several inflammatory diseases [1,47]. In vitro and in vivo studies suggest that the anti-
inflammatory activity of plants might occur through distinct mechanisms, including the inhibition 
of pro-inflammatory cytokines, intercellular adhesion molecules and enzymes (e.g. iNOS, 
COX-2, 5-LOX), as well as, transcription factors, such as NF-κB [19,187,192,195–197]. 
Therefore, biological activity of some enzymes or other inflammatory products has been 
accessed in chemico (e. g. inhibition of LOX-5 and COX activity) [38,177,198]. In addition, 
inflammatory molecules could be also measured by enzyme-linked immunosorbent assay 
(ELISA), flow cytometry and/or Western Blot methods [199–202], and its gene expression 
could be performed by analysis by real-time polymerase chain reaction (RT-PCR) [186,201]. 
Cell cultures methods were also used for studying the potential of natural products to 
counteract distinct mechanisms of inflammation (cytokines, enzymes, ROS or NO levels), after 
LPS and/or IFN-γ stimulation of human monocytic leukemia cell line (THP-1 cells) or, more 
61 
Andrea F. Afonso, 2019 | PHENOLIC COMPOSITION AND HEALTH-BENEFITS OF SALVIA AND THYMUS 
frequently, on monocyte/macrophage cell line RAW 264.7, simulating the acute inflammation 
process. Griess reaction is vastly used for measuring the nitrite accumulation in the culture 
supernatant on monocyte/macrophage cell line RAW 264.7 [171,196,203].  
 Anti-inflammatory activity of Salvia and Thymus plants – in vitro methods 
The anti-inflammatory potential of sage and thyme plants has been extensively assessed 
(Table 7). In particular, the capacity to inhibit enzymes involved in inflammation was evaluated 
for a water extract of S. officinalis and a methanolic extract of Salvia radula, which were 
demonstrated to be potent inhibitors of 5-LOX (EC50 values of 27.6 and 78.8 µg/mL, 
respectively) [38,177]. In addition, ethanolic and methanolic extracts of different Salvia species 
presented inhibitory capacity of LOX, with the highest values registered for Salvia sericeo-
tomentosa var. hatayica (74%), followed by Salvia freyniana (66%) [77]. Notably, the activity 
of 5-LOX was also retarded by Thymus polar extracts (Table 7), namely from T. camphoratus, 
T. carnosus and T. mastichina (EC50= 27-53 µg/mL) [177]. Moreover, inhibition of  COX-1 was 
reported for an aqueous extract of Salvia sclareoides [204] and for a hydroalcoholic extract of 
S. officinalis [198], in a concentration dependent manner (EC50 values of 271 and 19 μg/ml, 
respectively).  
On other hand, the anti-inflammatory potential of sage and thyme genera, was measured in 
chemico by the ability of scavenging NO●. In particular, ethanolic extracts of six Thymus 
species showed EC50 NO• scavenging results 1-3 times higher than the tested standard 
compound (Trolox), whith the best results being obtained for the T. pulegioides and T. 
longicaulis species (EC50 of 69.8 and 71.6 μg/mL, respectively) [45]. Moreover, ethanolic 
extracts of S. plebeia (rich in caffeic acid, luteolin-O-7-glucoside and hispidulin) were shown 
to exhibit higher NO● scavenging than quercetin (60% and 80% of inhibition, respectively, at 
200 μg/mL) [205]. 
Studies on cellular models also support the hypothesis that Salvia and Thymus phenolic-
enriched extracts possess anti-inflammatory activity. In this sense, ethanolic and methanolic 
extracts of S. plebeia, were shown to suppress iNOS and prostaglandin E2 (PGE2) expression, 
ROS and NO levels in LPS-activated RAW264.7 macrophage cells in a concentration-
dependent manner [196,206]. Likewise, aqueous extracts of S. miltiorrhiza were demonstrated 
to effectively decrease the levels of NO and iNOS expression on LPS-activated mouse 
macrophages [171,207]. In particular, S. miltiorrhiza, downregulates NO and TNF-α production 
(EC50= 200 and 900 μg/mL, respectively) without affecting the cell viability of LPS-stimulated 
macrophages [171]. Moreover, an ethanolic extract of S. plebeia (100 µg/ml) was able to 
suppress NO level (about 30% of inhibition) in LPS-activated RAW264.7 macrophage cells 
[196]. Besides, an hydroalcoholic extract of T. longicaulis, with high amounts of rosmarinic 
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acid, was shown to inhibit COX-2 gene expression in THP-1 macrophages [186], and the 
aquoues extracts of S. officinalis and T. vulgaris were able to decrease the release of the 
cytokine IL-8 for both H2O2 or TNFα-stimulated peripheral blood lymphocytes (PBL) [200]. 
Likewise, T. vulgaris was shown to inhibit the production of cytokines IL-1β and TNF-α in LPS-
activated RAW 264.7 macrophages after exposure to different concentrations of propylene 
glycol extracts [208]. 
Notably, some authors emphasized a straight correlation between the high levels of phenolics 
and/or flavonoids in the extract with its antioxidant/anti-inflammatory activities [171,200]. 
Among non-flavonoids, rosmarinic acid (the major phenolic in Salvia and Thymus plants in 
general) and its derivatives are probably positive contributors to anti-inflammatory activities, 
being able of counteracting proinflammatory cytokines and the enzymes COX-2 and iNOS in 
a dose-dependent manner in LPS-induced inflammatory cells, as well as, by downregulating 
expression of NF-κB promoter-related genes [202,209,210]. Moreover, ethyl rosmarinate, a 
structurally modified rosmarinic acid, was claimed to be a potent inhibitor against lung 
inflammation, based on NO and PGE2 inhibition and also by decreasing of mRNA and protein 
expression of iNOS and COX-2 in LPS-induced alveolar macrophages [209]. In addition, the 
anti-inflammatory potential of lithospermic acid extracted from root of S. miltiorrhiza was 
demonstrated by inhibition of the production and mRNA expression of cytokines TNF-α, IL-1β, 
and IL-6, and by downregulation of proteins involved in the signaling NF-kB-pathway, in 
stimulated THP-1 macrophages [211]. 
Similarly, flavonoids have also been shown to inhibit the expression of various enzyme 
systems, inflammatory mediators (e.g. molecules adhesion, cytokines and chemokines) and 
molecules involved in signal transduction pathways implicated in the inflammatory response 
[47,212]. In particular, luteolin (a flavone present in Salvia and Thymus plants in general), was 
demonstrated to inhibit the expression of COX2 and TNF‑α secretion in IFN‑γ‑stimulated 
RAW264.7 macrophage cells, and to inhibit the phosphorylation of signal transducer and 
activator of transcription (STAT)-3, a crucial transcription factor of proliferation and activation 
of T cells [199]. 
 Anti-inflammatory activity of Salvia and Thymus plants – in vivo methods 
The anti-inflammatory effect of sage and thyme species were observed in vivo models as well. 
Experimental animal models of acute inflammation comprise the paw edema induced by 
carrageenan, histamine, dextran and/or formalin; ear edema induced by toxics as croton oil, 
arachidonic-acid, oxazolone, phorbol myristate acetate and xylene; measurement of 
myeloperoxidase in leucocytes, total numbers of polymorphonuclear leukocytes (LPM); 
vascular permeability induced by acetic acid in tissues from animal models [196,201,207,213]. 
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Other in vivo studies include chronic inflammation models, namely cotton pellet-induced 
granuloma and glass rod granuloma [190,213].  
Among the reported bibliography of Salvia plants, significant inhibition of paw edema (21-28%) 
was reported after treatment with extracts obtained from S. virgata and S. halophila (at 100 
mg/kg) or Salvia splendens (at 1000 mg/kg) [115,214], which were rich in RA. Similar inhibition 
of paw edema (35%) was observed after treatment with a methanolic extract obtained from S. 
bicolor (at 50 mg/kg), which was particularly enriched in the flavones luteolin-7-O-glucoside 
and apigenin [128]. Moreover, oral administration of an ethanolic extract from S. sclarea in a 
rat model of periodontal disease, was able to decrease cytokines production IL-6, IL-1β and 
TNF-α, possibly due to its high content of rosmarinic acid (165.3 μg/mg of extract) [74]. In 
addition, Salvia przewalskii extract, rich in rosmarinic acid and salvianolic acid B, improved 
urinary protein excretion in a rat model of immune complex glomerulonephritis, increasing total 
serum protein and serum albumin values [215]. These findings showed that S. przewalskii 
extract treatment could maintain renal function effectively, displaying its anti-inflammatory 
potential, since inflammatory response is the characteristic feature of glomerular disease in 
immune glomerular injury [215].  
As for Thymus plants, Khouya et al [184] found that aqueous extracts of T. atlanticus, T. 
satureioides and T.zygis could suppress croton oil-induced mice ear edema (at 900 µg/ear) 
and T. atlanticus, and T. zygis also inhibited carrageenan-induced rat paw edema (at 50 
mg/kg), with similar potency to that of the non-steroidal anti-inflammatory drug indomethacin. 
These authors showed that a water extract of T. zygis could suppress croton oil-induced mice 
ear edema in 70% (at 900 µg/ear) and inhibit carrageenan-induced rat paw edema in 3.7% (at 
50 mg/kg), comparing to indomethacin [54,184]. 
It is possible that major phenolic constituents of sage and thyme extracts might contribute to 
their anti-inflammatory effects since either rosmarinic acid, caffeic acid, luteolin-7-O-glucoside 
and apigenin were previously reported as to effectively counteract inflammatory events in vivo 
models [201,202,216,217]. In particular, rosmarinic acid suppressed LPS-induced 
proinflammatory cytokine [201,202] and inhibited the expression of COX-2 and iNOS protein 
in mice disease -inflammatory models [202,218]. The overall data highlighs the anti-
inflammatory potential of Salvia and Thymus polar extracts throught distinct mechanisms, also 
emphasizing their potential to be used in the development of alternative drugs for the treatment 
of a variety of diseases settled on oxidative and/or inflammatory events, including infectious 
diseases, diabetes, cancers, ageing and others. 
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Table 7 – Anti-inflammatory properties of phenolic-enriched extracts of distinct Salvia and Thymus species 
Plant Species Origin Solvent extraction 
(Major 
components) 
Screen Assay Effect Ref 
Salvia species     
S. bicolor Egypt 
MeOH (Lut-7-O-Glr, 
Api) 
Carrageenan-induced paw edema 
At 50 mg/kg after 2 h: ↓18.1%, after 3h: ↓29.4%, after 4 h: 
↓35.4%  
[128] 
S. fruticosa Lebanon  
MeOH (Lut, Rut, 
GA) 
Carrageenan-induced paw edema At 200 mg/kg after 4 h: ↓50% (aerial parts), 44% (roots) 
[219] 






LPS- or IFN- γ-activated RAW 264.7 
macrophages / Inhibition of NO and 
TNF-α production 
NO (EC50, mg/mL) = 0.2  






IL-8 release of PBLs prior to 
stimulation by TNFα and H2O2  
↓IL-8 release in 25 and 35% upon stimulation of TNF-α and 
H2O2, respectively 
[200]  
S. officinalis Brazil EtOH-H2O (ND) 
Croton Oil-induced ear edema 
MPO activity 
At 5 mg/ear: ↓ear edema by 34.1%  
At 5mg/ear: ↓MPO activity by 46%  
[220] 
S. officinalis Portugal 
DE, EA, n-but, H2O 
(ND) 
5-LOX activity 
5-LOX (EC50 μg/mL): 29.6 (DE), 41.0 (EA), 39.3 (n-but), 27.6 
(H2O)   
[177] 
S. plebeia Korea EtOH (ND) 
Acetic acid-induced vascular 
permeability  
Carrageenan-induced inflammation in 
the air pouch 
Total numbers of LPM in the air 
pouches 
NO production in LPS-induced 
RAW264.7 macrophages 
At 50, 100 and 200 mg/kg: ↓ vascular permeability of 3.5%, 
22.9% and 66.4%, respectively 
At 0.1, 0.3 and 1.0 mg/pouch: ↓ exudate volume of 21.9%, 
27.1% and 42.7%, respectively (in comparison to 
dexamethasone (0.01 mg/pouch: ↓ exudate 60%) 
At 0.1, 0.3 and 1.0 mg/pouch: ↓ LPM 4.9%, 14.6% and 32.7%, 
respectively 
At 10, 50 and 100 μg/ml: ↓ NO of 50, 25 and 15 μM, 
respectively 
[196] 
S. plebeia China EtOH (Pld C, Plf) 
NO production in LPS-induced 
RAW264.7 macrophages 





MeOH (RA) 5-LOX inhibithy EC50 (µg/mL)= 78.8 
[38] 
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S. sclarea L. Serbia 
EtOH (RA, Lut-7-O-
Glc, Api-7-O-Glc) 
Cyokines measurement in rats’ 
gingival tissues 
↓ of TNF-α, IL-1β, and IL-6  
[74] 
S. splendens Egypt 
80% MeOH (RA, 
caffA deriv, flav 
glyc) 
Carrageenan-induced paw edema 
At 1000 mg/kg after 2 h: ↓28% (potency 0.55 in comparison to 
indomethacin) 
[115] 
S. sclareoides Portugal 
H2O (RA, Lut-di-Glr, 
Lut-acetyl-Glc) 
COX-1 inhibithy EC50 (µg/mL)= 271.0 
[204] 
S. virgata Turkey 
MeOH (RA, o-
CouA)  
Carrageenan-induced paw edema At 100 mg/kg after 4,5 h: ↓28%, after 6 h: ↓24%  
[214] 
Thymus species     
T. atlanticus Morocco 
H2O (RA, caffA, 
Que) 
Croton oil-induced mice ear edema 
Carrageenan-induced rat paw edema 
At 900 µg/ear after 8 h: ↓84.6% (in comparison to 
indomethacin) 




T. carnosus (T.cr) 
Portugal DE, EA, n-but (ND) 5-LOX inhibithy 
5-LOX (EC50 μg/ml): 29.9 (DE), 27.4 (EA), 28.0 (n-but), T.cm; 
23.5 (DE), 29.6 (EA), 18.3 (n-but), T.cr. 
[177] 
T. longicaulis Italy 
EtOH-H2O (RA, SA 
K, Lut-O-Hex, Quer-
O-Hex) 
COX-2 gene expression on THP-1 
cells 
At 50 µg/ml: ↓42% (extract collected in October) 
[186] 
T. mastichina Portugal DE, EA, n-but (ND) 5-LOX inhibithy 5-LOX (EC50 μg/ml): 62.5 (DE), 53.1 (EA), 30.5 (n-but) 
[177] 
T. satureioides Morocco 
H2O (RA, Lut-7-Glc, 
hesp) 
Croton oil-induced mice ear edema 







IL-8 release of PBLs prior to 
stimulation by TNFα and H2O2  







Cytokines production (pg/mL) by in 
LPS-induced RAW264.7 
macrophages 
IL-1β (pg/ml) = 28, 2, 2 at 25, 50 and 100 mg/mL extract, 
respectively 
TNF-α (pg/ml)= 4466, 824, 12 at 25, 50 and 100 mg/mL extract, 
respectively 
[208] 
T. zygis Morocco 
H2O (RA, caffA, Lut-
7-O-Glc) 
Croton oil-induced mice ear edema 
Carrageenan-induced rat paw edema 
At 900 µg/ear after 8 h: ↓70% (in comparison to indomethacin) 
At 50 mg/kg after 5 h: ↓3.7% (in comparison to indomethacin 10 
mg/kg) 
[54,184] 
Api– apigenin; CaffA/CaffA deriv– caffeic acid/caffeic acid derivatives; CouA – coumaric acid; COX-2– cyclooxygenase; DE - diethyl ether; EA - ethyl acetate; EO– essential oil; EtOH– ethanol; 
Flav/flav glyc– flavones/flavone glycosides; GA – gallic acid; Glc–glucoside; Glr – glucuronide; Hesp – hesperetin; Hex – hexoside; IFN-γ– interferon-γ; IL–interleucin; 5-LOX– 5-lipoxygenase; LPM 
- polymorphonuclear leukocytes; LPS– lipopolysaccharide; Lut – luteolin; MeOH– methanol; MPO – myeloperoxidase; n-but - n-butanol; ND – not determined;  NF-κB – nuclear factor-kappa B; NO– 
nitric oxide; PBL - peripheral blood lymphocytes; PG - Propylene glycol; PGE2 - prostaglandin E2;  Pld C - plebeiolide C; Plf – plebeiafuran; Que – quercetin; RA– rosmarinic acid; Rut – rutin; SA - 
salvianolic acid; THP-1 - human monocytic leukemia cell line; TNF-α– tumor necrosis factor-α. 
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1.3.3. Anticancer activity 
Cancer is a major health problem worldwide being the second leading cause of death globally 
and is estimated to account for 9.6 million death in 2018 [221]. The genesis of tumor can be 
diverse, namely, chronic inflammation, some infectious diseases (e.g. virus infection), 
radiation, environmental and chemical agents and genetic predisposition, has long been 
recognized as a risk factor for the development of tumors in many different tissues [222–224].  
The cancerous state develops when the normal tissue homeostasis is broken, resulting in an 
imbalance between cellular proliferation and cell death. A number of oncoproteins and tumor 
suppressors involved in regulation of these processes are often aberrant in cancer, thereby 
promoting cell proliferation and inhibition of programmed cell death (apoptosis). Indeed, 
cellular oncogenes products arise from malignantly transformed cells and can involve 
mutations, DNA amplifications or translocations, overall  increasing or decreasing expression 
of gene products, involved in cellular proliferation or cell death [222,225–227].  
Apoptosis can be induced by activation of the caspase cascade through death receptors 
pathway or the mitochondrial pathway, although others several signaling pathways are 
critically involved in the regulation of programmed cell death [225,226]. The Bcl-2 family of 
proteins have important roles in governing mitochondrial death signaling, whose members 
have either proapoptotic (Bax, Bad) or antiapoptotic (Bcl-2, Bcl-XL) [228]. Thus, the induction 
of programed cell death in cancer cells is one of the strategies used in the development of anti-
cancer drugs [229–231]. Recent reports showed that a new class of small regulatory RNA 
molecules, termed microRNAs (miRNAs), can modulate these major proliferation pathways 
through interacting with critical cell cycle regulators, which have been proposed as novel 
oncogenes or tumor suppressors [225,226,232,233]. In addition, is it presently accepted that 
chronic inflammation promotes oxidative events that contribute to magliant transformation of 
cells associated with tumor cell proliferation and tumor progression, as well as, angiogenesis 
and tissue remodeling, induction of neoplastic transformation and metastasis [163,167]. In 
these context, a notably body of experimental evidence suggests that pharmacologic 
attenuation of  inflammatory processes, can restore the cancer cells to an apoptosis-
permissive and growth-inhibitory state [163,168].  
Considering the high antioxidant, inflammatory and/or anticancer properties of diverse plants, 
recent researches have demonstrated that secondary metabolites can be effective regulators 
of the cell cycle of tumor cells at an early stage by targeting specific cell signaling molecules, 
leading to apoptosis or cellular senescence and/or to act at later stages of tumorigenesis by 
inhibition of angiogenesis or prevention of tumor invasion and metastasis [227,232,234–236]. 
In this context, plants used in traditional forms have been the focus of attention as plant-based 
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foods, whose regular consumption correlated with a lower incidence of cancer, because are 
rich in phenolic acids and flavonoids with promising chemopreventive and chemotherapeutic 
potentials for cancer prevention and/or treatment [227,232–236]. In many cases, the effects of 
natural compounds are due to the inhibition of the activity of different transcriptional factors, 
including the key factors NF-kB and AP-1, involved in the expression of several inflammation 
mediators [227,232,235,236].  
 Cell cytotoxicity assays  
Salvia and Thymus plants have been widely studied as potential sources of chemotherapeutic 
agents, particularly in vitro cellular models. As for drugs in general, the majority of these studies 
have used the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay as a 
first approach method to estimate cytotoxicity/growth-inhibitory activity of extracts in cancer 
cell lines (Table 8). Note that MTT is a colorimetric method that measures the activity of 
mitochondrial enzymes that reduce MTT to purple formazan, whose conversion is often used 
as a estimative of viable cells [178,229]. Similar principle methods are commonly used, 
including those based on the reduction of XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-
tetrazolium-5-carboxanilide) [186,237] and MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl) 2-(4-sulphophenyl)-2H-tetrazolium inner salt) [238,239] which result 
in the formation of the colored formazan; or sulforhodamine B (SRB) assay that is based on 
the ability of SRB to bind to protein components of cells, which have been fixed to tissue-
culture plates by trichloroacetic acid [240]. Most studies present the antioxidant activity 
expressed as IC50 values (half inhibition concentration), which is equivalent to sample 
concentration that inhibited 50% of the cell grow. 
In general, the anticancer activity of Salvia and Thymus extracts have been mostly accessed 
for S. officinalis, S. miltiorrhiza and T. vulgaris and mainly based on cytotoxic assays (Table 
8). Using MTT method, Brahmi et al. [176] reported that hydroalchoolic extracts of S. officinalis 
were able to inhibit the viability of neuroblastoma and hepatoblastoma HepG2 cells lines, 
showing dose dependent cytotoxic effects after 48 h exposure. Using the same assay, crude 
methanolic extract of S. officinalis showed cytotoxic effect against non-Hodgkin’s B-cell 
lymphoma (Raji), human leukemic monocyte lymphoma (U937), human acute myelocytic 
leukemia (KG-1A), human breast carcinoma (MCF-7), human prostate cancer (PC3), and 
mouse fibrosarcoma (WEHI-164) cell lines in a dose-dependent manner, as reflected by the 
comparatively low IC50 values (range between 142 and 179 µg/ml) to that obtained in Human 
Umbilical Vein Endothelial Cells (HUVEC, IC50 values exceeding 600 µg/mL) [241]. In addition, 
the cytotoxicity effect of Danshen alcohol, extracted from S. miltiorrhiza, was proved on human 
oral squamous carcinoma (OSCC) cell lines HSC-3 and OC-2 (IC50 values of 27 and 31 µg/ml, 
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respectively) [230]. In the same way, methanol extracts of S. miltiorrhiza roots, showed 
reduced cells survival in a dose-dependent manner on human lung cancer Glc-82, A549 and 
H460 cells, with respectively IC50 values of 21, 61 and 75 μg/mL [231].  
Extracts of other Salvia species have been shown to display cytotoxic capacity on several 
tumoral cell lines, including the methanolic extracts of Salvia eremophila (IC50 of 12, 16 and 48 
μg/ml on human promyelocytic leukemia HL60, human erythromyeloblastoid leukemia K562 
and breast cancer MCF-7 cells, respectively) [10]. Moreover, in this study, the authors also 
described that both methanol and dichloromethane (DCM) extracts of S. aegyptiaca, Salvia 
aethiopis, Salvia hypoleuca, Salvia limbata and Salvia santolinifolia were active against the 
tested cell lines, suggesting that compounds with different polarities must be involved in their 
cytotoxic activity [10]. In addition, Alimpic et al. [106,114] reported IC50 values in the range 9.8 
to 164 μg/mL for aqueous and ethanolic extracts of S. amplexicaulis and S. ringens (both rich 
in kaempferol glycosides), towards colon carcinoma HCT-116 cell line. 
Based on MTS assay, Jiang et al. [238] reported IC50 values of 84.0 and 75.8 µg/ml ethanolic 
extracts from leaves and roots of S. officinalis, respectively, towards HepG2 cells. Both extracts 
disclosed less anti-proliferation ability in normal human liver cells (WRL-68), with higher IC50 
values (>100 µg/ml), which further proved the anticancer property of leaves and roots extracts 
of S. officinalis and the safety to normal human liver cells (WRL-68) [238]. Cytotoxicity effect 
by the same method was also demonstrated by methanolic extracts of S. chloroleuca, together 
with n-hexan and DCM fractions, that showed a viability decrement of human breast cancer 
cell line MCF-7, in a concentration-dependent manner (IC50 of 60, 28 and 25 μg/mL, 
respectively) [239].  
As regard to  the anticancer effects of Thymus plants, despite most of previous works have 
been focus on T. vulgaris, some other species have also been suggested as good 
antiproliferative agents (Table 8). E.g. methanolic extracts of T. schimperi, rich in the flavone 
luteolin and derivatives, required doses of 50–100 μg/mL to inhibit human gastric 
adenocarcinoma AGS cells growth by 50% (IC50= 88 μg/mL) [147]. In addition, Galasso et al. 
[186] showed that T. longicaulis extracts, containing high amounts of quercetin-O-hexoside, 
luteolin-O-exoside and salvianolic acid K, caused a decrease of cell viability on breast cancer 
MDA-MB-23, colon carcinoma HCT-116 and lung fibroblast MRC-5 cells, equal to or higher 
than those observed for vinblastine, a known anti-cancer agent [186]. Besides, Esmaeili-
Mahani et al. [229] reported that polar extracts of Thymus caramanicus (at 150-200 μg/mL), 
could reduce the viability of human breast adenocarcinoma MCF-7 for about 60% and 
interestingly, its concomitant treatment (40 and 80 μg/mL extract) with the vincristine effectively 
potentiated the effect of the anticancer drug.  
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Moreover, based on MTT methods, commercial aqueous extracts of T. vulgaris and T. 
serpyllum were shown cytotoxic effect towards adriamycin-resistant human breast cancer cell 
line (MCF-7/Adr), with IC50 values of 407 and 399 μg/mL, respectively [242]. Amongst 
representative compounds of the extratcts (caffeic acid, rosmarinic acid, lithospermic acid, 
luteolin-7-O-glucuronide, luteolin-7-O-rutinoside and eriodictiol-7-O-rutinoside), rosmarinic 
acid and lithospermic acid were the most active. Notably, plant extracts (including T. vulgaris 
and T. serpyllum) proved to be more toxic against the cancer resistant cells than the analysed 
phenolics (that exhibited greater toxicity against the non-resistant cells), suggesting the 
existence of synergistic or additive effects among the extracts components.  
Finally, components of S. miltiorrhiza, including danshensu and salvianolic acids, were 
previously demonstrated to be exhert anticancer properties, both in vitro and in vivo models 
[243,244]. Similarly, tanshinones (tanshinone IIA, cryptotanshinone and tanshinone I), 
identified as major components of the methanol extract of the dried root of S. miltiorrhiza 
Bunge, is known to be one of the contributors to the anticancer properties of this plant [231].  
 Tumor-cell membrane integrity and DNA-protective evaluation 
Cell membrane integrity was generally used to determine the level of metabolically active cells, 
such as the activity of lactate dehydrogenase (LDH) and cell ATP quantity, the latter based on 
the fact that ATP is present in all metabolically active cells and can be a marker for cell viability 
and proliferation [238]. The anticancer properties of ethanolic extracts from leaves and roots 
of S. officinalis and ethanolic extracts from roots of S. miltiorrhiza was confirmed by LDH 
release and cellular ATP decrease when HepG2 cells were treated with different 
concentrations of extract, which resulted in a significant dose-dependent reduction in cellular 
proliferation related with untreated control cells [238]. In another study, S. miltiorrhiza 
polysaccharides (50 μg/mL) induced LDH leakage on LoVo colorectal carcinoma cell line, 
being more effective than  5-fluoro-2,4(1H,3H)-pyrimidinedione (100 μg/mL), a typical 
antitumor drug [234]. These results indicated that these sage extracts had significant cytotoxic 
effect on these cancers cells lines, and the inhibitory effect might have originated from inducing 
cell membrane damage. 
DNA repair ability is also important, as DNA damage can lead to carcinogenesis if replication 
proceeds without proper repair. The DNA-protective effects of plant extracts against DNA 
strand breaks induced by oxidant agents, hydrogen peroxide (H2O2) and 2,3-dimethoxy-1,4-
naphthoquinone (DMNQ), has been performed by the comet assay, based in single cell gel 
electrophoresis [178,245]. In fact, exposure for 24 h of H2O2-induced human colon carcinoma 
Caco-2 and human cervical cancer HeLa cells to aqueous extracts of S. officinalis and S. 
fruticosa resulted in a protective effect on DNA damage [245]. This effect was also observed 
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for the two major phenolic constituents of the extracts (rosmarinic acid and luteolin-7-O-
glucoside) thereby highlighting their intervention in this mechanism. The same authors also 
reported promising results in assays of DNA repair, as evaluated in oxidative-induced Caco-2 
cells. In this experimental conditions, the independent treatment with both extracts (50 μg/mL 
for 24h), as well as with luteolin-7-O-glucoside (20 µM), were able to increase the rate of 
rejoining of DNA strand breaks [245]. Notably, Kosics et al. [178] reported that the protective 
effects of S. officinalis and T. vulgaris (rich in rosmarinic acid) against DNA damage induced 
by strong oxidants (H2O2 and DMNQ), achieved  the highest DNA-protective capacity at 
concentrations of 2 and 0.5 mg/ml, respectively [178].  
 Apoptosis, cell cycle and angiogenesis evaluation 
Besides the decrement of cell viability of cancer cells, important effects of Salvia and Thymus 
extracts in key mechanisms of tumor formation/progression (e.g. apoptosis and angiogenesis) 
have also been attested. The apoptosis of proliferative cells after treatment with plant extracts 
has been screened in vivo and in vitro models, being the flow cytometry method extensively 
used for this purpose [231,234,238]. The most potent extracts/drugs treatment result in an 
increased number of tumoral cells undergoing apoptosis due to their accumulation in the early 
phases of the cell cycle, taking into account the sequential occurrence of sub-G1, G1, S, G2, 
culminating in the final mitosis (phase M) [169]. In particular, 43% of HCA-7 cells arrested in 
the G1 phase after treatment with ethanolic extracts of S. officinalis (16 µg/GAE/mL), while 
45% of cells arrested in these cell cycle phase after treatment with celocoxib (50 µM) [169]. 
Consistent with these results, after treatment with S. miltiorrhiza polysaccharides (at 100 and 
400 μg/mL), the percentage of human colon cancer LoVo cells in S phase were significantly 
increased (50% and 44%, respectively) in comparison with 32% of the untreated cells, probably 
by blockade of the the tumor cell transition from S to G2/M phase [234]. In addition, 
hepatocellular carcinoma HepG2 cells treated with ethanolic and acetone extracts of S. 
miltiorrhiza and S. officinalis, induced significantly cellular apoptosis at early and/or late 
stage/necrotic [238]. 
As a result of cell cycle arrest, DNA replication and protein synthesis in tumor cells could not 
be complete, leading to the disturbed cell cycle progression that causes the death of the tumor 
cells. Detection of molecules involved in cell proliferation or in apoptosis, kinases involved in 
several signaling pathways, oncogenes and tumor suppress activity can be evaluated by flow 
cytometry and western blot analysis [229–231,238]. Gene expression analysis of these 
biological components can also be performed by molecular methods such as RT-PCR 
[186,201].  
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Several studies have investigated the apoptosis induction of cancer cells through activation of 
the caspase cascade or by disruption in the balance between pro- and antiapoptotic Bcl-2 
family members, after exposure to sage and thyme extracts. Thus, the potential mediators of 
plant extracts induced cell damage can be analyzed by caspase cascade activation (e.g 
cleaved caspases) and by the expression of Bcl-2 family members, as cell apoptosis markers 
[169,229]. In particular, treatment of human lung cancer cells Glc-82 with methanolic extract 
of S. miltiorrhiza (20 and 40 μg/ml) showed a significant increase in the levels of cleaved 
caspase-9 and caspase-3, as well as, up-regulation the expression levels of pro-apoptotic Bax 
and down-regulation the expression of the Bcl-2 and Bcl-xl compared to control cells [231]. 
Moreover, treatment of human oral squamous carcinoma (OSCC) cell lines HSC-3 for 48 h 
with Danshen alcohol extract gradually increased the caspase-3 apoptotic pathway  [230]. 
Apoptotic capacity was also registered for aqueous extracts of T. vulgaris, which were shown 
to increase the activity of caspase3/7 on human colon carcinoma cells HCT116 [246]. In 
addition, Esmaeili-Mahani et al. [229] highlited the anticancer activity of T. caramanicus 
hydroalcoohlic extracts, based on their ability to induce apoptosis in human breast cancer cells 
MCF-7 through the increment of caspase-3 and Bax and decreasing of Bcl-2 expression. 
These T. caramanicus extracts (200 - 250 µg/ml) also potentiated the cytotoxicity of vincristine, 
which was accompanied by an increase in cleaved caspase-3 [229].   
Another characteristic event of cell apoptosis is the fragmentation of genomic DNA into 
multiples units producing a typical characteristic ladder on agarose gel electrophoresis. This 
event was observed in the human breast carcinoma MCF-7 cells, within 48 h after treatment 
with DCM solvent fraction of S. chloroleuca at 12.5, 50, 100 and 200 μg/mL [239].  
The effects of Salvia and Thymus compounds on the activity of different transcriptional factors, 
associated to the expression of tumor suppressors have also been investigated. In this context, 
methanolic extracts of S. miltiorrhiza were shown to downregulate the PI3K/Akt signaling 
pathways of human lung cancer cells Glc-82 [231]. These events resulted in an increased 
expression levels of the tumor suppressors p53 and p21 (4.2 and 3.4 times higher than those 
of untreated control cells, respectively) [231]. In addition, S. officinalis and S. fruticosa aqueous 
extracts (particularly enriched in rosmarinic acid and luteolin derivatives) were demonstrated 
to induce apoptotic cell death in rat insulinoma m5F and/or colon adenocarcinoma HCT15 and 
colon carcinoma CO115 cell lines. This effect was concentration-dependent for the two latter 
cell lines [247,248] and it was observed for rosmarinic acid (at 100 μM dose) as well. Authors 
correlated, at least in part, the activity of sage extracts/rosmarinic acid to the inhibition of 
MAPK/ERK pathway. 
The effects reported above were also investigated for individual compounds present in Salvia 
and Thymus, highlighting their relevance in the anticancer properties of these plants. 
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Rosmarinic acid has been implicated in inhibition of apoptotic factors (e.g. Bax and caspases 
3/ 9) [217], TLRs (e.g. TLR4) and transcriptional factors such as NF-κB, which regulate a 
number of target genes involved in cell proliferation, survival and angiogenesis in inflammatory 
diseases [201,202,217,218]. In turn, flavonoids have been claimed as cancer protective 
agents, e.g. quercetin was shown to produce cell cycle arrest in proliferating lymphoid cells 
and growth-inhibitory effects on several malignant tumor cell lines [47]. 
Since inhibition of angiogenesis has been recognized to be advantageous for prevention of 
inflammation and neoplastic growth, invading distant tissues forming metastasis [227,249], 
Salvia and Thymus species have been investigated with respect to their  antiangiogenic 
activity. In this context, non-toxic concentrations of ethanolic extracts of S. officinalis were 
shown to effectively inhibit proliferation and cell migration (two important mechanisms for new 
blood vessels formation) of human umbilical vein endothelial cells (HUVECs) [250]. As S. 
officinalis is enriched in rosmarinic acid, it is probable that this phenolic compound can play a 
role in that protective mechanism. In fact, Huang and colleagues [251] have stressed the ability 
of this caffeic acid dimer in inhibiting several important steps of angiogenesis including 
proliferation, migration, adhesion and tube formation of HUVEC. 
In vivo studies have also reported the tumor growth inhibition and antiangiogenic capacity of 
extracts from sage and thyme origin. In particular, ethanolic extracts of S. officinalis (at 100–
300 μg/mL) were shown to inhibit the capillary tube formation in rat aorta models [250]. In 
addition, the chick chorioallantoic membrane (CAM) angiogenesis model was used for 
assessing an inhibitory activity of the ethanol extract of S. plebeia on vascular development 
[196]. Moreover, S. miltiorrhiza methanolic extracts (10, 20, 40 mg/kg) were demonstrated to 
reduce tumor volume and weight of tumor xenografts in nude mice when compared to normal 
saline control, with growth inhibition rates of 36.7, 46.9 and 60.8, respectively [231]. In that 
study, TUNEL assay which enable to observe DNA fragmentation resultant from apoptosis, 
showed an increment of apoptotic cells after treatment with S. miltiorrhiza extracts [231]. 
Likewise, Wang et al. [230] demonstrated the reduction of tumor growth in mice treated with 
Danshen alcohol extract compared to the control group. 
 Molecules involved in inflammation 
A growing body of evidence suggests that the antitumoral activity of plant natural products are 
related to their anti-inflammatory and antioxidant activities, which in turn are claimed to be 
associated with their phenolic composition [227,235,236]. In this sense, the activity of enzymes 
involved in inflammation, such as COX-2 and its product PGE-2 (known as carcinogenesis 
promoters), those  involved in enhancing detoxification, like as GPX, SOD or catalase 
[232,235], and cytokines or others immunological mediators, can also be used for evaluation 
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of the antitumoral activity of Salvia and Thymus extracts [169,178,186]. In more detail, an 
extract obtained from commercially-available S. officinalis was shown to increase TNF-α 
secretion by macrophages [247]. Note that this is an important substance present in tumor 
microenvironments to counteract tumor cell survival and metastasis, as they act as pro-
inflammatory mediators, thus allowing macrophages to destroy cancer cells. On other hand, 
Moon et al. [252] found that rosmarinic acid could increase TNF-α-induced apoptosis in human 
leukemia U937 cells. Furthermore, ethanolic extract of S. officinalis decreased COX-2 
expression (40% at 40 μg GAE/mL) and consequently released PGE-2, and/or inhibited the 
growth and viability of colorectal cancer HCA-7 cell line, as well [169]. Likewise, hydroalcoholic 
extracts of T. longicaulis, particularly rich in rosmarinic acid and methylapigenin, exhibited a 
strong anti-inflammatory and anticancer effectiveness through inhibition of COX-2 gene 
expression on human leukemia cell line THP-1 macrophages [186]. These results suggest that 
there downregulation of COX-2 expression/activity and growth inhibition of tumor cells are 
closely associated [169,186], determining the relationships of anti-inflammatory, antioxidant 
and cytotoxic potential. 
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Table 8 – Anticancer properties of phenolic-enriched extracts of distinct Salvia and Thymus species 





Screen Assay Effect Ref 
Salvia species      






Cytotoxic effect (MTT) on HCT-
116 cells 
MTT (IC50, µg/mL)= 164 (EtOH), 114 (H2O), 0.02 (5-Fl), for 24h/ 582 
(EtOH), 161 (H2O), 0.8 (5-Fl), for 72h 
[106] 
S. chloroleuca Iran 
MeOH, DCM, 
H2O, n-hex (ND) 
Cytotoxic effect (MTS), 
apoptosis on MCF-7 cells 
MTS (IC50, µg/mL)= 60 (MeOH), 25 (DCM), >250 (H2O), 28 (n-hex), for 48h 
/ apoptosis (G1-peak): ↑ (DCM) after 12, 25 and 50 µg/mL extract for 48h, 
apoptosis (DNA fragmentation): ↑ (DCM) after 12, 50, 100 and 200 µg/mL 
extract for 48h 
[239] 




Cytotoxic effect (MTT) on HL60, 
K562, MCF-7 cells 
MTT (IC50, μg/mL)= HL60: 11 (DCM), 12 (MeOH), 25 (80% MeOH), 0.8 
(Cis); K562: 16 (DCM), 16 (MeOH), 43 (80% MeOH), 2.1 (Cis) / MCF-7 
Cells: 46 (DCM), 48 (MeOH), 75 (80% MeOH), 6.9 (Cis) 
[10] 
S. miltiorrhiza Commercial 
EtOH, EtOH-
H2O (ND) 
Cytotoxic effect (MTT) on 
OSCC (HSC-3 and OC-2 cells)/ 
markers of apoptosis (flow 
cytometry and western blot) / In 
vivo antitumor growth 
MTT (IC50, μg/mL)= HSC-3: 40 (EtOH), 47 (EtOH-H2O) after 24h; HSC-3: 
27 (EtOH); OC-2: 31 (EtOH) after 48h / Flow cytometry= HSC-3: ↑ caspase 
3, at 10, 25, or 50 𝜇g/mL, after 48h; change in mitochondrial membrane 
potential (Δ𝜓) / western blot: unchange of bcl-2, Bcl-xl, Bax and Bad / in 
vivo: ↓ mice tumor volumes= 1056 mm2 and 552 mm2, at 50 mg/kg and 100 
mg/kg extract, respectively 
[230] 
S. miltiorrhiza China 
MeOH (Tsh IIA, 
crytsh, Tsh I) 
Cytotoxic effect (MTT) on lung 
cancer Glc-82 cells/ Clonogenic 
survival in Glc-82 cells/ cell 
cycle and apoptosis (flow 
cytometry and western blot) / In 
vivo antitumor growth (TUNEL 
assay) 
MTT (IC50, μg/mL) = Glc-82: 21; A549: 61; H460: 75, after 24h / Clonogenic 
survival (% cell colonies rate): 65, 45, 30 at 10, 20, and 40 𝜇g/mL of extract, 
respectively; 
Flow cytometry = Glc-82 cells´s cell cycle: ↓ G0/G1 phase, G2/M arrest, at 40 
μg/ml extract, after 24h; apoptotic cells (%): 6, 10 and 31 at 10, 20 and 40 
𝜇g/mL of extract, respectively; 
Western blot = Glc-82 cells: ↑ caspase-9, ↑ caspase-3 at 20 and 40 𝜇g/mL 
of extract; ↑ p53, ↑ p21 at 40 𝜇g/mL of extract; ↑ Bax, ↓ Bcl-2, ↓ Bcl-xl, ↓ 
PI3K/Akt signaling pathways, at 10, 20 and 40 μg/ml extract, after 24h. 
[231] 
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In vivo: mice TGI (%)= 37, 47 and 61, at 10, 20, and 40 𝜇g/mL of extract, 
respectively; TUNEL-positive cells (%): 6, 14 and 26 at 10, 20, 40 mg 
extract/kg 
S. officinalis 







Cytoprotection (Comet assay) 
and DNA repair 
DNA protection against strand breaks induced by H2O2: 21% (HeLa cells, 
SL), 26% (Caco-2 cells, SF), at 50 µg/mL extract 
DNA repair in Caco-2 cells: 62% (SO), 86% (SF), at 50 µg/mL extract 
[245] 
S. miltiorrhiza 
leaves (L) and 
roots (R) 
Commercial EtOH, Acet (ND) 
Cytotoxic effect (MTS), LDH 
release, amount of ATP and 
apoptosis on HepG2 and WRL-
68 normal cells 
MTS (IC50, µg/mL)= HepG2: >200 (EtOH-L, Acet-L), 17 (EtOH-R), 83 (Acet-
R), for 48h; WRL-68: 19->200 / 14->200, for 24/48h  / LDH release: ↑ 
(EtOH- R) at 50 and 150 µg/mL for 18h / amount of ATP: ↓ (EtOH-R, Acet-
R) / early apoptosis: ↑ (EtOH-L), late apoptosis/necrosis: ↑ (EtOH-R), after 
100 µg/mL, for 24h 
[238] 
S. officinalis 
leaves (L) and 
roots (R) 
Commercial EtOH, Acet (ND) 
Cytotoxic effect (MTS), LDH 
release, amount of ATP and 
apoptosis on HepG2 and WRL-
68 normal cells 
MTT (IC50, µg/mL)= HepG2: 64 (EtOH-L), 90 (Acet-L), 20 (EtOH-R), 44 
(Acet-R), for 48h; WRL-68: 100->120 / 46-88, for 24/48h  / LDH release: ↑ 
(EtOH-L/R, Acet-L/R), at 50 and 150 µg/mL for 18h / amount of ATP: ↓ 
(EtOH-L/R, Acet-R) / early apoptosis: ↑ (EtOH-L, Acet-L), late 
apoptosis/necrosis: ↑ (EtOH-L/R), after 100 µg/mL, for 24h 
[238] 
S. officinalis Algerian 
EtOH-H2O (RA, 
Flav) 
Cytotoxic effect (MTT) on SK-N-
BE(2)C neuronal, HepG2 
hepatic cells 
MTT (CVI %): 10 (SK-N-BE(2)-C), 25 (HepG2),  for 48 h. [176] 
S. officinalis Commercial 
EtOH (RA, Salv 
K isomer, Lut-
Hex, Api-Glr) 
Cytotoxic effect (MTT), DNA 
damage (comet assay)  and 
enzymatic activity of HepG2 
cells 
MTT (IC50, mg/mL)= 5.7 / HepG2 DNA damage induced by H2O2 and 
DMNQ: ↓ after 2 mg/mL extracts, at 24h / Enzymatic activity: ↑ GPx, ↓ SOD,  
after 4, 2 and 1 mg/mL extracts 
[178] 
S. officinalis Commercial MeOH (ND) 
Cytotoxic effect (MTT) on Raji, 
U937, KG-1A, MCF-7, PC3, 
WEHI-164 and in non-tumor 
HUVEC cells 
MTT (IC50, μg/mL)= Raji: 167; U937: 205; KG-1A: 179; MCF-7: 142; PC3: 
76; WEHI-164: 40; HUVEC: > 600 
[241] 
S. officinalis  Commercial 
EtOH, EtOH-
H2O, H2O (ND) 
Growth Inhibition (SRB), COX-2 
inhibition (western blot) and cell 
cycle (flow cytometry) on HCA-7 
cells  
SRB (IC50, μg/mL DW) = HCA-7: 347 (EtOH), 414 (EtOH-H2O), > 442 (H2O) 
/ COX-2 inhibition (%): 40 (EtOH) at 40 μg GAE/ml; 70 (Celx) at 50 μM / 
HCA-7 cell cycle (%) = Sub G1: 16 (EtOH), 23 (Celx); G1: 42 (EtOH), 45 
(Celx), S: 23 (EtOH), 18 (Celx), G2: 18 (EtOH), 13 (Celx), at 16 μg GAE/mL 
of EtOH and 50 μM of Celx  
[169] 
76 
Andrea F. Afonso, 2019 | PHENOLIC COMPOSITION AND HEALTH-BENEFITS OF SALVIA AND THYMUS 
 





Cytotoxic effect (MTT) on HCT-
116 and SW480 cells 
MTT (IC50, µg/mL) = HCT-116:  32 (EtOH), 9.8 (H2O) at 24h / 179 (EtOH) / 
407 (H2O) at 72h / SW480: >500 (EtOH)/ >500 (H2O) at 24h / >500 (EtOH), 
412 (H2O), at 72h 
[114] 




Cytotoxic effect (MTT) on HL60, 
K562, MCF-7 cells 
MTT (IC50, μg/mL)= HL60: 48 (DCM), 47 (MeOH), 49 (80% MeOH), 0.8 
(Cis); K562: 79 (DCM), 49 (MeOH), 55 (80% MeOH), 2.1 (Cis) / MCF-7 
Cells: 147 (DCM), 109 (MeOH), 6.9 (Cis) 
[10] 
Other Salvia species     











Cytotoxic effect (MTT) on HL60, 
K562, MCF-7 
MTT (IC50, μg/mL)= S. aegyptiaca - HL60: 99.7 (DCM); K562: 97 (DCM); 
MCF-7: 116 (DCM) / S. aethiopis - HL60: 45 (DCM); K562: 41 (DMC), 50 
(MeOH); MCF-7: 44 (DMC), 79 (MeOH) / S. hypoleuca - HL60: 53 (DCM), 
96 (MeOH); K562: 49 (DMC), 94 (MeOH); MCF-7: 83 (DMC), 106 (MeOH), 
99 (80% MeOH) / S. limbata - HL60: 51 (DCM); K562: 45 (DMC), 111 
(MeOH), 110 (80% MeOH); MCF-7: 64 (DMC), 149 (MeOH) / S. nemorosa - 
K562: 87 (80% MeOH) / S. syriaca- MCF-7: 75 (80% MeOH) /  S. 
xanthocheila - HL60: 167 (MeOH); K562: 73 (MeOH); MCF-7: 128 (MeOH) / 
Cisplatin - HL60: 0.8; K562: 2.1; MCF-7: 6.9 
[10] 
Thymus species      
T. caramanicus Iran EtOH-H2O 
Cytotoxic effect (MTT) on MCF-
7 cells / Biochemical markers of 
apoptosis and cell proliferation 
(Wester blot) 
MTT (cell viability %) = MCF-7: 85 (EtOH-H2O), 85 (Vin), 65(EtOH-
H2O+Vin) after 40 µg/mL extract; MCF-7: 70 (EtOH-H2O), 85 (Vin), 50 
(EtOH-H2O+Vin), after 80 µg/mL extract / Wester blot = MCF-7 after 200 
µg/mL extract: ↑ caspase 3, ↑ bax, ↓Bcl2, ↓ cyclin D1 
[229] 
T. schimperi Ethiopia 
MeOH 70% (Lut, 
Lut-7-O-Glc, Lut-
7-O-xy) 
Cytotoxic effect (MTT) on AGS 
and HepG2 cells 
MTT (IC50, µg/mL)= AGS: 88, after 50-100 µg/mL extract; HepG2: 326, after 
200-400 µg/mL extract / MTT (cell inhibition %)= AGS: 38, HepG2: 35. 
[147] 
T. serpyllum (Ts), 
T. vulgaris (Tv) 
Commercial 





Ts H2O (RA, 
CaffA, LAc, Lut-
7-O-Glr, Lut-7-
Cytotoxic effect (MTT) on MCF-
7/Adr or wt cells 
MTT (IC50, µg/mL)= MCF-7/Adr: 399 (Ts), 407 (Tv) / (IC50, mM)= MCF-
7/Adr: 0.81 (RA), 1.26 (LAc), 1.81 (CaffA), 1.87 (Lut-7-O-Glr), 4.2 (Lut-7-O-
Rut), 2.6 (Erd-7-O-Rut), 5.8 (Ab); MCF-7/wt: 0.74 (RA), 1.09 (Lut-7-O-Glr), 
0.45 (LAc), 1.36 (CaffA), 18.2 (Lut-7-O-Rut), 1.71 (Erd-7-O-Rut), >1000 
(Ab) 
 MTT (CVI %)= MCF-7/Adr: 60 (Ts, Tv), MCF-7/wt: 30 (Ts), 60 (Tv) at 500 
mg/L extract / MCF-7/Adr: 86 (RA), 26 (Lut-7-O-Glr), MCF-7/wt: 92 (RA), 80 
(LA), 54 (Lut-7-O-Glr), at 1.25 mM 
[242] 
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O-Rut, Erd-7-O-
Rut) 
T. vulgaris Commercial 
EtOH (RA, Salv 
K isomer, Lut-
Hex, Api-Glr) 
Cytotoxic effect (MTT), DNA 
damage (comet assay); 
enzymatic activity of tumor 
HepG2 cells 
MTT (IC50, mg/mL)= 4.3 / HepG2 DNA damage induced by H2O2 and 
DMNQ: ↓ after 0.5 mg/mL extracts, at 24h / Enzymatic activity: ↑ GPx, ↓ 
SOD,  after 1 and 0.5 mg/mL extracts 
[178] 
T. vulgaris Commercial PG (ND) 
Cytotoxic effect (MTT, NR and 
CVA) on RAW 264.7, FMM-1, 
MCF-7 and HeLa cells 
MTT (cell viability %)= RAW 264.7 and FMM-1: ↓ at 25, 50 and 100 mg/mL; 
MCF-7: ↓ at 50 and 100 mg/mL; HeLa cells: ↓ at 100 mg/mL extract 
NR (cell viability %)= RAW 264.7: ↓ at 50 and 100 mg/mL; FMM-1: ↓ no 
significant; MCF-7: ↓ at 25, 50 and 100 mg/mL; HeLa cells: ↓ at 50 and 100 
mg/mL extract 
CVA (cell viability %): RAW 264.7: ↓ at 50 and 100 mg/mL; FMM-1: ↓ at 25, 
50 and 100 mg/mL; MCF-7: ↓ at 100 mg/mL; HeLa cells: ↓ at 50 mg/mL 
extract 
[208] 
T. vulgaris South Africa Acet (ND) 
Cytotoxic effect (XTT) on HeLa 
and non-tumor Vero cells 
XTT (IC50, µg/mL)= HeLa: > 200, 0.002 (AmD); Vero: 138, 0.027 (AmD) [237]   
A549 - human lung cancer cells; Acet – acetone; Adr -adriamycin-resistant; AGS - human gastric adenocarcinoma cells; AmD - actinomycin D; Ab - arbutin; BrdU– bromodeoxyuridine; Carn– 
carnosol; CarnA – carnosic acid; Celx – celecoxib; Cis - cisplatin; crytsh – cryptotanshinone; CVA - crystal violet assay; CVI - cell viability inhibition; DCM – dichloromethane; DMNQ - 2,3-dimethoxy-
1,4-naphthoquinone; EA– ethyl acetate; Erd - eriodictiol; Flav – flavonoids; 5-Fl - 5-Fluorouracil; FMM-1 - human gingival fibroblasts; Glc - glucoside; Glc-82 - human lung cancer cells; Glr - 
glucuronide; GPx - glutathione peroxidase; H460 - human lung cancer cells; HCA-7 - colorectal cancer cells; MCF-7 - human breast cancer cells; HCT-116 colon carcinoma cells; HeLa - cervical 
carcinoma cells; HepG2 - hepatocellular carcinoma cells; HUVEC - human umbilical vein endothelial cells; KG-1A - human acute myelocytic leucemia cells; LAc - lithospermic acid; LDH – lactic 
dehydrogenase; Lut – luteolin, MeOH– methanol; MCF-7 - human breast carcinoma cells; MTS - 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulphophenyl)-2H-tetrazolium inner 
salt; MTT– 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; ND– not determined; n-hex – n-hexan; NR - neutral red assay; OSCC - oral squamous cell carcinomas; PC3 - human 
prostate cancer cells; PG - Propylene glycol; RA– rosmarinic acid; Raji - non-Hodgkin’s B-cell lymphoma; Rut - rutinoside; SOD - superoxide dismutase; SRB - Sulphorhodamine B assay; SW480 
- colon adenocarcinoma cells;  6-OH-L-7-Glc – 6-hydroxyluteolin-7-glucoside, TGI - tumor growth inhibition rates; Tsh – tanshinone; TUNEL assay - terminal deoxynucleotidyl transferase dUTP nick 
end labeling; U937 - human leukemic monocyte lymphoma; Vin – vincristine; WEHI-164 - mouse fibrosarcoma cells; wt - wild-type; xy – xyloside; XTT - 2,3-bis-(2-methoxy-4- nitro-5-sulfophenyl)-
2H-tetrazolium-5-carboxanilide. 
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1.3.4. Antibacterial activity 
Infectious diseases involve complex interactions between the pathogens and the host. 
Pathogens enclose bacteria, fungus, virus or parasite, which can invade the host in different 
ways (e.g. respiratory, gastrointestinal, genitourinary tracts), when immune barriers are 
disrupted [188]. Overall, the infectious state is not only determined by the immunocompetence 
of the host, as well as the virulence of microorganisms, which is established by different factors  
contributing to the pathogenesis of infectious diseases [253]. 
The development of antibiotics has revolutionized the fight against infection by microbial 
agents, being able to control or even eradicate some infectious diseases in the world. However, 
the emergence and spread of resistance to these antibiotics in several microorganisms is 
difficulting the management of many infectious diseases [254]. Actually, the resistance to 
antibiotics has become a great concern to the World Health Organization (WHO), and 
antimicrobial resistance is recognized as an increasingly serious threat to global public health, 
being associated to diseases and high mortality rates, mainly at hospital level [254]. Thus, the 
search for new antimicrobial substances that might act as an alternative or complement 
existing antibiotics is imperative [20,47]. In this regard,  purified natural compounds from plants 
can serve as one of the therapeutic strategies for the synthesis of new generation and 
alternative chemical drugs with low toxicity, mainly in antimicrobial and anti-inflammatory 
therapy [20,47,190].  
Furthermore, foodborne diseases, that results from process of food production or from 
environmental contamination, encompass a wide spectrum of illnesses and also represent a a 
growing public health problem worldwide [255]. Moreover, a large variety of commercial 
antibiotics and food additives are used to control foodborne diseases, causing severe 
hypersensitivity reactions and increasing antibiotic resistance [255–257]. Thus, there it is 
important to reduce the rate of spoilage that impairs food quality, edibility and nutritional value, 
using suitable food preservation methods and resorting to organic food production [258]. The 
antibacterial activity of plant extracts and the presence of natural antioxidants can be useful as 
food preservatives because of their ability in controlling  degradative reactions [2,20]. In the 
last years, the antimicrobial potential of essential oils from aromatic plants, especially from 
thyme and sage species, has been exploited with promising results [48,259–262]. Although 
less searched, the antimicrobial effect of polar extracts from Salvia and Thymus species has 
also been described, and in some cases recognized as more promising than essential oils 
[98,116].  
Disc-diffusion and microdilution methods are the two most common methods for assessing 
antibacterial activity (Table 9). In the first assay, a disc is impregnated with drug/plant extracts, 
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and the effect is estimated by the measurement of inhibition zones (mm) around the disc 
[83,139]. In turn, in the microdilution assay, the microbial suspensions are prepared directly 
from the culture medium colonies and exposed to serial dilutions of antibiotic/plant extracts 
into wells of micro titer plates [263]. In these methods, the results can be delivered by the 
estimation of the minimum inhibitory concentration (MIC), that is defined as the lowest 
concentration at which visible growth is inhibit, as well as, the microbicidal (or bactericidal) 
concentrations (MMC/MBC), i.e., the lowest concentration of the tested substance which has 
a microbicidal effect (or bactericidal effect, if only bacteria is under research) [259,263]. MMC 
values are determined by sub-culturing from the MIC assay tubes onto appropriate culture 
medium and confirmation the lowest concentration with no visible growth [264].  
Previous studies assessing antimicrobial activity of sage and thyme extracts (Table 9), focused 
the sensitivity of several microorganisms, namely Gram-negative and Gram-positive bacteria, 
mycobacteria and fungal strains. Note that emphasis is herein given to the antibacterial activity, 
since this topic will be addressed in this Thesis for the polar extracts of the target Salvia and 
Thymus species.  
In general Gram-negative bacteria were shown to be more resistant  than Gram-positive 
bacteria to plant extracts, mainly because of their high complex cell wall and the additional 
protection afforded by the outer membrane [265,266]. In particular, aqueous extracts of S. 
ringens [114] and S. amplexicaulis [106], both rich in kaempferol glycosides, inhibited the 
Gram-positive Staphylococcus aureus in lower concentrations than those required for Gram-
negative specimens (Escherichia coli and Pseudomonas aeruginosa), when tested by the 
micro-well dilution assay [106]. Using the same method, a methanolic extract of S. veneris was 
claimed to have promising antimicrobial effects, particularly against Listeria monocytogenes 
(7.5 times higher than the antibiotic chloramphenicol), followed by Proteus vulgaris, Bacillus 
cereus and Staphylococcus aureus [98]. This effect was associated by the authors to 
rosmarinic acid and luteolin-O-glucoside, which are major phenolic components of S. veneris. 
Promising antibacterial results were also reported by Firuzi et al. [10] for different methanolic 
extracts from Salvia plants, including S. eremophila, S. limbata, S. santolinifolia and S. sclarea, 
which inhibited the growth of all the tested microorganisms at MIC values between 0.31-5.0 
mg/mL.  
In addition, based on both microdilution and disc-diffusion assays, a methanolic extract of S. 
bicolor, rich in gallic, p-coumaric and protocatchuic acids, was claimed to be ative against 
Gram-positive bacteria, especially S. aureus and Staphylococcus epidermidis, regardless it 
was 25-fold less active than gentamycin [139]. This extract also showed antibacterial effect 
towards Gram-negative bacteria, a fact that is related with agar disc diffusion results, whose 
larger halos (11.4 and 12.7 mm, for P. aeruginosa and E. coli, respectively) are in agreement 
80 
Andrea F. Afonso, 2019 | PHENOLIC COMPOSITION AND HEALTH-BENEFITS OF SALVIA AND THYMUS 
 
with the lowest MIC values (0.4 mg/mL) [139]. Moreover, considering both MIC and inhibition 
halos results, a methanolic extract of S. nemorosa (rich in rosmarinic acid, caffeic acid and 
quercetin) [73] and other of Salvia spinosa [267] were demonstrated to inhibit S. aureus in 
concentrations similar to gentamicin [73]. Besides, when testing the antibacterial effect of 
selected South African medicinal plants towards Gram-positive, Gram-negative and the 
mycobacteria Mycobacterium tuberculosis, Nielsen et al. [268] highlighted the promising 
effects of a methanolic extract of S. africana-lutea. This extract was able to prevent the growth 
of all the tested microorganisms (from which some were of clinical importance and most of 
them were found to be resistant to commonly used antibiotics), namely carbenicillin-resistant 
P. aeruginosa (CRPA), and the both β-lactamase positive (βL+) E. coli and methicillin-resistant 
S. aureus (MRSA), only 4-fold less active than gentamycin [268]. These authors showed also 
low MBC values for each drug-susceptible strains (MBC of 0.08 - 0.63 mg/mL) [268].  
Table 9 summarizes diverse studies focusing the ability of Salvia polar extracts to inhibit fungal 
strains. Particularly, decoctions of S. officinalis were reported to provide high antifungal activity 
towards Candida tropicalis (inhibition halo greater than 11 mm), a fact that was positively 
related to their phenolic composition [180]. On another study, the growth of Candida species 
(e.g. Candida albicans) was shown to be inhibited by aqueous extracts of S. amplexicaulis 
[106] and methanolic extracts of S. veneris [98], S. spinosa [267], and S. nemorosa [73]. 
Notably, the antifungal ability of the last species was shown by the authors to be equal to that 
of the antifungic  nystatin (MIC=0.05 mg/mL). 
The antibacterial activity of Thymus extracts has also been the focus of attention by diverse 
authors [1,261]. In detail, Ertas et al. [83] reported that a methanolic extract of T. nummularius, 
which was rich in rosmarinic acid, luteolin and kaempferol, presented the same antibacterial 
activity than rosmarinic acid used as positive standard control [83]. Moreover, Thymus 
lanceolatus extracts of n-hexane, chloroform, ethanol and water, were shown to have high 
antimicrobial potential against a representative panel of infectious bacteria in (MIC values 
similar or even better than gentamicin) [269]. In addition, Ertürk et al. demonstrated that an 
ethanolic extract of T. capitatus was as active as the antibiotics amoxicilin and cefazolin against 
S. aureus (MIC=0.5 mg/ml) [270]. 
Despite some exceptions [83,208], similarly to sage, Thymus extracts have been recognized 
to be more effective against Gram-positive bacteria (e.g. S. aureus strains) than to Gram-
negative specimens. In particular, an ethanolic extract of T. capitatus was reported to exhibit 
high antibacterial activity against S. aureus (MIC=0.5 mg/mL) comparatively to P. aeruginosa 
(MIC=2.0 mg/mL) [270]. Likewise, methanolic extracts of T. capitatus from Libya, were shown 
to have superior antibacterial effect against S. aureus (MIC of 5.0 mg/mL and inhibition zone 
of 13–18 mm) than to Salmonella species (MIC of 6.0 mg/mL and inhibition zone of 10–12 mm) 
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[271]. It should be noted for these Thymus extracts, MIC values taken from broth microdilution 
method were in accordance with the the diameter halos results gathered from the disc diffusion 
method. These evidences were also reported for different extracts of T. lanceolatus with a 
board-spectrum of activity [269]. In that study, the most sensitive strain was S. aureus 
(MIC=0.8 mg/ml), while the most resistant bacteria were the Gram-negative Acinetobacter 
baumannii, Salmonella species and Enterobacter cloacae, and the Gram-positive L. 
monocytogenes and Enterococcus faecalis( MIC values for all were equal to 4.0 mg/ml), which 
agree well with diameter halos by the disc diffusion method [269]. Distinct results were reported 
for hydroethanolic extracts of T. vulgaris, that presented the same inhibition magnitude against 
Gram-positive bacteria (including MRSA strains) and Gram-negative ones (E. coli and P. 
aeruginosa with MIC values of 6.25 mg/mL) [272]. Nevertheless, in that study, ethanolic 
extracts of T. caramanicus showed higher antibacterial efficacy than T. vulgaris, with MIC 
values comparatively below against the panel of tested strains [272].  
The sensitivity of fungal strains, namely Candida strains, to thyme extracts was also tested 
before. In particular, ethanolic extracts of T. capitatus [270] and ethanolic extracts of T. 
lanceolatus [269] were demonstrated to inhibit strains of C. albicans (MIC of 1.0 and 0.1 
mg/mL, respectively), with equal or more capacity than antifungal drugs nystatin and 
amphotericin B.  
Despite, Salvia and Thymus extracts have been previously demonstrated to inhibit the growth 
of a wide spectrum of bacterial strains (Table 9), only little studies determined the MBC of the 
tested extracts, allowing the knowledge of the lowest concentration that has a microbicidal 
effect. In these sense, the knowledge of the inhibitory and lethal capacity of the tested extracts 
is important, according as, different concentrations have potential to inhibit the growth and/or 
the viability of bacteria strains under research. In addition, the findings described above 
suggest the possibility of using these extracts as food preservatives due to its inhibition of the 
growth of food spoilage and foodborne pathogens, as well as, in the development of new drugs 
for the treatment of infectious diseases. Taking together, these considerations underly the 
need of additional investigation regarding the antimicrobial potential of sage and thyme 
extracts. 
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Table 9 – Antimicrobial properties of phenolic-enriched extracts of distinct Salvia and Thymus species 

















MIC (mg/mL)= Gram negative bacteria βL+EC: 0.04 (MeOH), 0.01 (Gen), ARKP:  
0.31 (MeOH), 0.02 (Gen), CRPA: 0.16 (MeOH), 0.02 (Gen), CRCF:  0.31 (MeOH), 
0.01 (Gen); Gram positive bacteria MRSA: 0.04 (MeOH), 0.01 (Gen); Mycobacteria 
M. smegmatis: 0.31 (MeOH), 0.0003 (Cpx), M. tuberculosis: 0.31 (MeOH), 0.00013 
(Inz); Fungal strains C. albicans: 0.16 (MeOH), 0.02 (Nyt), M. audouinii: 0.04 
(MeOH), 0.02 (Nyt)  
MMC (mg/mL)= Gram negative bacteria βL+EC: 0.08 (MeOH), 0.02 (Gen), ARKP:  
0.63 (MeOH), 0.04 (Gen), CRPA: 0.31 (MeOH), 0.04 (Gen), CRCF:  0.63 (MeOH), 
0.02 (Gen); Gram positive bacteria MRSA: 0.08 (MeOH), 0.02 (Gen); Mycobacteria 
M. smegmatis: 2.5 (MeOH), 0.0003 (Cpx); Fungal strains C. albicans: 0.31 (MeOH), 
0.04 (Nyt), M. audouinii: 0.63 (MeOH), 0.04 (Nyt) 
[268] 










MIC (mg/mL)= Gram negative bacteria E. coli: 40 (EtOH), >50 (H2O), 0.012 (Strm), S. 
typhimurium and S. enteritidis:  40 (EtOH), 50 (H2O), 0.010 (Strm), P. tolasii: 35 
(EtOH), 50 (H2O), 0.016 (Strm), P. aeruginosa:  40 (EtOH), >50 (H2O), 0.016 (Strm), 
P. mirabilis:  35 (EtOH), >40 (H2O), 0.005 (Strm); Gram positive bacteria S. aureus:  
30 (EtOH), 40 (H2O), 0.016 (Strm), B. cereus:  30 (EtOH), 35 (H2O), 0.005 (Strm), M. 
flavus:  30 (EtOH), 35 (H2O), 0.010 (Strm), S. lutea: 40 (EtOH), >40 (H2O) 0.012 
(Strm), L. monocytogenes:  30 (EtOH), 40 (H2O), 0.010 (Strm); Fungal strains C. 
krusei:  64 (H2O), C. albicans: 32 (H2O), C. parapsilosis: 16 (H2O), 0.0078 (ktz) 
[106] 






agar disc diffusion / 
broth microdilution 
method (MIC) 
MIC (mg/mL)= Gram negative bacteria E. coli: 0.4 (MeOH), 8x10-3 (Gen), P. 
aeruginosa and S. boydii: 0.4 (MeOH), 0.01 (Gen), K. pneumonia and P. vulgaris: 1 
(MeOH), 0.01 (Gen); Gram positive bacteria S. aureus: 0.2 (MeOH), 8x10-3 (Gen), S. 
epidermidis: 0.35 (MeOH), 0.01 (Gen), S. pyogens: 0.35 (MeOH), 8x10-3 (Gen); 
Fungal strains C. albicans: 0.35 (MeOH), 1x10-3 (Amb), C. krusei, C. glabrata. and C. 
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S. nemorosa Iran MeOH (RA, 
CaffA, Que)  
Antibacterial and 
antifungal activity: 
agar disc diffusion / 
broth microdilution 
method (MIC) 
MIC (mg/mL)= Gram negative bacteria E. coli: >1 (n-Hex), 0.8 (DCM), 0.1 (MeOH), 
0.025 (Gen), P. aeruginosa: >1 (n-Hex), 0.8 (DCM), 0.4 (MeOH), 0.05 (Gen); Gram 
positive bacteria S. aureus: 0.1 (n-Hex), 0.01 (DCM), 0.01 (MeOH), 0.01 (Gen), B. 
cereus: 0.1 (n-Hex), 0.1 (DCM), 0.05 (MeOH), 0.01 (Gen); Fungal strains C. albicans: 
1 (n-Hex), 1 (DCM), 0.2 (MeOH), 0.05 (Nyt), A. niger: 1 (n-Hex), 0.2 (DCM), 0.05 
(MeOH), 0.05 (Nyt) 
[73] 










MIC (mg/mL)= Gram negative bacteria E. coli: 15 (EtOH), 25 (H2O), 0.012 (Strm), S. 
typhimurium: 15 (EtOH), 25 (H2O), 0.012 (Strm), S. enteritidis: 15 (EtOH), 20 (H2O), 
0.010 (Strm), P. tolasii and P. aeruginosa: 20 (EtOH), 30 (H2O), 0.016 (Strm), P. 
mirabilis:  35 (EtOH), >40 (H2O), 0.005 (Strm); Gram positive bacteria S. aureus: 5 
(EtOH), 15 (H2O), 0.016 (Strm), B. cereus:  10 (EtOH), 20 (H2O), 0.005 (Strm), M. 
flavus: 10 (EtOH), 20 (H2O), 0.010 (Strm), L. monocytogenes:  5 (EtOH), 15 (H2O), 
0.010 (Strm), S. lutea: 15 (EtOH), 25 (H2O), 0.012 (Strm); Fungal strains C. krusei:  
64 (EtOH), C. albicans: 64 (EtOH), 0.0078 (ktz) 
[114] 
S. spinosa Iran 
n-Hex, DCM, 
MeOH (ND)  
Antibacterial and 
antifungal activity: 
agar disc diffusion / 
broth microdilution 
method (MIC) 
MIC (mg/mL)= Gram negative bacteria E. coli: >1 (n-Hex), >1 (DCM), 0.2 (MeOH), 
0.025 (Gen), P. aeruginosa: >1 (n-Hex), >1 (DCM), 0.8 (MeOH), 0.05 (Gen); Gram 
positive bacteria S. aureus: 0.01 (n-Hex), 0.05 (DCM), 0.01 (MeOH), 0.01 (Gen), B. 
cereus: 0.05 (n-Hex), 0.1 (DCM), 0.01 (MeOH), 0.01 (Gen); Fungal strains C. 
albicans: 0.2 (n-Hex), 0.8 (DCM), 0.05 (MeOH), 0.05 (Nyt), A. niger: 0.8 (n-Hex), 0.4 
(DCM), 0.1 (MeOH), 0.05 (Nyt) 
[267] 






MIC (mg/mL)= Gram negative bacteria P. aeruginosa: 0.5 (MeOH), 0.008 (Clp), E. 
aerogenes: 2 (MeOH), 0.002 (Clp), P. vulgaris: 0.25 (MeOH), 0.004 (Clp), E. coli and 
S. marcescens: 2 (MeOH), 0.004 (Clp), E. coli O157:H7: 1 (MeOH), 0.002 (Clp), S. 
typhimurium: 2 (MeOH), 0.032 (Clp); Gram positive bacteria S. aureus: 0.25 (MeOH), 
0.002 (Clp), S. epidermidis: 2 (MeOH), 0.002 (Clp), L. monocytogenes 0.06 (MeOH), 
0.008 (Clp), B. cereus: 0.25 (MeOH), 0.004 (Clp), B. subtilis: 0.5 (MeOH), 0.004 
(Clp); Fungal strains C. albicans: 0.5 (MeOH), 0.0005 (Amb), C. utilis: 0.06 (MeOH), 
0.00025 (Amb), C. krusei: 0.25 (MeOH), 0.0005 (Amb), C. glabrata and C. tropicalis: 
0.500 (MeOH), 0.0001 (Amb), C. parapsilosis:  0.12 (MeOH), 0.0005 (Amb) 
[98] 
S. eremophila (Se), 
S. limbata (Sl), S. 
santolinifolia (Ssa), 





agar disc diffusion / 
broth microdilution 
method (MIC) 
MIC (mg/mL)= Gram negative bacteria E. coli: 2.5 (Se, Ssa), 5 (Sl, Ssc), 0.05 (Clp), 
K. pneumonia: 2.5 (Se, Sl, Ssc), 5 (Ssa), 0.05 (Clp), S. typhimurium: 0.31 (Se, Ssc), 
1.25 (Sl, Ssa), 0.05 (Clp),; Gram positive bacteria B. subtilis: 2.5 (Se, Ssa), 5 (Sl, 
Ssc), 0.0125 (Clp), S. epidermidis: 0.3 (Se, Ssa), 1.25 (Ssa), 2.5 (Sl), 0.025 (Clp), S. 
aureus: 0.6 (Se), 1.25 (Ssc), 2.5 (Sl, Ssa), 0.0125 (Clp) 
[10] 
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Thymus species     
T. capitatus Turkey EtOH (ND) 
Antibacterial and 
antifungal activity: 
agar disc diffusion 
method / agar 
dilution method 
(MIC) 
MIC (mg/mL)= Gram negative bacteria E. coli: 8 (EtOH), ≤ 0.5 (Amx, Cfz), P. 
aeruginosa: 2 (EtOH), ≤ 0.5 (Amx, Cfz); Gram positive bacteria S. aureus: 0.5 
(EtOH), ≤ 0.5 (Amx, Cfz), B. subtilis: 4 (EtOH), ≤ 0.5 (Amx, Cfz); Fungal strains C. 
albicans: 1 (EtOH), ≤ 2 (Nyt), A. niger: 0.5 (EtOH), ≤ 2 (Nyt) 
[270] 
T. capitatus Libya MeOH (ND) 
Antibacterial 
activity: agar disc 
diffusion method / 
agar dilution 
method (MIC) 
MIC (mg/mL)= S. aureus: 5; B. subtilis: 1.25; Salmonella species: 6 
[271] 






agar disc diffusion 
method / broth 
microdilution 
method (MIC) 
MIC (mg/mL)= Gram negative bacteria A. baumannii: 4 (Hex), 0.125 (Chl), 0.125 
(EtOH), 4 (H2O), 2 (Gen); C. freundii: 2 (Hex), 1 (Chl), 0.5 (EtOH), 2.7 (Gen); E. coli: 
4 (Hex), 1 (Chl), 0.5 (EtOH), 2 (gen); E. cloacae: 1 (Chl), 0.25 (EtOH), 4 (H2O), 2 
(Gen); K. pneumonia: 1 (Chl), 0.5 (EtOH), 1.3 (Gen); P. mirabilis: 1 (Chl), 0.21 
(EtOH), 2 (H2O), >8 (Gen); P. aeruginosa: 2 (Chl), 0.25 (EtOH), 1 (Gen); P. 
fluorescens: 1 (Chl), 0.25 (EtOH), 1 (Gen); S. enteritidis: 1.33 (Chl), 0.5 (EtOH), 4 
(H2O), 2 (Gen); S. typhimurium: 4 (Hex), 0.5 (Chl), 0.25 (EtOH), 4 (H2O), 2 (Gen); 
Gram positive bacteria B. cereus: 0.08 (Chl), 0.125 (EtOH), 4 (Gen); B. subtilis: 0.125 
(Chl), 0.25 (EtOH), 4 (Gen); E. faecalis: 2 (Hex), 0.03 (Chl), 0.1 (EtOH), 4 (H2O), 8 
(Gen); L. monocytogenes: 0.03 (Chl), 0.25 (EtOH), 4 (H2O), 2 (Gen); S. aureus: 0.03 
(Chl), 0.06 (EtOH), 0.8 (H2O), 0.25 (Gen); Fungal strains C. albicans: 0.125 (Chl), 0.1 
(EtOH), 1 (Amb) 
[269] 
T. nummularius Turkey 
MeOH (QA, 
RA, Lut, Kam) 
Antibacterial 
activity: Agar disc 
diffusion method 
(MIC) 
MIC (mg/mL)= Gram negative bacteria E. coli: > 1 (MeOH, RA), P. aeruginosa: > 1 
(MeOH, RA); Gram positive bacteria S. aureus: > 1 (MeOH, RA), S. pyogenes: > 1 
(MeOH, RA) 
[83] 





MIC / MMC (mg/mL)= C. albicans: 50 /50; S. aureus, E. faecalis, S. mutans and P. 
aeruginosa: > 50 / > 50 / biofilms reductions in CFU/mL after exposure to T. vulgaris 
L. extract (200 mg/mL) 
[208] 
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/MMC) / biofilms 
reduction (CFU/ml) 






activity: agar disc 
diffusion method / 
broth microdilution 
method (MIC) 
MIC (mg/mL)= Gram negative bacteria E. coli: 6.25 (Tv), 1.56 (Tcar), P. aeruginosa: 
6.25 (Tv), 1.30 (Tcar); S. dysenteriae: 12.5 (Tv), 0.78 (Tcar); S. typhimurium: 12.5 
(Tv), 2.6 (Tcar); Gram positive bacteria S. aureus: 6.25 (Tv), 0.78 (Tcar); S. 
epidermidis: 6.25 (Tv), 1.04 (Tcar); B. subtilis: 10.4 (Tv), 1.56 (Tcar); MRSA: 6.25 
(Tv), 1.30 (Tcar) 
[272] 
Amb - amphotericin-B; Amx – amoxicillin; CaffA – caffeic acid; CFU - colony-forming unit; Cfz – cefazolin; Chl - chloroform; Clp - chloramphenicol; CouA - coumaric acid; Cpx – ciprofloxacin; DCM– 
dichloromethane; EA– ethyl acetate; GA – gallic acid; Gen - gentamicin; Glc - glucoside; Hex – hexane; Inz – isoniazid; Kam – kaempferol; Ktz - ketoconazole; Lut – luteolin; MeOH– methanol; MIC 
- minimum inhibitory concentrations; MMC - minimum microbicidal concentration; ND– not determined; Nyt – nystatin; PG - propylene glycol; PrcA - protocatchuic acid; QA - quinic acid; Que – 
quercetin; RA– rosmarinic acid; Rhm - rhamnoside; Strm – streptomycin. 
Microbial names: A. baumannii - Acinetobacter baumannii; A. niger - Aspergillus niger; ARKP - ampicillin-resistant Klebsiella pneumonia; B. subtilis - Bacillus subtilis; C. albicans - Candida albicans, 
C. freundii- Citrobacter freundii; C. krusei - Candida krusei; C. glabrata - Candida glabrata,; C. parapsilosis - Candida parapsilosis; CRPA - carbenicillin-resistant Pseudomonas aeruginosa; CRCF- 
chloramphenicol-resistant Citrobacter; C. tropicalis - Candida tropicalis; C. utilis - Candida utilis; βL+EC - β-lactamase positive Escherichia coli; B. cereus - Bacillus cereus; B. subtilis - Bacillus 
subtilis; E. aerogenes - Enterobacter aerogenes; E. cloacae - Enterobacter cloacae; E. coli - Escherichia coli; E. faecalis - Enterococcus faecalis; K. pneumoniae - Klebsiella pneumoniae; L. 
monocytogenes - Listeria monocytogenes; M. audouinii - Microsporum audouinii; M. flavus - Micrococcus flavus; MRSA - methicillin-resistant Staphylococcus aureus; M. smegmatis - Mycobacterium 
smegmatis; M. tuberculosis - Mycobacterium tuberculosis; P. aeruginosa - Pseudomonas aeruginosa; P. fluorescens - Pseudomonas fluorescens; P. mirabilis - Proteus mirabilis; P. vulgaris - 
Proteus vulgaris; P. tolasii - Pseudomonas tolasii; S. aureus - Staphylococcus aureus; S. boydii - Shigella boydii; S. dysenteriae - Shigella dysenteriae; S. epidermidis - Staphylococcus epidermidis; 
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1.3.5. Effects of Salvia and Thymus plants in diabetes and obesity 
The health-benefits of phenolic compounds, especially flavonoids and phenolic acids, 
have been associated to the risk control of metabolic syndrome and related 
complications such as obesity, diabetes and associated disorders (e.g. cardiovascular 
disease, neuropathy, nephropathy and retinopathy) [47,160]. In particular, these 
compounds are claimed to inhibit the activity of α-glucosidase, α-amylase and pancreatic 
lipase, which represent key digestive enzymes involved in the metabolism of 
carbohydrates and lipids. α-Amylase and α-glucosidase are responsible for the digestion 
of dietary carbohydrates to glucose, which enters in the blood stream. Thus, inhibiting 
the activity of these enzymes results in the slowing of liberation and absorption of 
glucose, which in turn, reduce blood glucose level and might contribute to the suppress 
of hyperglycemia and diabetes [160,273,274]. In turn, lipase inhibition decreases the 
digestion of dietary triglycerides in the small intestine [275]. In addition, dietary plant 
polyphenols are effective against body weight gain (bw), fat deposition and adipocyte 
dysfunction. Thus, these compounds modulates carbohydrate and lipid metabolism, 
attenuate hyperglycemia, dyslipidemia and insulin resistance, and weaken the oxidative 
stress and related inflammatory processes [160,273–275].  
Since both acute and chronic inflammatory responses are associated with the 
development of diabetes and insulin resistance (and these conditions are commonly 
observed in obesity), plant-based polyphenolic compounds represent important 
contributors in prevention of metabolic disorder associated with hyperglycemia and 
diabetes [160]. In these sense, in some countries, various anti-inflammatory and 
antioxidant plants have been used traditionally as an alternative strategy for the 
treatment of diabetes [1,276].  
Researches focusing the potentialities of polar extracts of Salvia and Thymus plants to 
act as natural antidiabetic and antiobesity agents, have mainly tested their ability to 
control glucose levels through inhibition of α-glucosidase activity. In particular, the ability 
of Salvia plants in inhibiting this enzyme was reported for S. officinalis (IC50 value of 69.7 
µg/mL), which was shown to be much stronger than acarbose (IC50=203 µg/mL) [277]. 
The α-glucosidase inhibition was also demosntrated for methanolic extracts of Salvia 
acetabulosa, S. nemorosa and S. chloroleuca (IC5 =76.9 µg/mL, IC50=19 µg/mL and 
IC50=13.3 µg/mL, respectively) [73,278,279]. Likewise, methanolic extracts of T. 
quinquecostatus were shown to have an inhibitory effect on α-glucosidase activity 
(IC50=4.39 µg/ml) [280]. The inhibitory capacity of polar extracts from Salvia and Thymus 
plants towards α-amylase and/or α-glucosidase have been also mostly correlated with 
their phenolic constituents. In fact, aqueous and methanolic extracts of S. cadmica, both 
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rich in rosmarinic acid, luteolin and apigenin, had high inhibitory effects against these 
two enzymes [71]. Moreover, several phenolic compounds isolated from S. miltiorrhiza, 
namely, tanshinone IIA, rosmarinic acid, rosmarinic acid methyl ester and salvianolic 
acid C methyl ester, were reported to be stronger inhibitors of α-glucosidase than 
acarbose [281]. Likewise, the flavonoid compounds luteolin-7-O-glucoside, luteolin-7-O-
glucuronide and diosmetin-7-O-glucuronide, isolated from the aerial parts of S. 
chloroleuca, also showed potent α-glucosidase inhibitory effects (IC50 of 18.3, 14.7, and 
17.1 μM, respectively), exhibiting an inhibitory effect close to that of acarbose (IC50=16.1 
μM) [279]. The inhibition of lipase activity by polar extracts of Salvia origin was previously 
reported in particular for the methanolic extracts of S. officinalis leaves [282], S. spinosa 
[283] and Salvia triloba [284], which reported IC50 values of 94.0, 156.2 and 100.8 μg/mL, 
respectively. 
Notably, the antidiabetic ability of sage and thyme extracts has also been demonstrated 
in in vivo models. A methanolic extract of S. officinalis (500 mg/kg bw) was shown to 
control the activity of α-glucosidase, alike acarbose (20 mg/kg bw) in alloxan-treated 
diabetic rats [285]. Moreover, Cam et al. [274] demonstrated the antidiabetic effects of 
methanolic extract of Thymus praecox subsp. skorpilii var. skorpilii in 
streptozotocin/nicotinamide-induced type 2 diabetic rats by restoring glucose 
homeostasis, ameliorating insulin resistance and improving pancreatic β-cell function 
[274]. The authors ascribed these positive effects to the phenolic composition of the 
extract (chlorogenic acid, luteolin-7-O-glucoside, 3-O-feruloylquinic acid, quercetin-3-O-
hexoside and apigenin-7-O-glucuronide) [274]. In addition, the treatment of diabetic rats 
with hydroalcoholic extracts of T. caramanicus (300 and 500 mg/kg bw) caused a 
significant reduction on the blood glucose level, serum total cholesterol, triglycerides, 
creatinine and liver function enzymes. In addition, it inhibited α-amylase and the 
reabsorption of glucose through the decrement of renal glucose transporters gene 
expressions [286]. 
In addition, clinical trials have evaluated the efficacy and safety of S. officinalis L. leaf 
extracts or tablets in the treatment of patients with hyperlipidemia and type-2 diabetes, 
for which it was shown to cause a decrease on blood levels of triglyceride, total 
cholesterol, low density lipoproteins (LDL) postprandial glucose after 2 h, and to increase 
the levels of high density lipoprotein (HDL) [174,287–289]. In another study, Sá et al. 
[290] reported the ability of a sage tea drinking in improving lipid profile, decreasing the 
plasma total and LDL cholesterol levels and increasing plasma HDL cholesterol levels 
during and two weeks after treatment. The authors evidenced also that sage tea drinking 
improved human erythrocyte antioxidant status by significantly increasing SOD and CAT 
activities, thus ameliorating antioxidant defenses, which may indirectly improve the 
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diabetic condition. Importantly, some of these studies indicate the safety of S. officinalis 
since it did not cause hepatotoxicity nor induce other adverse effects, such as changes 
in blood pressure, heart rate at rest and body weight [287,288,290].  
1.3.6. Future considerations 
It is well know that diet supplementation with plant-based products, which contain large 
amount of polyphenols and phytochemicals [2,160], can provide positive influence on 
human health, reducing the risk of cancer, diabetes and inflammatory diseases, and 
preventing neurodegenerative and cardiovascular system disorders [14,235,236]. The 
bioactivity of plant secondary metabolites that are still unexplored, enable them to 
development of functional foods, nutraceuticals and drugs based on plants, that could 
be the future of health supplies for world population [14,291]. In addition, antibacterial 
and antioxidant properties of plants and their secondary metabolites could be used in 
the development of new agents, with application in pharmaceutical and food industries, 
as drugs metabolites against infectious diseases or as preservative additives [2,20,292].  
There is a clear trend in consumer preference towards food ingredients and additives 
that are natural and that are perceived to be healthy [293]. In these sense, being thyme 
and sage plants rich in phenolic acids and flavonoids, with health-beneficial activities 
protecting against  inflammatory chronic diseases such as diabetes, cancers, ageing and 
others [1,47,158,159], their extracts have also been proposed to have promising 
applicability for the development of safe products and additives [1,65,294]. 
In recent years, a number of innovative therapeutic strategies are being developed in 
order to combat inflammatory associated diseases, namely glucocorticoids-
nanoformulations (e.g liposomes, nanoparticles, and organic and inorganic scaffolds) 
[295,296]. Based on the knowledge of plants as a source of various biologically active 
compounds, recent researches were based in production of biocompatible and 
environmentally safe nanoparticles of plant origin for medical applications. Furthermore, 
multiple approaches are needed to surpass limited solubility of phenolic compounds, 
including the development of novel drug delivery system and formulations such as 
nanoparticles, liposomal encapsulation, emulsions, and sustained released tablets 
[193,273,297]. Therefore, health-benefits promising-results and enhanced bioavailability 
of phenolic compounds from thyme and sage plants, could bring these promising natural 
products to the therapeutic agents for several diseases. 
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Salvia and Thymus plants are endowed of biochemical and organoleptic properties that 
enable their application in distinct fields such as culinary, cosmetic or medicinal. 
Importantly, their usage may be done in different procedures, that range from the direct 
application of fresh or dry plants, to essential oils and extracts, which can be obtained in 
different forms, including aqueous infusions and/or decoctions. 
Importantly, even though for the last years there has been an increasing number of 
researches aiming to screen of the biological properties of Salvia and Thymus plants, 
many species and/or cultivars remains poorly studied. Based on known bioactivities, as 
well as insufficient data of health properties of several less-known sage and thyme 
species, this study was aimed to provide comprehensive research of chemical 
composition and biological effects of aqueous extracts of several Salvia and Thymus 
species, with potential applications in food, pharmaceutical and cosmetic industries.  
In this context, the present Doctoral Thesis is intended to elucidate the phenolic 
composition and the beneficial properties of eigth Salvia (S. officinalis, S. elegans, S. 
officinalis ‘Icterina’, S. apiana, S. farinacea var. victoria blue, S. africana, S. greggii, and 
S. mexicana) decoctions and of six Thymus (T. herba barona, T. pseudolanuginosus, T. 
caespititius, T. zygis, T. fragrantissimus and T. pulegioides) decoctions. Specific aims 
were defined as: 
First aim: Establish the phenolic profile of S. officinalis, S. elegans, S. officinalis 
‘Icterina’, S. apiana, S. farinacea var. victoria blue, S. africana, S. greggii, and S. 
mexicana, T. herba-barona, T. pseudolanuginosus, T. caespititius, T. zygis, T. 
fragrantissimus and T. pulegioides decoctions by ultra-high performance liquid 
chromatography coupled to diode array detector and an electrospray mass spectrometer 
(UHPLC-DAD-ESI-MSn). 
Second aim: Determine the antioxidant potential of decoctions from the target sage and 
thyme plants using distinct chemical methods (scavenging of DPPH•, NO• and O2•–; ferric 
reducing power, TBARS inhibition, -carotene bleaching, xanthine oxidase inhibition 
activity and ORAC assays. 
Third aim: Evaluate the capacity of decoctions of T. herba barona, T. 
pseudolanuginosus, T. caespititius, S. officinalis ‘Icterina’, S. apiana, S. farinacea var. 
victoria blue, S. africana, and S. mexicana to counteract inflammatory events, namely by 
reducing the levels of nitric oxide, as assessed in chemical and/or in cellular models. 
Fourth aim: Evaluate the antibacterial activity of six Thymus decoctions (T. herba 
barona, T. pseudolanuginosus, T. caespititius, T. zygis, T. fragrantissimus and T. 
pulegioides), and of five Salvia (S. apiana, S. farinacea var. victoria blue, S. africana, S. 
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mexicana and S. officinalis ‘Icterina’) decoctions against Gram-positive (Staphylococcus 
epidermidis and Staphylococcus aureus) and Gram-negative bacteria (Salmonella 
typhimurium, Escherichia coli and Pseudomonas aeruginosa).  
Fifth aim: Evaluate the cytotoxic potential of decoctions of S. apiana, S. farinacea var. 
victoria blue, S. africana, S. mexicana and S. officinalis ‘Icterina’, towards four cancer 
cell lines: MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung cancer), HeLa 
(cervical carcinoma) and HepG2 (hepatocellular carcinoma).  
Sixth aim: Evaluate the inhibitory ability of S. elegans and S. greggii decoctions against 
key enzymes with impact in obesity and diabetes (α-glucosidase, α-amylase and 
pancreatic lipase), comparing the findings to those of the well-known S. officinalis 
species. 
Seventh aim: Evaluate the nutritional profile of T. zygis, T. fragrantissimus and T. 
pulegioides, in particular total carbohydrates, proteins, ach, fatty acids and minerals (Na, 



















Beneficios en la salud de extractos aquosos de Thymus herba-barona, 
Thymus pseudolanuginosus y Thymus caespititius  
Objetivos 
Caracterizar y cuantificar los componentes fenólicos y evaluar las actividades 
antioxidante, antiinflamatoria y antibacteriana de extractos acuosos de tres especies de 
tomillo - Thymus herba-barona, Thymus pseudolanuginosus y Thymus caespititius. 
1. Introducción 
El género Thymus incluye alrededor de 350 especies, que están particularmente bien 
adaptadas al clima cálido y seco de la región mediterránea y se extienden en las zonas 
áridas de la Península Ibérica [1,2]. En cuanto a la gran mayoría de las plantas 
Lamiaceae, se reconoce que el tomillo es muy aromático y se usa ampliamente para 
mejorar el sabor y la conservación de los alimentos [1]. Asimismo, estas plantas tienen 
cierto potencial en las industrias farmacéutica y cosmética debido a sus beneficios 
biológicos y medicinales [3–6].  
Varios autores han demostrado que plantas pertenecientes a la familia Lamiaceae, y 
particularmente las plantas de tomillo, son ricas en fitoquímicos bioactivos, incluidos los 
ácidos fenólicos y flavonoides [1,7–9], que a su vez se han descrito como agentes 
capaces de reducir el riesgo de enfermedades debido a sus extensas propiedades 
biológicas, incluyendo  antioxidante, cardioprotector, antitumorales, antienvejecimiento, 
antiinflamatorio y antibacteriano [4,5,10,11]. La evaluación de los posibles efectos 
bioactivos de los extractos polares de Thymus se realizó en estudios previos 
principalmente para Thymus vulgaris [12–15], Thymus serpyllum (tomillo silvestre) 
[2,16], y en algunas otras especies de tomillo. En general, se ha demostrado que los 
extractos acuosos o alcohólicos de Thymus exhiben fuertes actividades antioxidantes in 
vitro [17–19] y en modelos in vivo [17–19]. Además, otros efectos descritos en los 
extractos polares de especies de tomillo incluyen antimicrobiano [20,21], antidiabético 
[11,17], neuroprotector [15] y propiedades antiinflamatorias [22]. 
En contraste con los estudios mencionados anteriormente, las aplicaciones potenciales 
de los extractos acuosos de T. herba-barona, T. pseudolanuginosus y T. caespititius 
permanecen sin explorar. El presente estudio tiene como objetivo contribuir a la 
clarificación de los constituyentes fenólicos de estas tres especies de tomillo, así como 








Las plantas T. herba-barona, T. pseudolanuginosus y T. caespititius, compradas a la 
empresa  Ervital (Viseu, Portugal), se cultivaron bajo un régimen orgánico y, después 
de la recolección, sus partes aéreas (flores, hojas y tallos) se secaron en una incubadora 
ventilada a 20-35ºC, durante 3 a 5 días.  
2.2. Extracción de compuestos fenólicos 
Los extractos fenólicos de los tres tomillos se han obtenido utilizando una decocción en 
la proporción 1:20 (5 g en 100 ml de agua). Las soluciones se filtraron, se concentraron 
y el concentrado se desengrasó con n-hexano (1:1 v/v), se evaporó y se congeló a -
20°C y se liofilizó. Se obtuvieron tres extractos de cada planta. 
2.3 Identificación y cuantificación de compuestos fenólicos 
El contenido fenólico total de cada extracto de tomillo se determinó de acuerdo con el 
método colorimétrico de Folin-Ciocalteu, cuyos valores se expresaron en equivalentes 
de ácido gálico (EAG)/g de extracto o mg EAG/g de planta. 
 Los extractos resultantes fueron caracterizados y cuantificados por cromatografía 
líquida de alta eficiencia (UHPLC), asociada a espectrometría de masas por electrospray 
(ESI-MS) en el modo de ionización negativo y MSn. 
Para el análisis cuantitativo, los límites de detección (LOD) y cuantificación (LOQ) se 
calcularon a partir de los parámetros de las curvas de calibración obtenidas mediante la 
inyección de concentraciones conocidas de los compuestos estándar exactos o 
relacionados estructuralmente. 
2.4 Pruebas de bioactividad 
2.4.1 Capacidad antioxidante  
La actividad antioxidante de los extractos acuosos de tomillo se evaluó mediante 
ensayos químicos, utilizando la prueba de radicales 2,2-difenil-2-picrilhidrazilo (DPPH●), 
el cálculo del poder reductor por la reducción de hierro (III) y el blanqueo del β-caroteno. 
En la primera prueba se utilizó ácido ascórbico como control positivo y en los otros dos 
métodos se utilizó hidroxianisol butilado (BHA) como estándar. Los resultados se 
expresaron como valores de EC50 (concentración de la muestra que proporciona el 50% 
de la actividad antioxidante) en μg por ml de extracto. 
2.4.2 Capacidad antiinflamatoria  
Las propiedades antiinflamatorias de los tres extractos acuosos de tomillo se evaluaron 
in vitro mediante modelos químicos, determinándose las cantidades de óxido nítrico 
(NO●) producido y el efecto inhibidor del extracto frente a la actividad de la enzima 5-
lipoxigenasa (5-LOX). Se utilizó ácido ascórbico como control positivo. Los resultados 
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se expresaron en valores de EC50 (μg/ml), que corresponden a la concentración de la 
muestra que proporcionó el 50% de inhibición de la producción de NO o 5-LOX. 
2.4.3 Capacidad antibacteriana  
El potencial antibacteriano de los extractos polares de Thymus se evaluó frente a cinco 
cepas bacterianas, incluyendo dos Gram positivas (Gram+) Staphylococcus epidermidis 
y Staphylococcus aureus, y tres Gram negativas (Gram-) Salmonella typhimurium, 
Escherichia coli y Pseudomonas aeruginosa, por el método de microdilución en medio, 
lo que permitió el cálculo de la concentración inhibitoria mínima (CIM) y la concentración 
bactericida mínima (CBM). Se utilizó nisina como control positivo. 
3. Resultados y discusión 
3.1. Compuestos fenólicos en extractos acuosos de Thymus  
El rendimiento de extracción de los extractos acuosos de tomillo osciló entre 15 y 20%, 
siendo T. caespetitius el asociado a mayores rendimientos (Tabla 1). A su vez, este 
último mostró un contenido en fenólicos totales más bajo (236.0 mg EAG/g de extracto, 
equivalente a 47.0 mg EAG/g de planta seca), en comparación con los valores medios 
obtenidos en los extractos de T. herba-barona y T. pseudolanuginosus (272.9 y 293.0 
mg EAG/g de extracto o 41.6 y 49.2 mg EAG /g de planta seca), respectivamente.  
Tabla 1. Rendimiento de extracción (%), compuestos fenólicos totales (mg EAG/g de extracto), actividad 
antioxidante y antiinflamatoria (EC50, μg/mL) de extractos acuosos de T. herba-barona, T. 




CFT DPPH● PR β-Caroteno  NO●  5-LOX  
T. h-b 15.3 ± 1.8a 272.9 ± 16.6ac 11.6 ± 0.9a 35.1± 4.5a > 26.7a 286.1 ± 32.6a 840.8 ± 137.9a 
T. pseud 16.8 ± 0.9a 293.0 ± 30.5a 10.9 ± 0.7a 32.2± 8.2a 2.4 ± 0.2b 298.98 ± 23.4a 813.6 ± 87.2a 
T. caesp 19.9 ± 2.4a 236.0 ± 26.6bc 13.8 ± 0.6a 39.3 ± 2.7a 6.1 ± 0.2c 229.70 ± 21.5b 590.5 ± 166.3a 
AA   6.7 ± 0.7b -  228.0 ± 20.7b 7.8 ± 1.0b 
BHA   - 16.0 ± 2.0b 0.4 ± 0.02d   
Valores medios ± SD. El análisis estadístico se realizó mediante ANOVA de una vía, seguido de la prueba 
de Tukey. En cada fila, letras diferentes significan diferencias estadísticamente significativas (p <0.05). CFT: 
compuestos fenólicos totales; EAG: equivalentes de ácido gálico; LOX-5: enzima 5-lipoxigenasa; PR: poder 
reductor; T. h-b: T. herba-barona; T. pseud: T. pseudolanuginosus; T. caesp: T. caespititius; AA: ácido 
ascórbico; BHA: hidroxianisol butilado. 
Debe tenerse en cuenta que estos tres extractos acuosos tenían un contenido fenólico 
total considerablemente más alto que los encontrados por otros autores en distintas 
plantas de tomillo. En particular, los extractos de T. serpyllum a 50ºC y 100ºC contenían 





acuosos obtenidos de las hojas de Thymus zygis a 20ºC demostraran 25.8 mg de EAG/g 
de muestra seca [9].  
Los constituyentes fenólicos individuales de los tres extractos acuosos de tomillo fueron 
determinados mediante UHPLC-DAD-ESI-MSn, teniendo en cuenta los datos recogidos 
de los espectros UV-Vis y MS de los picos cromatográficos eluidos (Tabla 2) y 
comparación con los compuestos estándares y/o comparación con los datos de la 
literatura.  
Tabla 2. Identificación y cuantificación a través de UHPLC de las fracciones obtenidas por UHPLC-DAD-








T. h-b T. pseud T. caesp 
1 1.3 270 Acido quinicoA 191 D D D 
2 1.6 278 Ácido siringico-O-hexósidoB 359 D D D 
3 1.8 
281 DanshensuB 197 D D D 
292, 323 4-O-ácido cafeoilquinicoB 353 - D D 
4 2.2 286, 322 t-5-O- ácido cafeoilquinicoA 353 D 6.4 ± 0.4 D 
5 2.4 271, 333 Apigenina di-C-glucósidoB 593 D D 4.0 ± 0.2 
6 3.3 289, 321 Ácido cafeicoA 179 4.3 ± 0.1 D D 
7 3.4 
287, 318 Derivado del ácido salvianólico FB 375 D D D 
277 Derivado del ácido rosmarínicoB 377 - - D 
8 3.7 283 Eriodictiol-O-glucósidoA 449 1.9 ± 0.01 - - 
9 4.1 281, 342 Quercetina-O-glucurónidoB 477 2.3 ± 0.1 3.4 ± 0.04 1.1 ± 0.08 
10 4.6 341 Luteolina-C-glucósidoA 447 5.1 ± 0.1 2.9 ± 0.02 - 
11 5.1 282 Sulfato de ácido rosmarínicoB 439 - - D 
12 5.6 
253, 287, 
312 Ácido salvianólico I
B 537 - D D 




B 593 - - 2.2 ± 0.1 
15 6.8 281, 331 Luteolina-O-glucurónido (isómero 1)B 461 4.4 ± 0.02 54.1 ± 0.6 17.3 ± 1.1 
16 7.0 
255, 265, 
345 Luteolina-O-glucurónido (isómero 2)
B 461 10.5 ± 0.2 7.1 ± 0.2 6.8 ± 0.4 
17 7.3 261, 331 Apigenina-O-glucósido (isómero 1)A 431 - 0.9 ± 0.15 - 
18 8.0 285, 333 Derivado del ácido salvianólico CB 553 - D - 
19 8.3 
254, 283, 
344 Ácido salvianólico B (isómero 1)
B 717 - - 6.9 ± 0.5 
289, 318 Diidro- Ácido salvianólico B (isómero 
1)B 
715 10.8 ± 0.1 - - 
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20 8.5 289, 337 Crisoeriol-O- glucósidoB 461 D D - 
21 9.0 
228, 282, 
331 Apigenina-O-glucósido (isómero 2)




B 607 - - D 
23 9.1 267, 333 Apigenina-O- glucurónidoB 445 2.10 ± 0.03 8.30 ± 0.05 1.97 ± 0.1 
24 9.6 287, 325 Ácido rosmarínicoA 359 55.8 ± 2.8 40.2 ± 0.9 43.2 ± 3.2 
25 9.8 287, 311 3′-O-(8″-Z-Cafeoil) Ácido rosmarínico 
(isómero 1)B 
537 D D D 
26 9.0 289, 319 
Diidro - Ácido salvianólico B  
(isómero 2)B 
715 D - - 
27 10.1 
288, 326 Ácido salvianólico B (isómero 2)B 717 D D D 
287, 324 Ácido salvianólico KB 555 D 10.5 ± 0.1 - 
28 10.7 290, 323 3′-O-(8″-Z-Cafeoil) Ácido rosmarínico 
(isómero 2)B 
537 12.0 ± 0.2 D D 
29 12.2 288, 322 
Cafeoil ácido rosmarínico  
(isómero 1)B 
537 10.5 ± 0.06 D D 
30 12.5 287, 328 
Cafeoil ácido rosmarínico  
(isómero 2)B 
537 4.2 ± 0.1 - - 
31 12.8 288, 323 
Cafeoil ácido rosmarínico  
(isómero 3)B 
537 - D - 
32 13.3 287, 323 3′-O-(8″-Z-Cafeoil) ácido rosmarínico 
(isómero 3)B 
537 D D D 
   
Classes de Compuestos  
Fenolicos 
97.6 ± 2.6a 57.1 ± 1.3b 50.0 ± 3.8c 
   22.0 ± 0.3a 73.3 ± 1.0b 32.2 ± 2.0c 
   2.3 ± 0.1a 3.60 ± 0.04b 1.1 ± 0.1c 
   1.9 ± 0.01 - - 
     123.9 ± 2.8a 134.0 ± 2.4b 83.4 ± 5.8c 
T. h-b: T. herba-barona; T. pseud: T. pseudolanuginosus; T. caes: T. caespititius; D: Detectado; TR: tiempo de retención; 
ALa identificación del compuesto se basó en la comparación con el estándar; BLa identificación del compuesto se basó 
en la interpretación de espectros UV y datos de EM, más la comparación con la literatura; Valores medios ± SD de tres 
ensayos independientes; El análisis estadístico fue realizado por one-way ANOVA (teste de Tukey). En cada fila 
diferentes letras significan diferencias estadísticamente significativas (p < 0.05). 
 
Es conocido que las plantas de Thymus presentan grandes cantidades de ácido 
rosmarínico [1]. En este estudio, el ácido rosmarínico fue un componente fenólico 
importante en los tres extractos de tomillo, representando 55.8, 40.2 y 43.2 mg/g en T. 
herba-barona, T. pseudolanuginosus y T. caespititius, respectivamente. El ácido 
rosmarínico fue claramente menos representativo en el extracto de T. 
pseudolanuginosus (30% del total de fenólicos cuantificados) en comparación con los 
otros dos (45-52% del total de fenólicos cuantificados). Esta diferencia se debió 





461285) en el extracto de T. pseudolanuginosus (54.1 mg/g), mientras que sus niveles 
fueron de 17.3 y 4.4 mg/g en los extractos de T. caespititius y T. herba-barona, 
respectivamente. En general, se observó una elevada expresión de los dos derivados 
de la luteolina-O-glucurónido en la especie T. pseudolanuginosus (61.2 mg/g de 
extracto) que representaron 46% de sus compuestos fenólicos totales. Esto indica la 
riqueza en flavonas del T. pseudolanuginosus y una clara diferenciación de esto extracto 
en relación a T. herba-barona y T. caespititius. Es importante anotar que los derivados 
de la luteolina-O-glucurónido y otros glucósidos de flavona también se han descrito 
previamente para otras especies de Thymus, pero aun así, sus niveles fueron más altos 
en T. pseudolanuginosus que los publicados anteriormente (8-14 mg/g de planta) 
[1,19,23].  
Además del ácido rosmarínico, los restantes derivados de lo ácido cafeico estaban 
presentes en las tres especies de Thymus, siendo particularmente abundante en 
extractos de T. herba-barona (Tabla 2). Por otro lado, los ácidos salvianólicos K y B se 
encontraron en los extractos de T. pseudolanuginosus y T. caespititius, con niveles de 
10.5 y 6.9 mg/g de extracto, respectivamente. 
3.2. Actividad antioxidante 
La sobreproducción de oxidantes es responsable de la patogénesis de muchas 
enfermedades crónicas. A su vez, los distintos fitoquímicos de los alimentos y las plantas 
medicinales exhiben propiedades antioxidantes que podrían ser beneficiosas para 
contrarrestar el estrés oxidativo [10]. En este contexto, los extractos acuosos de T. 
herba-barona, T. pseudolanuginosus y T. caespititius se investigaron por su capacidad 
antioxidante, por distintos métodos in vitro, a saber, DPPH●, poder reductor y ensayos 
de blanqueo del β-caroteno (Tabla 1). El método de captación de DPPH● evalúa la 
capacidad de los extractos para atrapar los radicales libres sintéticos DPPH●, mientras 
que el método de la potencia reductora mide la conversión de Fe3+ a Fe2+, y el método 
de blanqueo β-caroteno mide la capacidad de inhibir la peroxidación lipídica.  
Teniendo en cuenta los resultados obtenidos, se puede concluir que los tres extractos 
de Thymus mostraron una alta capacidad antioxidante, lo cual fue particularmente 
evidente en las pruebas de DPPH● y del poder reductor, para las cuales los valores de 
EC50 son 1.6-2.0 más altos que los de los compuestos comerciales de referencia. Entre 
los tres extractos, había una tendencia a una mejor actividad de T. pseudolanuginosus 
(EC50 de 10.9 y 32.2 μg/mL en los métodos DPPH● y poder reductor, respectivamente), 
aunque las diferencias no fueron estadísticamente significativas. 
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La alta capacidad antioxidante aquí descrita está de acuerdo con los datos de la 
literatura encontrados para los extractos acuosos de T. serpyllum L. con bajos valores 
de EC50 en DPPH● (13.8 y 11.8 µg/mL obtenidos en 50ºC y 100ºC, respectivamente) 
[16] y para los extractos etanólicos de otras especies de tomillo, que presentaron valores 
EC50 en el ensayo del DPPH●, 1.8-3.6 más alto que los de los compuestos comerciales 
de referencia [15]. Resultados menos prometedores se habían descrito previamente 
para otras especies de tomillo usando el método DPPH●, a saber, en extractos polares 
de Thymus capitatus [24] y de Thymus pubescens, Thymus kotschyanus and Thymus 
daenensis [25], cuyos valores de EC50 fueron 6-9 veces superiores a los de los controles 
positivos utilizados. La capacidad de especies de Thymus para reducir Fe3+ a Fe2+ no 
está bien documentada, sin embargo Kindl et al. [15] habían descrito una fuerte 
capacidad en extractos etanólicos de Thymus longicaulis, Thymus praecox, Thymus 
pulegioides, T. serpyllum, Thymus striatus y T. vulgaris (EC50=11.4-15.1 μg/mL), con los 
mejores resultados registrados para T. pulegioides, cuyo EC50 fue solo 1.7 más alto que 
el control de referencia [15].  
La oxidación de -caroteno fue inhibida efectivamente por T. pseudolanuginosus 
(EC50=2.4 μg/mL), seguido de T. caespititius (EC50=6.1 μg/mL), mientras que T. herba-
barona se mostró  ineficaz (Table 1). Los datos de la literatura también señalan una 
actividad prometedora en el test de oxidación de -caroteno para otros tomillos. En 
particular, Iauk et al.  [24] describieron valores de EC50 para un extracto metanólico de 
T. capitatus que fue cercano a 0.7 µg/mL en 30 min y 1.9 µg/mL en 60 min. Se 
observaron valores más altos para los extractos etanólicos de T. daenensis, T. 
kotschyanus y T. pubescens (EC50= 23.7, 35.2 y 92.9 µg/mL, respectivamente) [25]. 
La información combinada de los tres métodos antioxidantes junto con la de los niveles 
de compuestos fenólicos sugiere que estos últimos constituyentes no son los únicos 
actores que dictan el potencial antioxidante de los extractos. La alta abundancia de 
compuestos fenólicos, y particularmente de las flavonas, en el extracto de T. 
pseudolanuginosus, se puede relacionar con su capacidad antioxidante superior en 
comparación con la de los extractos restantes. Por otra parte, el contenido fenólico 
directo y la actividad antioxidante no se observaron para las dos especies de plantas 
restantes en el ensayo de blanqueo de β-caroteno. Este fenómeno puede deberse a la 
presencia de componentes inductores oxidativos en el extracto de T. herba-barona, 







3.3 Actividad antiinflamatoria 
Debido a la relevancia de los procesos inflamatorios en la aparición de numerosas 
enfermedades (cáncer, Alzheimer, insuficiencia cardíaca, accidente cerebrovascular 
isquémico y otros), la búsqueda de extractos naturales de baja toxicidad capaces de 
contrarrestar a los principales elementos mediadores de la inflamación se ha 
incrementado considerablemente en los últimos años [31,32]. Los extractos acuosos de 
las tres especies de plantas se examinaron para determinar su capacidad para 
contrarrestar el incremento de NO● (es decir, un mediador proinflamatorio principal 
producido por fagocitos) y la actividad de la 5-LOX, la enzima que controla la producción 
de los leucotrienos proinflamatorios [6,26]. Como se detalla en la Tabla 1, todos los 
extractos mostraron una alta capacidad de reducir los niveles de NO●. Este efecto fue 
más evidente para T. caespititius, que exhibió la misma potencia que el ácido ascórbico 
(EC50=229.7 μg/mL y 228.0 μg/mL, respectivamente). T. caespetitius también fue el más 
relevante entre las tres muestras con respecto a la capacidad para inhibir la actividad 5-
LOX (EC50=590.5 μg/mL). Por lo tanto, los resultados sugieren que los extractos 
acuosos de tomillo de las plantas seleccionadas podrían tener aplicaciones potenciales 
como agentes antiinflamatorios, actuando a través de capacidades antiradicales hacia 
NO●. El hecho de que esta capacidad no esté directamente asociada al contenido 
fenólico de los extractos (el extracto de T. caespititius fue el menos rico en compuestos 
fenólicos) también sugiere que los compuestos no fenólicos pueden tener funciones 
importantes en el efecto antiinflamatorio. 
Por lo que sabemos, la capacidad de la eliminación de NO● de extractos polares de 
Thymus solo se ha informado previamente para extractos etanólicos de seis especies 
de Thymus: T. serpyllum subsp. serpyllum (EC50=176.6 μg/mL), T. praecox subsp. 
polytrichus (EC50 = 139.0 μg/mL), T. vulgaris (EC50 = 97.9 μg/mL), T. striatus (EC50 = 91.1 
μg/mL), T. longicaulis (EC50 = 71.6 μg/mL), T. pulegioides (EC50 = 69.8 μg/mL) [15], que 
mostraron valores EC50 1.3-3.2 veces más altos que el compuesto estándar (Trolox), 
mientras que la actividad de inhibición de 5-LOX no fue explorada.  
3.4. Actividad antibacteriana 
La resistencia a los antibióticos se viene  asociando a enfermedades y altas tasas de 
mortalidad [27]. Las investigaciones sobre nuevas sustancias antimicrobianas, como los 
compuestos naturales purificados de plantas, pueden servir de estrategia terapéutica 
para la obtención de fármacos alternativos y de nueva generación con baja toxicidad. 
En este campo, los compuestos fenólicos han ido ganando importancia [28]. La actividad 
antibacteriana de la familia Lamiaceae ha sido ampliamente estudiada, con resultados 
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prometedores para los aceites esenciales de Thymus [29,30] mientras que se ha 
avanzado menos en el conocimiento de extractos polares de estas plantas. 
Los datos recopilados mostraron que, entre las 5 cepas analizadas (Tabla 3), S. 
aureus fue la más sensible a los tres extractos de tomillo, que fueron capaces de inhibir 
tanto su crecimiento como su viabilidad a 0.6, 1.6 y 3.5 mg/ml para T. herba-barona, T. 
pseudolanuginosus y T. caespititius, respectivamente. Estos resultados son 
consistentes con los descritos por Benbelaïd et al. [21] para un extracto acuoso de T. 
lanceolatus, que exhibió un valor de CIM de 1.0 mg/ml para S. aureus, evaluado 
mediante el método de microdilución en caldo. Además, los resultados obtenidos 
utilizando el método de dilución en agar, mostraron valores de CIM de 0,78 mg/ml para 
extractos etanólicos de T. caramanicus, cuando se expusieron a S. aureus [20]. 
Table 3. CIM (mg/ml) and CBM (mg/ml) de extractos de planta y nisina (mg/ml) contra cinco patógenos  
 Valores medios; CIM: concentración inhibitoria mínima; CBM: concentración bactericida mínima 
Las tres especies de Thymus estudiadas, también mostraron un efecto antibacteriano 
relevante contra las bacterias restantes analizadas, aunque con menos potencia que el 
conservante de alimentos nisina. Más concretamente, se registraron valores de CIM de 
5.0 y 6.5 mg/ml para T. herba-barona y T. pseudolanuginosus, respectivamente, contra 
S. typhimurium, S. epidermidis, E. coli y P. aeruginosa. A pesar de que T. caespititius 
fue, en general, el extracto menos activo, su actividad hacia S. epidermidis (CIM=3.5 
mg/ml) fue más efectiva que las restantes. Las concentraciones de CIM que se recogen 
en este estudio son cercanas a las publicadas previamente por otros autores para los 
extractos polares de T. vulgaris, Thymus caramanicus [20] y T. lanceolatus [21] contra 
una panel semejante de bacterias. 
En general, los resultados mostraron que los extractos de tomillo no eran letales para 
algunas bacterias Gram- (S. typhimurium , E. coli y P. aeruginosa), con una CBM alta 
(Tabla 3). Además, las bacterias Gram- fueron más resistentes (CIM entre 5.0 y 7.0 
mg/ml) que las bacterias Gram +, particularmente S. aureus (CIM en el rango de 0.6 - 
 T. herba-barona T. pseudolanuginosus T. caespititius Nisina 
Bacteria CBM CIM CBM CIM CBM CIM CBM CIM 
S. typhimurium 5.0 5.0 >6.5 6.5 >7.0 7.0 0.5 0.5 
S. epidermidis 5.0 5.0 6.5 6.5 7.0 3.5 <0.03 <0.03 
S. aureus 0.6 0.6 1.6 1.6 3.5 3.5 0.25 0.25 
E. coli >5.0 5.0 >6.5 6.5 7.0 7.0 0.5 0.5 





3.5 mg/ml). Estos resultados están de acuerdo con los de otros autores, que investigaron 
extractos acuosos de T. lanceolatus (CIM=4.0 mg/ml contra S. typhimurium  y CIM=0.83 
mg/ml contra S. aureus) [21]. La misma evidencia se observó en varias investigaciones 
que analizaron el efecto de aceites esenciales extraídos de plantas Thymus [29,30]. 
4. Conclusiones 
Este trabajo describe en detalle la composición fenólica de decocciones de T. herba-
barona, T. pseudolanuginosus y T. caespititius, así como sus actividades antioxidante, 
antiinflamatoria y antimicrobiana. Los tres extractos acuosos se caracterizaron 
principalmente por la presencia de ácidos fenólicos y flavonoides, que en parte parecen 
estar relacionados con sus actividades biológicas. T. pseudolanuginosus presentó los 
mejores resultados antioxidantes en los tres métodos utilizados. Los extractos de 
tomillos seleccionados mostraron actividad antibacteriana contra el panel de bacterias 
utilizado en este estudio, especialmente las cepas de S. aureus, que en general fueron 
también las más sensibles. T. caespititius tiene potencial antiinflamatorio, basado en su 
prometedora actividad inhibitoria en la producción de NO●. Teniendo en cuenta la 
creciente demanda de extractos bioactivos de origen botánico, este trabajo abre una 
puerta para la expansión de la explotación comercial de estas especies de tomillo. 
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Abstract: Thymus herba-barona, Thymus pseudolanuginosus, and Thymus caespititius decoctions were
screened for their phenolic constituents, along with their potential antioxidant, anti-inflammatory,
and antibacterial activities. The total phenolic compounds in the extracts of the three plants
ranged from 236.0 ± 26.6 mgGAE/g (T. caespititus) to 293.0 ± 30.5 mgGAE/g of extract
(T. pseudolanuginosus), being particularly rich in caffeic acid derivatives, namely rosmarinic acid and
its structural isomers, as well as flavones, such as luteolin-O-glucuronide. The T. pseudolanuginosus
extract presented the best DPPH radical scavenging ability (EC50 = 10.9 ± 0.7 µg/mL), a high
reducing power (EC50 = 32.2 ± 8.2 µg/mL), and effectively inhibited the oxidation of β-carotene
(EC50 = 2.4 ± 0.2 µg/mL). The extracts also showed NO• scavenging activity close to that of ascorbic
acid, and thus might be useful as anti-inflammatory agents. In addition, they exhibited antibacterial
activity against gram-negative and gram-positive bacteria. Staphylococcus aureus strains were the
most sensitive bacteria to thyme extracts, with minimum inhibitory concentration and minimum
bactericidal concentration values in the range of 0.6–3.5 mg/mL. Overall, this work is an important
contribution for the phytochemical characterization and the potential antioxidant, anti-inflammatory,
and antimicrobial activities of these three Thymus species, which have been poorly explored.
Keywords: thymus; thyme; LC-MS; mass spectrometry; phenolic; antioxidant; anti-inflammatory;
antiradicalar; antimicrobial activity
1. Introduction
The Thymus genus encloses about 350 species, which are particularly well adapted to the hot and
dry climate of the Mediterranean region and widespread in the arid parts of the Iberian Peninsula [1,2].
As for the vast majority of Lamiaceae plants, Thymus are recognized as being strongly aromatic and
are widely used as spices to enhance sensory attributes such as the taste and aroma of foods [1].
These properties highlight the potential application of Thymus plants in the food industry, e.g., in meat,
butter, chewing gum, liqueurs, ice cream, and candy production. Besides flavouring, their usage
also improves the preservation of food, contributing to the prevention of food oxidation and color
changes [3,4]. Likewise, these plants have some potential applications in pharmaceutical and cosmetic
industries due to their biological and medicinal benefits. They are largely used in the manufacturing
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of perfumes, pharmaceutical products, and toilet articles [4–7]. Although these applications have been
mostly associated with essential oils, nowadays, Thymus polar extracts are an attractive target for
the screening of health-promoting properties for possible industrial applications in food, cosmetics,
or pharmaceutical industries, among others [1,8].
Several authors have demonstrated that Lamiaceae, and particularly Thymus plants, are rich
in bioactive phytochemicals, including phenolic acids and flavonoids [1,3,9,10], which in turn,
have been shown to reduce the risk of diseases due to their extensive biological properties,
including those which are antioxidant, cardioprotective, anticancer, anti-ageing, anti-inflammatory,
and antibacterial [5,6,8,11].
The screening of the potential bioactive effects of Thymus polar extracts has been mainly
conducted for Thymus vulgaris [12–15] and Thymus serpyllum (wild thyme) [2,16], although other species,
including Thymus pulegioides [4,15], Thymus praecox [15], Thymus sipyleus [17], Thymus striatus [15],
Thymus longicaulis [15], Thymus mastichina [18], have also been studied with respect to their antioxidant
activities. Overall, aqueous or alcoholic extracts from Thymus have been shown to exhibit strong
antioxidant activities in in vitro [17,19] or in vivo models [20]. Moreover, other effects reported in the
polar extracts of thyme species include antimicrobial [21,22], antidiabetic [8,19], neuroprotective [15],
and inflammatory properties [23].
In contrast to the above mentioned studies, the potential applications of the polar extracts from
less-widespread Thymus like Thymus herba-barona, Thymus pseudolanuginosus, and Thymus caespititius
remain unexplored. These three species are particularly known for being well-adapted to the Atlantic
climate, thus growing spontaneously in the Iberian Peninsula and Mediterranean islands. As reported,
their essential oils exhibit antioxidant, antimicrobial, and insecticidal effects and can potentially be used
as preservatives in storage products for food flavouring, and as deodorants and disinfectants [24,25].
The present study aims to contribute to the clarification of phenolic constituents of T. herba-barona,
T. pseudolanuginosus, and T. caespititius, as well as to exploit their free radical scavenging, antibacterial,
and anti-inflammatory activities.
2. Results and Discussion
2.1. Phenolic Compounds in Thymus Aqueous Extracts
The mass yield of thyme aqueous extracts ranged from 15% to 20%, with T. caespititius being the
most predominant (Table 1). In turn, the latter showed a lower total phenolic content (236 ± 26.6 mg
GAE/g extract, equivalent to 47.0 mg GAE/g dry plant) in comparison to the mean values obtained for
the T. herba-barona and T. pseudolanuginosus extracts (273 and 293 mg GAE/g extract or 41.6 and 49.2 mg
GAE/g dry plant, respectively). However, it is important to note that these three aqueous extracts
had a considerably higher total phenolic content than those found by other authors in distinct Thymus
plants. In particular, aqueous extracts obtained from wild thyme (T. serpyllum) at 50 and 100ºC were
found to contain 79.02 ± 6.62 and 91.07 ± 9.25 mg GAE/g extract, respectively [16], while aqueous
extracts obtained from Thymus zygis leaves at 20ºC produced a 25.8 ± 2.0 mg GAE/g dry sample [3].
In addition, the phenolic content in phosphate buffer or hydromethanolic extracts from T. vulgaris
were reported to account for 2.1 ± 0.1 mg GAE/g fresh leaves [26] or 19.2 ± 0.3 mg GAE/g of fresh
weight [14], respectively.
Individual phenolic constituents of the three thyme aqueous extracts were elucidated by ultra
high performance liquid chromatography coupled to diode array detector and an a electrospray
mass spectrometer (UHPLC-DAD-ESI-MSn), taking into consideration the gathered ultraviolet-visible
(UV-Vis) and mass spectrometry (MS) spectra data of the eluted chromatographic peaks (Figure 1,
Table 2) and in comparison to those of standard compounds and/or in comparison to literature data.
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Table 1. Yield of extraction (%), total phenolic content (mg GAE/g of extract), and antioxidant and
anti-inflammatory activities (EC50, µg/mL) of T. herba-barona, T. pseudolanuginosus, and T. caespititius
aqueous extracts.
Plant Extract Yield (%) TPC DPPH• RP β-Carotene NO• 5-LOX
T. herba-barona 15.3 ± 1.80 a 273 ± 16.6 a,c 11.6 ± 0.90 a 35.1± 4.50 a >26.70 a 286 ± 32.6 a 841 ± 138 a
T. pseudolanuginosus 16.8 ± 0.90 a 293 ± 30.5 a 10.9 ± 0.70 a 32.2± 8.20 a 2.40 ± 0.20 b 299 ± 23.4 a 814 ± 87.2 a
T. caespititius 19.9 ± 2.40 a 236 ± 26.6 b,c 13.8 ± 0.60 a 39.3 ± 2.70 a 6.10 ± 0.20 c 230 ± 21.5 b 591 ± 166 a
AA 6.70 ± 0.70 b − 228 ± 20.7 b 7.80 ± 1.00 b
BHA − 16.0 ± 2.00 b 0.40 ± 0.02 d
Mean values ± standard deviations. Statistical analysis was performed by one-way ANOVA, followed by a Tukey
test. In each column, different letters (a–d) stand for significant statistical different data (p < 0.05). TPC: Total Phenolic
Compounds; RP: Reducing Power; AA: Ascorbic acid; BHA: Butylated hydroxyanisole; LOX: lipoxygenase.
Note that despite the fact that Thymus plants are generally known for their richness in
rosmarinic acid [1], the specific phenolic composition of thyme extracts is dependent on several
factors, including the botanical species and the applied extraction conditions. To the best of our
knowledge, there is no reported literature regarding the phenolic composition of T. herba-barona,
T. pseudolanuginosus, and T. caespititius extracts.
Rosmarinic acid was a major phenolic component in the three thyme extracts, accounting for
55.8 ± 2.8 mg/g in T. herba-barona and 40.2 ± 0.9 and 43.2 ± 3.2 mg/g in T. pseudolanuginosus
and T. caespititius, respectively. Despite the common abundance, rosmarinic acid was clearly less
representative in the T. pseudolanuginosus extract (30% of total quantified phenolics) in comparison
to the other two, in which it amounted for 45–52% of the total quantified phenolics. This difference
was mainly due to the high abundance of luteolin-O-glucuronide (6.8 min, [M − H]− at m/z 461→285)
in the T. pseudolanuginosus extract, which accounted for 54.1 ± 0.6 mg/g, while its levels were only
17.3 ± 1.1 mg/g and 4.4 ± 0.02 mg/g in the T. caespititius and T. herba-barona extracts, respectively.
Globally, the two O-glucuronide derivatives of luteolin eluted in fractions 15 and 16 (RT 6.8 and
7.0 min respectively) in the T. pseudolanuginosus extract accounted for 61.2 mg/g of the extract and
represented 46% of its total phenolics. This caused a clear differentiation between the extracts,
with T. pseudolanuginosus phenolic components being mainly represented by flavones. Note that
O-glucuronide derivatives of luteolin and other flavone glycosides such as luteolin-C-glucoside,
apigenin-O-glucuronide and apigenin-O-glucoside herein detected have also been previously described
for other Thymus species, but still, their levels, particularly those of luteolin-O-glucuronide derivatives,
are higher in T. pseudolanuginosus than in previously reported data (8–14 mg/g of dry plant) [1,17,27].
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Table 2. Identification and quantification of UHPLC (ultra high performance chromatography) eluting fractions by UHPLC-DAD-MSn of T. herba-barona, T.
pseudolanuginosus, and T. caespititius aqueous extracts.
Fraction RT (min) λmax (nm) Compound [M-H]− Main Fragments ESI-MSn
(mg/g Extract)
T. h-b T. pseud T. caesp
1 1.3 270 Quinic acid A 191 MS2 [191]: 111, 173 D D D
2 1.6 278 Syringic acid-O-hex B 359 MS2 [359]: 197, 179, 161, 153, 135 D D D
3 1.8
281 Danshensu B 197 MS2 [197]: 179 D D D
292, 323 4-O-CQA B 353 MS2 [353]: 173, 179, 191 − D D
4 2.2 286, 322 t-5-O-CQA A 353 MS2 [353]: 191 , 179, 161, 135, 119 D 6.4 ± 0.4 D
5 2.4 271, 333 Apigenin di-C-glc B 593 MS2 [539]: 473, 353, 383, 503, 575, 297 D D 4.0 ± 0.2
6 3.3 289, 321 Caffeic acid A 179 MS2 [179]: 135, 151, 161, 107, 97 4.3 ± 0.1 D D
7 3.4
287, 318 SA F der B 375 MS2 [375]: 313, 269, 179, 135, MS3 [313]: 269, 161 D D D
277 RA der B 377 MS2 [377]: 359; MS3 [359]: 161, 179, 197, 223, 133 − − D
8 3.7 283 Eriodictyol-O-glc A 449 MS2 [449]: 287, 269, 259, 267 1.9 ± 0.01 − −
9 4.1 281, 342 Quercetin-O-glcA B 477 MS2 [477]: 301, 343, 397 2.3 ± 0.1 3.4 ± 0.04 1.1 ± 0.08
10 4.6 341 Luteolin-C-glc A 447 MS2 [447]: 357, 285, 327 5.1 ± 0.1 2.9 ± 0.02 −
11 5.1 282 RA sulfate B 439 MS2 [439]: 259, 421, 225, 371, 359, 197; MS3 [259]: 161 − − D
12 5.6 253, 287, 312 SA I B 537 MS2 [537]: 339, 493; MS3 [339]: 295, 229, 293 − D D
13 5.7 289, 318 SA F der B 519 MS2 [519]: 475, 313; MS3 [475]: 313, 269, 179, 431 D − −
14 6.2 254, 266, 345 Luteolin-O-rut B 593 MS2 [593]: 285 − − 2.2 ± 0.1
15 6.8 281, 331 Luteolin-O-glcA (isom 1) B 461 MS2 [461]: 285, 175; MS3 [285]: 267, 239, 241, 213, 185 4.4 ± 0.02 54.1 ± 0.6 17.3 ± 1.1
16 7.0 255, 265, 345 Luteolin-O-glcA (isom 2) B 461 MS2 [461]: 285; MS3 [285]: 241, 199, 175, 151, 267 10.5 ± 0.2 7.1 ± 0.2 6.8 ± 0.4
17 7.3 261, 331 Apigenin-O-glc (isom 1) A 431 MS2 [431]: 269 − 0.9 ± 0.15 −
18 8.0 285, 333 SA C der B 553 MS2 [553]: 491, 399, 179, 429, 473; MS3 [491]: 473 − D −
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Table 2. Cont.
Fraction RT (min) λmax (nm) Compound [M − H]− Main Fragments ESI–MSn
(mg/g Extract)
T. h-b T. pseud T. caesp
19 8.3
254, 283, 344 SA B (isom1) B 717 MS2 [717]: 519, 475, 339; MS3 [519]: 475, 339 − − 6.9 ± 0.5
289, 318 Dedihydro-SA B (isom 1) B 715 MS2 [715]: 313, 627, 671, 269; MS2 [313]: 179, 135 10.8 ± 0.1 − −
20 8.5 289, 337 Chrysoeriol-O-glc B 461 MS2 [461]: 299, 284; MS3 [299]: 284 D D −
21 9.0 228, 282, 331 Apigenin-O-glc (isom 2) B 431 MS2 [431]: 269; MS3 [269]: 225, 149, 117, 183, 167, 199 D − −
22 9.0 252, 267, 342 Chrysoeriol-O-rut B 607 MS2 [607]: 299, 284 ; MS3 [299]: 284 − − D
23 9.1 267, 333 Apigenin-O-glcA B 445 MS2 [445]: 269, 175 2.1 ± 0.03 8.3 ± 0.05 1.97 ± 0.1
24 9.6 287, 325 RA A 359 MS2 [359]: 161, 179, 197, 223 55.8 ± 2.8 40.2 ± 0.9 43.2 ± 3.2
25 9.8 287, 311 3′-O-(8”-Z-Caffeoyl) RA (isom 1) B 537 MS2 [537]: 493, 515, 375, 357, 339, 313, 197 D D D
26 9.0 289, 319 Dedihydro- SA B (isom 2) B 715 MS2 [715]: 313, 671, 627, 269 D − −
27 10.1
288, 326 SA B (isom 2) B 717 MS2 [717]: 519, 357, 555 MS3 [519]: 357, 475, 295 D D D
287, 324 SA K B 555 MS2 [555]: 493, 357, 393, 313; MS3 [493]: 359, 313, 161 D 10.5 ± 0.1 −
28 10.7 290, 323 3′-O-(8”-Z-Caffeoyl) RA (isom 2) B 537 MS2 [537]: 493, 359; MS3 [493]: 359, 313, 295, 161 12.0 ± 0.2 D D
29 12.2 288, 322 Caffeoyl RA (isom 1) B 537 MS2 [537]: 375, 493, 359, 519 10.5 ± 0.06 D D
30 12.5 287, 328 Caffeoyl RA (isom 2) B 537 MS2 [537]: 439, 519, 357, 493, 323, 197 4.2 ± 0.1 − −
31 12.8 288, 323 Caffeoyl RA (isom 3) B 537 MS2 [537]: 519, 359, 357, 339, 235, 493; MS3 [519]: 357 − D −
32 13.3 287, 323 3′-O-(8”-Z-Caffeoyl) RA (isom 3) B 537 MS2 [537]: 493, 375, 359; MS3 [493]: 359, 197 D D D
Phenolic compounds groups
Caffeic acid and derivatives 97.6 ± 2.6 a 57.1 ± 1.3 b 50.0 ± 3.8 c
Flavones 22.0 ± 0.3 a 73.3 ± 1.0 b 32.2 ± 2.0 c
Flavonols 2.3 ± 0.1 a 3.6 ± 0.04 b 1.1 ± 0.1 c
Flavanones 1.9 ± 0.01 − −
Total 123.9 ± 2.8 a 134.0 ± 2.4 b 83.4 ± 5.8 c
T. h-b: Thymus herba-barona; T. pseud: Thymus pseudolanuginosus; T. caes: Thymus caespititius; D: detected; RT: retention time; CQA: caffeoylquinic acid; Der: derivative; Glc: glucoside;
GlucA: glucuronide; Hex: hexoside; isom: isomer; RA: rosmarinic acid; Rut: rutinoside; SA: salvianolic acid; Acompound identification was based on comparison to standard; Bcompound
identification was based on interpretation of UV spectral and MS data, plus comparison to literature; Mean values ± standard deviations of three independent assays; Statistical analysis
was performed by one-way ANOVA (Tukey’s test). In each row, different letters (a–c) stand for significant statistical different data (p < 0.05).
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Apart from rosmarinic acid, the remaining caffeic acid derivatives represented 8%, 13%, and 34%
of the total quantified phenolic compounds in T. caespititius, T. pseudolanuginosus, and T. herba-barona
extracts, respectively. Among the three plant species, the latter was clearly the richest in this
group of compounds, comprising simple compounds, namely caffeic acid (4.3 ± 0.1 mg/g
extract) and t-5-O-CQA (in vestigial concentrations), as well as several depsides (Table 2), namely
3′-O-(8”-Z-caffeoyl)rosmarinic acid (a compound previously described in other thyme species [28])
and/or its isomers (MW 538 Da, fractions 25, 28 and 32), together with dihydro-salvianolic acid B
(fraction 19; MW 716 Da). On the other hand, salvianolic acids K (fraction 27, [M − H]− at m/z 555→
493→ 359) and B (fraction 19, [M−H]− at m/z 717→ 519→ 475) were found in the T. pseudolanuginosus
and T. caespititius extracts, with levels of 10.5 ± 0.1 and 6.9 ± 0.5 mg/g of the extract, respectively.
2.2. Antioxidant Capacity
The overproduction of oxidants is responsible for the pathogenesis of many chronic diseases.
In turn, distinct phytochemicals from foods and medicinal plants exhibit antioxidant properties
that might be beneficial to counteract oxidative events [11]. In this context, the three Thymus
aqueous extracts were investigated for their antioxidant abilities through distinct in vitro methods,
namely DPPH•, reducing power and β-carotene bleaching assays. The DPPH• scavenging method
evaluates the free radical scavenging ability of the plant extracts to trap the synthetic free radicals
DPPH•, while the reducing power and β-carotene bleaching methods measure the extract’s ability to
reduce Fe3+ to Fe2+ or to inhibit lipidic peroxidation, respectively.
The antioxidant potentialities of T. herba-barona, T. pseudolanuginosus, and T. caespititius aqueous
extracts are detailed in Table 1, in terms of their EC50 values. Considering the results, one can conclude
that all three Thymus extracts showed a high antioxidant capacity, which was particularly evident in
the DPPH• and reducing power tests, for which the EC50 values are 1.6–2.0 higher than those of the
reference commercial compounds. Among the three extracts, there is a tendency for the better activity
of T. pseudolanuginosus (EC50 of 10.9 ± 0.7 and 32.2 ± 8.2 µg/mL for DPPH• and reducing power tests,
respectively), although differences are not statistically significant.
The high antioxidant ability herein reported is in accordance with the literature data found
for Thymus plants. Indeed, low DPPH• EC50 values were previously registered for T. serpyllum L.
aqueous extracts (EC50 of 13.75 ± 1.14 and 11.76 ± 0.25 µg/mL for extracts obtained at 50 and 100◦C,
respectively) [16] and for the ethanolic extracts from T. longicaulis, T. praecox, T. pulegioides, T. serpyllum,
T. striatus, and T. vulgaris, which exhibited DPPH• EC50 values in the range of 3.01–6.01 µg/mL, i.e.,
1.8–3.6 higher than those of the reference commercial compounds [15]. Less promising results were
previously reported for Thymus capitatus methanolic and hexane extracts, with EC50 = 44.5 ± 1.9
and 38.2 ± 1.2 µg/mL, respectively (eight to nine times less active than the positive control
EC50 = 5.0 ± 0.8) [29] and for hydroalcoholic extracts from Thymus pubescens, Thymus kotschyanus,
and Thymus daenensis (EC50 range between 31.47 and 48.68 µg/mL), also six to nine times less active
that the positive control, i.e., galic acid [30]; for T. vulgaris and wild thyme infusions, the EC50 values
were 300 and 450 µg/mL, respectively, and corresponded to a 17–25 times lower efficacy than butylated
hydroxytoluene [12]. The ability of Thymus species to reduce Fe3+ to Fe2+ is not reported as often;
however, Kindl et al. have reported a strong ability for ethanolic extracts from T. longicaulis, T. praecox,
T. pulegioides, T. serpyllum, T. striatus, and T. vulgaris (EC50 = 11.4–15.1 µg/mL), with the best results
being registered for T. pulegioides, whose EC50 was only 1.7 higher than the reference control [15].
Contrary to the results of the above antioxidant methods, the three Thymus extracts presented clear
differences in the β-carotene bleaching assay. The oxidation of β-carotene was effectively inhibited by
T. pseudolanuginosus (EC50 = 2.4 ± 0.2 µg/mL), followed by T. caespititius (EC50 = 6.1 ± 0.2 µg/mL),
while T. herba-barona was ineffective (Table 1). Notably, literature data also point out promising activity
toward the β-carotene oxidation protection from other thymes. In particular, Iauk et al. [29] described
an EC50 value for a T. capitatus methanolic extract that was close to that of 0.7 ± 0.03 µg/mL in
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30 min and 1.9 ± 0.6 µg/mL in 60 min. Higher values were observed for the ethanolic extracts from
T. daenensis, T. kotschyanus, and T. pubescens (EC50 = 23.7, 35.2, and 92.9 µg/mL, respectively) [30].
The combined information from the three antioxidant methods, together with that from the
phenolic compounds´ levels, suggests that these last constituents are not the only actors dictating the
antioxidant potential of the extracts. Indeed, although phenolic compounds are abundant (particularly
flavones) in the T. pseudolanuginosus extract, which can be correlated to its superior antioxidant ability
in comparison to those of the remaining extracts, the direct phenolic content and antioxidant activity
were not observed for those of the two remaining plant species in the β-carotene bleaching assay.
This phenomenon could be due to the presence of oxidative—inducer components in the T. herba-barona
extract, thus mitigating the activity of the antioxidant phenolic compounds.
2.3. Anti-Inflammatory Activity
Because of the major relevance of inflammatory processes in the onset of numerous diseases
(cancer, Alzheimer, heart failure, ischemic stroke, and others), the search for low-toxic natural extracts
able to counteract pivotal inflammatory players has increased dramatically in the last years [31,32].
The aqueous extracts from the three plant species were screened for their ability to counteract two key
inflammatory events, namely the increment of NO• (i.e., a main proinflammatory mediator produced
by macrofages) and lipoxygenase (LOX) activity (i.e., the enzyme that controls the production of
proinflammatory leukotrienes) [7,33]. As detailed in Table 1, all the extracts revealed a high NO•
scavenging ability. Curiously, this effect was more evident for T. caespititius, which exhibited the
same potency as ascorbic acid (EC50 of 229.7 ± 21.5 µg/mL and 228.0 ± 20.7 µg/mL, respectively).
Despite having a low ability to inhibit LOX activity, T. caespetitius was also the most relevant amongst
the three samples (EC50 = 590.5 ± 166.3 µg/mL). Hence, the gathered results suggest that Thymus
aqueous extracts of the selected plants might have potential applications as anti-inflammatory
agents, acting through anti-radical capacities towards NO•. The fact that this ability is not directly
associated the extracts´ phenolic content (T. caespititius extract was the less rich in phenolics) also
suggests that non-phenolic compounds can have major roles in this action. To our knowledge,
the NO• scavenging ability of Thymus polar extracts has only been previously reported for ethanolic
extracts of six Thymus species: T. serpyllum subsp. serpyllum (EC50 = 176.6 ± 8.1 µg/mL),
T. praecox subsp. polytrichus (EC50 = 139.0 ± 5.7 µg/mL), T. vulgaris (EC50 = 97.9 ± 2.9 µg/mL),
T. striatus (EC50 = 91.1 ± 5.3 µg/mL), T. longicaulis (EC50 = 71.6 ± 4.9 µg/mL), and T. pulegioides
(EC50 = 69.8 ± 4.4 µg/mL) [15], which showed EC50 values 1.3–3.2 times higher than the tested
standard compound (Trolox), while that of LOX inhibition activity was not exploited.
2.4. Antibacterial Activity
The resistance to antibiotics has been associated with diseases and high mortality rates [34].
Research into new antimicrobial substances, such as purified natural compounds from plants, can serve
as one of the therapeutic strategies for the synthesis of new generation and alternative chemical
drugs with low toxicity. In this field, phenolic compounds have been gaining magnitude [35].
The antibacterial activity of the Lamiaceae family has been extensively studied, with promising
results being observed for Thymus essential oils [36,37], while little knowledge has been gathered
regarding polar extracts from a thyme origin.
Overall, the collected data showed that, among the five tested strains (Table 3), Staphylococcus
aureus was the most sensitive to the three Thymus extracts, which were able to inhibit both its growth
and viability at 0.6, 1.6, and 3.5 mg/mL for T. herba-barona, T. pseudolanuginosus, and T. caespititius,
respectively. These results are consistent with those reported for other Thymus species, such as in
the study described by Benbelaïd et al. for a water extract of Thymus lanceolatus, which exhibited a
minimum inhibitory concentration (MIC) value of 1.0 mg/ml for S. aureus, as evaluated by the broth
microdilution method [22]. Results acquired using the agar dilution method showed MIC values of
0.78 mg/ml for ethanolic extracts of Thymus caramanicus when exposed to S. aureus [21].
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Table 3. MIC (mg/mL) and MBC (mg/mL) of plant extracts and nisin (mg/mL) against selected
test pathogens.
Bacteria
T. herba-barona T. pseudolanuginosus T. caespititius Nisin
MBC MIC MBC MIC MBC MIC MBC MIC
Salmonella typhimurium 5.0 5.0 >6.5 6.5 >7.0 7.0 0.5 0.5
Staphylococcus epidermidis 5.0 5.0 6.5 6.5 7.0 3.5 <0.03 <0.03
Staphylococcus aureus 0.6 0.6 1.6 1.6 3.5 3.5 0.25 0.25
Escherichia coli >5.0 5.0 >6.5 6.5 7.0 7.0 0.5 0.5
Pseudomonas aeruginosa >5.0 5.0 >6.5 6.5 >7.0 7.0 1.0 0.5
Mean values; MIC: minimum inhibitory concentration; MBC: minimum bactericidal concentration.
The three Thymus plants also exhibited a relevant antibacterial effect against the remaining
tested bacteria, although with less potency than the food preservative nisin. In detail, MIC values
of 5.0 and 6.5 mg/mL were registered for T. herba-barona and T. pseudolanuginosus, respectively,
against Salmonella typhimurium, Staphylococcus epidermidis, Escherichia coli, and Pseudomonas aeruginosa.
Despite T. caespititius generally being the less active extract, its activity towards S. epidermidis (MIC of
3.5 mg/mL) was more effective than the remaining ones. Note that the MIC concentrations herein
found are close to those previously reported for T. vulgaris ethanolic extracts, against the same panel
of bacteria (MIC in the range 6.25–12.5 mg/mL) [21] or to that of T. lanceolatus aqueous extracts
against S. typhimurium (MIC of 4.0 mg/mL) [22], although they are less effective than a T. caramanicus
hydroethanolic extract towards E. coli and P. aeruginosa (MIC values of 1.56 mg/mL and 1.30 mg/mL,
respectively) [21].
Overall, the gathered results showed that the thyme extracts were not lethal to some gram-negative
bacteria (S. typhimurium, E. coli, and P. aeruginosa), with a high minimum bactericidal concentration
(MBC) (Table 3). T. herba-barona is effective against S. typhimurium, but needs a concentration superior
to 5.0 mg/mL to kill E. coli and P. aeruginosa; a concentration of 6.5 mg/mL of T. pseudolanuginosus
was not effective against S. typhimurium, E. coli, and P. aeruginosa; T. caespititius can be lethal to E. coli,
but required a concentration superior to 7.0 mg/mL to eliminate S. typhimurium and P. aeruginosa).
Additionally, gram-negative bacteria were more resistant (MIC between 5.0 and 7.0 mg/mL) than
gram-positive bacteria, particularly S. aureus (MIC in the range 0.6 –3.5 mg/mL). These results
are in agreement with those of other authors, who tested aqueous extracts for T. lanceolatus
(MIC = 4.0 mg/mL against S. typhimurium and MIC = 0.83 mg/mL against S. aureus) [22]. The same
evidence was observed in several researches that tested oils extracted from Thymus plants [36,37].
3. Materials and Methods
3.1. Chemicals
Rosmarinic acid, apigenin-7-O-glucoside, luteolin-7-O-glucoside, eriodictyol-7-O-glucoside,
luteolin-8-C-glucoside, quinic acid, caffeic acid, and t-5-O-caffeoylquinic acid were obtained from
Extrasynthese (Genay Cedex, France). Gallic acid and nisin were obtained from Sigma Chemical Co.
(St. Louis, MO, USA). Folin-Ciocalteu reagent, Na2CO3, formic acid, and ethanol were purchased from
Panreac (Barcelona, Spain). n-hexane, methanol, and acetonitrile with HPLC purity were purchased
from Lab-Scan (Lisbon, Portugal). Mueller-Hinton agar was obtained from VWR, Prolabo Chemicals,
West Chester, PA, USA. Water was treated in a Direct-Q® water purification system (Merck Life
Science, Germany).
3.2. Plant Materials
T. herba-barona, T. caespititus, and T. pseudolanuginosus species were purchased as a mixture of
flowers, leaves, and stems from Ervital (Viseu, Portugal). The plants had been cultivated under an
organic regime and, after collection, their aerial parts (flowers, leaves, and stems) were dried in a
ventilated incubator at 20–35 ◦C, for three to five days.
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3.3. Extraction of Phenolic Compounds
Phenolic compounds were extracted by decoction, as according to Martins et al. [38],
thyme phenolic compounds are efficiently recovered by this methodology. Decoction was performed
according to the method described by Ferreira et al. [39], with adaptations. A total of 100 mL of
distilled water was added to 5 g of plant material (0.5 mm mesh powder) and the mixture was heated
and then boiled for 15 min. After extraction, the mixture was left to stand for 5 min, followed by
filtration under reduced pressure through a G3 sintered plates filter. The resulting filtrated solution
was concentrated in a rotary evaporator (BUCHI Labortechnik AG, Flawil, Switzerland) at 37 ◦C,
followed by deffating with n-hexane (1:1 v/v). The aqueous defatted fraction was frozen, freeze-dried,
and kept under vacuum in a desiccator in the dark, for subsequent use. Three extracts were obtained
for each plant.
3.4. Identification and Quantification of Phenolic Compounds
The total phenolic content of each Thymus extract was determined according to the adapted
Folin-Ciocalteu colorimetric method, as described by Pereira et al. [40]. The individual phenolic
compounds were identified by a UHPLC-DAD-ESI-MSn analysis of extracts (5 mg/mL), performed on
Ultimate 3000 (Dionex Co., Sunnyvale, CA, USA) apparatus equipped with an ultimate 3000 Diode
Array Detector (Dionex Co.) and coupled to a mass spectrometer. The chromatographic apparatus was
composed of a quaternary pump, an autossampler, a photodiode-array detector, and an automatic
thermostatic column compartment. The column used had a 100 mm length, 2.1 mm i.d., 1.9 µm particle
diameter, and end-capped Hypersil Gold C18 column (Thermo Scientific, Waltham, MA, USA), and its
temperature was maintained at 30 ◦C. Gradient elution was carried out with a mixture of 0.1% (v/v) of
formic acid in water (solvent A) and acetonitrile (solvent B), which were degassed and filtered before
use. The solvent gradient consisted of a series of linear gradients, starting with 15–28% of solvent B
over 5.6 min, increasing to 29% at 8.8 min, 100% of solvent B at 13.1 min, and maintaining this value up
to 17 min, followed by the return to the initial conditions, with a total running time of 20 min. The flow
rate used was 0.2 mL·min−1 and the UV–Vis spectral data for all peaks were accumulated in the range
200–600 nm. The chromatographic profiles were recorded at 280, 320, and 340 nm.
The mass spectrometer used was a Thermo LTQ XL (Thermo Scientific) ion trap MS equipped
with an ESI source. Control and data acquisition were carried out with the Thermo Xcalibur Qual
Browser data system (Thermo Scientific). Nitrogen above 99% purity was used and the gas pressure
was 520 kPa (75 psi). The instrument was operated in negative-ion mode with an ESI needle voltage
set at 5.00 kV and an ESI capillary temperature of 275 ◦C. The full scan covered the mass range from
m/z 100 to 2000. CID–MS/MS and MSn experiments were simultaneously acquired for precursor ions
using helium as the collision gas with a collision energy of 25–35 arbitrary units.
For quantitative analysis, the limits of detection (LOD) and quantification (LOQ) were calculated
from the parameters of the calibration curves obtained by an injection of known concentrations of the
exact or structurally-related standard compounds, represented in Table S1.
3.5. Bioactivity Tests
3.5.1. DPPH• Scavenging Test
The radical scavenging capacity of T. herba-barona, T. pseudolanuginosus, and T. caespititius extracts
was evaluated by a DPPH radical test, according to the previously described methodology [41].
Ascorbic acid was used as the positive control.
3.5.2. Reducing Power Test
The ability of T. herba-barona, T. pseudolanuginosus, and T. caespititius (0.05–0.25 mg/mL) aqueous
extracts in reducing iron (III) was assessed by the method previously described [41]. Butylated
hydroxyanisole (BHA) was used as the positive control.
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3.5.3. β-Carotene Bleaching Carotene
The assay was performed as previously described by Juntachote and Berghofer [42]. A stock
emulsion of β-carotene/linoleic acid was initially prepared by dissolving 20 mg of β-carotene in
10 mL of chloroform. A total of 1 mL of the β-carotene solution was added to 1 g of tween 80 and,
after chloroform removal, 50 mg of linoleic acid was added. Distilled water (100 mL) was added to the
mixture and homogenized using the rotary evaporator. Aliquots of β-carotene/linoleic acid emulsion
(250 µL) were mixed with 50 µL of extract at different concentrations and the initial absorbance at
470 nm was immediately recorded. After incubation at 50 ◦C for 2 h, the reaction was stopped using
an ice bath and the absorbance at 470 nm was measured. The blank used was prepared by adding
chloroform without β-carotene. BHA was used as the positive control. The % of inhibition was
calculated using the formula:
% of inhibition =
(Ct = 0 − Ct = 2)− (Et = 0 − Et = 2)
(Ct = 0 − Ct = 2)
× 100
where Ct=0 corresponds to the absorbance of control at t = 0 min; Ct=2 corresponds to the absorbance of
control at t = 120 min; Et=0, Absorbance of extract at t = 0 min; Et=2, Absorbance of extract at t = 120 min.
3.5.3. NO• Scavenging Test
This assay was performed according to the method described by Bor et al. [43]. In brief, 100 µL of
sodium nitroprusside (3.33 mM) in PBS 100 mM (pH = 7.4) was added to 100 µL of extract solution
at different concentrations (0.07–0.5 mg/mL) and incubated for 15 min at room temperature under
light irradiation. The generated NO• interacts with molecular oxygen, producing NO2−, which in
the presence of 100 µL of Griess reagent (1% of sulfanilamide and 0.1% of naphthylethylenediamine
dihydrochloride in 2.5% of phosphoric acid) produces a purple azo dye. The measurement of the
absorbance was determined spectrophotometrically at 562 nm and ascorbic acid was used as the
positive control.
3.5.4. Inhibition of 5-Lipoxygenase
The LOX inhibitory assay was performed in a quartz 96-well plate according to the Tappel et al.
procedure, with some modifications [44]. During this procedure, 20 µL of the ascorbic acid or extract
sample solutions and 20µL of the LOX work solution were added to each well and incubated at
37 ◦C in the plate reader for 10 min. After incubation, 40 µL of linoleic acid, previously heated at
37 ◦C, was added and quickly placed in the plate reader. The reaction was followed for 20 min
taking measurements every minute at 234 nm. The reaction rate at each inhibitor concentration was
calculated by determining the slope of the experimental values and the percentage of inhibition by the
following formula:




where v0 corresponds to the reaction rate of control and v[inhibitor] is the reaction rate of the extract.
3.5.5. Antimicrobial Activity
The antibacterial potential of the Thymus polar extracts were evaluated against five bacterial
strains, including gram-positive bacteria (S. epidermidis NCTC 11047 and S. aureus NCTC 6571) and
gram-negative bacteria (S. typhimurium NCTC 12023, E. coli NCTC 9001, and P. aeruginosa NCTC 10662)
from the National Collection of Type Cultures, operated by Public Health England. All strains were
cultured in Mueller-Hinton agar and incubated at 37 ◦C for 24 h.
The MIC and MBC of plant extracts were determined by the broth microdilution method
using a modified standard protocol [45]. Bacterial suspensions were prepared by direct colony
suspensions in sterile distilled water and adjusted to obtain 1.5 × 108 colony-forming units (CFU)/mL,
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approximately equivalent to 0.5 McFarland units. A final inoculum of 1.5 × 105 CFU/mL was required
for suspensions diluted in a 1:100 ratio in Mueller-Hinton broth.
One hundred microliters of Mueller-Hinton broth was dispensed into wells of 96-well micro
titer plates (BioTek Instruments, Inc., Winooski, VT, USA). Aqueous solutions of T. herba-barona,
T. pseudolanuginosus, and T. caespititius extracts were added at a final concentration of 10, 13, and
14 mg/mL, respectively, and were then serially diluted four times across the plate. One hundred
microliters of bacteria suspension was finally added to each well and the plates were incubated at
37 ◦C for 24 h. The assay for each pathogen was repeated three times.
The MIC was defined as the lowest concentration at which visible growth was inhibited while the
MBC is the lowest concentration of the tested substance which has a bactericidal effect. MBC values
were determined by subculturing 10 µL of the culture from each negative well onto Mueller-Hinton
agar and then determining the dilution at which growth was detected [46].
The solvent without extracts served as the negative control and nisin was used as the positive
control. Nisin is an antibacterial polypeptide approved as a food preservative whose stock solution
was prepared by dissolving 2 mg of nisin in 1 mL of HCl 0.02 N [47].
3.6. Statistical Analysis
All data are presented as mean ± standard deviations. One-way analysis of variance (ANOVA)
followed by a Tukey’s test were used to detect any significant differences among different means.
A p-value of less than 0.05 was assumed to indicate a significant difference. The results were analyzed
using GraphPad Prism (GraphPad Software, CA, USA, version 6.0).
4. Conclusions
This work elucidates the phenolic composition of T. herba-barona, T. pseudolanuginosus,
and T. caespititius decoctions, whilst also exploiting their antioxidant, anti-inflammatory,
and antimicrobial activities. The three aqueous extracts were mainly characterized by the
presence of phenolic acids and flavonoids, which are in part related to their biological activities.
T. pseudolanuginosus presented the best antioxidant results concerning the three methods used.
The selected Thymus plants extracts exhibited antibacterial activity against the panel of tested bacteria
(S. typhimurium, S. epidermidis, S. aureus, E. coli, and P. aeruginosa ), especially S. aureus strains,
which were in general the most sensitive. T. caespititius appears to have anti-inflammatory potential,
based on its promising inhibitory activity on NO• production. Bearing in mind the increasing demand
for bioactive extracts of a botanical origin, this work opens a door for the expansion of the commercial
exploitation of the thyme species.
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/1422-0067/18/9/1879/s1.
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Metabolitos y actividades biológicas de Thymus zygis, Thymus pulegioides 
y Thymus fragrantissimus obtenidos por cultivo orgánico 
 
Objetivos 
El presente estudio tiene como objetivo evaluar la composición nutricional de tres 
especies de timo económicamente importantes (Thymus zygis, Thymus pulegioides y 
Thymus fragrantissimus) cultivadas en un régimen orgánico, así como establecer el 




Los productos medicinales y aromáticos cultivados orgánicamente son más fácilmente 
aceptados por los mercados globales [1], y se consideran más saludables por los 
consumidores, ya que esta práctica agrícola restringe el uso de fertilizantes sintéticos, 
pesticidas y herbicidas [2,3]. En este contexto, en varios estudios [4] se encontró que 
las concentraciones de una gama de polifenoles como los ácidos fenólicos, flavanonas, 
estilbenos, flavonas, flavonoles y antocianinas estaban sustancialmente aumentadas en 
alimentos de cultivos orgánicos. Las plantas de tomillo cultivadas pueden 
comercializarse para una amplia gama de aplicaciones, especialmente en la cocina [5,6] 
y en la medicina tradicional [7]. La aplicación generalizada de las plantas Thymus ha 
estado asociada durante mucho tiempo con su agradable sabor y olor, pero en la 
actualidad, los componentes de estas plantas se han asociados estrechamente con su 
alto valor nutricional debido a los compuestos bioactivos, como sus aceites esenciales 
pero también, con creciente interés, sus extractos polares [8,9].  
Por lo que sabemos, este es el primer trabajo que se centra en las plantas T. zygis, T. 
pulegioides y T. fragrantissimus cultivadas orgánicamente. También hay que señalar 
que la composición química y las potencialidades biológicas de estas especies 
botánicas han sido poco estudiadas, incluso para las plantas silvestres [10,11]. 
2. Métodos 
2.1. Plantas y extracción de compuestos fenólicos 
Las especies T. zygis, T. fragantissimus y T. pulegioides han sido compradas a la 
empresa Ervital (Viseu) donde se cultivaron bajo un régimen orgánico y en que sus 
partes aéreas (flores, hojas y tallos) fueron recogidas y secas. No se aplicó ningún 
tratamiento químico o bacteriológico a las plantas. Su apariencia y comportamiento 
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fueron comprobados regularmente para asegurar su salud y la ausencia de patógenos. 
Cuando fue apropiado, las malas hierbas fueron eliminadas del suelo circundante. 
Los extractos fenólicos de los tres tomillos se han obtenido utilizando una decocción en 
la proporción 1:20 (5 g en 100 ml de agua). Las soluciones se filtraron, se concentraron 
y el concentrado se desengrasó con n-hexano (1:1 v/v), se evaporó y se congeló a -
20°C y se liofilizó. Se obtuvieron tres extractos para cada planta. 
1.2 Análisis nutricional 
El contenido de proteína bruta de las muestras se determinó mediante el método macro-
Kjeldahl. El contenido de ceniza y de la grasa cruda se determinaron por cuantificación 
gravimétrica. Los carbohidratos totales se calcularon por diferencia. El contenido de 
calorías se calculó de acuerdo con la ecuación: Energía (kcal) = 4 × (g de proteína + g 
de carbohidratos) + 9 × (g de grasa) [10]. 
Los minerales (Na, K, Ca, Mg, Fe, Mn, Cu y Zn) se cuantificaron mediante 
espectrometría de absorción atómica de llama. Los ácidos grasos fueron analizados por 
un método de cromatografía de gases. 
2.3 Identificación y cuantificación de compuestos fenólicos 
El contenido fenólico total de cada extracto de tomillo se determinó de acuerdo con el 
método colorimétrico de Folin-Ciocalteu, cuyos valores se expresaron en equivalentes 
de ácido gálico (EAG)/g de extracto. Los compuestos fenólicos individuales fueron 
caracterizados y cuantificados mediante cromatografía líquida de alta eficiencia 
(UHPLC-DAD-ESI-MSn).  
2.4 Ensayos de bioactividad 
2.4.1 Capacidad antioxidante  
La actividad antioxidante de los extractos acuosos de tomillo se evaluó mediante dos 
ensayos químicos: i) prueba de radicales 2,2-difenil-1-picrilhidrazilo (DPPH●), usando 
ácido ascórbico como control positivo; ii) el cálculo del poder reductor por la reducción 
de hierro (III), usando hidroxianisol butilado (BHA) como estándar. Los resultados se 
expresaron como valores de EC50 (concentración de la muestra que proporciona el 50% 
de la actividad antioxidante) en μg por ml de extracto.  
2.4.2 Capacidad antibacteriana  
El potencial antibacteriano de los extractos polares de Thymus se evaluó frente a cinco 
cepas bacterianas, incluyendo dos Gram positivas (Gram+) (Staphylococcus 
epidermidis y Staphylococcus aureus) y tres Gram negativas (Gram-) (Salmonella 
typhimurium, Escherichia coli y Pseudomonas aeruginosa), por el método de 
microdilución en medio, para calcular la concentración inhibitoria mínima (CIM) y la 





3. Resultados y Discusión 
3.1. Composición nutricional  
El perfil nutricional de las tres especies de Thymus se muestra en la Tabla 1. Las plantas 
secas eran esencialmente ricas en carbohidratos, variando de 78 a 87% peso en seco 
(ps), mientras que los contenidos en proteína, grasa y ceniza estaban en los rangos de 
3.6–10.5%, 2.3–4.5% y 5.0–8.2%, respectivamente. T. pulegioides fue la especie más 
rica con respecto a los niveles de estos macronutrientes en comparación con los 
resultados reportados por Fernandes et al. [10] para T. pulegioides silvestre 
recolectados en el noreste de Portugal.  
T. pulegioides fue también la especie más rica con respecto a su contenido mineral. Sin 
embargo, hay que subrayar que las tres plantas presentaron niveles altos de Ca (0.57–
1.04 g/100 g ps) y K+ (1.23–2.19 g/100 g ps), pero cantidades moderadas de Na+, lo que 
representa altos niveles de provisión de K+/Na+, que es de gran importancia cuando se 
trata de compensar la dieta occidental moderna, que suele ser rica en NaCl. Esta 
relación fue particularmente evidente en T. pulegioides, debido a su riqueza en K+ 
(K+/Na+=294), un hecho que determina un enorme potencial de la planta para su 
aplicación en alimentos funcionales dirigidos a salud cardiovascular.  
Con respecto a los ácidos grasos, los resultados indicaron que las plantas de tomillo 
eran más ricas en ácidos grasos insaturados (AGI), que representaban del 69 al 74%, 
mientras que los ácidos grasos saturados (AGS) representaban del 27 al 31% del total 
de los ácidos grasos. Entre los AGI, los ácidos grasos poliinsaturados (AGPI) fueron los 
principales representantes, y oscilaron entre 48, 49 y 55% en T. zygis, T. pulegioides y 
T. fragrantissimus, respectivamente.  
En general, el AGPI comprendía ácido linoleico (C18: 2n6c) y ácido α-linolénico (C18: 
3n3), mientras que la fracción de ácidos grasos monoinsaturados (AGMI) estaba 
compuesta de ácido oleico (C18: 1n9c) y ácido erúcico (C22: 1n9). Aunque encontramos 
varios AGS, el ácido palmítico (C16: 0) fue el más abundante en las tres muestras, ya 
que representó entre el 18 y el 24% de los ácidos grasos. Debido a eso, la proporción 
de AGPI/AGS de las plantas de tomillo fue considerablemente alta (1.62-1.83). Esto es 
particularmente relevante teniendo en cuenta la recomendación de la Organización 
Mundial de la Salud para el consumo de alimentos ricos en AGPI como parte de un estilo 
de vida saludable, orientado a la protección cardiovascular [12,13]. 
Además, las proporciones de ácidos grasos omega-6/omega-3 se encuentran dentro de 
los valores recomendados (<10) [14], y las especies T. fragrantissimus y T. pulegioides 
(0.54 y 0.75, respectivamente) asumen relevancia debido a su bajo valor, que se cree 
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que está asociado con la prevención de muchas enfermedades inflamatorias crónicas, 
incluyendo la artritis reumatoide, la inflamación intestinal y varias otras condiciones 
[13,15].  
Tabla 1. Valor nutricional de las tres especies de plantas de Thymus 
Contenido total T. zygis T. pulegiodes T. fragrantissimus 
Carbohydratos  total (g/100 g ps) 86.88 ± 0.51 81.22 ± 0.90 77.56 ± 0.16 
Proteínas (g/100 g ps) 3.59 ± 0.13 8.28 ± 0.81 10.49 ± 0.13 
Ceniza (g/100 g ps) 5.02 ± 0.25 8.24 ± 0.06 7.66 ± 0.22 
Minerales (mg/100 g ps) *    
Na 7.6 7.4 9.0 
K 1229.3 2185.6 1719.5 
Ca 566.0 1039.4 865.6 
Mg 119.8 148.3 241.8 
Fe 4.4 1.9 7.8 
Mn 9.8 15.7 6.9 
Cu 0.1 0.1 0.3 
Zn 2.1 1.7 2.7 
Grasa (g/100 g ps) 4.52 ± 0.12 2.27 ± 0.03 4.30 ±0.19 
Ácidos grasos (relativo %) *    
C12: 0 0.48 0.5 0.7 
C14: 0 1.2 1.1 1.4 
C16: 0 18.8 23.6 23.3 
C18: 0 3.2 3.3 2.8 
C18: 1n9 16.9 19.0 8.6 
C18: 2n6c 32.6 20.4 19.3 
C18: 3n3 15.6 27.6 36.2 
C20: 0 2.8 1.8 2.6 
C22: 1n9 8.3 2.7 5.0 
AGS 26.5 30.2 30.9 
AGMI 25.3 20.9 13.8 
AGPI 48.3 48.9 55.3 
AGPI/AGS 1.8 1.6 1.8 
n-6/n-3 2.1 0.8 0.5 
Contenido calórico (kcal/100 g ps) 402.50 ± 0.42 378.39 ± 0.08 390.86 ± 1.83 
AGS: ácidos grasos saturados; AGMI: ácidos grasos monoinsaturados; AGPI: ácidos grasos poliinsaturados; 
Ácido laurico (C12: 0); Ácido mirístico (C14: 0); Ácido palmítico (C16: 0); Ácido esteárico (C18: 0); Ácido 
oleico (C18: 1n9c + t); Ácido linoleico (C18: 2n6c); Ácido α-linolénico (C18: 3n3); Ácido araquidico (C20: 0); 
Ácido erúcico (C22: 1n9); * S.E.M. < 10%. 
Los datos presentados en este documento apuntan a una menor prevalencia de AGS y 
mayores cantidades de AGMI en comparación con estudios anteriores, particularmente 
en T. pulegioides silvestre [10], cuyas diferencias pueden estar naturalmente 
 5/11 
 
relacionadas con múltiples factores, incluidas las condiciones de crecimiento (agricultura 
orgánica vs silvestre). 
3.2. Caracterización fenólica de las decocciones de tomillo 
El rendimiento de los extractos de decocción de las tres especies de Thymus ha sido 
12%, 16% y 25% en T. zygis, T. fragrantissimus y T. pulegioides, respectivamente. La 
decocción de T. pulegioides también mostró un contenido superior de compuestos 
fenólicos totales en comparación con T. zygis y T. fragrantissimus (391, 288 y 287 μg 
EAG/mg de extracto, respectivamente). 
Los constituyentes fenólicos individuales de los tres extractos acuosos de tomillo fueron 
determinados mediante UHPLC-DAD-ESI-MSn (Tabla 2). Estos eran principalmente 
ricos en ácido rosmarínico (fracción 26), consistente con estudios previos sobre 
extractos polares de tomillo [16,17]. Curiosamente, sus niveles (62–82 µg/mg de 
extracto) fueron más altos que los encontrados previamente para las decocciones de T. 
herba-barona, T. pseudolanuginosus y T. caespititius (40–56 µg/mg extracto) [17], así 
como para extractos hidroetanólicos de Thymus x citriodorus (10 µg/mg de extracto) [18] 
y extractos metanólicos de Thymus praecox (15 mg/g de peso seco (ps)) [19]. Se 
encontró la misma tendencia para los isómeros del cafeoil- ácido rosmarínico (MW 538, 
eluidos en las fracciones 27, 29, 30, 31 y 32), que ascendieron de 16 a 60 µg/mg de 
extracto en estas especies. El ácido cafeico y sus derivados (ácido rosmarínico, cafeoil 
ácido rosmarínico, ácido salvianólico I/H) representaron la mayoría de los componentes 
fenólicos en los extractos acuosos de Thymus (valores de p <0,01), aunque fueron 
menos representativos en T. pulegioides (64% de compuestos fenólicos totales) en 
comparación con las especies restantes (cerca del 80%). 
Tabla 2. Identificación y cuantificación de compuestos en extractos de T. zygis, T. pulegioides y 




λmax Compuesto [M − H]− T. zig T. pul T. fragr 
1 1.3 298 Ácido quinico 191 D D D 
2 1.6 277 Ácido siringico hexósido 359 D D D 
3 1.8 281 Danshensu 197 D D D 
4 1.9 283 Eriodictiol- di-O-hexósido 611 - D - 






449 - 9.43 ± 0.21 - 
7 289, 321 Ácido cafeico 179 8.46 ± 0.02a  2.54 ± 0.14b 
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8 3.4 285 
Derivado del ácido 
salvianólico F  
375 D - D 
9 3.7 283 
Eriodictiol-O-hexosido 
(isómero 2) 
449 6.02 ± 0.94a 9.90 ± 0.19b 2.71 ± 0.03c 
10 4.1 281, 342 Quercetina glucurónido 477 - 3.28 ± 0.03a 1.13 ± 0.25b 
11 4.2 282, 342 Quercetina-O-hexosido 463 2.97 ± 0.90a - 1.48 ± 0.02b 
12 4.6 341 Luteolina-C-glucósido 447 4.86 ± 0.03a 8.27±0.13b 2.00 ± 0.02c 




Luteolina-O-di glucósido 593 1.19 ± 0.01a - 0.36 ± 0.02b 
15 6.2 283 Naringenina-O-glucósido 433 - 1.90 ± 0.97 - 






461 7.57 ± 0.05a 26.14 ± 0.78 b 16.86 ± 0.21c 
18 7.1 283 Eriodictiol-O-glucurónido 463 - D D 
19 7.3 282, 336 Quercetina-O-pentosido 433 D - - 
20 
7.6 






461 - D - 
22 
8.5 
240, 339 Crioseriol-O-hexosido 461 0.78 ± 0.01a 12.00 ± 0.15b  
23 281 Derivado del ácido cafeico 553 - - D 
24 8.7 283 Ácido sagerínico 719 D D D 
25 9.3 267, 334 Apigenina-O-glucurónido 445 D 9.20 ± 0.21a 1.76 ± 0.10b 
26 9.6 290, 328 Ácido rosmarínico 359 62.36 ± 2.72a 81.65 ± 7.02b 81.04 ± 7.93b 
27 9.8 287, 311 
Cafeoil ácido rosmarínico 
(isómero 1) 
537 2.79 ± 0.24a 5.25 ± 0.19b - 
28 10.1 287, 328 Ácido salvianólico B 717 1.89 ± 0.20 - - 
29 10.7 290, 323 
Cafeoil ácido rosmarínico 
(isómero 2) 
537 19.40 ± 0.76a 57.73 ± 1.95b 16.21 ± 0.54c 
30 12.1 288, 322 
Cafeoil ácido rosmarínico 
(isómero 3) 
537 D D D 
31 12.5 287, 328 
Cafeoil ácido rosmarínico 
(isómero 4) 
537 - D - 
32 12.8 288, 323 
Cafeoil ácido rosmarínico 
(isómero 5) 
537 - D - 
   Total  119.9 ± 3.31a 225.79 ± 15.08b 126.65 ± 9.73a 
   Ácido cafeico y derivativados  94.89 ± 1.84a 144.63 ± 8.79b 101.12 ± 6.75a 
   Flavonas  16.01 ± 0.27a 55.62 ± 1.05b 21.67 ± 0.59c 
   Flavonoles  2.97 ± 0.90a 3.28 ± 0.03a 2.62 ± 0.25a 
   Flavanonas  6.02 ± 0.94a 19.93 ± 0.46b 2.71 ± 0.03c 
D: Detectado; Fr: fracción; TR: tiempo de retención; T. zig-T. zygis; T. pul-T. pulegioides; T. fragr-T. fragrantissimus; 
Valores medios ± SD de tres ensayos independientes; El análisis estadístico fue realizado por one-way ANOVA (prueba 
de Tukey. deTukey). En cada fila diferentes letras significan diferencias estadísticamente significativas (p < 0.05). Los 
valores se expresan como µg/mg. 
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A su vez, la decocción de T. pulegioides fue la más rica en flavonas (55.62 ± 1.05 µg/mg 
de extracto, p <0.001), representada principalmente por luteolina-O-glucurónido 
(fracciones 17 y 21), luteolina-C-glucósido, crioseriol-O-hexósido y apigenina-O-
glucurónido (fracciones 12, 22 y 25, respetivamente). En general, los niveles de flavonas 
en la decocción de T. pulegioides fueron más altos que los encontrados previamente en 
T. herba-barona y T. caespititius (22 y 32 µg/mg de extracto), pero más bajos que T. 
pseudolanuginosus (73 µg/mg de extracto) [17]. 
El extracto de T. pulegioides también presentó mayores cantidades de flavanonas 
(19.93±0.46 µg/mg de extracto), principalmente compuesto por eriodictyol-O- hexósido 
y naringenina-O-glucósido. Se señala que los compuestos descritos aquí (derivados del 
ácido cafeico y flavonoides, incluyendo las formas glicosídicas) se detectaron 
previamente en extractos polares de otras especies de Thymus [16,18]. 
3.3 Actividad antioxidante 
En este estudio, la capacidad antioxidante de las decocciones de T. zygis, T. 
fragrantissimus y T. pulegioides se analizó mediante dos ensayos, a saber, el método 
de captación de DPPH● y del poder reductor, que evalúan respectivamente la capacidad 
para atrapar los radicales libres sintéticos DPPH y la capacidad de reducir el ion férrico 
(Fe3+) a ion ferroso (Fe2+), respectivamente. En general, los extractos presentaron una 
alta capacidad antioxidante, ya que los valores de EC50 eran hasta dos veces más altos 
que los compuestos de referencia comerciales (Tabla 3). Entre los tres extractos, T. 
pulegioides tuvo el valor más bajo de DPPH● EC50 (9.50 μg/mL), alrededor de 1.4 veces 
el ácido ascórbico (EC50=6.9μg/mL), mientras que T. fragrantissimus y T. zygis se 
establecieron a 13 µg/mL. Este hecho muestra la mayor capacidad de T. pulegioides 
para eliminar el radical libre DPPH● en comparación con las otras dos especies de 
plantas y posiblemente puede asociarse con su mayor contenido fenólico. 
Relativamente al poder reductor (EC50=30.73 μg/mL), la superioridad antioxidante de T. 
pulegioides no fue tan clara, lo que sugiere que los componentes no fenólicos también 
podrían desempeñar un papel relevante en esta reacción.  
La alta capacidad antioxidante aquí descrita para las decocciones de T. pulegioides 
superó la descrita anteriormente para el extracto metanólico de T. pulegioides silvestre 
(EC50=680 y 490 μg/mL para DPPH● y poder reductor, respectivamente) [10]. Más 
recientemente, Kindl et al. [11] encontraron resultados prometedores para un extracto 
hidroananólico de T. pulegioides silvestre, (EC50=4.18 y 11.39  μg/mL en las pruebas 
DPPH● y poder reductor, respectivamente), que correspondió a aproximadamente 1.7-
2.5 veces de los compuestos comerciales de referencia. Sin embargo, según nuestro 
conocimiento, no hay datos bibliográficos sobre la capacidad antioxidante de extractos 
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acuosos de T. zygis, T. pulegioides o T. fragrantissimus. Aun así, las altas habilidades 
reportadas en el presente documento para las decocciones están en línea con las 
descritas anteriormente por nuestro grupo para extractos acuosos de T. herba-barona, 
T. pseudolanuginosus y T. caespititius [17]. 
Tabla 3. Actividad antioxidante y antibacteriana de extractos acuosos de tres plantas de tomillo 
 T. zygis T. pulegioides T. fragrantissimus Estándar 
Actividad antioxidante    
DPPH● (1) (μg/mL) 12.65 ± 2.30 a,b 9.50 ± 1.98 a,b 12.87 ± 3.79 a 6.90 ± 0.5 b 
Poder reductor (2) 
(μg/mL) 
33.66 ± 1.93 a 30.73 ± 1.48 a 32.44 ± 4.27 a 16.30 ± 1.5 b 
Actividad antibacteriana (3) (CIM/CBM, mg/mL)   
G (+) bacteria     
S. aureus 1.13/1.13 5.75/5.75 3.75/3.75 0.25/0.25 
S. epidermidis 4.50/4.50 5.75/11.50 7.50/>7.50 <0.06/<0.06 
G (-) bacteria     
S. typhimurium 4.50/4.50 5.75/11.50 7.50/7.50 0.50/0.50 
E. coli >4.5/>4.5 >11.50/>11.50 7.50/>7.50 0.50/0.50 
P. aeruginosa 4.5/>4.5 5.75/11.50 7.50/>7.50 0.50/1.0 
(1) Cantidad de extracto requerido para reducir 50% de 60 μM DPPH●; Se utilizó ácido ascórbico como compuesto de 
referencia; (2) Cantidad de extracto capaz de proporcionar 0.5 de absorbancia reduciendo 3.5 μM Fe3+ a Fe2+; Se utilizó 
BHA como compuesto de referencia; Valores medios ± SD; El análisis estadístico se realizó mediante ANOVA de una 
vía, seguido de la prueba de Tukey. En cada fila, letras diferentes (a, b) significan diferencias estadísticamente 
significativas (p <0.05); (3) La nisina se utilizó como compuesto de referencia; Valores medios; CIM: Concentración 
inhibitoria mínima; CBM: concentración bactericida mínima. 
3.4. Actividad antibacteriana 
En el presente estudio, evaluamos la actividad inhibitoria y letal de los extractos acuosos 
de T. zygis, T. pulegioides y T. fragrantissimus contra cinco bacterias, a través del 
ensayo de microdilución en medio. S. aureus fue la especie más sensible a las 
decocciones del tomillo, y su crecimiento y viabilidad se inhibieron a 1.13, 3.75 y 5.75 
mg/ml para T. zygis, T. fragrantissimus y T. pulegioides, respectivamente (Tabla 3). Los 
resultados, combinados con los informados previamente para T. herba-barona, T. 
pseudolanuginosus y T. caespititius [17], nos permiten concluir que, entre los seis 
extractos acuosos de tomillo, T. herba-barona y T. zygis son los dos más activos contra 
S. aureus (CIM/CBM de 0.6 y 1.13 mg/ml, respectivamente). Entre las bacterias Gram 
negativas, S. typhimurium fue la más susceptible, y se ha inhibido tanto su crecimiento 
como su viabilidad frente a T. zygis, T. fragrantissimus y T. pulegioides (concentraciones 
inhibitorias y/o letales en el intervalo 4.50-11.5 mg/ml). Se informaron valores de la 
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misma magnitud cuando S. typhimurium fue tratado con extractos polares de Thymus 
lanceolatus [20], Thymus capitatus [21], Thymus caramanicus y Thymus vulgaris [22], 
presentando valores CIM de 4.0, 6.0, 2.6 y 12.5 mg/ml, respectivamente. 
A su vez, P. aeruginosa y E. coli fueron incluso más resistentes a los extractos de tomillo, 
aunque a diferentes niveles. Si bien el crecimiento de P. aeruginosa fue inhibido por 
todas las muestras (Tabla 3), solo T. fragrantissimus tuvo un impacto negativo en el 
crecimiento de E. coli a 7.5 mg/ml. Además, T. pulegioides fue capaz de matar a P. 
aeruginosa (CBM=11.5 mg/ml), mientras que no se observó ningún efecto sobre la 
viabilidad de E. coli. Se ha demostrado previamente que extractos polares de plantas 
de tomillo han inhibido cepas de P. aeruginosa (CIM de 0.25 y 2.0 mg/ml) [20,23], y E. 
coli (MIC en el rango de 0.5–8 mg/ml) [22,23], aunque no se obtuvo información sobre 
sus efectos sobre la viabilidad de estas bacterias. 
4. Conclusiones 
La composición nutricional, el perfil fenólico, las actividades antioxidantes y 
antimicrobianas de tres especies de timo cultivadas en la agricultura orgánica se 
informan en este estudio. Con base en nuestros resultados, es posible inferir que estas 
especies de tomillo presentan una riqueza de ácidos grasos poliinsaturados y una 
interesante relación de ácidos grasos omega-6/omega-3, junto con altas proporciones 
de K+/Na+ que pueden contribuir a la protección cardiovascular. 
T. pulegioides presentó la mayor capacidad antioxidante, en consonancia con su alto 
contenido en polifenoles, en los que se destacan el ácido rosmarínico y el cafeoil ácido 
rosmarínico, junto con niveles considerables de flavonas y flavanonas. Además, los 
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Abstract: Thymus plants are marketed for diverse usages because of their pleasant odor, as well as
high nutritional value and wealth of health-promoting phytochemicals. In this study, Thymus zygis,
Thymus pulegioides, and Thymus fragrantissimus grown under organic cultivation regime were
characterized regarding nutrients and phenolic compounds. In addition, the antioxidant and
antibacterial properties of these species were screened. The plants were particularly notable for
their high K/Na ratio, polyunsaturated fatty acids content and low omega-6/omega-3 fatty acids
ratios, which are valuable features of a healthy diet. Caffeic acid and/or its derivatives, mainly
rosmarinic acid and caffeoyl rosmarinic acid, represented the majority of the phenolic constituents
of these plants, although they were less representative in T. pulegioides, which in turn was the
richest in flavones. The latter species also exhibited the highest antioxidant capacity (DPPH• EC50 of
9.50 ± 1.98 µg/mL and reducing power EC50 of 30.73 ± 1.48 µg/mL), while T. zygis was the most
active towards Gram-positive and Gram-negative bacteria. Overall, the results suggest that the three
thyme plants grown in organic farming are endowed with valuable metabolites that give them high
commercial value for applications in different industries.
Keywords: Thymus; thyme; phenolic compounds; nutrients; antioxidant; antibacterial activity
1. Introduction
Thymus plants, belonging to the Lamiaceae family, represent a large botanical genus well known
in the West Mediterranean region. Due to their high capacity to adapt to extreme climate conditions
concerning temperature and water supply, the plants can often be found in rocks or stones growing in
cold and arid conditions [1]. In general, they appear as perennial and subshrubs or shrubs 10 to 30 cm
tall, with small and simple leaves, a quadrangular stem erect to prostate, ramified and prostrated
branches, and big clusters of small pink, white, cream or purple flowers [2,3].
Because of its easy growth and the wide variety of Thymus-derived products that can be used by
diverse industries, the cultivation of thyme species for commercial purposes has increased greatly in
recent decades [4]. Special interest is given to organic farming, since this is recognized as a sustainable
agricultural system. Indeed, organic agriculture has developed rapidly worldwide in recent years,
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being presently practiced in approximately 120 countries. At the level of the European Union, the area
under organic production increased by about 70% in the last decade, reaching about 11 million
hectares [5]. Moreover, medicinal and aromatic plants represent one of the top 10 crops cultivated under
the organic regime. Organically grown medicinal and aromatic products are readily accepted in global
markets and command higher prices than those grown with chemical inputs [6]. Indeed, crops grown
under an organic regime are considered healthier by consumers, since this agriculture practice restricts
the use of synthetic fertilizers, pesticides, and herbicides [7,8]. Moreover, there is evidence that organic
agriculture can lead to more valuable products. In this context, the concentrations of a range of
polyphenolics such as phenolic acids, flavanones, stilbenes, flavones, flavonols, and anthocyanins were
found to be substantially higher in organic crops/crop-based foods in several studies [9]. In particular,
Sousa et al. [10] showed that the levels of phenolic compounds in leaves of tronchuda cabbage from
organic culture had higher amounts of phenolics, probably due to the interference of mineral fertilizers
and pesticides with the biosynthetic pathway of phenolic compounds.
Cultivated Thymus plants can be commercialized for a wide range of applications. In fact, Thymus
are amongst the main aromatic plants used as culinary ingredients for fish, meat, salad and vegetable
dishes [11,12]. Also, dried thyme leaves are used for teas as well as in other several products such as
lotion, bath soap, and toothpaste [1,13]. In addition, thyme-derived products are applied in traditional
medicine to treat respiratory and throat ailments, and skin problems such as oily skin, sciatica, acne,
dermatitis, parasite affections, eczema, fungal infections, and insect bites, among others [14]. Moreover,
thyme essential oil is a globally respected commodity and is currently used in many industries such as
food, pharmaceuticals, personal health care, detergents, and insecticides [1,15].
The widespread application of Thymus plants has long been associated with their pleasant
taste/odor, but at present, highly valuable products of these plants are closely associated with
their high nutritional value and/or predominance of bioactive compounds. Among the latter,
essential oils have undoubtedly been the most exploited health promoters of Thymus, being
recognized for their antimicrobial, preservative, antispasmodic, diuretic, antihypertensive, and calming
properties [12,16,17]. Although less studied, a growing number of investigations have been focused
on the potential biological activities of extracts rich in phenolic compounds, and their prospective for
application as high-value products [16,17].
The present study aims to evaluate the nutritional composition of three economically important
Thymus species (Thymus zygis, Thymus pulegioides, and Thymus fragrantissimus) (Figure S1) cultivated
in an organic farming regime, as well as to establish the phenolic profile and biological potencies
(antioxidant and antimicrobial) of their respective decoctions. As far as we know, this is the first
work focusing on organically grown T. zygis, T. pulegioides, and T. fragrantissimus plants. One must
also remark that the chemical composition and/or biological potentials of these botanical species
remain poorly studied, even for wild plants. In this regard, Fernandes et al. [18] previously reported
the nutritional value of a wild T. pulegioides collected in the northeast of Portugal. In addition, these
authors and Kindl et al. [19], also evaluated the antioxidant potential of methanolic or hydroethanolic
extracts of wild T. pulegioides (in northeast Portugal and Croatia) against oxidative events.
2. Results and Discussion
2.1. Nutritional Composition
The nutritional profile of the three Thymus species cultivated under an organic farming regime
is shown in Table 1. The dried plants were essentially rich in carbohydrates, varying from 78 to 87%
dw, while protein, fat, and ash contents were in the ranges of 3.6–10.5%, 2.3–4.5%, and 5.0–8.2%,
respectively. The levels of these macronutrients in T. pulegioides were 81.2, 8.3, 2.3, and 8.2 g/100 g
dw, respectively, which, compared to those reported by Fernandes et al. [18] for a wild T. pulegioides
collected in the northeast of Portugal (89.4, 5.5, 0.2, and 4.9 g/100 g dw, respectively), presented higher
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non-carbohydrate macronutrients. To our knowledge, there are no previous data on the nutritional
value of T. zygis and T. fragrantissimus plants.
T. pulegioides was also the richest species with respect to its mineral content. However, it is worth
mentioning that all three plants had high levels of Ca (0.57–1.04 g/100 g dw) and K (1.23–2.19 g/100 g
dw), but modest Na amounts, thus representing high K/Na suppliers, which is of great importance
when aiming to compensate for the modern Western diet, which is typically rich in NaCl. This ratio
was particularly high in T. pulegioides, which, due to its richness in K, was established at 294, a fact that
can give the plant enormous potential for application in functional foods directed to cardiovascular
health claims.
Regarding fatty acids, the results indicated that thyme plants were richer in unsaturated fatty
acids (UFA), which represented 69–74%, whereas saturated fatty acids (SFA) represented 14 to 25% of
the total fatty acids. Among UFA, polyunsaturated fatty acids (PUFA) were the main representatives,
ranging from 48 to 49% in T. zygis and T. pulegioides, to 55% in T. fragrantissimus. Overall, PUFA
comprised linoleic acid (C18: 2n6c) and α-linolenic acid (C18: 3n3), while monounsaturated fatty acids
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Figure 1. Chemical structures of fatty acids and phenolic compounds identified in Thymus zygis, Thymus
pulegioides, and Thymus fragrantissimus. Numbers in the figure correspond to the UHPLC-DAD-ESI-MSn
peaks of Figure 2.
Although we found several SFA, palmitic acid (C16: 0) was by far the most abundant in the
three samples, accounting for 18–24% of the fatty acids. Because of that, the PUFA/SFA ratio of the
thyme plants was considerably high (1.62–1.83). This is particularly relevant when one examines the
recommendation of the World Health Organization for the consumption of PUFA-rich foods as part
of a healthy lifestyle, aiming at cardiovascular protection [20,21]. Moreover, it must be noted that
the omega-6/omega-3 fatty acids ratios fall within the recommended values (<10) [22], and those
of the T. fragrantissimus and T. pulegioides species (0.54 and 0.75, respectively) assume relevance due
to its low value, which is believed to be associated with the prevention of many chronic diseases,
including inflammatory bowel disease, rheumatoid arthritis, asthma, kidney disease, and several other
inflammatory conditions [21,23].
Regardless of this generic similarity, specific features could be found among the plants. Linoleic
acid was the most abundant fatty acid in T. zygis, while α-linolenic acid prevailed in the other
species, with percentages of 28% and 36% in T. pulegioides and in T. fragrantissimus, respectively.
Fernandes et al. [18] have found similar results for T. pulegioides (37% of α-linolenic acid) in a wild
T. pulegioides plant. Nevertheless, the present data point to a lower prevalence of SFA and higher
amounts of MUFA compared to that study. Naturally, differences may be related to multiple factors,
including growth conditions (organic farming versus wild).
Molecules 2018, 23, 1514 5 of 15
Table 1. Nutritional value of the three Thymus plant species.
Total Content T. zygis T. pulegioides T. fragrantissimus
Total Carbohydrates (g/100 g dw) 86.88 ± 0.51 81.22 ± 0.90 77.56 ± 0.16
Protein (g/100 g dw) 3.59 ± 0.13 8.28 ± 0.81 10.49 ± 0.13
Ash (g/100 g dw) 5.02 ± 0.25 8.24 ± 0.06 7.66 ± 0.22
Minerals (mg/100 g dw) *
Na 7.6 7.4 9.0
K 1229.3 2185.6 1719.5
Ca 566.0 1039.4 865.6
Mg 119.8 148.3 241.8
Fe 4.4 1.9 7.8
Mn 9.8 15.7 6.9
Cu 0.1 0.1 0.3
Zn 2.1 1.7 2.7
Fat (g/100 g dw) 4.52 ± 0.12 2.27 ± 0.03 4.30 ±0.19
Fatty acids (relative %) *
C12: 0 0.48 0.5 0.7
C14: 0 1.2 1.1 1.4
C16: 0 18.8 23.6 23.3
C18: 0 3.2 3.3 2.8
C18: 1n9 16.9 19.0 8.6
C18: 2n6c 32.6 20.4 19.3
C18: 3n3 15.6 27.6 36.2
C20: 0 2.8 1.8 2.6
C22: 1n9 8.3 2.7 5.0
SFA 26.5 30.2 30.9
MUFA 25.3 20.9 13.8
PUFA 48.3 48.9 55.3
PUFA/SFA 1.8 1.6 1.8
n-6/n-3 2.1 0.8 0.5
Caloric content (kcal/100 g dw) 402.50 ± 0.42 378.39 ± 0.08 390.86 ± 1.83
Lauric acid (C12: 0); Myristic acid (C14: 0); Palmitic acid (C16: 0); Stearic acid (C18: 0); Oleic acid (C18: 1n9c + t);
Linoleic acid (C18: 2n6c); α-Linolenic acid (C18: 3n3); Arachidic acid (C20: 0); Erucic acid (C22: 1n9); * S.E.M. < 10%.
2.2. Phenolic Characterization of Thymus Decoctions
The yield range of the decoctions extracts of the three Thymus species was between 12% and 25%,
with minimum and maximum values corresponding to T. zygis and T. pulegioides, respectively (Table 2).
The decoction of T. pulegioides also showed a superior content of total phenolic compounds when
compared to the others (391 versus 287–288 µg GAE/ mg extract, p-values < 0.01) or to decoctions
of Thymus herba-barona, Thymus pseudolanuginosus, and Thymus caespititius (236–293 µg GAE/mg of
extract) [24], or even to aqueous extracts obtained from Thymus serpyllum at 50 and 100 ◦C (79 and
91 µg GAE/mg extract, respectively) [25]. Moreover, the extraction yield of this decoction was close to
the one reported by other authors for methanol or 70% ethanol extracts of T. pulegioides wild plants
(24.6 and 22.5, respectively) and its phenolic richness was superior to the latter (391 versus 210 µg
GAE/mg extract) [18,19].
Table 2. Yield and total phenolic compounds of aqueous extracts of T. zygis, T. pulegioides and
T. fragrantissimus.
T. zygis T. pulegioides T. fragrantissimus
Yield of Extraction (%) 12.39 ± 0.60 a 24.86 ± 1.71 b 15.67 ± 4.56 a
Total phenolic compounds
(µg GAE/mg of extract) 287.86 ± 18.50
a 390.94 ± 2.48 b 287.08 ± 3.76 a
Mean values ± S.D.; Statistical analysis was performed by one-way ANOVA, followed by Tukey’s test. In each line
different letters (a,b) mean significant differences (p < 0.05).
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The phenolic profiles of T. zygis, T. pulegioides and T. fragrantissimus decoctions were evaluated
using UHPLC-ESI-DAD-MS2/MS (Figure 2, Table 3). Moreover, the extracted ion chromatogram (EIC)
and MS/MS spectrum of the main identified compounds are shown in Figure S2. Consistent with
previous studies on Thymus polar extracts [3,24], these were mainly rich in rosmarinic acid (peak 26,
UVmax at 290 and 328 nm, and [M − H]− at m/z 539). Interestingly, its levels (62–82 µg/mg extract,
Table 3) were higher than those previously found for decoctions of T. herba-barona, T. pseudolanuginosus,
and T. caespititius (40–56 µg/mg extract) [24], as well as for hydroethanolic extracts of Thymus x citriodorus
(10 µg/mg extract) [26] and methanolic extracts of Thymus praecox (15 mg/g dry weight) [27]. The same
tendency was found for caffeoyl rosmarinic acid isomers (MW 538, eluted in peaks 27, 29, 30, 31 and
32), which amounted from 16 to 63 µg/mg extract in these species, whereas they were only vestigial
in T. pseudolanuginosus and T. caespititius or up to 15 µg/mg extract, in T. herba-barona decoctions [24].
Apart from that, levels of caffeoyl rosmarinic acid in hydroethanolic extracts of T. x citriodorus were
reported to only reach about 2 µg/mg extract [26]. Notably, caffeic acid and its derivatives (rosmarinic
acid, caffeoyl rosmarinic acid, salvianolic acid I/H) represented most of the phenolic components
in Thymus aqueous extracts (p-values < 0.01), although they were less representative in T. pulegioides
(64% of total phenolic compounds) when compared to the remaining species (close to 80%).
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Figure 2. Chromatographic representation of T. zygis (a), T. pulegioides (b), and T. fragrantissimus
(c) aqueous extracts at 280 nm. Numbers in the figure correspond to the UHPLC-DAD-ESI-MSn peaks
described in Table 3.
In turn, the T. pulegioides decoction was the richest in flavones (55.62 ± 1.05 µg/mg extract,
p-values < 0.001), represented mainly by luteolin-O-glucuronide (peaks 17 and 21, [M − H]− at m/z
461→285), luteolin-C-glucoside (peak 12, MW 448), chrysoeriol-O-hexoside (peak 22, [M − H]− at m/z
461→299, 285) and apigenin-O-glucuronide (peak 25, MW 446, UVmax at 267 and 334). Overall, levels
of flavones in T. pulegioides decoction were higher than those previously found in T. herba-barona and
T. caespititius (22 and 32 µg/mg extract), but lower than T. pseudolanuginosus (73 µg/mg extract) [24].
The extract of this species was also noticeable due to its greater amounts of flavanones
(23.68 ± 0.57 µg/mg extract, with statistically significant differences, p-values < 0.001), mainly
comprised by eriodictyol-O-hexoside (factions 6 and 9, UVmax 283 nm, [M − H]− at m/z 449→287),
naringenin-O-glucoside (peak 15, UVmax 283 nm, MW 434 and [M−H]− at m/z 433→271), that overall
accounted for 19.93 ± 0.46 µg/mg extract. Please note that the compounds described herein (caffeic
acid derivatives and flavonoids, including glycosidic forms) were previously detected in aqueous or
methanolic/ethanolic extracts of other Thymus species [3,26].
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Table 3. Identification and quantification of the compounds in the aqueous extracts of T. zygis, T. pulegioides and T. fragrantissimus by UHPLC-DAD-ESI-MSn.
NP RT (min) λmax Compound [M − H]− MS2 Main Fragments ESI-MSn (m/z) T. zig T. pul T. fragr
1 1.3 298 Quinic Ac 191 111, 173, 93, 85 D D D
2 1.6 277 Syringic Ac hex 359 197, 179, 135 D D D
3 1.8 281 Danshensu 197 179, 73 D D D
4 1.9 283 Eriod di-O-hex 611 449, 287 - D -
5 2.4 271, 326 Api di-C-glc 593 473, 503, 575, 353 1.60 ± 0.32 a - 2.69 ± 0.50 a
6
3.3
283 Eriod-O-hex (isom1) 449 287 - 9.43 ± 0.21 -
7 289, 321 CaffAc 179 135 8.46 ± 0.02 a 2.54 ± 0.14 b
8 3.4 285 SA F der 375 313, 179 D - D
9 3.7 283 Eriod-O-hex (isom2) 449 287 6.02 ± 0.94 a 9.90 ± 0.19 b 2.71 ± 0.03 c
10 4.1 281, 342 Querc glcA 477 301 - 3.28 ± 0.03 a 1.13 ± 0.25 b
11 4.2 282, 342 Querc-O-hex 463 301 2.97 ± 0.90 a - 1.48 ± 0.02 b
12 4.6 341 Lut-C-glc 447 357, 285, 327 4.86 ± 0.03 a 8.27 ± 0.13 b 2.00 ± 0.02 c
13 5.6 281, 342 SA I/H 537 339, 493 - D -
14 6.2 258, 268, 342 Lut-O-di glc 593 285, 447 1.19 ± 0.01 a - 0.36 ± 0.02 b
15 6.2 283 Nar-O-glc 433 271, 313 - 1.90 ± 0.97 -
16 6.8 282, 333 Scut-O-glcA 461 285, 175, 284, 257 D D -
17 7.0 254, 265, 345 Lut-O-glcA (isom1) 461 285 7.57 ± 0.05 a 26.14 ± 0.78 b 16.86 ± 0.21 c
18 7.1 283 Eriod-O-glcA 463 287, 175, 151 - D D
19 7.3 282, 336 Querc-O-pent 433 301 D - -
20
7.6
288, 321 RA hex 521 359 D - D
21 254, 267, 344 Lut-O-glcA (isom2) 461 285 - D -
22
8.5
240, 339 Chrys-O-hex 461 299, 285 0.78 ± 0.01 a 12.00 ± 0.15 b
23 281 CaffAc der 553 465, 311, 535, 357 - - D
24 8.7 283 Sagerinic Ac 719 359, 539, 521, 341 D D D
25 9.3 267, 334 Api-O-glcA 445 269, 175 D 9.20 ± 0.21 a 1.76 ± 0.10 b
26 9.6 290, 328 RA 359 223, 197, 179 62.36 ± 2.72 a 81.65 ± 7.02 b 81.04 ± 7.93 b
27 9.8 287, 311 CaffRA (isom1) 537 493, 515, 357, 335, 519, 153 2.79 ± 0.24 a 5.25 ± 0.19 b -
28 10.1 287, 328 SA B 717 519, 357, 555, 359 1.89 ± 0.20 - -
29 10.7 290, 323 CaffRA (isom2) 537 493, 359, 519, 179 19.40 ± 0.76 a 57.73 ± 1.95 b 16.21 ± 0.54 c
30 12.1 288, 322 CaffRA (isom3) 537 375, 493, 357, 359 D D D
31 12.5 287, 328 CaffRA (isom4) 537 439, 519, 357, 197, 493, 323, 331, 313 - D -
32 12.8 288, 323 CaffRA (isom5) 537 519, 359, 357, 339, 235, 493, 279, 207 - D -
Total 119.90 ± 3.31 a 225.79 ± 15.08 b 126.65 ± 9.73 a
Caffeic acid and derivatives 94.89 ± 1.84 a 144.63 ± 8.79 b 101.12 ± 6.75 a
Flavones 16.01 ± 0.27 a 55.62 ± 1.05 b 21.67 ± 0.59 c
Flavonols 2.97 ± 0.90 a 3.28 ± 0.03 a 2.62 ± 0.25 a
Flavanones 6.02 ± 0.94 a 19.93 ± 0.46 b 2.71 ± 0.03 c
NF-Number of peak represented in Figure 2; D-Detected; T. zig-T. zygis; T. pul-T. pulegioides; T. fragr-T. fragrantissimus; Ac-acid; Api-Apigenin; CaffAc-Caffeic acid; Caff-Caffeoyl;
Chrys-Chrysoeriol; Der-Derivative; Eriod-Eriodictyol; Glc-Glucoside; GlcA-Glucuronide; Hex-Hexoside; Lut-Luteolin; Nar-Naringenin; Pent-Pentoside; Querc-Quercetin; RA-Rosmarinic
acid; SA-Salvianolic acid; Scut-Scutellarein; Values are expressed as µg/mg extract; In each line different letters (a,b,c) mean significant differences (p < 0.05).
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2.3. Antioxidant Activity
It is widely known that the antioxidant capacity of plant extracts are closely associated
with phenolic components, which might interact with free radicals through electron or hydrogen
donation [28]. In this study, the antioxidant potency of Thymus decoctions was screened by two
generalized assays, namely the DPPH• scavenging method and reducing power, which respectively
evaluate the ability to trap the synthetic free radicals DPPH• and to reduce ferric ion (Fe3+) to ferrous ion
(Fe2+). In general, the extracts presented a high antioxidant capacity, since EC50 values were up to twice
as high as the commercial reference compounds (Table 4). Among the three extracts, T. pulegioides had
the lowest DPPH• EC50 value (9.50 ± 1.98 µg/mL), which corresponded to about 1.4-fold of ascorbic
acid (EC50 = 6.9 ± 0.5), while T. fragantissimus and T. zygis were established at 13 µg/mL. This fact
shows the greater ability of T. pulegioides to scavenge the free radical DPPH• in comparison to the
other two plant species and can possibly be associated with its higher phenolic contents. Interestingly,
regardless of the higher ferric ion reduction tendency (EC50 = 30.73 ± 1.48 µg/mL), the superiority of
this extract was not so clear, suggesting that non-phenolic components might also play a relevant role
in this reaction.
Table 4. Antioxidant and antibacterial properties of aqueous extracts from T. zygis, T. pulegioides and T.
fragrantissimus.
T. zygis T. pulegioides T. fragrantissimus Standard
Antioxidant properties
DPPH• (1) (µg/mL) 12.65 ± 2.30 a,b 9.50 ± 1.98 a,b 12.87 ± 3.79 a 6.90 ± 0.5 b
Reducing Power (2) (µg/mL) 33.66 ± 1.93 a 30.73 ± 1.48 a 32.44 ± 4.27 a 16.30 ± 1.5 b
Antibacterial properties (3) (MIC/MBC, mg/mL)
G (+) bacteria
Staphylococcus aureus 1.13/1.13 5.75/5.75 3.75/3.75 0.25/0.25
Staphylococcus epidermidis 4.50/4.50 5.75/11.50 7.50/>7.50 <0.06/<0.06
G (−) bacteria
Salmonella typhimurium 4.50/4.50 5.75/11.50 7.50/7.50 0.50/0.50
Escherichia coli >4.5/>4.5 >11.50/>11.50 7.50/>7.50 0.50/0.50
Pseudomonas aeruginosa 4.5/>4.5 5.75/11.50 7.50/>7.50 0.50/1.0
(1) Amount of extract required to reduce 50% of the 60 µM radical 2,2-diphenyl-1-picrylhydrazyl (DPPH•); Ascorbic
acid was used as reference compound; (2) Amount of extract able to provide 0.5 of absorbance by reducing 3.5 µM
Fe3+ to Fe2+; 2,6-Di-tert-butyl-4-methylphenol was used as reference compound; Mean values ± S.D.; Statistical
analysis was performed by one-way ANOVA, followed by Tukey’s test. In each line different letters (a,b) mean
significant differences (p < 0.05); (3) Nisin was used as reference compound. Mean values; MIC: minimum inhibitory
concentration; MBC: minimum bactericidal concentration.
The high antioxidant ability herein described for T. pulegioides decoctions exceeded that previously
described for the methanolic extract from a wild T. pulegioides plant (EC50 = 680± 30 and 490± 30 µg/mL
DPPH• and reducing power assays, respectively) [18]. More recently, Kindl et al. [19] found promising
results for an hydroethanolic extract of wild Croatian T. pulegioides plants, reporting DPPH• EC50 =
4.18 ± 0.02 µg/mL and reducing power EC50 = 11.39 ± 0.07 µg/mL, which corresponded to about
1.7–2.5 times those of the reference commercial compounds [19]. To our knowledge, there are no
literature data regarding the antioxidant abilities of aqueous extracts from T. zygis, T. pulegioides
or T. fragantissimus origin. Still, the high abilities reported herein for decoctions are in line with
those previously described by us for T. herba-barona, T. pseudolanuginosus, and T. caespititius aqueous
extracts [24]. However, Baharfar et al. [29] also observed that a Thymus kotschyanus aqueous extract
could request DPPH• with half the potency of ascorbic acid.
2.4. Antibacterial Activity
In opposition to Thymus essential oils, the antibacterial effects of polar extracts from Thymus plants
have been scarcely exploited. In the present study, we evaluated the inhibitory activities of T. zygis,
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T. pulegioides or T. fragantissimus aqueous extracts against the Gram-positive bacteria Staphylococcus aureus
and Staphylococcus epidermidis, and the Gram-negative bacteria Salmonella typhimurium, Escherichia coli,
and Pseudomonas aeruginosa, through the broth microdilution assay.
Interestingly, T. zygis decoctions were the most active among the three plant samples. As the levels
of phenolic compounds in this decoction were below those of T. pulegioides, the results suggest that
phenolic components do not lead this bioactivity. Staphylococcus aureus was the most sensitive species
to thyme decoctions, with its growth and viability being inhibited at 1.13, 3.75, and 5.75 mg/mL for
T. zygis, T. fragantissimus, and T. pulegioides, respectively (Table 4). The results, combined with those
previously reported for T. herba-barona, T. pseudolanuginosus, and T. caespititius allow us to conclude that,
among the six aqueous extracts of thyme [24], T. herba-barona and T. zygis (MIC/MBC of 0.6 mg/mL
and of 1.13, respectively) are the two most active towards Staphylococcus aureus. Overall, MIC and MBC
for the six thyme species against this bacterium were established in the range of 0.6 to 5.75 mg/mL,
which is in accordance with the reported data for thyme extracts of distinct origins. In this context,
Benbelaïd et al. [30] reported an MIC value of 1.0 mg/mL for an aqueous extract of Thymus lanceolatus,
while MIC values of 6.25 mg/mL, 5.0 mg/mL, and 0.5 mg/mL were previously reported for ethanolic
extracts of Thymus vulgaris, and methanolic and ethanolic extracts of Thymus capitatus [31–33].
Among the tested Gram-negative bacteria, S. typhimurium was the most susceptible to Thymus
extracts. Both the growth and viability of S. typhimurium were inhibited at 4.5 mg/mL by T. zygis and
at 7.5 mg/mL by T. fragrantissimus. Instead, T. pulegioides inhibited bacterial growth at 5.75 mg/mL,
but its viability was only affected at higher levels (MBC 11.5 mg/mL). Combined with our previous
results for T. herba-barona, T. pseudolanuginosus, and T. caespetitius decoctions (MIC in the range of
3.5–7 mg/mL) [24], it may be suggested that, to inhibit S. typhimurium, aqueous extracts of thyme
should be used in high concentrations. These results are also consistent with those from other authors.
In particular, Benbelaïd et al. [30] reported a MIC value of 4.0 mg/mL when S. typhimurium was
treated with a water extract from T. lanceolatus. Values of the same magnitude were reported for a
methanolic extract of T. capitatus (MIC = 6 mg/mL) [32], or hydroethanolic extracts from T. vulgaris
and Thymus caramanicus (MIC values of 12.5 and 2.6 mg/mL, respectively) [31].
In turn, P. aeruginosa and E. coli were even more resistant to thyme extracts, albeit at different
levels. While P. aeruginosa growth was inhibited by all samples (MIC values of 4.5, 5.75, and 7.5 mg/mL
for T. zygis, T. pulegioides, and T. fragantissimus, respectively), only the latter species negatively impacted
E. coli growth at 7.5 mg/mL. Moreover, T. pulegioides was able to kill P. aeruginosa (MBC = 11.5 mg/mL),
while no effect on the viability of E. coli was observed. Thymus ethanolic extracts have been previously
demonstrated to inhibit P. aeruginosa, with MIC values of 2.0 mg/mL (T. capitatus) [33] and 0.25 mg/mL
(T. lanceolatus) [30], but no data on their ability to kill this bacterium were delivered. Likewise, ethanolic
extracts of T. capitatus, T. vulgaris, T. caramanicus, and T. lanceolatus were shown to inhibit the growth of
E. coli strains (MIC in the range of 0.5–8 mg/mL) [31,33] although no information was given about
their effects on the viability of this bacterium.
3. Materials and Methods
3.1. Chemicals
Rosmarinic acid, apigenin-7-O-glucoside, luteolin-7-O-glucoside and eriodictyol-7-O-glucoside
were obtained from Extrasynthese (Genay, France). Gallic acid, nisin, ascorbic acid and
2,6-Di-tert-butyl-4-methylphenol and the fatty acids methyl ester (FAME) reference standard mixture 37
(fatty acids C4 to C24; standard 47885-U) from Supelco (Bellefonte, PA, USA) were obtained from
Sigma Chemical Co (St. Louis, MO, USA). Folin–Ciocalteu reagent, Na2CO3, formic acid and ethanol
were purchased from Panreac (Barcelona, Spain). n-hexane, methanol, and acetonitrile with HPLC
purity were purchased from Lab-Scan (Lisbon, Portugal). Mueller–Hinton agar was obtained from
VWR, Prolabo Chemicals (Radnor, PA, USA). Water was treated in a Direct-Q ® water purification
system (Merck Life Science, Darmstadt, Germany).
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3.2. Plant Cultivation and Material
The T. zygis, T. fragantissimus, and T. pulegioides species have been cultivated under an organic
regime by Ervital (Mezio-Castro Daire, Portugal, GPS coordinates 40.976351,−7.903492). The cultivation
soil was of granitic origin, medium to coarse in texture. It was moderately acidic (pH in water 5.6),
with an organic matter content of 3.9%, with low levels of extractable phosphorus (18 ppm) and high
levels of extractable potassium (110 ppm). During the time of cultivation (April 2014–June 2015),
local temperatures ranged from 2 ◦C to 27 ◦C. Minimum values were registered in winter (November
2014 to February 2015, 2 ◦C–12 ◦C), while temperatures in the spring varied between 11 ◦C to 22 ◦C
and reached a maximum of 27 ◦C in June 2015. Relative humidity varied from 2% to 90% with 29% on
average, while the average total precipitation was 75 mm (65–94 mm).
No chemical or bacteriological treatment was applied to the plants. Their appearance and behavior
were regularly monitored to ensure their health and the absence of pathogens. Whenever appropriate,
weeds were removed from the surrounding soil.
The aerial parts of each individual Thymus (flowers, leaves, and stems) were collected and dried
in a ventilated incubator at 20 to 35 ◦C for three to five days. After drying, the plants were transported
in Kraft paper-type bags to the lab, where they were kept frozen until use.
3.3. Extraction of Phenolic Compounds
The extraction of phenolic compounds was performed according to the method described by
Ferreira et al. [34], with adaptations. Briefly, 0.5 mm mesh powder of the aerial parts (flowers,
leaves, and stems) of T. zygis, T. fragantissimus, and T. pulegioides (5 g) were extracted for 15 min
using a decoction 20:1 (5 g in 100 mL of water), filtrated, and concentrated using a rotary evaporator.
The concentrate was defatted with n-hexane (1:1 v/v) and freeze-dried. This procedure was performed
in three independent assays.
3.4. Nutritional Value
The chemical composition of samples was determined according to AOAC methods [35]. Crude protein
content (N × 6.25) of the samples was estimated through the macro-Kjeldahl method. Ash content
was determined by incineration in a muffle furnace at 550 ◦C for 6 h and gravimetric quantification.
Crude fat was obtained by Soxhlet extraction with light petroleum for 8 h, followed by filtration through
a 0.2 µm nylon filter, solvent removal in a rotary evaporator, and drying, followed by gravimetric
quantification. Total carbohydrates were calculated by difference. Calorific content was calculated
according to the following equation: Energy (kcal) = 4× (g protein + g carbohydrates) + 9× (g fat) [18].
For mineral determination, approximately 1 g of ash was digested with nitric acid. After digestion,
samples were filtered and the volume adjusted to 100 mL with ultrapure water. Minerals (Na, K, Ca,
Mg, Fe, Mn, Cu, and Zn) were quantified in a Perkin Elmer Analyst 100 flame atomic absorption
spectrometer (Villepinte, France) equipped with a single hollow cathode lamps for each element and
an air-acetylene burner [36].
Fatty acids were analyzed by transesterification of the fat fraction in the presence of sodium
methoxide. The crude fat (1 g) was placed in a 15-mL glass tube and rod crushed and dissolved in
6 mL of n-heptane. Next, 400 µL of 0.2 M sodium methoxide were added to each sample and the
tube was vigorously stirred in a vortex for 1–2 min at room temperature, allowing the formation
of fatty acid methyl esters (FAME) from triglycerides. After decanting, sample supernatants were
filtered through a 0.2 µm nylon filter from Milipore and injected in the gas chromatography system.
Fatty acids were analyzed in a DANI 1000 gas chromatographer (GC) equipped with a split/splitless
injector and a flame ionization detector (FID), following the method used by Fernandes et al. [18].
The identification was performed by comparing the relative retention times from samples with FAME
peaks (standard mixtures). The results were recorded and expressed as a relative percentage of each
fatty acid.
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3.5. Identification and Quantification of Phenolic Compounds
The total phenolic content of each Thymus extract was determined according to the adapted
Folin–Ciocalteu colorimetric method, as described by Pereira et al. [37]. The individual phenolic
compounds were identified through UHPLC-DAD-ESI-MSn analysis of extracts (5 mg/mL),
as described by Afonso et al. [24]. Elution was carried out with a mixture of 0.1% (v/v) of formic acid in
water (solvent A) and acetonitrile (solvent B) and the flow rate used was 0.2 mL/min–1, following the
same program. UV–Vis spectral data for all peaks accumulated in the range 200–600 nm and the
chromatographic profiles were recorded at 280, 320, and 340 nm. The mass spectrometer used was a
Thermo LTQ XL (Thermo Scientific, San Jose, CA, USA) ion trap MS, equipped with an ESI source with
Thermo Xcalibur Qual Browser software. The instrument was operated in negative-ion mode and the
full scan covered the mass range from m/z 100 to 2000. Nitrogen above 99% purity was used and the
gas pressure was 520 kPa (75 psi). ESI needle voltage set at 5.00 kV and an ESI capillary temperature
of 275 ◦C. CID–MS/MS and MSn experiments were simultaneously acquired for precursor ions using
helium as the collision gas with collision energy of 25–35 arbitrary units.
For quantitative experiments, the limits of detection (LOD) and quantification (LOQ) were
calculated from the parameters of the calibration curves obtained by injection of known concentrations
of the exact or structurally related standard compounds represented in Table S1.
3.6. Antioxidant Activity
3.6.1. DPPH•Scavenging Test
The scavenging capacity of different concentrations (0.05–0.8 mg/mL) of T. zygis, T. fragantissimus,
and T. pulegioides extracts was tested using a DPPH radical test, as described before [38]. Ascorbic acid
was used as the positive control.
3.6.2. Reducing Power Test
The ability of T. zygis, T. fragantissimus, and T. pulegioides (0.05–0.25 mg/mL) aqueous extracts to reduce
iron (III) was assessed by the method previously described [39]. 2,6-Di-tert-butyl-4-methylphenol was used
as the positive control.
3.7. Antimicrobial Activity
The antibacterial potential of the Thymus polar extracts was evaluated against five bacterial
strains, including Gram-positive bacteria (S. epidermidis NCTC 11047 and S. aureus NCTC 6571) and
Gram-negative bacteria (S. typhimurium NCTC 12023, E. coli NCTC 9001, and P. aeruginosa NCTC
10662) from the National Collection of Type Cultures, operated by Public Health England. All strains
were cultured in Mueller–Hinton agar and incubated at 37 ◦C for 24 h.
The MIC and MBC of aqueous solutions of T. zygis, T. fragantissimus, and T. pulegioides were
determined by the broth microdilution method, using an adapted method previously described by
Afonso et al. [24]. Nisin, an antibacterial polypeptide approved as a food preservative, was used as the
positive control [40].
3.8. Statistical Analysis
One-way analysis of variance (ANOVA) followed by Tukey’s test were used to detect any
significant differences among different means. Alternatively, Student’s t test was used to determine the
significant difference between two different samples. A p-value under 0.05 was assumed to indicate
a significant difference. The results were analyzed using GraphPad Prism 6 (GraphPad Software,
San Diego, CA, USA).
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4. Conclusions
The nutritional composition, phenolic profile, antioxidant and antimicrobial activities of three
species of Thymus grown under organic farming are reported within this study. Based on our results,
it is possible to infer that these thyme species present a richness of polyunsaturated fatty acids and
an interesting omega-6/omega-3 fatty acids ratio, along with high K/Na ratios that can contribute to
cardiovascular protection. T. pulegioides presented the highest antioxidant capacity, consistent with its
high content of polyphenols, which were mainly composed of rosmarinic acid and caffeoyl rosmarinic
acid, also showing considerable levels of flavones (luteolin-C-glucoside, luteolin-O-glucuronide,
and apigenin-O-glucuronide) and flavanones (eriodictyol-O-hexoside isomers). In addition, aqueous
extracts obtained from these Thymus species, particularly T. zygis, showed antibacterial potential.
Supplementary Materials: Supplementary materials can be found in a separate file: Figure S1: Pictures of
Thymus zygis (a), Thymus pulegioides (b) and Thymus fragrantissimus (c); Figure S2: Extracted ion chromatograms
and (inset) mass spectrum of ESI–MS2 of the corresponded ion of main phenolic compounds identified in
Thymus zygis, Thymus pulegioides and Thymus fragrantissimus by UHPLC-DAD-ESI-MSn; Table S1: Linearity, LOD
and LOQ of the standard compounds used as references.
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Decocciones de Salvia elegans, Salvia greggii y Salvia officinalis: 
actividades antioxidantes e inhibición de enzimas metabólicas 
Objetivos 
El presente estudio tiene como objetivo dilucidar la composición fenólica y los efectos 
biológicos de las decocciones de Salvia elegans y Salvia greggii, centrándose 
principalmente en su potencial antioxidante y en las actividades en enzimas metabólicas 
con un impacto relevante en la obesidad y la diabetes, al mismo tiempo que se comparan 
con la especie bien conocida de Salvia officinalis. 
1. Introducción 
Los géneros de Salvia (Salvia spp.), pertenecientes a la familia Lamiaceae, comprenden 
más de 900 especies que se utilizan para distintos fines, incluida la industria culinaria, 
cosmética o la medicina tradicional debido a sus beneficios para la salud [1,2]. Entre 
ellos, S. officinalis, es decir, la salvia común o Salvia dálmata, se cultiva ampliamente, y 
ha sido la especie mejor investigada en lo que respecta al potencial biológico, así como 
de sus aceites esenciales y extractos polares. En estudios in vivo y in vitro con esta 
especie de Salvia, se obtuvieron resultados prometedores que se enfocaron en su efecto 
sobre la memoria y las funciones cognitivas, perfil bioquímico de glucosa y lípidos [3], 
actividad antiinflamatoria [4,5], actividad antioxidante [6,7], o la citotoxicidad frente a 
distintas células cancerígenas [8,9]. Sin embargo, muchas especies menos 
ampliamente distribuidas, como S. greggii A. Gray y S. elegans Vahl., siguen estando 
poco estudiadas. S. greggii, (conocida como "salvia de otoño") y S. elegans son 
especies originarias de México y actualmente se cultivan en los Estados Unidos y otras 
regiones del mundo [10,11]. Estas dos especies de plantas se usan ampliamente en la 
medicina tradicional, particularmente en forma de infusiones o decocciones, para tratar 
problemas digestivos y orales (S. greggii) [1] o para disminuir la presión arterial y 
combatir los trastornos del sistema nervioso central como la ansiedad y el insomnio (S. 
elegans) [12–14]. Sin embargo, hasta donde se sabe, la composición fitoquímica y los 
efectos beneficiosos de los extractos polares, en particular los relacionados con el uso 
tradicional (acuoso), permanecen sin explorar. Por lo que sabemos, S. greggii ha sido 
evaluada en busca de compuestos terpénicos [15,16], y los extractos polares de S. 
elegans han sido objeto de atención, y en particular, se han demostrado sus efectos 






2.1. Plantas y extracción de compuestos fenólicos 
Las partes aéreas de las plantas S. elegans, S. greggii y S. officinalis se cultivaron bajo 
un régimen orgánico y se secaron en una incubadora ventilada a 20-35ºC, durante 3 a 
5 días. Los extractos fenólicos se han obtenido utilizando una decocción en la proporción 
1:20. Seguidamente las soluciones se filtraron, se concentraron, se evaporaron, se 
congelaron a -20°C y se liofilizaron. Se obtuvieron tres extractos de cada planta. 
2.2 Identificación y cuantificación de compuestos fenólicos  
Los extractos fueron caracterizados y cuantificados por cromatografía líquida de alta 
eficiencia, asociada a espectrometría de masas por electrospray en el modo de 
ionización negativo (UHPLC-DAD-ESI / MSn).  
2.3 Pruebas de bioactividad 
2.3.1 Capacidad antioxidante  
La actividad antioxidante de los extractos acuosos de las tres salvias se evaluó mediante 
seis ensayos químicos [17,18]: i) eliminación de radicales libres estables como el 2,2-
difenil-1-picrililhidracilo (DPPH●), anión superoxido (O2●-) y óxido nítrico (NO●); ii) el 
poder reductor por la reducción de hierro (III); iii) la capacidad de absorción de radicales 
de oxígeno (ORAC), que evalúa la actividad antioxidante a través de la inhibición de la 
oxidación, inducida por el radical peroxil (RO2●); y la inhibición de la actividad de la 
xantina oxidasa (XO) [19], es decir, la enzima que cataliza la oxidación de la hipoxantina 
a la xantina, y además cataliza la xantina al ácido úrico con una producción 
concomitante de O2●-.  
En las pruebas DPPH y NO● se utilizó ácido ascórbico como control positivo; en los 
métodos del poder reductor, O2●- y de inhibición de xantina oxidasa (XO) se utilizaron 
hidroxianisol butilado (BHA), ácido gálico y alopurinol como estándares, 
respectivamente. Los resultados de la prueba ORAC se expresaron en μM de 
equivalentes de trolox (μM TE) por mg de extracto. Los restantes resultados se 
expresaron como valores de EC50 (concentración de la muestra que proporciona el 50% 
de la actividad antioxidante) en μg por ml de extracto. 
2.3.2 Inhibición de las actividades enzimáticas 
La actividad enzimática metabólica de los tres extractos acuosos de salvias se evaluaron 
in vitro mediante la inhibición de la actividad de tres enzimas, la α-glucosidasa, la α-
amilasa y la lipasa pancreática [20,21]. En las pruebas de inhibición de las actividades 
α-glucosidasa y α-amilasa se utilizó acarbosa como control positivo, mientras que en la 
prueba de inhibición de la lipasa pancreática se utilizó orlistat como estándar. En el 
método de inhibición de la actividad de α-glucosidasa, los resultados se expresaron en 
valores de EC50 (μg/ml), que corresponden a la concentración de la muestra que 
3/12 
proporcionó 50% de inhibición de la enzima. En las pruebas de inhibición de α-amilasa 
y lipasa pancreática se determinó el porcentaje de inhibición de las enzimas en 0.5 y 0.2 
mg/ml de cada muestra de Salvia, respectivamente, o el EC50 para los compuestos de 
referencia. 
3. Resultados y discusión 
3.1. Compuestos fenólicos  
Los rendimientos de las tres decocciones de Salvia fueron aproximadamente del 20%, 
con niveles ligeramente más altos observados para S. elegans y S. greggii en 
comparación con S. officinalis (22.1% y 22.2% vs. 19.3%, respectivamente). Consistente 
con su prevalencia en varias plantas de Salvia [1,2,22,23], los derivados del ácido 
cafeico (particularmente el ácido rosmarínico) fueron compuestos dominantes en las 
decocciones de S. officinalis, S. elegans y S. greggii, que representan aproximadamente 
un tercio de las especies fenólicas identificadas (Tabla 1). Sin embargo, se encontraron 
diferencias significativas entre los extractos de las tres plantas. De hecho, S. elegans se 
distinguió por su riqueza en derivados del ácido cafeico, a saber, ácido rosmarínico, 
cafeoil ácido rosmarínico, ácido salvianólico B (fracciones 36, 39 y 27, respectivamente), 
que en general fueron alrededor de 70% del total de los fenólicos cuantificados.  







mg/g de extracto 
S. off  S. ele  S. gre  
1 1.5 275 149 2,4-Dimetil ácido benzóico 4.1 ± 0.2 5.1 ± 0.1 7.3 ± 0.2 
2 1.7 205 191 Ácido quinico 0.6 ± 0.1 0.6 ± 0.1 0.5 ± 0.01 
3 3.6 280 197 Danshensu D D D 
4 5.0 290, 324 353 cis 3-O- Ácido cafeioilquinico - - 3.10 ± 0.03 
5 5.7 220, 278 137 Ácido hidroxibenzoico D 2.0 ± 0.1 - 
6 8.3 313 295 p- ácido pentosido de coumaroil  - - 0.30 ± 0.02 
7 8.8 290, 325 353 Trans-5-O- Ácido cafeoilquinico - - 1.9 ± 0.1 
8 9.4 
313 265 Derivado del ácido cumárico - - 2.90 ± 0.05 
ND 325 Cafeoil hexósido D - - 
9 9.7 290, 323 179 Ácido cafeico 1.80 ± 0.04 1.50 ± 0.02 - 
10 9.8 314 325 Cumaroil hexósido  D - - 
11 9.9 255, 265, 350 625 Quercetina di-hexósido - - D 
12 12.1 271, 336 593 
Apigenina-6-C-glucósido-7-O-
glucósido 
4.3 ± 0.1 - - 
13 13.1 291, 311 637 Derivado del ácido ferúlico - D - 
14 13.5 274 571 Ácido yunnanico E (isómero 1) - 1.9 ± 0.1 - 
15 13.9 256, 267, 345 447 Luteolina-C-hexósido - - 4.60 ± 0.09 
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16 13.9 281, 345 477 Hidroxi-luteolina-glucurónido D 1.9 ± 0.2 - 
17 14.1 276 571 Ácido yunnanico E (isómero 2) D - - 
18 14.4 269, 304 473 Ácido cichorico - 1.60 ± 0.07 - 
19 14.8 267, 345 621 Apigenina-di-glucurónido 4.6 ± 0.3 - - 
20 15.2 268, 336 431 Apigenina-C- hexósido - - 15.7 ± 0.3 
21 15.4 274 
555 Ácido salvianólico K 1.6 ± 0.2 - - 
571 Ácido yunnanico E (isómero 3) D - - 
22 15.8 255, 350 463 Quercetina-O-hexósido - - 2.7 ± 0.2 
23 15.9 280, 333 461 Scutelareina-O-glucurónido 13.4 ± 0.6 3.9 ± 0.1 - 
24 16.0 255, 265, 348 447 Luteolina-7-O-glucósido - - 26.1 ± 0.9 
25 16.1 255, 266, 345 461 
Luteolina-7-O-glucurónido 
(isómero 1) 
8.4 ± 0.3 5.1 ± 0.3 - 
26 16.9 271, 306 521 Salviaflasida - D - 
27 17.2 278 717 Ácido salvianólico B (isómero 1) - 7.8 ± 0.4 - 
28 17.3 279 571 Ácido yunnanico E (isómero 4) 0.9 ± 0.1 - - 
29 17.7 279 717 Ácido salvianólico (isómero 2) - 1.7 ± 0.6 - 
30 17.9 
268, 334 577 Apigenina-rutinósido 4.5 ± 0.1 D - 
283 719 Ácido sagerinico 6.0 ± 0.3 D - 
31 18.1 271, 304 717 Ácido salvianólico B (isómero 3) - 1.7 ± 0.1 - 
32 18.1 269, 329 431 Apigenina-hexósido D - 3.4 ± 0.2 
33 18.4 267, 337 445 Apigenina-glucurónido 48.4 ± 1.3 3.2 ± 0.5 - 
34 18.6 254, 266, 345 533 Luteolina malonil hexósido - - D 
35 18.6 270, 291, 326 717 Ácido salvianólico B (isómero 4) D - - 
36 19.0 218, 290, 328 359 Ácido rosmarínico 28.3 ± 0.6 35.5 ± 0.8 10.9 ± 0.2 
37 19.2 269, 307, 343 461 
Luteolina-O-glucurónido 
(isómero 2) 
- 1.8 ± 0.1  
38 20.8 293, 328 373 Rosmarinato de metilo - - D 
39 21.2 290, 333 537 
Cafeoil ácido rosmarínico/ Ácido 
salvianólico I (isómero 1) 
1.2 ± 0.1 17.9 ± 0.1 - 
40 21.4 
293, 328 329 Derivado del ácido cafeico  - - 5.0 ± 0.03 
239, 285, 330 537 
Cafeoil ácido rosmarínico 
(isómero 2) 
- 1.3 ± 0.04 - 
41 22.1 295, 325 713 Derivado del ácido cafeico - D - 
42 22.3 280 537 
Cafeoil ácido rosmarínico 
(isómero 3) 
- 0.7 ± 0.04 - 
43 23.0 289, 327 717 Ácido salvianólico B isómero D 2.4 ± 0.04 - 
    Ácido cafeico y derivados 39.8 ± 0.9 74.1 ± 0.5 20.8 ± 0.3 
    Ácido cumárico y derivados - - 3.20 ± 0.06 
    Flavonas 83.5 ± 2.3 15.9 ± 0.9 49.7 ± 1.3 
    Flavonoles - - 2.7 ± 0.2 
D: Detectado; TR: tiempo de retención; S. off—S. officinalis; S. ele—S. elegans; S. gre—S. greggii. 
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El extracto acuoso de S. greggii se caracterizó por altos porcentajes de flavonas 
glicosídicas, en particular luteolina-O-hexósido y apigenina-C-hexósido (fracciones 24 y 
20, respectivamente); y de cantidades moderadas de luteolina-C-hexósido, flavonol 
quercetina-O-hexósido y de dos derivados de ácido cumárico (fracciones 15, 22, 6 y 8, 
respectivamente). Ninguno de estos compuestos se detectó en las decocciones de las 
otras dos especies. Por lo tanto, a nivel general los extractos obtenidos de S. elegans y 
S. greggii fueron claramente distintos de los de S. officinalis, con esta última dominada 
por la forma O-hexurónica de apigenina y scutelareina, junto con ácido rosmarínico 
(48.4, 13.4 y 28.3 mg/g de extracto, respectivamente). Es de señalar que el predominio 
de apigenina-O-glucurónido y ácido rosmarínico en esta decocción es coherente con la 
abundancia de estos dos constituyentes previamente descritos en extractos polares de 
esta especie [2,24], sin embargo, es curioso que esta sea la primera vez que se detecte 
scutelareina-O-glucurónido en extractos de S. officinalis, mientras que los estudios 
anteriores solo describieron su forma de aglicona. 
3.2. Actividad antioxidante 
En general, la decocción de S. elegans fue más prometedora que la de S. greggii en lo 
que se refiere a su capacidad para eliminar los radicales libres y reducir el Fe3+ (Tabla 
2). S. elegans presentó valores de EC50 aproximadamente 1.8–2.5 más bajos que S. 
greggii en DPPH•, NO•, O2• y en la prueba de poder reductor, y una tendencia a una 
mayor habilidad para capturar radicales peroxil (RO2).  
Tabla 2. Propiedades antioxidantes de las plantas S. officinalis, S. elegans, and S. greggii  
 S. officinalis S. elegans S. greggii  Standard 
DPPH• (EC50 μg/mL) (1) 34.8 ± 3.3a 10.7 ± 2.1b 21.1 ± 2.5c 6.69 ± 0.7b 
Reducing Power (EC50 μg/mL) (2) 40.0 ± 11.2a 31.3 ± 5.0a,c 77.9 ± 5.6b 16.30 ± 1.5c 
NO• (EC50 μg/mL) (1) 118.2 ± 16.4a 91.5 ± 14.5a 167.8 ± 23.9b 212.1 ± 9.7c 
O2•– (EC50 μg/mL) (3) 32.8 ± 0.6a 30.6 ± 1.3a 61.7 ± 3.4b 7.8 ± 0.5c 
ORAC (μM TE/mg ext) (4) 404.4 ± 1.80a 373.1 ± 28.1a 335.6 ± 69.6a - 
Xanthine oxidase (EC50 μg/mL) (5) 55.1 ± 10.6a 71.8 ± 3.8b 70.1 ± 4.0a,b 0.09 ± 0.01c 
(1) Se utilizó ácido ascórbico como control positivo. (2) Cantidad de extracto capaz de proporcionar 0.5 de absorbancia 
reduciendo 3.5 μM Fe3+ a Fe2+. Se utilizó BHA como control positivo. (3)  Se utilizó ácido gálico como como compuesto 
de referencia. (4) TE— equivalentes de trolox. (5) Se utilizó alopurinol como compuesto de referencia. Valores medios ± 
SD; El análisis estadístico se realizó mediante ANOVA de una vía, seguido de la prueba de Tukey. En cada fila, letras 
diferentes significan diferencias estadísticas significativas (p < 0.05). 
El extracto de S. elegans también presentó un potencial antioxidante mejor que S. 
officinalis, con valores EC50 que presentaban una tendencia decreciente en las pruebas 
de NO•, O2• y poder reductor, y incluso tres veces más bajo para el ensayo DPPH. 
Además, hay que destacar que la potencia de S. elegans para contrarrestar el DPPH• y 
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el NO• fue mayor que la del ácido ascórbico. La única excepción se observó para el 
ensayo ORAC, para el cual el resultado observado para S. officinalis fue mejor que el 
de S. elegans, aunque no fue estadísticamente significativo. 
La Tabla 3 resume los coeficientes de correlación entre las cantidades de clases de 
componentes fenólicos encontrados en las decocciones de Salvia y los datos de los 
distintos experimentos biológicos. De acuerdo con estos resultados, es posible sugerir 
que la actividad antioxidante superior de la decocción de S. elegans está fuertemente 
asociada con su riqueza en ácido cafeico y derivados, ya que los factores de correlación 
en los ensayos DPPH•, poder reductor, NO• y O2•- fueron 0.801, 0.948, 0.986 y 0.844, 
respectivamente. 
Tabla 3. Coeficientes de correlación entre las cantidades de componentes fenólicos encontrados 
en las decocciones de Salvia (ácido cafeico y derivados, derivados de ácido cumárico, flavonas 
y flavonoles) y los datos de los distintos experimentos biológicos. 
 DPPH RP ORAC NO O2 XO AG L 
Flavones −0.971 −0.357 0.454 −0.498 −0.123 0.901 −0.551 −0.367 
Flavonols −0.239 −0.934 −0.891 −0.868 −0.992 −0.434 −0.835 0.930 
CafAcD 0.801 0.948 0.400 0.986 0.844 −0.237 0.995 −0.485 
CouAcD −0.239 −0.934 −0.891 −0.868 −0.992 −0.434 −0.835 0.930 
DPPH  0.570 −0.228 0.690 0.356 −0.771 0.734 0.134 
RP   0.670 0.988 0.971 0.084 0.976 −0.738 
ORAC    0.547 0.829 0.796 0.493 −0.995 
NO     0.922 −0.071 0.998 * −0.624 
O2      0.321 0.996 −0.878 
XO       −0.134 −0.735 
AG        −0.574 
Valores de coeficiente de correlación de Pearson R; AG: actividad inhibidora de la α-glicosidasa; CafAcD — 
ácido cafeico y derivados; CouAcD: derivados del ácido cumárico; DPPH - actividad de captación de 
radicales DPPH; L - actividad inhibidora de la lipasa; NO — capacidad de eliminación de óxido nítrico; 
ORAC: capacidad de absorción de radicales de oxígeno; O2: actividad de captación de aniones 
superóxido; RP: poder reductor; XO: actividad inhibidora de la xantina oxidasa; * p < 0.05. 
Los extractos polares de S. officinalis se han utilizado comúnmente como una referencia 
para la evaluación de las propiedades antioxidantes de otras plantas menos 
investigadas [25,26]. Por lo tanto, se podría concluir que, de acuerdo con otros estudios 
para extractos polares de varias especies de Salvia, las decocciones de S. officinalis, S. 
elegans y S. greggii, tienen una alta capacidad para eliminar el DPPH•, con S. elegans 
mostrando la actividad más prometedora, seguido por S. greggii y S. officinalis. Aunque 
la prueba DPPH sea la más frecuentemente estudiada [25–28], los extractos polares 
obtenidos de las plantas de Salvia también se han analizado previamente para 
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determinar su capacidad antioxidante a través de varios otros ensayos, como el poder 
reductor [29], y la eliminación de radicales libres NO• [30] y O2•- [31]. 
Del mismo modo, las decocciones de S. officinalis, S. elegans y S. greggii mostraron 
una gran capacidad para eliminar RO2• (335–404 μM TE/mg) y para inhibir la actividad 
de la XO, aunque con menor potencia que el medicamento comercial alopurinol. Entre 
los extractos, S. officinalis fue la mejor, un hecho que podría estar relacionado con su 
riqueza en glucurónido de apigenina o en otras flavonas (es decir, glicósidos de 
escutellareina y luteolina), ya que estos compuestos se han descrito como inhibidores 
fuertes de esta enzima [32,33]. Aunque el efecto individual de los compuestos no ha 
sido probado por nosotros, los coeficientes de correlación entre los ensayos de 
antioxidantes y los compuestos principales de cada extracto acuoso están en buena 
concordancia (Tabla 3). En el ensayo inhibidor de XO, el contenido de flavonas de la 
decocción de S. officinalis presentaba una correlación significativa (0.901) con su 
capacidad para inhibir esta actividad enzimática. 
3.3. Actividad enzimática metabólica 
Las α-glucosidasa, α-amilasa y lipasa pancreática son enzimas digestivas involucradas 
en el metabolismo de los carbohidratos y los lípidos, que se asumen como puntos de 
control terapéutico en la obesidad y la diabetes. α-Amilasa y α-glucosidasa catalizan la 
hidrólisis de los carbohidratos en azúcares simples, por lo que su inhibición retrasa la 
digestión del almidón y los oligosacáridos contribuyendo a la reducción del aumento 
posprandial en los niveles de glucosa en plasma. A su vez, la inhibición de la lipasa 
disminuye la digestión de los triglicéridos de la dieta, lo que reduce los niveles de ácidos 
grasos libres y monoacilgliceroles en el intestino [34–36].  
Tabla 4. Propiedades inhibitorias enzimáticas de decociones de las plantas S. officinalis, S. 
elegans, and S. greggii  
 S. officinalis S. elegans S. greggii Standard 
α-Glucosidasa (EC50 μg/mL) (1) 71.2 ± 5.0a 36.0 ± 2.7b 345.3 ± 6.4c 357.8 ± 12.3c 
α-Amilasa (2) - - 6.5 ± 3.0 0.7 ± 0.2 
Lipasa pancreática (3) 4.6 ± 3.6a 8.2 ± 0.3a 14.4 ± 7.4a 1.8 ± 0.4 
(1) Acarbose se utilizó como estándar (2) Los resultados se expresan como porcentaje (%) de inhibición a la 
concentración de 0,5 mg/ml (decocciones de Salvia) o como EC50 (μg/ml), para el compuesto de referencia 
acarbosa. (3) Los resultados se expresan como porcentaje (%) de inhibición a la concentración de 0.2 
mg/mL (decocciones de Salvia) o como EC50 (μg/ml), para el compuesto de referencia En cada línea, letras 
diferentes significan diferencias significativas (p < 0.05). 
En este estudio, se evaluó la capacidad de las decocciones de S. officinalis, S. elegans 
y S. greggii para inhibir la actividad de estas tres enzimas digestivas. En particular, las 
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actividades inhibitorias de los tres extractos de Salvia contra la α-glucosidasa fueron 
muy prometedoras para S. elegans y S. officinalis (EC50 = 36.0 µg/mL y 71.2 µg/mL, 
respectivamente), demostrando actividades de 9 y 4 veces superiores que la droga 
antidiabética, acarbosa, respectivamente (Tabla 4). 
Además, a pesar de menos eficaz que S. elegans y S. officinalis, la decocción de S. 
greggii fue tan efectiva como la acarbosa. Por lo tanto, nuestros resultados sugieren que 
las decocciones de S. elegans, S. officinalis y S. greggii podrían servir como agentes 
antidiabéticos y antiobesidad naturales para ayudar a controlar los niveles de glucosa a 
través del control de la actividad de la α-glucosidasa. Esto es consistente con estudios 
previos que informaron resultados idénticos para extractos polares de Salvia contra esta 
enzima [35,37].  
Además, la capacidad inhibitoria de los extractos polares de las especies de Salvia hacia 
la α-glucosidasa se ha relacionado previamente con sus constituyentes fenólicos [38–
40]. Tiendo en cuenta que el ácido rosmarínico y el caffeoil-ácido rosmarínico son dos 
componentes fenólicos principales en las decocciones de S. elegans, es factible suponer 
que podrían ser contribuyentes importantes para la mayor capacidad inhibitoria de este 
extracto. De hecho, se demostró una fuerte correlación entre los resultados obtenidos 
para las actividades inhibitorias de la α-glucosidasa y el contenido en ácido cafeico y 
derivados de los extractos (0.995). Curiosamente, también se observaron altos 
coeficientes de correlación entre la α-glucosidasa y los ensayos antioxidantes (Tabla 3), 
lo que sugiere que los efectos metabólicos y antioxidantes podrían posiblemente estar 
relacionados. 
Sin embargo, a pesar de los datos de la literatura que parecen sugerir que algunos 
extractos polares de especies de Salvia pueden ser prometedores con respecto a sus 
habilidades para controlar la actividad de la α-amilasa [40] y la lipasa pancreática [41] 
[42], esto no fue lo observado para las decocciones de S. officinalis, S. elegans y S. 
greggii estudiadas en esta investigación. 
4. Conclusiones 
Este trabajo demostró que entre las tres plantas S. elegans, S. greggii y S. officinalis, 
las decocciones de S. elegans fueron las más prometedoras en cuanto a la actividad 
antioxidante y el potencial inhibitorio contra la α-glucosidasa, un hecho que podría estar 
relacionado con su riqueza en ácido cafeico y sus derivados. A su vez, se resalta la 
capacidad inhibitoria superior de S. officinalis, que posiblemente esté asociada con la 
presencia de flavonas. En conclusión, de manera similar que la bien conocida especie 
de S. officinalis, también S. elegans y S. greggii son una fuente valiosa de metabolitos 
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naturales y podrían usarse para aplicaciones comerciales en nuevos alimentos 
funcionales o ingredientes farmacéuticos dirigidos al tratamiento de la diabetes y la 
prevención de la obesidad. 
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Abstract: Salvia elegans Vahl., Salvia greggii A. Gray, and Salvia officinalis L. decoctions were
investigated for their health-benefit properties, in particular with respect to antioxidant activity
and inhibitory ability towards key enzymes with impact in diabetes and obesity (α-glucosidase,
α-amylase and pancreatic lipase). Additionally, the phenolic profiles of the three decoctions were
determined and correlated with the beneficial properties. The S. elegans decoction was the most
promising in regard to the antioxidant effects, namely in the scavenging capacity of the free radicals
DPPH•, NO• and O2•–, and the ability to reduce Fe3+, as well as the most effective inhibitor of
α-glucosidase (EC50 = 36.0 ± 2.7 µg/mL vs. EC50 = 345.3 ± 6.4 µg/mL and 71.2 ± 5.0 µg/mL
for S. greggii and S. officinalis, respectively). This superior activity of the S. elegans decoction over
those of S. greggii and S. officinalis was, overall, highly correlated with its richness in caffeic acid and
derivatives. In turn, the S. officinalis decoction exhibited good inhibitory capacity against xanthine
oxidase activity, a fact that could be associated with its high content of flavones, in particular the
glycosidic forms of apigenin, scutellarein and luteolin.
Keywords: sage; phenolic compounds; antioxidant; α-glucosidase; pancreatic lipase; α-amylase;
LC-MS analysis
1. Introduction
Salvia genus (Salvia spp.), belonging to the Lamiaceae family, comprises more than 900 species
that are used for distinct purposes, including the culinary and cosmetic industries or in traditional
medicines due to their claimed health benefits [1,2]. Among them, Salvia officinalis L., i.e., “common
sage” or “Dalmatian sage”, is widely cultivated. These plants usually grow 30–70 cm tall, with a
woody stem, whitish beneath and grayish-green above, and with purple-blue flowers up to 3 cm
long appearing from early summer to early autumn [1]. Due to its worldwide spread, S. officinalis
has been the most monitored species in relation to the biological potential of the whole plant as
well as of its essential oils and polar extracts. For example, promising results were obtained in
clinical studies with aqueous or ethanolic extracts of this Salvia species when focused on memory
and cognitive functions, pain, and the biochemical profile of glucose and lipids [3]. In addition,
in vivo assays in an ear edema induced by croton oil model pointed out the good anti-inflammatory
activity of hydroethanolic extracts [4]. Indeed, in vitro experiments demonstrated that its ability to
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inhibit 5-lipoxygenase activity [5] and to reduce the levels of interleukin 8 (IL-8) [6] might be based
on these anti-inflammatory properties. Moreover, several authors also reported the benefits of S.
officinalis polar extracts towards cell protection in distinct cell-based studies such as in HepG2, HeLa
and Caco-2 cell lines, evidencing their possible usage as DNA-protective agents [7,8]. Notably, polar
extracts from S. officinalis (aqueous, methanolic, ethanolic, and hydroalcoholic) have also been proven
to have protective effects against oxidative events [9,10] or oxidative stress-related processes [11,12],
as demonstrated in in chemico, cell-based or in vivo models [5,10–17].
In addition to S. officinalis, other widely distributed sage species such as Salvia miltiorrhiza Bge.
and Salvia hispanica L. were highlighted by their richness in bioactive compounds and their potential
health-promoting properties [1,2,18–20]. Still, many less-distributed species, including Salvia greggii
A. Gray and Salvia elegans Vahl., remain poorly studied regardless of their broad use for culinary and
medicinal purposes. S. greggii, also known as “autumn sage”, is originated from Mexico and Texas,
although it is currently spread in southwestern United States and Arizona and cultivated in some parts
of the world. It grows as a soft, evergreen shrub taller than about 1.2 m, and, similarly to S. officinalis,
its leaves are green and smooth [21]. Its flowers, which appear between spring to autumn, can be of
different colors (red, pink, purple, white or orange) and are characterized by an intense aroma and
abundant nectar. In turn, Salvia elegans is a species native of Mexico and is currently grown in the
United States, Canada, and other regions of the world [22]. It grows as a sub-bush of 1–1.5 m high
with a pineapple aroma and flavor, opposite leaves and oval, hairy, elliptic, pale green, and ruby red
flowers [23].
S. greggii and S. elegans are widely used in traditional medicine, particularly in the form of
infusions or decoctions, to treat digestive and oral problems (S. greggii) [1] or to lower blood pressure
and combat central nervous system disorders for anxiety and insomnia (S. elegans) [23–25]. However,
as far as we know, the phytochemical composition and beneficial effects of polar extracts, in particular
those related to traditional usage (aqueous), remain unexplored. Regardless of this, S. greggii has been
screened for terpenic compounds [26,27], and the antigerminative activity of its essential oils [28],
while aspects related to polar extracts have not yet been studied. In turn, polar extracts from S. elegans
have been the focus of some attention, and, in particular, hydroalcoholic extracts have been shown
to exhibit antihypertensive, antidepressant, and anxiolytic effects [23–25] in in vitro models. Yet,
to our knowledge, bioactive constituents of S. elegans polar extracts and their ability to counteract
oxidative-stress-related events have not been previously elucidated.
Hence, the present study aimed to elucidate the phenolic composition and biological effects
of S. elegans and S. greggii decoctions (mainly focusing on their potential antioxidant activity and
inhibitory capacities towards key metabolic enzymes with impact in diabetes and obesity), while
comparing the findings to those of the well-known S. officinalis species.
2. Results and Discussion
2.1. Phytochemical Composition
The decoction yields of the three Salvia species were approximately 20%, with slightly higher
levels observed for S. elegans and S. greggii in comparison to S. officinalis (22.1 ± 2.2% and 22.2 ±
1.5% vs. 19.3 ± 2.3%, respectively). Consistent with their prevalence in Salvia plants [1,2,29], caffeic
acid derivatives (particularly rosmarinic acid) were dominant compounds in S. officinalis, S. elegans,
and S. greggii decoctions, accounting for about one third of the global identified phenolic species
(Table 1, Figure 1, Figure S1). Nevertheless, significant differences could be found between extracts.
S. elegans was distinguished by its richness in caffeic acid derivatives, namely rosmarinic acid (peak 36,
[M − H]− at m/z 359→161, 179), caffeoylrosmarinic acid (peak 39, [M − H]− at m/z 537→493, 359)
and salvianolic acid B (peak 27, [M − H]− at m/z 717→519), which overall represented approximately
70% of the total quantified phenolics, while the aqueous extract of S. greggii was characterized by high
percentages of glycosidic flavones, mostly consisting of luteolin-O-hexoside and apigenin-C-hexoside
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(peaks 24 and 20, [M − H]− at m/z 447 and 431, respectively), representing 33% and 20%, respectively,
of total quantified phenolic compounds. Moderate amounts of luteolin-C-hexoside (peak 15, [M −
H]− at m/z 447→327, 357), quercetin-O-hexoside (peak 22, [M − H]− at m/z 463→ 301) and two
coumaric acid derivatives (peaks 6 and 8, [M − H]− at m/z 295 and 265, respectively) have also been
detected in this extract. Interestingly, none of these compounds were detected in the decoctions of the
two other species. Hence, globally, the extracts obtained from S. elegans and S. greggii species were
clearly distinguishable from that of the S. officinalis, which was dominated by the O-hexuronic form
of apigenin ([M − H]− at m/z 445→269, 48.4 ± 1.3 mg/g extract) and scutellarein ([M − H]− at m/z
461→285, 13.4 ± 0.6 mg/g extract), in addition to rosmarinic acid (28.3 ± 0.6 mg/g extract). Note that
the predominance of apigenin-O-glucuronide and rosmarinic acid in this decoction is coherent with
the abundance of these two constituents previously reported for polar extracts of this species (e.g.,
ethanol, methanol, aqueous, hydroalcoholic) [2,30]; however, it is worth noting that this is the first
time that scutellarein-O-glucuronide was detected in S. officinalis extracts, while the previous studies
only described its aglycone form.
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Table 1. Phytochemical composition of S. officinalis, S. elegans, and S. greggii decoctions determined by UHPLC-DAD-ESI-MSn.
NP RT (min) λmax [M − H]− ESI-MS2 Main Fragments Compound S. off * S. ele * S. gre *
1 1.5 275 149 103, 87, 131, 59 2,4-DimethylBA 4.1 ± 0.2 5.1 ± 0.1 7.3 ± 0.2
2 1.7 205 191 111, 173 Quinic acid 0.6 ± 0.1 0.6 ± 0.1 0.5 ± 0.01
3 3.6 280 197 179, 73, 153 Danshensu D D D
4 5.0 290, 324 353 191, 179, 135, 173 cis 3-O-CQA - - 3.1 ± 0.03
5 5.7 220, 278 137 109, 93, 119 HydroxyBA D 2.0 ± 0.1 -
6 8.3 313 295 163 p-Coum Ac Pent - - 0.3 ± 0.02
7 8.8 290, 325 353 191, 179 trans-5-O-CQA - - 1.9 ± 0.1
8 9.4
313 265 177, 149, 119 Coumaric Ac Der - - 2.9 ± 0.05
ND 325 163, 119 Caff Hex D - -
9 9.7 290, 323 179 135 CaffAc 1.8 ± 0.04 1.5 ± 0.02 -
10 9.8 314 325 265, 235, 163 Coum Hex D - -
11 9.9 255, 265, 350 625 463, 301 Querc diHex - - D
12 12.1 271, 336 593 473, 503, 353 Api-6-C-Glc-7-O-Glc 4.3 ± 0.1 - -
13 13.1 291, 311 637 351, 285, 193 Ferulic Ac Der - D -
14 13.5 274 571 527, 483, 439, 373 YA E (isom1) - 1.9 ± 0.1 -
15 13.9 256, 267, 345 447 327, 357 Lut-C-Hex - - 4.6 ± 0.09
16 13.9 281, 345 477 301, 373, 343, 397 Hydroxy-Lut-GlcA D 1.9 ± 0.2 -
17 14.1 276 571 527, 439, 553, 483 YA E (isom2) D - -
18 14.4 269, 304 473 311, 293, 179, 135 Cichoric acid - 1.6 ± 0.07 -
19 14.8 267, 345 621 351, 269 Api-diGlcA 4.6 ± 0.3 - -
20 15.2 268, 336 431 311, 341, 269 Api-C-Hex - - 15.7 ± 0.3
21 15.4 274
555 313, 357 SA K 1.6 ± 0.2 - -
571 527, 553, 509, 329 YA E (isom3) D - -
22 15.8 255, 350 463 301 Querc-O-Hex - - 2.7 ± 0.2
23 15.9 280, 333 461 285 Scut-O-GlcA 13.4 ± 0.6 3.9 ± 0.1 -
24 16.0 255, 265, 348 447 285 Lut-7-O-Glc - - 26.1 ± 0.9
25 16.1 255, 266, 345 461 285 Lut-7-O-GlcA (isom1) 8.4 ± 0.3 5.1 ± 0.3 -
26 16.9 271, 306 521 359, 197, 179, 135 Salviaflaside - D -
27 17.2 278 717 519, 475, 537, 339 SA B (isom1) - 7.8 ± 0.4 -
28 17.3 279 571 527, 553, 329 YA E (isom4) 0.9 ± 0.1 - -
29 17.7 279 717 537, 519, 339, 295 SA B (isom2) - 1.7 ± 0.6 -
30 17.9
268, 334 577 269 Api-rut 4.5 ± 0.1 D -
283 719 359, 539, 521, 341 Sagerinic acid 6.0 ± 0.3 D -
31 18.1 271, 304 717 519, 607, 339, 537 SA B (isom3) - 1.7 ± 0.1 -
32 18.1 269, 329 431 269 Api-Hex D - 3.4 ± 0.2
Molecules 2018, 23, 3169 5 of 17
Table 1. Cont.
NP RT (min) λmax [M − H]− ESI-MS2 Main Fragments Compound S. off * S. ele * S. gre *
33 18.4 267, 337 445 269, 175 Api-GlcA 48.4 ± 1.3 3.2 ± 0.5 -
34 18.6 254, 266, 345 533 489, 447, 433 Lut malonyl Hex - - D
35 18.6 270, 291, 326 717 555, 519, 475, 357 SA B (isom4) D - -
36 19.0 218, 290, 328 359 161, 179, 197, 223 RA 28.3 ± 0.6 35.5 ± 0.8 10.9 ± 0.2
37 19.2 269, 307, 343 461 285 Lut-O-GlcA (isom2) - 1.8 ± 0.1
38 20.8 293, 328 373 343, 329, 311, 179 Methyl rosmarinate - - D
39 21.2 290, 333 537 493, 359, 375 CaffRA/SA I (isom1) 1.2 ± 0.1 17.9 ± 0.1 -
40 21.4
293, 328 329 285, 314, 311, 161 CaffAc derivative - - 5.0 ± 0.03
239, 285, 330 537 456, 493, 375, 359 CaffRA (isom2) - 1.3 ± 0.04 -
41 22.1 295, 325 713 493, 359, 375 CaffAc der - D -
42 22.3 280 537 456, 493, 359, 161 CaffRA (isom3) - 0.7 ± 0.04 -
43 23.0 289, 327 717 519, 357, 555 SA B isomer D 2.4 ± 0.04 -
Caffeic acid and derivatives 39.8 ± 0.9 74.1 ± 0.5 20.8 ± 0.3
Coumaric acid derivatives - - 3.2 ± 0.06
Flavones 83.5 ± 2.3 15.9 ± 0.9 49.7 ± 1.3
Flavonols - - 2.7 ± 0.2
NP—Number of peak represented in Figure 1; D—Detected; Ac—acid; Api- Apigenin; BA—Benzoic acid; CaffAc—Caffeic acid; Caff—Caffeoyl; CQA—Caffeoylquinic acid;
Coum—Coumaroyl; Der—Derivative; Glc—Glucoside; GlcA—Glucuronide; Hex—Hexoside; Lut—Luteolin; Pent—Pentoside; Querc—Quercetin; Rut—Rutinoside; RA—Rosmarinic acid;
SA—Salvianolic acid; S. off —S. officinalis; S. ele—S. elegans; S. gre—S. greggii; Scut—Scutellarein; YA—Yunnaneic acid; * values expressed as mg/g of extract.
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Figure 1. Chromatographic representation of Salvia officinalis (a), Salvia elegans (b), and Salvia 
greggii (c) decoctions at 280 nm. The numbers in the figure correspond to the UHPLC-DAD-ESI-MSn 

























































































































































































Figure 1. Chromatographic representation of Salvia officinalis (a), Salvia elegans (b), and Salvia greggii
(c) decoctions at 280 nm. The umbers in the figure correspond to the UHPLC-DAD-ESI-MSn peaks
described in Ta le 1.
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2.2. Biological Activities
2.2.1. Antioxidant Activity
The antioxidant ability of the aqueous extracts obtained from the Salvia plants were evaluated
in regard to their ability to scavenge free radicals, namely DPPH• (2,2-diphenyl-1-picrylhydrazyl),
superoxide (O2•–), nitric oxide (NO•), and peroxyl (RO2•), and their capacity to reduce Fe3+ to Fe2+.
Furthermore, all the extracts were screened for their potency in inhibiting xanthine oxidase.
Globally, the S. elegans decoction was more promising than S. greggii in regard to its ability to
scavenge free radicals and to reduce Fe3+ (Table 2). It presented EC50 values about 1.8–2.5 lower
than the latter in DPPH•, NO•, O2•–, and reducing power tests, and a tendentially higher ability to
capture RO2•. Notably, the S. elegans extract also presented tendentially better antioxidant potential
than S. officinalis, with tendentially reduced EC50 values being registered for NO•, O2•–, and reducing
power tests, and even three times lower for the DPPH• assay. In addition, one must highlight that the
potency of S. elegans decoction to counteract DPPH• and NO• was 0.6- and 2.3-fold that of the ascorbic
acid, respectively. The only exception was observed for the oxygen radical absorbance capacity (ORAC)
assay for which the result observed for S. officinalis was better than that for S. elegans, although it was
not statistically significant.
Table 2. Antioxidant properties of S. officinalis, S. elegans, and S. greggii decoctions.
S. officinalis S. elegans S. greggii Standard
DPPH• (EC50 µg/mL) (1) 34.8 ± 3.3a 10.7 ± 2.1b 21.1 ± 2.5c 6.69 ± 0.7b
Reducing Power (EC50 µg/mL) (2) 40.0 ± 11.2a 31.3 ± 5.0a,c 77.9 ± 5.6b 16.30 ± 1.5c
NO• (EC50 µg/mL) (1) 118.2 ± 16.4a 91.5 ± 14.5a 167.8 ± 23.9b 212.1 ± 9.7c
O2•– (EC50 µg/mL) (3) 32.8 ± 0.6a 30.6 ± 1.3a 61.7 ± 3.4b 7.8 ± 0.5c
ORAC (µM TE/mg ext) (4) 404.4 ± 1.80a 373.1 ± 28.1a 335.6 ± 69.6a -
Xanthine oxidase (EC50 µg/mL) (5) 55.1 ± 10.6a 71.8 ± 3.8b 70.1 ± 4.0a,b 0.09 ± 0.01c
(1) Ascorbic acid was used as the reference compound. (2) Amount of extract able to provide 0.5 of absorbance
by reducing 3.5 µM Fe3+ to Fe2+. Butylated hydroxyanisole (BHA) was used as a reference compound. (3) Gallic
acid was used as the reference compound. (4) TE—Trolox Equivalent. (5) Allopurinol was used as the reference
compound. Mean values ± SD; statistical analysis was performed by one-way ANOVA followed by Tukey’s test.
In each line, different letters mean significant differences (p < 0.05).
Table 3 summarizes the correlation coefficients between the amounts of classes of phenolic
components found in the Salvia decoctions (caffeic acid and derivatives, coumaric acid derivatives,
flavones and flavonols) and the data from the distinct biological experiments. According to these
results, it is possible to suggest that the superior antioxidant activity of the S. elegans decoction is
strongly associated with its richness in caffeic acid and derivatives, since correlation factors in DPPH•,
reducing power, NO•, and O2•– assays were 0.801, 0.948, 0.986, and 0.844, respectively.
The comparison of the herein gathered data with that previously reported for other solvent-
extracts or other Salvia species is not an easy task, since methodologic adaptations (e.g., radical
precursor concentrations and their producing conditions) cause inevitable changes in EC50 values. This
difficulty can be partly overcome by the comparison of the extract’s potencies with that of reference
compounds. Unfortunately, this approach is often not addressed by the authors. Moreover, there
is no universal reference compound for a specific antioxidant assay, and variations in the selected
standards are frequent within literature. Regardless of that, one must note that S. officinalis polar
extracts have been commonly used as a reference for the assessment of antioxidant properties of
other less-investigated plants [14,15], showing EC50 values in the range of 2.0 to 233.0 µg/mL for the
DPPH• assay [5,7,13–15,31]. Other ethanolic, methanolic, or aqueous extracts of Salvia origin, including
those obtained from Salvia amplexicaulis [32], Salvia ringens [33], Salvia verbenaca, S. sclarea [34], Salvia
argentea [15], and Salvia nemorosa [35], have been claimed to be good DPPH• scavengers as well, with
antioxidant potentials that, in some cases, equal those of the standard compounds (ascorbic acid,
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butylated hydroxytoluene—BHT, or butylated hydroxyanisole—BHA). Hence, one might conclude
that, in agreement with other studies reported for polar extracts of several Salvia species, S. officinalis,
S. elegans, and S. greggii decoctions have a high ability to scavenge DPPH•, with S. elegans showing the
most promising activity, followed by S. greggii and S. officinalis.
Table 3. Correlation coefficients between the amounts of phenolic components found in the Salvia
decoctions (caffeic acid and derivatives, coumaric acid derivatives, flavones and flavonols) and the
data from the distinct biological experiments.
DPPH RP ORAC NO O2 XO AG L
Flavones − 0.971 − 0.357 0.454 − 0.498 − 0.123 0.901 − 0.551 − 0.367
Flavonols − 0.239 − 0.934 − 0.891 − 0.868 − 0.992 − 0.434 − 0.835 0.930
CafAcD 0.801 0.948 0.400 0.986 0.844 − 0.237 0.995 − 0.485
CouAcD − 0.239 − 0.934 − 0.891 − 0.868 − 0.992 − 0.434 − 0.835 0.930
DPPH 0.570 − 0.228 0.690 0.356 − 0.771 0.734 0.134
RP 0.670 0.988 0.971 0.084 0.976 − 0.738
ORAC 0.547 0.829 0.796 0.493 − 0.995
NO 0.922 − 0.071 0.998 * − 0.624
O2 0.321 0.996 − 0.878
XO − 0.134 − 0.735
AG − 0.574
Values expressed as Pearson correlation coefficient R; AG—α-glycosidase inhibitory activity; CafAcD—caffeic
acid and derivatives; CouAcD—coumaric acid derivatives; DPPH—DPPH radical scavenging activity; L—lipase
inhibitory activity; NO—nitric oxide radical scavenging capacity; ORAC—oxygen radical absorbance capacity;
O2—superoxide anion scavenging activity; RP—reducing power potential; XO—xanthine oxidase inhibitory activity;
* p < 0.05.
Polar extracts obtained from Salvia plants have also been previously screened for antioxidant
abilities through other assays, although not as frequent as for DPPH•. In this context, Hamrouni-
Sellami et al. [36] reported that the Fe3+ reducing ability of S. officinalis methanolic extracts was 6.5-fold
less that of ascorbic acid, being in agreement with our results which also pointed to good effectiveness
for decoctions of the same species. In general, our results also indicate that the three sage species herein
studied possess promising NO• scavenging capacities, as all the extracts had a lower EC50 compared
to ascorbic acid. Moreover, their activity seems to be superior to that described by Chen and Kang [37]
for the methanolic extracts of Salvia plebeia (EC50 = 216 ± 2.9 µg/mL), albeit that the absence of a
reference compound in that study hampered solid conclusions. Furthermore, in our study, S. elegans
and S. officinalis decoctions showed good O2•– scavenging capacity, also suggesting that these extracts
might be more active than the methanolic extracts of Salvia splendens (EC50 = 527 µg/mL) [38]. Likewise,
decoctions of S. officinalis, S. elegans, and S. greggii showed high capacity to scavenge RO2• (336–404 µM
TE/mg), which was significantly superior to those previously reported for the aqueous and ethanolic
extracts of S. officinalis (1143 and 2535 µM TE/g) and that other Salvia species (279–4735 µM TE/g).
Phenolic compounds have been previously reported to counteract the activity of xanthine oxidase
(XO) [39,40], i.e., the enzyme that catalyzes the oxidation of hypoxanthine to xanthine, and further
catalyzes xanthine to uric acid with a concomitant production of O2•–, thus contributing to increment of
oxidative stress events in cells. As can be observed in Table 2, the decoctions of the three Salvia species
could effectively inhibit the activity of XO, albeit being less potent than the commercial drug allopurinol
(EC50 = 55.1–71.8 µg/mL for Salvia extracts vs. 0.09± 0.01 µg/mL for allopurinol, respectively). Among
the extracts, the most powerful was that from S. officinalis, a fact that could be related to its richness
in apigenin glucuronide or in other flavones (i.e., scutellarein and luteolin glycosides), since these
compounds have been described as strong inhibitors of this enzyme [41–44]. Although the individual
effect of the compounds has not been tested by us, the correlation coefficients between the antioxidant
assays and the main compounds of each aqueous extract are in good agreement (Table 3). In XO
inhibitory assay, the flavones content of the S. officinalis decoction was highly correlated (0.901) with its
XO inhibition capacity.
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2.2.2. Metabolic Enzyme Activity
α-Glucosidase, α-amylase and pancreatic lipase are key digestive enzymes involved in the
metabolism of carbohydrates and lipids, which make them important targets for therapeutic control
of diabetes and obesity. α-Amylase and α-glucosidase catalyze the hydrolysis of carbohydrates into
simple sugars, thus their inhibition retards the digestion of starch and oligosaccharides contributing
to the reduction of postprandial increase in plasma glucose levels. In turn, lipase inhibition
decreases the digestion of dietary triglycerides, hence reducing the levels of free fatty acids and
monoacylglycerols in the intestinal lumen [40,45,46]. In this study, the ability of S. officinalis, S. elegans,
and S. greggii decoctions to inhibit the activity of these three digestive enzymes were assessed through
in chemico models.
Notably, the inhibitory activities of the three Salvia extracts against α-glucosidase were very
promising, especially for S. elegans and S. officinalis (EC50 = 36.0 ± 2.7 µg/mL and 71.2 ± 5.0 µg/mL,
respectively), demonstrating activities of 9- and 4-times that of the antidiabetic pharmaceutical drug,
acarbose, respectively (Table 4). Moreover, despite being less effective than S. elegans and S. officinalis,
S. greggii decoction was as effective as acarbose. Hence, our results suggest that the decoctions of
S. elegans, S. officinalis, and S. greggii could serve as natural antidiabetic and anti-obesity agents to help
in the control of glucose levels through the control of α-glucosidase activity. This hypothesis is also
consistent with previous studies that reported identical results for polar extracts of Salvia against this
enzyme, e.g., hydroethanolic extracts of S. officinalis (EC50 value of 69.7 µg/mL) [47] and methanolic
extracts of Salvia acetabulosa, S. nemorosa, and Salvia chloroleuca (EC50 = 76.9 µg/mL, EC50 = 19 µg/mL
and EC50 = 13.3 µg/mL, respectively) [35,48,49]. In vivo experiments have even demonstrated that
the administration of a daily dose of S. officinalis methanolic extracts (500 mg/kg body weight) to
alloxan-induced diabetic rats caused the inhibition of α-glucosidase activity comparable to that of the
administration of acarbose (20 mg/kg bw) [45].
Table 4. Enzyme inhibitory properties of S. officinalis, S. elegans, and S. greggii decoctions.
S. officinalis S. elegans S. greggii Standard
α-Glucosidase (EC50 µg/mL) (1) 71.2 ± 5.0a 36.0 ± 2.7b 345.3 ± 6.4c 357.8 ± 12.3c
α-Amylase (2) - - 6.5 ± 3.0 0.7 ± 0.2
Pancreatic lipase (3) 4.6 ± 3.6a 8.2 ± 0.3a 14.4 ± 7.4a 1.8 ± 0.4
(1) Acarbose was used as standard. (2) Results are expressed as percentage (%) inhibition at the concentration of
0.5 mg/mL (Salvia decoctions) or as EC50 (µg/mL), for the reference compound acarbose. (3) Results are expressed
as percentage (%) inhibition at the concentration of 0.2 mg/mL (Salvia decoctions) or as EC50 (ng/mL), for the
reference compound orlistat. In each line, different letters mean significant differences (p < 0.05).
The inhibitory capacity of polar extracts of Salvia species towards α-glucosidase have been mostly
correlated with their phenolic constituents. In fact, Chen and Kang [37] reported that the inhibition of
this enzyme by S. plebeia methanolic extracts increased proportionally to their total phenolic content.
Moreover, Kocak et al. [50] reported that aqueous and methanolic extracts of S. cadmica, both rich
in rosmarinic acid, luteolin, and apigenin, had high inhibitory effects towards α-glucosidase and
α-amylase. Moreover, several phenolic compounds isolated from S. miltiorrhiza, namely, tanshinone
IIA, rosmarinic acid, rosmarinic acid methyl ester and salvianolic acid C methyl ester, were reported
to be stronger inhibitors of α-glucosidase than acarbose (EC50 = 0.042–0.23 µM and EC50 = 5.8 µM,
respectively) [51]. The flavonoid compounds luteolin-7-O-glucoside, luteolin-7-O-glucuronide, and
diosmetin-7-O-glucuronide, isolated from the aerial parts of S. chloroleuca, also showed potent
α-glucosidase inhibitory effects with EC50 values of 18.3, 14.7, and 17.1 µM, respectively, exhibiting
an inhibitory effect close to that of acarbose (EC50 = 16.1 µM) [49]. Note that rosmarinic acid and
caffeoyl rosmarinic acid are two major phenolic components in S. elegans decoctions and, based on the
mentioned bibliographic data, it is feasible to hypothesize that they might be important contributors
for the higher inhibitory ability of this extract compared to the other two. In fact, correlation coefficients
determined for the different assays have shown a strong correlation between the results obtained for
Molecules 2018, 23, 3169 10 of 17
inhibitory activities on α-glucosidase and the content in caffeic acid and derivatives of the extracts
(0.995). Interestingly, high correlation coefficients were also observed between the α-glucosidase
and the antioxidant assays (0.976, 0.998, and 0.996 for reducing power, nitric oxide scavenging,
and superoxide anion scavenging, respectively; Table 3), suggesting that metabolic and antioxidant
effects might possibly be related.
However, regardless the great α-glucosidase inhibitory capacity and the fact that some authors
have previously found potential inhibitory capacities in polar extracts of Salvia, namely for aqueous
and methanolic extracts of S. cadmica, as well as for some individual phenolic compounds from Salvia
origin [49], our results showed no substantial inhibition towards α-amylase up to the concentration of
0.5 mg/mL. Moreover, at 0.2 mg/mL, only S. greggii showed an anti-lipase activity higher than 10%.
This could possibly be owed to its main phenolic component, i.e., luteolin-7-O-glucoside, since its
aglycone has been reported to be a good lipase inhibitor [52,53], a hypothesis also supported by the
high correlation found between the content of this flavone and the anti-lipase activity (0.930, data not
shown). Interestingly, the anti-lipase activity of polar extracts of Salvia species has been previously
described, namely for the methanolic extract of the leaves of S. officinalis (EC50 = 94 µg/mL) [54],
the methanol extract of Salvia spinosa (EC50 = 156.2 µg/mL) [55], and methanol extracts of Salvia triloba
(EC50 = 100.8 µg/mL) [56]. Hence, despite data from literature that seems to suggest that at least
some polar extracts from Salvia species might be promising with respect to their abilities to control the
activity of α-amylase and pancreatic lipase, this was not the observed for S. officinalis, S. elegans and S.
greggii decoctions herein studied.
3. Materials and Methods
3.1. Chemicals
Ethanol, potassium di-hydrogen phosphate, and gallic acid were purchased from Panreac.
Dimethylsulfoxide (DMSO), sodium chloride, potato starch, sodium and potassium tartrate,
sodium hydroxide, and tris-HCl were purchased from Fisher (Pittsburgh, PA, USA). Fluorescein,
2,2′-azobis(2-amidinopropane)di- hydrochloride (AAPH), sodium nitroprusside, sulfanilamide,
and 3,5-dinitrosalicylic acid (DNS) were purchased from Acros Organics (Hampton, NH, USA).
Trolox, xanthine oxidase from bovine milk, allopurinol, α-glucosidase from Saccharomyces cerevisiae,
4-nitrophenyl α-D-glucopyranoside (pNPG), lipase from porcine pancreas and 4-nitrophenyl butyrate,
α-amylase from porcine pancreas, β-nicotinamide adenine dinucleotide (β-NADH), phenazine
methosulphate (PMS), nitrotetrazolium blue chloride (NBT), BHA (butylated hydroxyanisole), DPPH
radical (2,2-diphenyl-2-picrylhydrazyl), ascorbic acid, and BHT (2,6-di-tert-butyl-4-methylphenol)
were obtained from Sigma (St. Louis, MO, USA). Calcium chloride and sodium di-hydrogen
phosphate were purchased from ChemLab (Eernegem, Belgium). Orlistat was purchased from TCI
(Tokyo, Japan), acarbose from Fluka (Bucharest, Romania), xanthine from AlfaAesar (Ward Hill,
MA, USA), and N-(1-naphthyl)ethylenediamine dihydrochloride from VWR (Radnor, PA, USA).
Standard phenolics used for quantitative analysis were obtained from Extrasynthese. Folin-Ciocalteu
reagent, Na2CO3, formic acid, and ethanol were purchased from Panreac (Barcelona, Spain). n-Hexane,
methanol, and acetonitrile with high performance chromatography (HPLC) purity were purchased
from Lab-Scan (Lisbon, Portugal). Water was treated in a Direct-Q® water purification system
(Merck Life Science, Darmstadt, Germany). All reagents were of analytical grade or of the highest
available purity.
3.2. Plant Sampling and Preparation of Extracts
S. officinallis, S. elegans¸and S. greggii were purchased from Ervital (Viseu, Portugal) as a mixture
of flowers and leaves, and stems where were cultivated under an organic regime. After collection,
the aerial parts were dried in a ventilated incubator at 20 to 35 ◦C for 3 to 5 days.
Phenolic compounds were extracted by decoction according the method described by
Ferreira et al. [57], with adaptations. A volume of 100 mL of distilled water was added to 5 g of
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plant material (0.5 mm mesh powder) and the mixture was heated and then boiled for 15 min and
filtered under reduced pressure through a G3 sintered plate filters. The resulting filtrated solution
was concentrated in a rotary evaporator at 37 ◦C, followed by defatting with n-hexane (1:1 v/v). The
resulting fraction was frozen, freeze-dried, and kept under vacuum in a desiccator in the dark for
subsequent use [58].
3.3. Identification and Quantification of Phenolic Compounds
UHPLC-DAD-ESI/MSn analyses of phenolic profiles from S. officinalis, S. elegans, and S. greggii
decoctions (5 mg/mL) were carried out on an Ultimate 3000 (Dionex Co., San Jose, CA, USA) apparatus
equipped with an ultimate 3000 Diode Array Detector (Dionex Co., San Jose, CA„ USA) and coupled to
a Thermo LTQ XL mass spectrometer (Thermo Scientific, San Jose, CA, USA), an ion trap MS equipped
with an electrospray ionization (ESI) source, following a method previous described [58]. Control
and data acquisition were carried out with the Thermo Xcalibur Qual Browser data system (Thermo
Scientific, San Jose, CA, USA). Nitrogen above 99% purity was used, and the gas pressure was 520 kPa
(75 psi). The instrument was operated in negative-ion mode with the ESI needle voltage set at 5.00 kV
and an ESI capillary temperature of 275 ◦C. The full scan covered the mass range from m/z 100 to 2000.
CID–MS/MS and MSn experiments were simultaneously acquired for precursor ions using helium as
the collision gas with a collision energy of 25–35 arbitrary units.
Gradient elution was carried out with a mixture of two solvents. Solvent A consisted of 0.1%
(v/v) of formic acid in water, and solvent B consisted of acetonitrile, which was degassed and filtrated,
using a 0.2 µm Nylon filter (Whatman International, Ltd., Maidstone, England) before use. The solvent
gradient used consisted of a series of linear gradients starting from 5% of solvent B and increasing to
23% at 14.8 min, to 35% at 18 min, and to 100% at 21 min over three minutes, followed by a return to
the initial conditions.
For quantitative determinations, the parameters of calibration curves, obtained by injection of
known concentrations of the exact or structurally-related standard compounds, allowed the calculation
of the limits of detection (LOD) and quantification (LOQ) [58].
3.4. Antioxidant Activities
3.4.1. DPPH• Scavenging Assay
Extracts capacity for scavenging DPPH• were evaluated following the procedure previously
described by Catarino et al. [59]. Ascorbic acid was used as positive control. The concentration of the
extract/standard able to scavenge 50% of DPPH• (EC50) was determined using linear regression by
plotting the percentage of inhibition against the concentration of the extracts.
3.4.2. Ferric Reducing Antioxidant Power (FRAP) Assay
For the reducing power assay, five different concentrations of each extract were prepared
(0.05–0.25 mg/mL), and the assay was carried out according to a procedure described previously [59].
BHA was used as the positive control. A linear regression analysis was carried out by plotting the
mean absorbance against the concentrations, and the EC50 value was determined considering the
extract/standard concentration that provided 0.5 of absorbance.
3.4.3. Oxygen Radical Absorbance Capacity (ORAC) Assay
The ORAC assay was performed according to the method previously described by Catarino et al. [60].
In a 96-well plate, 150 µL of fluorescein (10 nM), diluted from the stock solution of 250 µM, with
75 mM phosphate buffer (pH 7.4) were placed together with 25 µL of different trolox concentrations
(3.13–25 µM). The same process was repeated for the extracts with final concentrations ranging between
0.4–6.3 µg/mL. For blanks, 25 µL of phosphate buffer was added instead of antioxidant solutions.
After 10 min incubation at 37 ◦C, 25 µL of 2,2′-azobisisobutyramidinium chloride (AAPH) (153 mM)
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solution was added to each well to reach a final reaction volume of 200 µL. The plate was immediately
placed in the plate reader (Biotek, Austria), and fluorescence was monitored every minute over 60 min.
The measurement was carried out at 37 ◦C with automatic agitation for 5 s prior to each reading.
Excitation was conducted at 485 nm with a 20 nm bandpass, and emission was measured at 528 nm
with a 20 nm bandpass. Six concentration-dependent kinetic curves were obtained for each sample
and for trolox as well. The area under the curve (AUC) of the fluorescence decay and Net AUC were
calculated according to the following equations (1–3):
AUC = 1 +
ti = 60 min
∑




Net AUC = AUC sample −AUC blank, (2)
where R0 is the fluorescence reading at the initiation of the reaction and Ri is the fluorescence reading at






where me is the slope of the curve of Net AUC vs. extract concentrations, and mT is the slope of
the curve of Net AUC vs. trolox concentrations. The final results were expressed in µM of trolox
equivalents (µM TE) per µg of sample extract.
3.4.4. NO• Scavenging Assay
The NO• scavenging method was adapted from Catarino et al. [60]. Briefly, 100 µL of six different
extract concentrations (0–1 mg/mL) were mixed with 100 µL of sodium nitroprusside (3.33 mM in
100 mM sodium phosphate buffer pH 7.4) and incubated for 15 min under a fluorescent lamp (Tryun
26 W). Afterwards, 100 µL of Griess reagent (0.5% sulphanilamide and 0.05% naphthyletylenediamine
dihydrochloride in 2.5% H3PO4) were added to the mixture, which was allowed to react for another
10 min in the dark. The absorbance was then measured at 562 nm, and the percentage of NO•
scavenging was calculated using the equation described by Yen and Der Duh [61] as follows:




where Ac is the absorbance of the control (without extract addition) and Ae is the absorbance of the
extract. Ascorbic acid was used as the reference compound. The concentration of the extract/standard
able to scavenge 50% of NO• (EC50) was then calculated by plotting the percentage of inhibition
against the extract concentrations.
3.4.5. Superoxide Anion (O2•–) Scavenging Assay
The O2•– scavenging method was carried out according to the method described by
Catarino et al. [60]. Briefly, in a 96-well plate, 75 µL of six different sample concentrations
(0.0–250 µg/mL) were mixed with 100 µL of β-NADH (300 µM), 75 µL of NBT (200 µM), and 50
µL of PMS (15 µM). After 5 min, the absorbances at 560 nm were recorded and the scavenging activity
of superoxide radicals was calculated according to Equation (4). Gallic acid was used as the reference
compound. The concentration of the extract/standard able to scavenge 50% of O2•– (EC50) was
determined using linear regression by plotting the percentage of inhibition against the concentration
of the extracts.
3.4.6. Inhibition of Xanthine Oxidase Activity
Inhibition of xanthine oxidase activity was carried out following the method described by
Filha et al. [62], with slight modifications. Briefly, in a 96-well plate, 40 µL of extract concentrations
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(0–2 mg/mL) were mixed with 45 µL of sodium dihydrogen phosphate buffer (100 mM, pH 7.5)
and 40 µL of enzyme (5 mU/mL). After 5 min incubation at 25 ◦C, the reaction was started with
the addition of 125 µL of xanthine (0.1 mM dissolved in buffer) and the absorbance at 295 nm was






where mc is the slope of the straight-line portion of the curve generated by the control (no inhibitor)
and me is the slope of the straight-line portion of the curve generated by each extract. Allopurinol was
used as a positive control of inhibition. The concentration of the extract/standard able to inhibit 50%
(EC50) of the activity of the enzyme was determined using linear regression by plotting the percentage
of inhibition against the concentration of the extracts.
3.5. Inhibition of Enzymatic Activities
3.5.1. Inhibition of α-Glucosidase Activity
Inhibition of α-glucosidase activity was measured following the method described by Neto et al. [63],
with slight modifications. In short, 50 µL of different extract concentrations (0–2 mg/mL, in 50 mM
phosphate buffer pH 6.8) were mixed with 50 µL of 6 mM 4-nitrophenyl α-D-glucopyranoside (pNPG),
dissolved in deionized water. The reaction was started with the addition of 100 µL of α-glucosidase
solution, and the absorbance was monitored at 405 nm every 60 s for 20 min at 37 ◦C. The inhibitory
effects towards α-glucosidase activity was calculated as in Equation (5). Acarbose was used as a
positive control of inhibition. The concentration of the extract/standard able to inhibit 50% (EC50)
of the activity of the enzyme was determined using linear regression by plotting the percentage of
inhibition against the concentration of the extracts.
3.5.2. Inhibition of α-Amylase Activity
Inhibition of α-amylase activity was measured according to Wickramaratne et al. [64], with slight
modifications. Briefly, 200 µL of extract six different extract concentrations (0–2 mg/mL) dissolved in
20 mM phosphate buffer (pH 6.9, containing 6 mM of NaCl) were added to 400 µL of a 0.8% (w/v)
starch solution in the same phosphate buffer, and the mixture was incubated for 5 min at 37 ◦C.
The reaction was then started with the addition of 200 µL of α-amylase solution, and after 5 min of
incubation, 200 µL of the reaction mixture was collected and immediately mixed with 600 µL of DNS
reagent (10 g/L of 3,5-dinitrosalicylic acid, 300 g/L of potassium and sodium tartrate tetrahydrate,
and 0.4 M NaOH) to stop the reaction. A second aliquot of 200 µL was further collected 15 min
later and mixed with DNS reagent as well. Samples were then boiled for 10 min, and, once they had
cooled, 250 µL were transferred to each well in a 96-well microplate for absorbance reading at 450 nm.
Blank readings (no enzyme) were then subtracted from each well and the inhibitory effects towards





where ∆Absc is the variation in the absorbance of the negative control and ∆Abse is the variation in
the absorbance of the extract. Acarbose was used as a positive control of inhibition.
3.5.3. Inhibition of Pancreatic Lipase Activity
The lipase activity was measured according to the procedure described by Neto et al. [63], with
slight modifications. The reaction mixture was prepared in a microtube by mixing 55 µL of five
different concentrations of extract (0–2 mg/mL) dissolved in tris buffer 100 mM (pH 7.0) with 467.5 µL
of tris-HCl (100 mM, pH 7.0, containing 5 mM of CaCl2) and 16.5 µL of enzyme. The reaction was
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started by adding 11 µL of 20 mM 4-nitrophenyl butyrate diluted in DMSO. Final DMSO concentration
in the reaction mixture did not exceed 2%. The reaction mixture was then quickly transferred to a
96-well plate and incubated for 35 min at 37 ◦C while the absorbance was being measured every 60 s
at 410 nm. The inhibitory effects towards pancreatic lipase activity was calculated as in Equation (5).
Orlistat was used as a positive control of inhibition.
3.6. Statistical Analysis
All data are presented as mean ± standard deviations from three independent assays performed
at least in duplicate. One-way analysis of variance (ANOVA) followed by Tukey´s test was used to
detect any significant differences among different means. Correlation analyses were performed using
a two-tailed Pearson’s correlation test. A p-value less than 0.05 was assumed as significant. The results
were analyzed using GraphPad Prism 6 (GraphPad Software, La Jolla, CA, USA) and SPSS v 23.0
(Statistical Package for the Social Sciences).
4. Conclusions
This work clarifies the antioxidant properties of S. elegans, S. greggii, and S. officinalis decoctions as
well as their inhibition towards the activity of carbohydrate and lipid metabolic enzymes, highlighting
possible correlations with their phenolic components. It was shown that among the three plants,
S. elegans decoctions were the most promising regarding antioxidant activity and inhibitory potential
against α-glucosidase, a fact that might be related to its richness in caffeic acid and its derivatives.
In turn, despite all the three decoctions of Salvia species could effectively inhibit the activity of xanthine
oxidase, one should highlight the superior inhibitory capacity of S. officinalis, which is possibly
associated with the presence of flavones. In conclusion, similarly to the well-known S. officinalis
species, S. elegans and S. greggii are a valuable source of natural metabolites and could be used for
commercial applications in novel functional foods or pharmaceutical ingredients targeting diabetes
and obesity prevention.
Supplementary Materials: Supplementary Materials can be found in a separate file: Figure S1: UV spectra of the
main peaks identified in S. elegans, S. greggii, and S. officinalis decoctions.
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Beneficios para la salud y perfil fitoquímico de decocciones de Salvia 
apiana y Salvia farinacea var. victoria blue 
Objetivos 
El presente estudio tiene como objetivo investigar los posibles efectos biológicos de las 
decocciones de S. apiana y S. farinacea var. victoria blue, relacionadas con sus 
actividades antioxidantes, antiinflamatorias, citotoxicidad y antibacterianas, asociando 
estos efectos con los compuestos fenólicos presentes en sus extractos. 
1. Introducción 
El estrés oxidativo surge cuando se rompe el equilibrio entre la formación de especies 
reactivas y su eliminación, produciéndose la acumulación de estos compuestos, que 
causan varios daños celulares. Esta situación está asociada con el envejecimiento y la 
aparición de diversas enfermedades, incluido el cáncer. En este contexto, se cree que 
los suplementos dietéticos con productos de origen vegetal ricos en fitoquímicos pueden 
contrarrestar los eventos relacionados con la oxidación, aportando beneficios para la 
salud [1,2].  
Salvia es el género mayor entre las plantas de la familia Lamiaceae, siendo conocidas 
por su riqueza en aceites esenciales y/o compuestos fenólicos [3,4]. Salvia apiana y 
Salvia farinacea var. victoria blue son dos plantas originarias de las regiones del 
suroeste de los Estados Unidos y México. La primera también se conoce como salvia 
blanca, es un arbusto ramificado con hojas blancas y plateadas, muy aromáticas y flores 
blancas o de color lavanda pálida. Salvia farinacea var. victoria blue es un arbusto 
perenne, con hojas de color verde, irregularmente aserradas, y contiene unas puntas de 
flores de color violeta-azul abundantes y compactas, de múltiples ramas, que se 
asemejan a la lavanda [5–7]. S. apiana se ha estudiado previamente con respecto a la 
composición de sus aceites esenciales y extractos, que tienen altas cantidades de 
terpenos y sus derivados [8,9]. Con respecto a la S. farinacea var. victoria blue, las 
propiedades químicas y biológicas de los extractos polares permanecen inexploradas.  
2. Métodos 
2.1. Plantas y extracción de compuestos fenólicos 
Las partes aéreas de las plantas S. apiana y S. farinacea var. victoria blue se cultivaron 
bajo un régimen orgánico, se cosecharon y se secaron durante 3 a 5 días. Los extractos 
fenólicos se han obtenido utilizando una decocción en la proporción 1:20. Seguidamente 
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las soluciones se filtraron, se concentraron, se evaporaron, se congelaron a -20°C y se 
liofilizaron. Se obtuvieron tres extractos acuosos de cada planta. 
2.2 Identificación y cuantificación de compuestos fenólicos  
Los extractos fueron caracterizados y cuantificados por cromatografía líquida de alta 
eficiencia, asociada a espectrometría de masas por electrospray en el modo de 
ionización negativo (UHPLC-DAD-ESI/ MSn).  
2.3 Pruebas de bioactividad 
2.3.1 Capacidad antioxidante  
La actividad antioxidante de los extractos acuosos de S. apiana y S. farinacea var. 
victoria blue se evaluó mediante cuatro ensayos químicos. Se hicieron las pruebas de 
radicales 2,2-difenil-1-picrilhidrazil (DPPH●) y del poder reductor por la reducción de 
hierro (III) [10], usando como estándar ácido ascórbico y hidroxianisol butilado (BHA), 
respectivamente. Se evaluó también la inhibición de la peroxidación de lípidos por la 
prueba del blanqueo del β-caroteno y la prueba de la disminución de las sustancias 
reactivas al ácido tiobarbitúrico (TBARS) [11], usando en ambos ensayos Trolox como 
control positivo. Los resultados se expresaron como valores de EC50 (concentración de 
la muestra que proporciona el 50% de la actividad antioxidante) en μg por ml de extracto. 
2.3.2 Capacidad anti-inflamatoria 
La actividad antiinflamatoria de los extractos de Salvia se determinó mediante un modelo 
celular, evaluando la inhibición de la producción de NO en líneas celulares de 
macrófagos RAW 264.7 después de la estimulación con LPS (lipopolisacárido) [12]. Los 
resultados se expresaron como EC50 (μg/mL), que corresponde a la concentración de la 
muestra que proporciona 50% de inhibición de la producción de NO. La dexametasona 
se utilizó como control positivo mientras que los controles negativos no tenían LPS.  
2.3.3 Citotoxicidad en células tumorales y no tumorales  
El efecto citotóxico de los extractos de S. apiana y S. farinacea var. victoria blue se 
llevaron a cabo mediante el ensayo de sulforodamina B (SRB) [12], en cuatro líneas 
celulares de tumores humanos MCF-7 (adenocarcinoma de mama), NCI-H460 (cáncer 
de células del pulmón), HeLa (carcinoma cervical) y HepG2 (carcinoma hepatocelular). 
Además, la citotoxicidad de los extractos de Salvia se analizó mediante un ensayo de 
hepatotoxicidad, en células primarias no tumorales de hígado de cerdo (PLP2). Los 
resultados de la citotoxicidad se expresaron como valores GI50 (μg/mL), 
correspondientes a la concentración de la muestra que inhibió el 50% del crecimiento 
celular. En estos experimentos, se utilizó elipticina como control positivo. 
2.3.4 Capacidad anti-bacteriana 
El potencial antibacteriano de los extractos polares de las dos plantas de Salvia se 





Staphylococcus epidermidis y Staphylococcus aureus, y tres Gram negativas (Gram-) 
Salmonella typhimurium, Escherichia coli y Pseudomonas aeruginosa, por el método de 
microdilución en el medio, calculándose la concentración inhibitoria mínima (CIM) y la 
concentración bactericida mínima (CBM). La nisina se utilizó como control positivo. 
3. Resultados y discusión 
3.1. Actividad antioxidante 
En general, la decocción de S. apiana presentó una capacidad antioxidante superior a 
la de S. farinacea var. victoria blue, una tendencia que fue particularmente evidente con 
respecto a los eventos de peroxidación lipídica (Tabla 1), con valores de EC50 alrededor 
de ocho veces menor o igual que el estándar comercial, en los ensayos de blanqueo del 
β-caroteno y TBARS, respectivamente. A pesar de ser menos activa, S. farinacea var. 
victoria blue también se puede considerar como un agente antioxidante prometedor, ya 
que los valores de EC50 en todas las pruebas fueron solo 1.8-3.7 veces mayores que los 
de los compuestos estándar. 
Tabla 1 – Actividad antioxidante (EC50, μg/mL) de decoctions de S. apiana y S. farinacea var. victoria blue  
Prueba S. apiana 
S. farinacea var. 
victoria blue 
Estándar 
AA BHA Trolox  
DPPH• 13.3±1.1a 17.4±5.5a 6.7±0.7b   
Poder Reductor 55.0±5.6a 59.9±3.6a  16.1±2.0b  
TBARS  2.79±0.1a 42.2±0.6b   23.0±1.0c 
β-carotene bleaching inhibition 41.2±1.6a 153.5±2.2b   41.7±0.3a 
AA – Ácido ascórbico; BHA - hidroxianisol butilado; DPPH• - 2,2-difenil-1-picrilhidrazil; TBARS - sustancias reactivas al 
ácido tiobarbitúrico. Valores medios ± SD. El análisis estadístico se realizó mediante ANOVA de una vía, seguido de la 
prueba de Tukey. En cada fila, letras diferentes significan diferencias estadísticas significativas (p <0.05). 
Las capacidades antioxidantes de los extractos polares de S. apiana y S. farinacea var. 
victoria blue no han sido explorados anteriormente. Sin embargo, las prometedoras 
habilidades descritas en este estudio para estas decocciones están de acuerdo o 
incluso, y en particular en el caso de S. apiana, han excedido las descritas anteriormente 
para plantas de salvia [13–15]. 
3.2. Actividad antiinflamatoria 
Se ha descrito que el óxido nítrico producido en altas concentraciones por los 
macrófagos está involucrado en la inflamación y los compuestos dirigidos a su 
producción se consideran buenos candidatos para atenuar las enfermedades 
relacionadas con la inflamación [16]. La potencia de las decocciones de S. apiana y S. 
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farinacea var. victoria blue para contrarrestar la producción de NO● por macrófagos 
RAW 264.7 activados por LPS, se muestra en la Tabla 2. Ambos extractos fueron 
efectivos, y particularmente el de S. apiana fue bastante prometedor, ya que su potencia 
(EC50=49.9 μg/mL) equivalía a aproximadamente un tercio de la de dexametasona 
(EC50=16.0 μg/mL). 
Tabla 2 – Actividad antiinflamatoria (EC50, μg/mL) y efecto citotóxico (GI50, μg/mL) de extractos 
acuosos de S. apiana y S. farinacea var. victoria blue  
 S. apiana 
S. farinacea var. 
victoria blue 
Estándar 
Actividad antiinflamatoria   Dexametasona 
NO● production 49.9±2.5a 80.8±0.4b 16.0±1.0 c 
Citotoxicidad hacía células tumorales   Elipticina 
HepG2 (carcinoma hepatocelular) 40.9±3.3a 87.4±5.4b 1.0±0.2c 
HeLa (carcinoma cervical) 57.3±5.1a 77.8±3.5b 2.0±0.1c 
MCF-7 (adenocarcinoma de mama) 60.2±4.2a 59.8±0.1a 1.00±0.04b 
NCI-H460 (cáncer de células del pulmón) 245.7±6.3a 279.5±10.1b 1.0±0.1c 
Citotoxicidad hacía células no tumorales    
Inhibición de PLP2 361.7±5.3a 335.4±8.0b 3.0±1.0c 
Los medios seguidos por las mismas letras en cada fila no difieren según la prueba estadística de Tukey (p < 0.05) 
 
Además, su actividad fue superior a la descrita anteriormente para extractos polares de 
Salvia miltiorrhiza [17] y Salvia plebeia [18] (EC50 de 200 y ≥1000 μg/mL, 
respectivamente), aunque los autores no establecieron ninguna relación entre los 
efectos antiinflamatorios y los posibles compuestos involucrados. 
3.3 Efecto citotóxico en células tumorales y no tumorales  
Las plantas medicinales, incluidas las especies de Salvia, se han estudiado 
ampliamente como fuentes potenciales de agentes quimioterapéuticos para el cáncer, 
particularmente en modelos celulares in vitro [19,20]. En general, las decocciones S. 
apiana y S. farinacea var. victoria blue presentaron efecto citotóxico hacía células 
tumorales, en particular células del adenocarcinoma de mama MCF-7, carcinoma 
cervical HeLa y carcinoma hepatocelular HepG2 (Tabla 2). Entre los dos extractos, S. 
apiana exhibió más citotoxicidad que la de S. farinacea var. victoria blue, un hecho que 
quedó claro en las células HepG2 (GI50 de 40.9 vs 87.4 μg/mL, respectivamente) y HeLa 





encontraron un elevado efecto citotóxico de los extractos metanólicos de S. apiana 
contra células de leucemia sensibles y resistentes a múltiples fármacos (valores GI50 de 
7.17±0.67 y 9.91±0.80 μg/mL, respectivamente). Además, aunque nuestros resultados 
no pueden compararse directamente con los publicados anteriormente para otras 
plantas, debido a las diferencias en las metodologías y los estándares empleados, 
apoyan el concepto de que los extractos polares de plantas de Salvia pueden actuar 
como agentes citotóxicos. De hecho, otros autores han descrito previamente los efectos 
citotóxicos para extractos polares de otras especies de Salvia, a saber, Salvia 
eremophila, que fue efectiva contra células del carcinoma de mama MCF-7 [19], o raíces 
de S. miltiorrhiza y Salvia officinalis [20] con actividad citotóxica frente a células de 
carcinoma hepatocelular HepG2, que presentaron en general buenos valores de GI50 
(rango 17 y 83 µg/ml). 
Además, nuestros resultados también indicaron que las decocciones de S. apiana y S. 
farinacea var. victoria blue tienem capacidad de discriminar las células tumorales, lo que 
es esencial para minimizar los efectos citotóxicos en las células normales, como se 
refleja en valores de GI50 bajos en las líneas celulares de cáncer en comparación con 
los de las células PLP2 (GI50 = 361.7 y 335.4 μg/mL, respectivamente). 
3.4. Actividad antibacteriana 
Las potencialidades de compuestos de plantas, incluyendo Salvias, como agentes 
antimicrobianos, evidencian sus aplicaciones potenciales en la conservación de 
alimentos en la industria alimentaria, así como en el desarrollo de nuevos fármacos para 
el tratamiento de enfermedades infecciosas [7,22].  
Tabla 3 – CIM (mg/mL) y CBM (mg/mL) de extractos de S. apiana y S. farinacea var. victoria 
blue y nisina (mg/mL) hacía bacterias seleccionadas 
 
CIM - concentración inhibitoria mínima; CBM - concentración bactericida mínima 
 
Bacteria 
S. apiana S. farinacea var. victoria blue Nisina 
CBM CIM CBM CIM CBM CIM 
Gram+       
S. epidermidis 0.69 0.34 8.50 8.50 <0.63 <0.63 
S. aureus 0.69 0.69 2.12 1.06 <0.63 <0.63 
Gram-       
S. tyiphimurium 2.75 2.75 >8.5 >8.5 0.5 0.5 
E. coli 2.75 2.75 8.5 8.5 1.0 0.5 
P. aeruginosa 2.75 2.75 >8.5 >8.5 1.0 1.0 
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El potencial antibacteriano de las dos decocciones de Salvia hacia las cinco bacterias 
se resume en la Tabla 3. En general, S. apiana mostró que tenía propiedades 
antibacterianas prometedoras, con capacidad inhibitoria y letal en concentraciones 
iguales o inferiores a 0.69 mg/ml (para S. aureus y S. epidermidis) y de 2.75 mg/ml (para 
el S. typhimurium, E. coli y P. aeruginosa), que correspondían a solo 3 a 5 veces menos 
que la nisina.  
De una manera diferente, S. farinacea var. victoria blue mostró un efecto antibacteriano 
relevante contra la bacteria Gram+ S. aureus (MIC y MBC de 1.06 y 2.12 mg/ml, 
respectivamente), aunque se requería una mayor concentración (CMI y MBC de 8.5 
mg/ml) para tener un efecto bactericida contra S. epidermidis y E. coli. 
Además, esta planta no mostró ninguna actividad inhibitoria o letal contra las bacterias 
Gram- S. typhimurium y P. aeruginosa. Poco se sabe sobre los efectos antibacterianos 
de estas especies de Salvia, aunque existen resultados prometedores en otras 
especies, en algunos casos asociados con su riqueza en compuestos fenólicos. Por 
ejemplo, Salvia bicolor mostró actividad poderosa contra bacterias Gram+ y Gram- 
(valores de CIM en el rango de 0,2 a 1 mg/mL), cuyo efecto antibacteriano fue asociado 
a su riqueza en compuestos, que eran en su mayoría ácidos gálico, p-cumárico y 
protocatecúico, y flavonoides (por ejemplo, luteolina-7-O-glucósido) [23].  
3.5. Caracterización de los extractos 
Los niveles de compuestos fenólicos en las decocciones de Salvia fueron 
significativamente diferentes, con valores aproximadamente seis veces más elevados 
en S. apiana que en S. farinacea var. victoria blue (Tabla 4). Además de su riqueza en 
ácido rosmarínico (56.8 y 17.8 mg/g de extracto, respectivamente), como es habitual en 
los extractos polares de plantas de Salvia, los dos extractos difirieron con respecto a 
sus constituyentes fenólicos, así como a los descritos previamente para la decocciones 
de Salvia elegans, Salvia greggii y Salvia officinalis [24]. De hecho, la decocción de S. 
apiana se caracterizó por su riqueza en derivados de terpenos, que estaban 
representados principalmente por el rosmanol, un derivado de sageone y ácido 
hidroxicarnosico, con niveles estimados de 192.4, 174.1 y 69,7 mg/g de extracto, 
respectivamente (Tabla 4). S. apiana también contenía otros compuestos menos 
abundantes, como carnosol, ácido carnósico y algunos flavonoides (hesperidina, 
quercetina-O-hexósido y cirsimaritina). Estos resultados están de acuerdo con los 
publicados previamente [9,25,26], permitiendo concluir que los extractos polares de S. 
apiana son particularmente ricos en terpenos fenólicos. 
Aunque menos ricos en compuestos fenólicos, además del ácido rosmarínico, la 





comunes a las plantas de Salvia [27–29], como la apigenina-O-hexósido (fracción 28, 
16.7 mg/g de extracto) y la luteolina-O-glucurónido (fracción 24, 15.8 mg/g de extracto). 
Tabla 4 – Identificación y cuantificación de los compuestos identificados en las decocciones de 
S. apiana y S. farinacea var. victoria blue por UHPLC-DAD-ESI-MSn. 
Fr TR UV max [M-H]- Compuesto probable S. apiana* 
S. farinacea var. 
victoria blue* 
1 1.5 275 149 Ácido dimetil benzoico - 5.9±0.1 
2 1.7 205 191 Ácido quinico 5.0±0.3 0.40±0.01 
3 3.6 280 197 Danshensu D D 
4 4.4 261, 289 153 Ácido protocatechuico D - 
5 5.1 290, 324 353 cis 3-O- Ácido cafeioilquinico D - 
6 5.4 294, 322 353 trans 3-O- Ácido cafeioilquinico - D 
7 7.9 309 337 Ácido cumarico quinico D 0.30±0.03 
8 8.3 313 295 p- Ácido cumarico pentosido 0.40±0.04 - 
9 8.8 290, 325 353 trans 5-O- Ácido cafeioilquinico - 0.60±0.03 
10 9.5 290, 325 353 4-O- Ácido cafeiiloquinico 5.5±0.1 - 
11 9.7 290, 323 179 Ácido cafeico - 0.8±0.0 
12 9.8 314 325 Ácido cumarico hexósido - 0.3±0.0 
13 11.8 311 337 Ácido cumarico quinico D 0.2±0.0 
14 12.8 287, 324 367 Ácido feruloil quínico - D 
15 13.0 309 225 Derivado del ácido cumaroico 1.8±0.1 - 
16 13.1 291, 311 637 Derivado del ácido ferúlico - 0.5±0.0 




447 Luteolina-C-hexósido - 3.20±0.02 
19 14.7 274 571 Ácido yunnanico E (isómero 1) - 4.5±0.2 
20 15.0 235, 277 539 Ácido yunnanico D / isómero - 3.9±0.3 
21 15.2 268, 336 431 Apigenina-C-hexósido - 5.9±0.6 
22 15.6 285, 315 555 Ácido salvianólico K - D 
23 15.8 255, 350 
463 Quercetina-O-hexósido 14.6±0.3 - 




461 Luteolina-7-O-glucurónido - 15.8±0.02 
25 16.5 274 571 Ácido yunnanico E (isómero 2) - 1.00±0.08 




27 17.9 283 719 Ácido sagerinico (isómero1) D 2.10±0.08 
28 18.1 269, 329 431 Apigenina-O-hexósido - 16.7±0.05 
29 18.3 238, 341 607 Crioseriol-O-rutinósido D - 




717 Ácido salvianólico B (isómero 1) - D 




359 Ácido rosmarínico 56.8±0.6 17.8±0.1 
34 19.5 285, 305 537 Ácido rosmarinico cafeico (isómero 1) - 1.0±0.04 
35 19.8 278 719 Ácido sagerinico (isómero 2) - 2.2±0.02 
36 20.2 290, 333 537 
Ácido rosmarinico cafeico/ Ácido 
salvianólico I (isómero 2) 
D - 
37 20.6 267, 336 517 Apigenina malonil hexóxido - 2.50±0.03 
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38 21.5 287, 320 373 Rosmarinato de metilo - 0.60±0.02 
39 21.8 290 491 Derivado del ácido cumárico 0.50±0.01 - 




361 Derivado de sageone 174.1±14.1 - 








347 Ácido hidroxicarnosico 69.7±11.2 - 
45 25.7 286 329 Carnosol 17.3±0.7 - 
46 26.3 262 331 Ácido carnósico 14.3±0.7 - 
47 26.4 277 301 Tetrahidrohidroxi rosmariquinona 17.4±0.2 - 
    Total 643.3±18.9 102.1±0.7 
* Valores expresados en mg/g de extracto; D: Detectado; Fr. Fracción; TR: tiempo de retención 
Esto estudio sugiere que la alta bioactividad de las decocciones de S. apiana se asocia 
con su abundancia en componentes fenólicos, como los flavonoides y los derivados  
terpenicos, como se había descrito anteriormente en diferentes especies de Salvia 
[3,30,31]. Algunos de estos compuestos ejercen varias propiedades biológicas, incluida 




El presente estudio demostró que las decocciones de S. apiana y S. farinacea var. 
victoria blue tienen propiedades antioxidantes, antiinflamatorias, citotóxicas y 
antibacterianas, que son fuertemente prometedores en la primera planta. Así, S. apiana 
mostró capacidad para contrarrestar eventos clave en el estrés oxidativo, y suprimió la 
actividad de células inflamatorias. Además, las acciones de esta decocción fueron 
selectiva para las celulas tumorales, exhibiendo capacidad citotóxica en líneas celulares 
de cáncer con bajo efecto citotóxico en células normales. Por otra parte, también ejerció 
un potencial inhibitorio y letal contra cinco especies bacterianas. Posiblemente, el gran 
potencial bioactivo de esta decocción puede estar parcialmente asociado con sus altos 
niveles en compuestos fenólicos (643.3 μg/mg), particularmente en compuestos 
terpenoides. Aunque también con potencial interés, la bioactividad de S. farinacea var. 
victoria blue fue en general significativamente más baja que la de S. apiana, y también 
contenía niveles modestos de compuestos fenólicos (102.1 µg/mg). La excelente 
actividad in vitro antioxidante de la especie de S. apiana, junto con sus buenos efectos 
antiinflamatorios, de citotoxicidad y antibacterianos, la hace especialmente interesante 
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 15 
Abstract: Salvia apiana and Salvia farinacea var. victoria blue decoctions were screened for diverse 16 
bioactivities, including the ability to counteract oxidative and inflammatory events, as well as to act 17 
as cytotoxic and antimicrobial agents. Regardless both extracts showed good activities, that of S. 18 
apiana origin was particularly effective regarding the ability to prevent lipid peroxidation and to 19 
prevent nitric oxide (NO●) production in LPS-activated RAW 264.7 macrophages (EC50=50 μg/mL). 20 
Moreover, it displayed high cytotoxic capacity against hepatocellular carcinoma HepG2, cervical 21 
carcinoma HeLa and breast carcinoma cells MCF-7 but comparatively low effects in porcine liver 22 
primary cells, which highlights its selectivity (GI50= 41-60 μg/mL vs 362 μg/mL, respectively). As well, 23 
it exhibited inhibitory and lethal potential against a panel of Gram-positive and Gram-negative 24 
bacteria. Possibly, the bioactive properties of the two Salvia extracts are partially associated to their 25 
phenolic components, and in the particular case of S. apiana, to its richness in phenolic terpenes, 26 
particularly in rosmanol, hydroxycarnosic acid and a derivative of sageone, which were found in the 27 
extract.  28 
Keywords: Sage, bioactivity, antioxidant, anti-inflammatory, cytotoxicity, antibacterial, phenolic 29 
compounds, terpenes. 30 
 31 
1. Introduction 32 
In normal physiological conditions, cells maintain a redox homeostasis, i.e., the balance between 33 
reactive species formation and their elimination. Still, when equilibrium is disrupted, oxidative stress 34 
is settled and the overproduction of reactive species causes several mitochondrial and cellular 35 
damages, namely in lipids, proteins, DNA and other macromolecules. Ultimately, these events are 36 
known to be associated with aging and the onset and/or development of distinct diseases, including 37 
cancer [1,2]. In this context, diet supplementation with plant-based products rich in phytochemicals 38 
are believed to counteract oxidative-related events, thus contributing to human health [1,3,4]. 39 
Salvia is the largest genus in the Lamiaceae family plants, with over 900 species [5], being claimed 40 
for their richness in essential oils and/or phenolic compounds [6–9], a fact that is closely associated 41 
to their usage in traditional medicine and potential applications in distinct industries, including food, 42 
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pharmaceutical and cosmetics [4,10]. Salvia farinacea var. victoria blue and Salvia apiana are two edible 43 
Salvia plants native to southwestern regions of the USA and Mexico. The first is a perennial shrub 44 
typically growing 45-90 cm, whose gray-green leaves are drooping, irregularly-serrate, ovate-45 
lanceolate and it contains a compact multi-branched rich violet-blue flowers spikes, resembling 46 
lavender [11–13]. In turn, S. apiana, also known as white sage, is a branched shrub growing up to 1.5 47 
m, with silvery white petiolate leaves highly aromatic, and white to pale lavender flowers [14,15].  48 
Although low exploited, S. apiana has been previously studied regarding its essential oils 49 
composition, which are known to contain high amounts of terpenes and terpene derivatives, 50 
particularly β-pinene, α-pinene, borneol, 1,8-cineole, campholenic acid and β-caryophyllene [13,16]. 51 
Moreover, phytochemical analysis of hydroethanolic or acetone extracts of this species have allowed 52 
the identification of distinct diterpenes and triterpenes, and the flavonoids cirsimaritin and 53 
salvigenin [17,18]. Still, as far as we know, the biological properties of polar extracts from S. apiana 54 
aerial parts were limited to screen of the cannabinoid or opioid receptors activity of an ethanolic 55 
extract [17] and the potential cytotoxicity against leukemia cell lines of a methanolic extract [19]. As 56 
regard to S. farinacea var. victoria blue, both chemical and biological properties of polar extracts remain 57 
unexplored. Hence, the present study aimed to investigate potential biological effects of S. apiana and 58 
S. farinacea var. victoria blue, having in mind the traditional usage of Salvia species, which are used for 59 
centuries in form of infusions and decoctions. The antioxidant, anti-inflammatory, cytotoxicity and 60 
antibacterial potencies of decoctions will be associated with their specific phenolic components.   61 
2. Materials and Methods  62 
2.1. Chemicals 63 
 Rosmarinic acid and the 7-O-glucoside derivatives of apigenin, luteolin, eriodyctiol, quinic acid, 64 
caffeic acid, 5-O-caffeoylquinic acid, 4-O-hydroxybenzoic acid, salvianolic acid B, caffeic acid, ferulic 65 
acid and 4-O-coumaric acid were obtained from Extrasynthese (Genay Cedex, France). Trolox, 66 
sulforhodamine B (SRB), DPPH (2,2-diphenyl-2-picrylhydrazyl) radical, acetic acid, ellipticine, 67 
trypan blue, trichloroacetic acid (TCA), Tris, lipopolysaccharide (LPS), carnosol, nisin, ascorbic acid 68 
and butylated hydroxyanisole (BHA) were obtained from Sigma Chemical Co (St Louis, MO, USA). 69 
Fetal bovine serum (FBS), L-glutamine, trypsin-EDTA (ethylenediaminetetraacetic acid), 70 
penicillin/streptomycin solution (100 U/mL and 100 mg/mL, respectively), RPMI-1640 and DMEM 71 
media were from Hyclone (Logan, Utah, USA). The Griess reagent system was purchased from 72 
Promega Corporation (Madison, WI, USA). Mueller-Hinton agar was from VWR (Prolabo Chemicals, 73 
USA); formic acid and ethanol was from Panreac (Barcelona, Spain). n-Hexane, methanol and 74 
acetonitrile were purchased from Lab-Scan (Lisbon, Portugal). Purified water was obtained from a 75 
Direct-Q® water purification system (Merck Life Science, Germany).  76 
2.2. Plant material 77 
The S. apiana and S. farinacea var. victoria blue species were collected from the fields of Coimbra 78 
College of Agriculture, Portugal, GPS coordinates 40.211439, -8.451251. After collection, its aerial 79 
parts were dried in a ventilated incubator at 35ºC for 3 days and kept in dark room until use.  80 
2.3 Preparation of extracts 81 
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Extraction of the phenolic compounds was performed by decoction, following a method 82 
previously described [20], with slight changes. Briefly, the aerial parts (flowers, leaves and stems) of 83 
sage plants were boiled for 15 minutes (5 g of plant in 100 mL of water), filtrated and concentrated to 84 
about half of the volume in a rotary evaporator, to reduce the amount of water, followed by defatting 85 
with n-hexane (1:1 v/v). Traces of n-hexane in the aqueous phase were eliminated by rotary 86 
evaporation before freeze-drying. The resulting extract was kept under vacuum in a desiccator in the 87 
dark and a stock water solution (10 mg/mL) was prepared just before the analysis.  88 
2.4. Identification and quantification of phenolic compounds  89 
UHPLC-DAD-ESI/MSn analyses of phenolic profiles from the two decoctions (5 mg/mL) were 90 
carried out on an Ultimate 3000 (Dionex Co., San Jose, CA, USA) apparatus equipped with an 91 
ultimate 3000 Diode Array Detector (Dionex Co., San Jose, CA, USA) and coupled to a Thermo LTQ 92 
XL mass spectrometer (Thermo Scientific, San Jose, CA, USA), an ion trap MS equipped with an 93 
electrospray ionization (ESI) source, following a method previous described [21]. Gradient elution 94 
was carried out with a mixture of 0.1% (v/v) of formic acid in water (solvent A) and acetonitrile 95 
(solvent B). The solvent gradient used consisted of a series of linear gradients starting from 5% of 96 
solvent B and increasing to 23% at 14.8 min, to 35% at 18 min, and to 100% at 21 min over three 97 
minutes, followed by a return to the initial conditions. The mass spectrometer used was a Thermo  98 
Xcalibur Qual Browser (Thermo Scientific, USA) and the operations were carried out using the 99 
conditions previously described [22]. Quantification was performed by the external standard method 100 
using the calibration curves of structurally-related standard compounds. Considering the nature of 101 
the phenolic compounds, their quantification was performed at 280, 320 or 340 nm, also considering 102 
the detection and quantification limits (LOD and LOQ, respectively). LOD and LOQ were determined 103 
from the parameters of the calibration curves, being defined as 3.3 and 10 times the value of the 104 
regression error divided by the slope, respectively [21]. 105 
2.5. Antioxidant activity 106 
2.5.1. DPPH● scavenging test 107 
The extracts capacity for scavenging DPPH• was evaluated following the procedure previously 108 
described by Catarino et al. [23]. Ascorbic acid was used as positive control and the results were 109 
expressed as EC50 values (sample concentration providing 50% of antioxidant activity). 110 
2.5.2. Ferric reducing power assay 111 
The ability of the two sage extracts to reduce iron (III) to iron (II) was carried out according to a 112 
procedure described before [23], on which the antioxidant compounds from the extracts form a 113 
colored complex with potassium ferricyanide, trichloroacetic acid and ferric chloride, measurable at 114 
700 nm. BHA (2,6-di-tert-butyl-4-methylphenol) was used as positive control and the results were 115 
expressed as EC50 values. 116 
2.5.3. Thiobarbituric acid reactive substances (TBARS) 117 
The decrease in thiobarbituric acid reactive substances (TBARS) was evaluated by the inhibition 118 
of lipid peroxidation in porcine (Sus scrofa) brain homogenates, according to a procedure described 119 
by Martins et al. [24]. The color intensity of the malondialdehyde-thiobarbituric acid (MDA-TBA) 120 
Antioxidants 2019, 8, x FOR PEER REVIEW 4 of 16 
was measured as its absorbance at 532 nm; the inhibition ratio (%) was calculated using the following 121 
equation: [(A−B) / A] × 100%, where A and B were the absorbance of the control and the sample 122 
solutions, respectively. Trolox was used as positive control and the results were expressed as EC50 123 
values.  124 
2.5.4. β-Carotene bleaching assay 125 
 β-carotene linoleate general assay was performed as described by Barros et al. [25]. Trolox was 126 
used as positive control and the results were expressed as EC50 values.  127 
2.6. Anti-inflammatory activity 128 
The extracts ability in scavenging the NO radical was evaluated in the mouse macrophage-like 129 
cell line RAW 264.7 following the general procedure previously described [26]. Cells were treated 130 
under 5% CO 2 in humidified air, using DMEM culture medium enriched with 10% heat inactivated 131 
fetal bovine serum, glutamine and antibiotics at 37 ºC. For the tests, cells were seeded in 96-well plates 132 
(150,000 cells/well) and allowed do attach to the plate overnight. Then, these were treated with extract 133 
solutions (concentration of 25 and 100 μg/mL, for each extract) for 1 h, followed by the stimulation 134 
with LPS (1 μg/mL) for 18 h. The effect of all the tested samples in the absence of LPS was also 135 
evaluated, in order to observe if they induced changes in nitric oxide (NO●) basal levels. 136 
Dexamethasone (50 μM) was used as a positive control while negative controls had no added LPS. 137 
The NO levels produced were determined by the Griess reaction, used for measuring the nitrite 138 
accumulation in the culture supernatant on macrophage cell line RAW 264.7 [26]. The anti-139 
inflammatory activity of each extract was determined by calculating EC50 values (μg/mL), which 140 
corresponds to the sample concentration that provides 50% inhibition of NO production. 141 
2.7. Cytotoxic effect in four human tumor cell lines 142 
The cytotoxic effect of S. apiana and S. farinacea var. victoria blue extracts towards four human 143 
tumor cell lines were carried out by the sulforhodamine B (SRB) assay, using the conditions 144 
established by Souza et al. [26]. The tumor cell lines MCF-7 (breast adenocarcinoma), NCI-H460 (non-145 
small cell lung cancer), HeLa (cervical carcinoma) and HepG2 (hepatocellular carcinoma), were 146 
maintained in enriched medium, at 37 °C, in a humidified air incubator containing 5% CO2. Each cell 147 
line was plated at an appropriate density (7.5 × 103 cells/well for MCF-7 and NCI-H460 or 1.0 × 104 148 
cells/well for HeLa and HepG2) in 96-well plates. The cytotoxicity results were expressed as GI50 149 
values (μg/mL), corresponding to sample concentration that inhibited 50% of the cell growth. 150 
Ellipticine was used as positive control. 151 
2.8. Cytotoxic effect in non-tumor liver cells 152 
The cytotoxicity of the sage extracts were tested by hepatotoxicity assay, in a primary non-tumor 153 
cell culture obtained from porcine liver (PLP2) following the described procedures [26]. For the tests, 154 
cells were seeded (at 1.0 × 104 cells/well) in enriched medium. Results were expressed as GI50 values 155 
(μg/mL) and ellipticine was used as a positive control. 156 
2.9. Antimicrobial activity 157 
The antibacterial potential of the S. apiana and S. farinacea var. victoria blue species was evaluated 158 
against five bacterial strains, including Gram-positive bacteria (Staphylococcus epidermidis NCTC 159 
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11047 and Staphylococcus aureus NCTC 6571) and Gram-negative bacteria (Salmonella typhimurium 160 
NCTC 12023, Escherichia coli NCTC 9001, and Pseudomonas aeruginosa NCTC 10662) from the National 161 
Collection of Type Cultures, operated by Public Health England. All strains were cultured in Mueller-162 
Hinton agar and incubated at 37 °C for 24 h. The minimum inhibitory concentration (MIC) and 163 
minimum bactericidal concentration (MBC) of aqueous solutions of both Salvia species were 164 
determined by the broth microdilution method using an adapted method previous described by 165 
Afonso et al [21]. MIC is defined as the lowest concentration at which visible growth is inhibit, while 166 
MBC is the lowest concentration of the tested substance which has a bactericidal effect. Briefly, 167 
bacterial suspensions were prepared by direct colony suspensions and a final inoculum of 1.5 × 105 168 
CFU/mL was required for final suspensions that was diluted in a 1:100 ratio in Mueller-Hinton broth. 169 
One hundred microliters of this medium was dispensed into wells of 96-well micro titer plates and 170 
S. apiana and S. farinacea var. victoria blue decoctions were added and serially diluted four times across 171 
the plate. One hundred microliters of bacteria suspension was finally added to each well and the 172 
plates were incubated at 37 °C for 24 h. The assay for each pathogen was repeated three times [27]. 173 
MBC values are determined by sub-culturing from each negative well onto Mueller-Hinton agar and 174 
confirmation the lowest concentration with no visible growth [28]. Nisin was used as the positive 175 
control.  176 
2.10. Statistical analysis 177 
The results were analyzed using GraphPad Prism 6 (GraphPad Software, CA, USA). Data were 178 
expressed as mean ± S.D. of 3-4 independent experiments performed at least in triplicate. One-way 179 
analysis of variance (ANOVA) followed by Tukey´s test was used to detect any significant differences 180 
among different means. The p-value less than 0.05 were assumed as significant difference.  181 
3. Results and discussion 182 
3.1. Antioxidant activity 183 
Many plants, including Salvia species, have been evaluated for their claimed antioxidant 184 
capacities and/or ability to ameliorate oxidative-stress related disorders, being these properties 185 
commonly associated to the richness in phenolic compounds [4, 27]. 186 
 187 
Table 1 – Antioxidant activity (EC50, μg/mL) of S. apiana and S. farinacea var. victoria blue decoctions  188 
Assay S. apiana 
S. farinacea var. 
victoria blue 
Standard 
AA BHA Trolox  
DPPH• 13.3±1.1a 17.4±5.5a 6.7±0.7b   
Ferric Reducing Power 55.0±5.6a 59.9±3.6a  16.1±2.0b  
TBARS  2.79±0.1a 42.2±0.6b   23.0±1.0c 
β-carotene bleaching inhibition 41.2±1.6a 153.5±2.2b   41.7±0.3a 
AA - Ascorbic acid; BHA - butylated hydroxyanisole; DPPH - 2,2-diphenyl-1-picrylhydrazyl; TBARS - 189 
thiobarbituric acid reactive substances. Means followed by the same letters in rows do not differ by Tukey's test 190 
(p < 0.05). 191 
The antioxidant activity of Salvia decoctions was evaluated by four generalized methods, namely 192 
DPPH●, ferric reducing power assay, bleaching of β-carotene and TBARS. Globally, S. apiana 193 
decoction presented superior antioxidant capacity than that of S. farinacea var. victoria blue, a trend 194 
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that was particularly evident with respect to lipid peroxidation events (Table 1), with EC50 values 195 
obtained of about one-eight or the same magnitude of the commercial standard, in the TBARS and β-196 
carotene bleaching assays, respectively. Regardless of being less active, note that S. farinacea var. 197 
victoria blue extract may also be considered as a promising antioxidant agent, since EC50 values in all 198 
tests were only 1.8-3.7 fold those of the standard compounds.  199 
As far as we know, the antioxidant capacities of S. apiana and S. farinacea var. victoria blue polar 200 
extracts have not been exploited before. However, the promising abilities herein reported for 201 
decoctions agree and/or, in particular in the case of S. apiana, have exceeded those previously 202 
described for sage plants [7,6,28,29].  203 
3.2. Anti-inflammatory activity 204 
 Nitric oxide produced in high concentrations by macrophages has been reported to be involved 205 
in inflammation and compounds targeting its production are considered as good candidates for 206 
attenuating inflammatory-related diseases [30]. In our study, the potency of S. apiana and S. farinacea 207 
var. victoria blue extracts to counteract NO● production was evaluated in an LPS-activated RAW 264.7 208 
macrophage model. As shown in Table 2, both extracts were effective, and particularly that of S. 209 
apiana was quite promising as its potency corresponded to about one third of the drug 210 
dexamethasone (EC50=49.9±2.5 and 16.0±1.0, respectively). Moreover, their activity seems to be 211 
superior to that described by Ravipati et al. [31] and by Jang et al [32] for commercial aqueous extracts 212 
of Salvia miltiorrhiza (EC50=200 μg/mL) and for the 80% ethanolic extracts of aerial parts and of roots 213 
of Salvia plebeia (EC50 between 500-1000 and superior to 1000 μg/mL), albeit that the absence and/or 214 
the use of a different reference compound by the authors hamper more solid conclusions. In addition, 215 
no relationship was made by the authors between the anti-inflammatory effects and the possible 216 
compounds involved. 217 
Table 2 – Anti-inflammatory (EC50, μg/mL) and cytotoxicity properties (GI50, μg/mL) of S. apiana 218 
and S. farinacea var. victoria blue decoctions. 219 
 S. apiana S. farinacea var. victoria blue Standard 
Anti-inflammatory activity    Dexamethasone 
NO● production 49.9±2.5a 80.8±0.4b 16.0±1.0 c 
Cytotoxicity to tumor cell lines   Ellipticine 
HepG2 (hepatocellular carcinoma) 40.9±3.3a 87.4±5.4b 1.0±0.2c 
HeLa (cervical carcinoma) 57.3±5.1a 77.8±3.5b 2.0±0.1c 
MCF-7 (breast carcinoma) 60.2±4.2a 59.8±0.1a 1.0±0.04b 
NCI-H460 (non-small cell lung cancer) 245.7±6.3a 279.5±10.1b 1.0±0.1c 
Cytotoxicity to non-tumor cells    
PLP2 growth inhibition 361.7±5.3a 335.4±8.0b 3.0±1.0c 
Means followed by the same letters in rows do not differ by Tukey's test (p < 0.05). 220 
 221 
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3.3. Cytotoxic activity 222 
The effect of the two Salvia decoctions on the growth of tumor and non-tumor cell lines was 223 
evaluated by the sulforhodamine B (SRB) assay. In general, both Salvia extracts showed promising 224 
cytotoxic effects against tumoral cell lines, particularly hepatocellular carcinoma HepG2, cervical 225 
carcinoma HeLa and breast carcinoma cells MCF-7. Again, between the two extracts, S. apiana 226 
exhibited more cytotoxicity than that of S. farinacea var. victoria blue, a fact that was clear in HepG2 227 
cells (GI50 of 40.9±3.3 vs 87.4±5.4 μg/mL, respectively) and HeLa (GI50 of 57.3±5.1 vs 77.8±3.5 μg/mL, 228 
respectively). Note that these data seems to reinforce the results of Saeed et al. [19], who reported a 229 
high cytotoxic effect of S. apiana methanolic extracts against both sensitive and multidrug-resistant 230 
leukemia cells (GI50 values of 7.17±0.67 and 9.91±0.8 μg/mL, respectively), as assessed by the resazurin 231 
reduction assay. As well, although our results cannot be directly compared to those reported 232 
previously for other plants (due to the absence or use of different standards or methodologies), they 233 
generally reinforce the theory that polar extracts of sage plants may act as cytotoxic agents. In fact, 234 
other authors have previously highlighted cytotoxic effects for such extracts, e.g Salvia eremophila 235 
methanolic or hydromethanolic extracts, which were effective in breast cancer MCF-7 cell lines (GI50 236 
values of 47.7 and 75.2 μg/ml, respectively), with 7 to 11 - fold less potency of the drug cisplatin [33]. 237 
Using the MTS assay, Jiang et al. [34] also highlighted a high cytotoxicity capacity of ethanolic and 238 
acetone extracts from S. miltiorrhiza roots against HepG2 cell lines (GI50=17.3 and 83.2 μg/ml, 239 
respectively), as well as of Salvia officinalis roots and leaves (GI50=19.6-43.8 μg/ml and 64.4-90.0 μg/ml, 240 
respectively). 241 
Moreover, our results also indicated that the anti-proliferative activity of S. apiana and S. farinacea 242 
var. victoria blue decoctions were tumor-selective, as reflected by comparatively low GI50 values in the 243 
cancer cell lines compared to those of PLP2 cells (GI50=361.7 and 335.4 μg/mL, respectively). This 244 
ability to discriminate tumor cells is essential to minimize cytotoxic effects in normal cells, and has 245 
also been described for other Salvia polar extracts, including S. officinalis, which regardless being 246 
cytotoxic to MCF-7 cancer cells (GI50=142.4 μg/mL), showed no significant effects against normal 247 
human umbilical vein endothelial cell cells (IC50 values above 600 μg/mL) [19]. 248 
3.4. Antibacterial activity 249 
The antibacterial potential of the two Salvia decoctions towards the Gram-positive bacteria S. 250 
aureus and S. epidermidis and the Gram-negative bacteria S. typhimurium, E. coli and P. aeruginosa are 251 
summarized in Table 3. In general, S. apiana had promising antibacterial properties, with inhibitory 252 
and lethal capacity at concentrations equal or below to 0.69 mg/mL (for S. aureus and S. epidermidis) 253 
and of 2.75 mg/mL (for the S. typhimurium, E. coli and P. aeruginosa), which corresponded to only 3-5 254 
times less that of the drug nisin. This contrasted with S. farinacea var. victoria blue decoction, that only 255 
showed relevant antibacterial effect towards the Gram-positive bacteria S. aureus (MIC and MBC of 256 
1.06 and 2.12 mg/mL, respectively).  257 
As far as we know, the antibacterial effects of S. apiana and S. farinacea var. victoria blue polar 258 
extracts have not been previously exploited. Still Córdova-Guerrero et al. [35] has remarked the 259 
antimicrobial activity of a S. apiana hexane extract against Gram-positive bacteria, using the agar disc 260 
diffusion assay, for which they obtained an inhibition hale of S. aureus in the range of 10 to 24 mm at 261 
0.34 – 2.7 μg/μL. Unfortunately, as the authors did not present the MIC value, a direct comparison to 262 
our results is not possible. Nonetheless, other authors have previously described promising 263 
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antimicrobial effects of polar extracts of sage species. E.g., Ibrahim et al [36] described a powerful 264 
activity of Salvia bicolor methanolic extract against a distinct Gram-positive bacteria, especially on S. 265 
aureus and S. epidermidis (MIC values of 0.2 and 0.35 mg/mL, respectively) and Gram-negative 266 
bacteria (MIC values in the range 0.4 to 1 mg/mL) [36], a fact that the authors associated with its 267 
richness in phenolic compounds, which were mostly gallic, p-coumaric and protocatechuic acids, and 268 
flavonoids (e.g. luteolin-7-O-glucoside). Moreover, when screening the antimicrobial potential of 269 
hydromethanolic extracts of different Salvia species through the nutrient-broth microdilution assay, 270 
Firuzi et al. [33] reinforced that S. eremophila, Salvia limbata, Salvia santolinifolia and Salvia sclarea 271 
extracts were able to inhibit the growth of a panel of six microorganisms, with MIC values in the 272 
range of 0.31-5 mg/mL. 273 
Table 3 – MIC (mg/mL) and MBC (mg/mL) of extracts of S. apiana and S. farinacea var. victoria blue 274 
and nisin (mg/mL) against selected test bacteria. 275 
MIC: minimum inhibitory concentration; MBC: minimum bactericidal concentration. 276 
3.5. Characterization of the extracts  277 
Not surprisingly, the levels of phenolic compounds in Salvia decoctions were significantly 278 
different, with S. apiana being about six times richer than S. farinacea var. victoria (Table 4). Moreover, 279 
regardless of being rich in rosmarinic acid (56.8 and 17.8 mg/g extract, respectively) as in general for 280 
polar extracts from Salvia plants, the two extracts differed with regard to their phenolic constituents, 281 
as well as to those previously reported for Salvia elegans, Salvia greggii and S. officinalis decoctions [37]. 282 
Indeed, S. apiana decoction was characterized by its richness in terpenes derivatives (peaks 41 and 283 
43-47, in Figure 1 and Table 4), which were mainly represented by rosmanol ([M−H]− at m/z 345→ 284 
301, 271, 283), a derivative of sageone ([M−H]− at m/z 361) and hydroxycarnosic acid ([M−H]− at m/z 285 
347→ 303, 273), with estimated levels of 192.4±17.1, 174.1±14.1 and 69.7±11.2 mg/g extract, 286 
respectively, and other less abundant ones, including carnosol, carnosic acid and 287 
tetrahydrohydroxyrosmariquinone (peaks 45, 46 and 47, respectively), in addition to some flavonoids 288 
(hesperidin, quercetin-O-hexoside and cirsimaritin). These results strengthen those previously 289 
reported [17,18,38], allowing to conclude that polar extracts from S. apiana are particularly rich in 290 
phenolic terpenes. Note that, among the compounds herein detected in the decoction of S. apiana, 291 
rosmanol and hydroxycarnosic acid has been previously described in the acetone extracts [18], while 292 
carnosol, sageone and carnosic acid were reported in aqueous ethanolic and/or methanolic extracts 293 
Bacteria 
S. apiana S. farinacea var. victoria blue Nisin 
MBC MIC MBC MIC MBC MIC 
Gram-positive       
S. epidermidis 0.69 0.34 8.50 8.50 <0.63 <0.63 
S. aureus 0.69 0.69 2.12 1.06 <0.63 <0.63 
Gram-negative       
S. typhimurium 2.75 2.75 >8.5 >8.5 0.5 0.5 
E. coli 2.75 2.75 8.5 8.5 1.0 0.5 
P. aeruginosa 2.75 2.75 >8.5 >8.5 1.0 1.0 
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from the same plant [17,38]. In turn, the diterpenes rosmadial, 16-hydroxycarnosol, 16-294 
hydroxyrosmanol, salvicanol and the triterpenes oleanolic acid, uvaol and ursolic acid were found in 295 
S. apiana polar extracts by other authors [17,18].  296 
Although less rich in phenolic compounds, in addition to rosmarinic acid, S. farinacea var. victoria 297 
blue decoction presented moderate quantities of common flavones to the Salvia plants, namely 298 
apigenin-O-hexoside (peak 28, 16.7 mg/g extract) and luteolin-O-glucuronide (peak 24, 15.8 mg/g 299 
extract) [39–41].  300 
Table 4 – Identification and quantification of the compounds identified in S. apiana and S. farinacea 301 
var. victoria blue decoctions determined by UHPLC-DAD-ESI-MSn. 302 
NF Rt UV max [M-H]- 
MS2 Main fragments 




S. farinacea var. 
victoria blue* 
1 1.5 275 149 103, 87, 131, 59 DimethylBA - 5.9±0.1 
2 1.7 205 191 111, 173 Quinic Ac 5.0±0.3 0.4±0.01 
3 3.6 280 197 179, 73, 153 Danshensu D D 
4 4.4 261, 289 153 109 Protoc Ac D - 
5 5.1 290sh, 324 353 191, 179, 135 cis 3-O-CQA D - 
6 5.4 294sh, 322 353 191, 179, 135 trans 3-O-CQA - D 
7 7.9 309 337 163 Coum Quinic Ac D 0.3±0.03 
8 8.3 313 295 163 p-Coum Ac Pent 0.4±0.04 - 
9 8.8 290sh, 325 353 191 trans 5-O-CQA - 0.6±0.03 
10 9.5 290sh, 325 353 173, 179, 191 4-O-CQA 5.5±0.1 - 
11 9.7 290sh, 323 179 135 Caff Ac - 0.8±0.0 
12 9.8 314 325 265, 235, 163 Coum Hex - 0.3±0.0 
13 11.8 311 337 191, 163 Coum Quinic Ac D 0.2±0.0 
14 12.8 287sh, 324 367 173, 191 Fer Quinic Ac - D 
15 13.0 309 225 207, 181, 165, 163 Coum Ac Der 1.8±0.1 - 
16 13.1 291sh, 311 637 351, 285, 193 Ferulic Ac Der - 0.5±0.0 




447 327, 357 Lut-C-Hex - 3.2±0.02 
19 14.7 274 571 527, 509, 553, 483, 285 YA E (isom1) - 4.5±0.2 
20 15.0 235, 277 539 297, 359, 377, 279, 315 YA D/isomer - 3.9±0.3 
21 15.2 268, 336 431 311, 341, 269 Api-C-Hex - 5.9±0.6 
22 15.6 285, 315 555 409, 391, 537, 511, 365 SA K - D 
23 15.8 255, 350 
463 301 Querc-O-Hex 14.6±0.3 - 
593 285 Lut Rut D - 
24 16.1 255, 266, 345 461 285 Lut-7-O-GlcA - 15.8±0.02 
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25 16.5 274 571 527, 409 YA E (isom2) - 1.0±0.08 
26 17.6 268, 336 575 431, 341, 311, 513, 413 Api Hex HMG - 6.3±0.02 
27 17.9 283 719 359, 539, 521, 341 Sag Ac (isom1) D 2.1±0.08 
28 18.1 269, 329 431 269 Api-O-Hex - 16.7±0.05 
29 18.3 238, 341 607 299, 284 Chrys-O-Rut D - 
30 18.4 267, 337 445 269, 175 Api-O-GlcA - 2.2±0.01 
31 18.6 270, 291, 326 717 555, 519, 475, 357 SA B (isom1) - D 
32 18.7 284, 330sh 609 301 Hesperidin 41.3±2.2 - 
33 19.0 290sh, 328 359 161, 179, 197, 223 RA 56.8±0.6 17.8±0.1 
34 19.5 285sh, 305 537 493, 295 CaffRA (isom1) - 1.0±0.04 
35 19.8 278 719 521, 341, 359 Sag Ac (isom2) - 2.2±0.02 
36 20.2 290sh, 333 537 493, 359, 375 
CaffRA/ SA I 
(isom2) 
D - 
37 20.6 267, 336 517 269, 473 Api malonyl Hex - 2.5±0.03 




39 21.8 290 491 163, 329, 119 Coumaric Ac Der 0.5±0.01 - 
40 22.4 281, 330sh 717 537, 357 SA B (isom2) 6.6±0.4 - 
41 23.7 199, 229, 287 361 299, 269, 281, 213, 343 Sageone Der 174.1±14.1 - 




345 301, 271, 283 Rosmanol 192.4±17.1 - 




45 25.7 286 329 285 Carnosol 17.3±0.7 - 
46 26.3 262 331 287 Carnosic Ac 14.3±0.7 - 




     Total 643.3±18.9 102.1±0.7 
*Values expressed as mg/g of extract; NF- Number of peak represented in Figure 1; D- Detected; Ac- acid; Api- 303 
Apigenin; BA- Benzoic acid; CaffAc- Caffeic acid; Caff- Caffeoyl; CQA- Caffeoylquinic acid ; Chrys- Chrysoeriol; 304 
Coum- Coumaroyl Der- Derivative; Fer- Feruloyl; Glc- Glucoside; GlcA- Glucuronide; Hex- Hexoside; HMG- 3-305 
hydroxy-3-methylglutaroyl; Hy - hydroxy; Lut- Luteolin; Pent- Pentoside; Protoc- Protocatechuic; Querc- 306 
Quercetin; Rut- Rutinoside; RA- Rosmarinic acid; Sag- Sagerinic; SA- Salvianolic acid; Scut- Scutellarein; YA- 307 
Yunnaneic acid. 308 
 309 
 310 
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 311 
Figure 1. Chromatographic representation of Salvia decoctions at 280 nm: (a) S. apiana; (b) S. farinacea 312 
var. victoria blue. Numbers in the figure correspond to the UHPLC-DAD-ESI-MSn peaks described in 313 
Table 4. 314 
Thus, our study suggests that the high bioactivity of S. apiana decoctions is associated with its 315 
fertility in phenolic components, namely flavonoids and terpene derivatives. In fact, the diterpene 316 
rosmanol (the most predominant compound in S. apiana extract) and its derivatives have previously 317 
been associated with the high antioxidant potential of S. officinalis [42,43] and the cytotoxic activity of 318 
several other Salvia plants [8]. In addition, sageone is an abietane diterpenoid previously reported in 319 
S. apiana species [17] that has already been described to exert antiviral activity [8]. Moreover, others, 320 
including carnosol and carnosic acid, are claimed to exert several biological properties, including 321 
lipase inhibitory activity [44], antioxidant, antimicrobial, anti-inflammatory and antitumoral 322 
[42,43,45]. Naturally, the possible contribution of other components of the extract, including 323 
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cirsimaritine, which have already been considered relevant in the antibacterial and antioxidant 324 
activities of Salvia species [9], should not be overlooked [8,43]. 325 
4. Conclusions 326 
The antioxidant, anti-inflammatory, cytotoxic and antibacterial properties of S. apiana and S. farinacea 327 
var. victoria blue decoctions were reported in the present work, allowing to conclude that both have 328 
potential bioactive effects, which were extremely promising in the first, particularly with regard to 329 
counteract key events in oxidative stress, showing EC50 values of 2.79 μg/mL and 41.2 μg/mL in 330 
TBARS and β-carotene bleaching assays, respectively. Decoction of S. apiana had also an effect on the 331 
suppression of inflammatory events, since it displayed a third of the potency of the drug 332 
dexamethasone on the inhibition of NO● production by LPS-activated RAW 264.7 macrophages. In 333 
addition, this decoction was selective for tumors, exhibiting cytotoxic capacity in cancer cell lines 334 
with low cytotoxic effect in normal cells. As well, it exerted inhibitory and lethal potential against 335 
five bacteria (MIC and MBC equal or below to 0.69 and 2.75 mg/mL for Gram-positive and Gram-336 
negative bacteria, respectively). Possibly, the great bioactive potential of this decoction might be 337 
partially associated to its high levels in phenolic compounds (643.3±18.9 μg/mg), particularly in 338 
terpene compounds mainly rosmanol, a derivative of sageone and hydroxycarnosic acid. In turn, 339 
although promising, the bioactivity of S. farinacea was in general significantly lower than that of S. 340 
apiana, and also contained modest levels of phenolic compounds (102.1±0.7 μg/mg) comprises 341 
moderate quantities of rosmarinic acid and glycosidic forms of the flavones apigenin and luteolin. 342 
The promising biological activities of S. apiana and S. farinacea var. victoria blue species herein found 343 
through in vitro methods suggest that decoctions of these species, and particularly that of S. apiana, 344 
might be useful for the application in the food and pharmaceutical industry, although their health-345 
promoting potencies need to be further proved in vivo and pre-clinical studies.  346 
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First conclusion: The Salvia and Thymus decoctions focused in this study contained 
relevant amounts of phenolic compounds, in particular of phenolic acids and flavonoids. 
Those of six thyme origin were mostly rich in caffeic acid derivatives, namely in 
rosmarinic acid and caffeoyl rosmarinic acids. These compounds were particularly 
relevant in T. pulegioides and T. fragrantissimus extracts (rosmarinic acid accounting for 
about 81 mg/g extract). Moreover, some extracts contained considerable amounts of 
flavones, namely isomers of luteolin-O-glucuronide, particularly in T. pseudolanuginosus 
and T. pulegioides (54 and 26 mg/g extract, respectively). 
The eight sage decoctions were also rich in rosmarinic acid, being the maximum amount 
found in S. africana (77.0 mg/g extract). Other caffeic acid derivatives were present in 
abundance in some sage species, namely caffeoylrosmarinic acid and salvianolic acid B 
(in S. elegans) and yunnaneic acid derivatives (in S. africana). The majority of Salvia 
species showed also moderate to high percentages of glycosidic flavones, in particular 
of luteolin-O-hexoside and apigenin-C-hexoside (in S. greggii) and apigenin-O-hexoside 
and luteolin-O-glucuronide (in S. farinacea var. victoria blue), with overall concentration 
in the range 16 to 26 mg/g extract. In addition, S. officinalis and its cultivar S. officinalis 
‘Icterina’ were characterized by high abundancy of the O-hexuronic form of apigenin (48 
and 34 mg/g extract respectively) and scutellarein. S. mexicana decoction was the 
poorest in phenolic compounds, while S. apiana was particularly rich in phenolic 
terpenes, mainly in rosmanol, a derivative of sageone and in hydroxycarnosic acid (192, 
174 and 70 mg/g extract, respectively). 
Second conclusion: The six Thymus decoctions possessed high antioxidant activity as 
determined by the two chemical assays, DPPH● scavenging and ferric reducing power. 
Based in these two methods, T. pulegioides decoction was the most effective extract 
(EC50=9.5 and 30.7 μg/mL, respectively), opposing to that of T. caespititius origin 
(EC50=13.8 and 39.3 μg/mL, respectively). In addition, T. herba-barona, T. 
pseudolanuginosus and T. caespititius aqueous extracts evaluated by β-carotene 
bleaching assays, presented clearly different results, because β-carotene was inhibited 
only by T. pseudolanuginosus and T. caespititius (EC50=2.4 and 6.1 μg/mL, respectively), 
while T. herba-barona was ineffective. 
Concerning the eight Salvia decoctions targeted in this study, these also possessed high 
antioxidant activity, as estimated by distinct methods. Based in the DPPH● assay, S. 
africana, S. mexicana, S. officinalis ‘Icterina’ and S. elegans showed promising results 
(EC50= 6.6-10.7 μg/mL), while S. africana, S. elegans and S. mexicana (EC50= 21-34 
μg/mL) were more promising with respect to the ability to reduce Fe3+. 
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Among the three plants S. officinalis, S. elegans, and S. greggii, decoctions of S. elegans 
had the highest antioxidant potential for NO● and O2●– tests, while S. officinalis was the 
most potent in xanthine oxidase and showed slightly better results in ORAC assay. In 
respect to lipid peroxidation events, S. apiana decoction presented superior antioxidant 
capacity than that the other sage species (EC50= 2.8 and 41 μg/mL in TBARS inhibition 
and -carotene bleaching assays, respectively). 
Third conclusion: Among T. herba-barona, T. pseudolanuginosus, and T. caespititius 
decoctions, that of T. caespititius revealed the highest anti-inflammatory potential, 
showing high ability to scavenge NO● and to inhibit the activity of LOX (EC50= 230 and 
591 μg/mL, respectively). 
In addition, as evidenced in LPS-activated RAW 264.7 macrophages, Salvia decoctions 
were able to decrease the production of NO● in the order S. africana and S. apiana 
(EC50= 48 and 50 μg/mL, respectively) > S. officinalis ‘Icterina’ > S. mexicana > S. 
farinacea var. victoria blue. 
Fourth conclusion: All the Thymus and Salvia decoctions also exhibited a relevant 
antibacterial effect against a panel of five bacteria, with promising results observed 
towards Gram-positive bacteria, especially S. aureus (MIC and MBC values between 0.6 
and 6 mg/mL, respectively). Concerning Gram-negative bacteria, decoctions of S. 
apiana, S. officinalis ‘Icterina’, S. africana, T. zygis and T. herba-barona presented 
inhibitory and lethal activities against S. typhimurium, with the lowest MIC and MBC 
values (3 to 5 mg/mL). T. herba-barona, T. pseudolanuginosus and T. caespititius 
inhibited the growth of Gram-negative bacteria E. coli and P. aeruginosa (MIC= 5 to 7 
mg/mL), while S. apiana, S. officinalis ‘Icterina’, S. officinalis, S. elegans and S. mexicana 
presented inhibitory and lethal capacity towards these strains (both MIC and MBC values 
of 2.8, 7.5, 8.0, 8.5 and 9.5 respectively). 
Fifth conclusion: S. apiana, S. farinacea var. victoria blue, S. africana, S. officinalis 
‘Icterina’ and S. mexicana decoctions exhibited cytotoxicity activity towards tumoral cell 
lines, particularly hepatocellular HepG2, cervical HeLa and breast MCF-7 carcinoma 
cells. The anti-proliferative activity of these extracts were tumor-selective, as evidenced 
by comparatively low GI50 values in the cancer cell lines (41-89 μg/mL) to those of non-
tumor liver cells (297 - 362 μg/mL). Overall, these sage extracts have less cytotoxic effect 
to non-small lung cancer NCI-H460 cell line. 
Sixth conclusion: Decoctions of S. elegans, S. officinalis and S. greggii presented were 
active against key digestive enzymes of relevance diabetes and obesity. S. elegans 
displayed the best ability to counteract α-glucosidase activity, followed by S. officinalis 
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and S. greggii. Possibly, this activity might be correlated to its richness in caffeic acid 
and its derivatives.  
Seventh conclusion: Aqueous extracts of T. zygis, T. pulegioides and T. 
fragrantissimus have important nutritional value, being particularly distinguished for their 
high K+/Na+ ratio, richness in polyunsaturated fatty acids and low omega-6/omega-3 fatty 
acids ratio, which are valuable features of a healthy diet. 
Global conclusion: 
Salvia and thymus decoctions are good sources of phenolic compounds, mostly phenolic 
acids and flavonoids. The results highlighted the biological activities of the plant extracts 
under study, including antioxidant, anti-inflammatory and antibacterial properties. In 
addition, the cytotoxic effects against tumor cells, the metabolic enzyme activity and the 
nutritional composition of some sage and/or thymus species emphasizes their potential 
utility for the development of new agents, with application in pharmaceutical and/or food 
industries. 
 
